<SEC-DOCUMENT>0001040130-23-000013.txt : 20230207
<SEC-HEADER>0001040130-23-000013.hdr.sgml : 20230207
<ACCEPTANCE-DATETIME>20230207172615
ACCESSION NUMBER:		0001040130-23-000013
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		47
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230207
DATE AS OF CHANGE:		20230207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28827
		FILM NUMBER:		23596173

	BUSINESS ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
		BUSINESS PHONE:		(561) 426-4444

	MAIL ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>pets-20221231.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:66cb9e58-a04f-48d4-a0bc-a601d74b20f7,g:93132296-a4cf-4603-975d-122774d1cfdf,d:7a10caab6f5047e1a02f0366bdb90d7a--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:pets="http://www.1800petmeds.com/20221231" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pets-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80L2ZyYWc6NWYxMWIxZTFmZmMzNGI2NjhlZGY2ZDVmNDgzNDNlZTkvdGFibGU6ODhlZWE0MWU4MzU0NDNjZWI4ZTM2NWViOGIzZmY5NjAvdGFibGVyYW5nZTo4OGVlYTQxZTgzNTQ0M2NlYjhlMzY1ZWI4YjNmZjk2MF8yLTEtMS0xLTE0NTg0_48dec86a-9f0d-4037-b535-a8a71ad25060">0001040130</ix:nonNumeric><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80L2ZyYWc6NWYxMWIxZTFmZmMzNGI2NjhlZGY2ZDVmNDgzNDNlZTkvdGFibGU6ODhlZWE0MWU4MzU0NDNjZWI4ZTM2NWViOGIzZmY5NjAvdGFibGVyYW5nZTo4OGVlYTQxZTgzNTQ0M2NlYjhlMzY1ZWI4YjNmZjk2MF8zLTEtMS0xLTE0NTg0_fc397cb3-acc5-4bdb-8374-e5da350a9fac">--03-31</ix:nonNumeric><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80L2ZyYWc6NWYxMWIxZTFmZmMzNGI2NjhlZGY2ZDVmNDgzNDNlZTkvdGFibGU6ODhlZWE0MWU4MzU0NDNjZWI4ZTM2NWViOGIzZmY5NjAvdGFibGVyYW5nZTo4OGVlYTQxZTgzNTQ0M2NlYjhlMzY1ZWI4YjNmZjk2MF80LTEtMS0xLTE0NTg0_a2d5f9ca-0dd6-4998-8fae-4311b596e951">2023</ix:nonNumeric><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80L2ZyYWc6NWYxMWIxZTFmZmMzNGI2NjhlZGY2ZDVmNDgzNDNlZTkvdGFibGU6ODhlZWE0MWU4MzU0NDNjZWI4ZTM2NWViOGIzZmY5NjAvdGFibGVyYW5nZTo4OGVlYTQxZTgzNTQ0M2NlYjhlMzY1ZWI4YjNmZjk2MF81LTEtMS0xLTE0NTg0_e0a371d6-578d-42b7-8496-3249a9eced37">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80L2ZyYWc6NWYxMWIxZTFmZmMzNGI2NjhlZGY2ZDVmNDgzNDNlZTkvdGFibGU6ODhlZWE0MWU4MzU0NDNjZWI4ZTM2NWViOGIzZmY5NjAvdGFibGVyYW5nZTo4OGVlYTQxZTgzNTQ0M2NlYjhlMzY1ZWI4YjNmZjk2MF82LTEtMS0xLTE0NTg0_de9eab6a-f5c3-41f4-ac12-f1df422d6fc8">false</ix:nonNumeric><ix:nonNumeric contextRef="i8c2ce15d936e45dd931cb405b5d2ef93_D20220401-20221231" name="pets:RestrictionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfNjgz_191b9281-4145-40ce-abe4-217b2cb8eccc">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ib29dce32b1424514860c1e7e96b95363_D20220401-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjk2OQ_1aaf0ccb-d1a0-41ef-bb85-02c3837aae7b">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pets-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6ac52f3534e4298b31908c876c060eb_I20230207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i137fc368100c4411981905d28135f59f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="iaf36910fa826464cac0a33af2dcec06b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67ee1fba64a441af905ddeb1f446539b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd375a412244dc48910945ff35d18c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bcec245ba8f4bca88ec8b71bb599cdf_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i65bde03e5d464408a705348a0a0f41cc_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if68375ef4a7542af96e74af2ada80410_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f0f687e16e445ef9491c6c0fccac673_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8150fab077f042849b44c3d66cd1be01_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8424940f0f714f6bb29ebc7cef78ee72_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e261220a35145458a0bb7962680a283_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5c88edd5dd84e9abd3087efd2f42496_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c58fb706aaa4b1e98d81a7a0bfea1a7_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaadbc1c61234f73a3bb5e185c89cf4c_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0e4320425bc46a0a1fea6b2994f5d9f_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dff8f4be4934a6c8be36b9f8a2211ba_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if63c295485f4407fa7e066bf30570500_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2bc6f8fae324212a7cadd450f94abe5_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4c9b15003614ac8a3226d1f0a7f6ee0_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85db176f3142452d8eb6189c15ae2cd2_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8877e07cd58945f6bbc7b58579686efe_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f7d9324da564d5386147bd5643fe51f_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a6c5dc1cfd04bad979e42463356b32b_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41a9cc96267d4f77b87be8a4fba4c3c2_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad23aff6e73f4936ae99c55a2a704298_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaf0a8da7b2e4c5bb6b4975bba8d57ca_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fe4a15e0e42437d808ed2840f2e171f_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37ab1b450b194b00bf3e03586f0f9a1f_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7fa3fa4a984a9283d58153706677c9_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">pets:SharesIssuableUponVestingOfRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fd0d3f40e08458eb598ab1db5019057_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad28657a6a0b4952ba10608b59c49e38_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f5c94e1389f4483aa7c73b4b9c00e93_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c2ce15d936e45dd931cb405b5d2ef93_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b31dfb51bb44783b638d191bbc7a980_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7442254753449318736ecb33c3c2b59_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d8b91f663f3474c99076e130bb65446_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e6712ee77de4a729affbf86d32800d4_D20220803-20220803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-03</xbrli:startDate><xbrli:endDate>2022-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i974cd15bc1f84107b36c802dfb84787d_D20220803-20220803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-03</xbrli:startDate><xbrli:endDate>2022-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d506cc607c04a3ebf6a185593e1dc41_D20220803-20220803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-03</xbrli:startDate><xbrli:endDate>2022-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d5cbb72af874387884242be4246de02_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe371187742843408787486f68f274b3_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida28de54333842baae92c105ccb153e2_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53207e2d9eb14013aa52bab22358b457_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97cda5016db34ee48cec4f2f8a6755f2_D20210401-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a336deb41434c5ea068a787ed8d62e9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bdd189cee1942858b848f337aac4919_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib29dce32b1424514860c1e7e96b95363_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i802698039a084839a3f7f1d98357ba6e_D20220401-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ed1086383e343e69ff226fd59a926d5_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic43fa5ecc4024171ad3cc5adcab3dead_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5c6583bec134c2b919d20f2ac9ffdd8_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i436e706c942c451990e2aa84cb93940f_D20220701-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i864561553fdf4df0ac1140a600d033a4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46fd83d710f74df093e8b4c8bcb39594_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc9aeeb29c4742208591d84ff5c3f38f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3726f4e149f4c17892e094ff0d250d3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a965f8b26994fc58ac8950bbd13c3d8_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90c28b24bd8c465fba8956a43b6b42ba_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifca299ce29fa401f9edd0c4cc2d16abb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6e858548b03478893794331fd102d06_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6e22b4c43d942b8968fdc0f92828472_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc4d4debbecb42c6a5c7bf76f83cfd04_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if04a59c0e21b4165abb829478afa536e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0616732cc964c29af2566aecd430715_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib30acdba9294412b8455cee53c346bbc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49e30612ead546a68ffa3cc45d3f0c77_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46d17e7cf38c48cca155dcb2ddb012cc_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae5e3adc0e244df78831aead28031b7c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedd0a502d0114c6b9a8e7b297688cbcf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28a4779f6fab4613b28885ae9cac19e6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7ae2226e077465abd6ae8cf00b6f532_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i562c11f99bb548b69e78e029f0d65860_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1dae6dbb35c4a6da152924d34b0365d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc4da35a89ae49178deb59c2d6bb3d07_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ffa3d3f184241dabcf76d81522ac2d2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfb6fe66922848658885a8bc6e9481e9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35f0d7d912c3464e849f72990a167356_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5acf5cd16dff4f088c9398f33c3cddca_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c67a17e20334c189d487ee28cf75bf1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9a920eeb13942fe81148b446dcc66cf_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i128c8af1cec14be1ae200b38a29fd0a9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic12b54a9ab4242d5a1dca7c82eba46df_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d10742b5f544f5594cb0909107de875_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75d4eab0c05241e793a7d11cdc5e2f2a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88fc8739d1ab480e97d26ea983b689de_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26b4c5393a8c4e5092769bb380417953_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6f47c348e3745359b8952cad7998881_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3794039ab2794369b1521e3a036acaab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6978944526c3459c9248ffc7c6ca9745_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab14d6c222714d4fa9eeef808f9de70c_D20220419-20220419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pets:PartnershipAgreementWithVetsterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-19</xbrli:startDate><xbrli:endDate>2022-04-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i443214d583e24ab29051706bdba05419_I20220419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pets:PartnershipAgreementWithVetsterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba0d1147b871412bb5ee913ee43a4458_D20230113-20230113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pets:PetCareRxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-13</xbrli:startDate><xbrli:endDate>2023-01-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i193309c747ed4183bc1fc06e289d1aba_D20230206-20230206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">pets:QuarterlyDividendMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-06</xbrli:startDate><xbrli:endDate>2023-02-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if721328002364681bee1ba0655718256_I20230207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">pets:QuarterlyDividendMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5ac5ca2e988435eaad69a43bc5b154f_D20230101-20230207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-02-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7ef6fce92814d58987c014afa0ebf0d_D20230101-20230207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:MZHCILLCInvestorRelationsConsultingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-02-07</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDMz_f4fceead-bd85-4666-b368-ae76263f5aff">10-Q</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDM0_de410e5a-065b-4cc3-9af4-79400624b6ce">x</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV81NDk3NTU4MTYzNTg_bc921079-9132-4a95-98bf-0ae3154a8953">December 31, 2022</ix:nonNumeric> </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDI2_05d3c155-dac6-46dc-b23e-99c694481f90">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from _____________ to _____________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDEx_f5711434-0c2b-47d7-b6b5-e93a774e4977">000-28827</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDI0_07a79f8c-0248-44c6-bd95-61c4d40d9893">PETMED EXPRESS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MjAwMGJhYTNhMTZhNDAxNmIyNjk2MjViM2MyM2NmNzIvdGFibGVyYW5nZToyMDAwYmFhM2ExNmE0MDE2YjI2OTYyNWIzYzIzY2Y3Ml8wLTAtMS0xLTE0NTg0L3RleHRyZWdpb246OTM0YmNjZjA3MDRhNGU0ZThlODkwODRmN2I5OGViZGZfNA_72d9f488-dc98-4243-b200-b9f1597a0dc1">FL</ix:nonNumeric>ORIDA</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MjAwMGJhYTNhMTZhNDAxNmIyNjk2MjViM2MyM2NmNzIvdGFibGVyYW5nZToyMDAwYmFhM2ExNmE0MDE2YjI2OTYyNWIzYzIzY2Y3Ml8wLTEtMS0xLTE0NTg0_62750e04-aa6c-4e7e-a032-146196152943">65-0680967</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDE5_cde2c359-2993-4380-9bb6-1cc0ff84ae8c">420 South Congress Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDEy_a1602d3c-ed1b-413e-90df-b8fb51144360">Delray Beach</ix:nonNumeric>, <ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDE2_827d0fa6-2255-4a7f-b2db-92a52e27b52f">Florida</ix:nonNumeric> <ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDI5_7a626688-0e4a-4ab1-81c3-cee07e9cc54d">33445</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV82MTc_15cd978b-aeee-41f0-836f-44bf1c052d67">561</ix:nonNumeric>) <ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDE3_15dcfe16-bf3e-48b5-bbd1-8b9f62afa5ce">526-4444</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MzNmNDBmMmJhYzFkNDYyZjgyNjE4Yzk1OGM4ODA1YmMvdGFibGVyYW5nZTozM2Y0MGYyYmFjMWQ0NjJmODI2MThjOTU4Yzg4MDViY18xLTAtMS0xLTE0NTg0_547e83d4-15a6-4a14-85e1-779b0d731ce8">Common Stock, par value $.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MzNmNDBmMmJhYzFkNDYyZjgyNjE4Yzk1OGM4ODA1YmMvdGFibGVyYW5nZTozM2Y0MGYyYmFjMWQ0NjJmODI2MThjOTU4Yzg4MDViY18xLTEtMS0xLTE0NTg0_b8b539a9-aad5-4dc9-bfca-228a0336314e">PETS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MzNmNDBmMmJhYzFkNDYyZjgyNjE4Yzk1OGM4ODA1YmMvdGFibGVyYW5nZTozM2Y0MGYyYmFjMWQ0NjJmODI2MThjOTU4Yzg4MDViY18xLTItMS0xLTE0NTg0_876a6bb9-2d64-42aa-8e81-8b76859e919e">NASDAQ Global Select Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDMw_2d56fd86-b776-4c7e-a0c1-dd7ee9517aab">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDI4_a42268a0-9e87-4c47-8dc7-91757a3d2236">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Large accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:114%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MTY2MzZhMmFlNGRiNDk3NThmMjg4MTI1NTgzYmVkODMvdGFibGVyYW5nZToxNjYzNmEyYWU0ZGI0OTc1OGYyODgxMjU1ODNiZWQ4M18wLTEtMS0xLTE0NTg0L3RleHRyZWdpb246MDhkNTI1Yzk4Yjk2NGQ4Njk2OGU1MWIwZDBiOWJmZWNfNA_8a917157-825c-4061-8079-e9f38346de7c">Accelerated Filer</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:114%">x</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:114%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MTY2MzZhMmFlNGRiNDk3NThmMjg4MTI1NTgzYmVkODMvdGFibGVyYW5nZToxNjYzNmEyYWU0ZGI0OTc1OGYyODgxMjU1ODNiZWQ4M18xLTEtMS0xLTE0NTg0_72858b0d-c560-4295-b291-1b7e25a5f6ff"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Smaller reporting company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:114%">o</span></ix:nonNumeric></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:54pt;text-align:justify"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MTY2MzZhMmFlNGRiNDk3NThmMjg4MTI1NTgzYmVkODMvdGFibGVyYW5nZToxNjYzNmEyYWU0ZGI0OTc1OGYyODgxMjU1ODNiZWQ4M18yLTAtMS0xLTE0NTg0_9bbbd1c8-df29-4ad3-b176-e25636e57736"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:114%">o</span></ix:nonNumeric></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (defined in Rule 12b-2 of the Exchange Act).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDMx_b90c78a5-a091-4776-918b-4cfa79726791">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date: </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ib6ac52f3534e4298b31908c876c060eb_I20230207" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yMzUy_dfaaa850-e276-43c8-83c6-b696d2d22791">21,084,277</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of Common Stock, $.001 par value per share, at</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> February&#160;7, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_10"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. FINANCIAL STATEMENTS.</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_13"></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except for per share amounts)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNS0xLTEtMS0xNDU4NA_d666bbbe-9a2f-4915-a5e7-47d4b06a6241">102,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNS0zLTEtMS0xNDU4NA_9dd32fc0-0ebc-48c1-8ad5-556d2e6dfaeb">111,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, less allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNi0wLTEtMS0xNDU4NC90ZXh0cmVnaW9uOmY2ZDcyYTUyNzFiYjQ4MDQ4MGViNDE2YWNkYmMxZTY4XzY1_0e59d75a-0c6d-4753-b2d9-90d715eeaa30">40</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNi0wLTEtMS0xNDU4NC90ZXh0cmVnaW9uOmY2ZDcyYTUyNzFiYjQ4MDQ4MGViNDE2YWNkYmMxZTY4Xzcy_278cec95-a0b8-418e-a2e4-6807891e05a7">39</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNi0xLTEtMS0xNDU4NA_ee3eedf6-4aee-4567-be89-23351f9e482a">1,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNi0zLTEtMS0xNDU4NA_938ce329-226b-4133-9677-b28d2f2b69a7">1,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories - finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNy0xLTEtMS0xNDU4NA_fabe07ab-bb8e-4758-b40c-c0cf060bc6fb">22,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNy0zLTEtMS0xNDU4NA_c70d16ee-4960-4ac7-ac6e-54ff9fa5f690">32,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfOC0xLTEtMS0xNDU4NA_bbade7da-700c-43da-8c19-3a228c77d6ee">5,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfOC0zLTEtMS0xNDU4NA_53d9db52-a7e5-44c6-b9c5-b9f3be03ebea">4,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfOS0xLTEtMS0xNDU4NA_a7c5d370-11b9-406c-ac7a-b04f1cabf2b3">1,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:PrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfOS0zLTEtMS0xNDU4NA_e8726d9c-a5e2-4b1c-b250-2c6020d1425c">681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTAtMS0xLTEtMTQ1ODQ_ca06ded0-a763-4676-9f46-217a4b2ed561">134,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTAtMy0xLTEtMTQ1ODQ_b90fa5ed-d253-43c5-98af-cf64a9cc682f">150,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncurrent assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTMtMS0xLTEtMTQ1ODQ_9494c33b-271e-481a-ac44-ea9952503642">25,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTMtMy0xLTEtMTQ1ODQ_682ffe21-391e-4eda-a07f-c773260c72ce">24,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="pets:IntangibleAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTQtMS0xLTEtMTQ1ODQ_33e993f9-6ec3-4ea6-9621-c7da235d0c03">5,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="pets:IntangibleAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTQtMy0xLTEtMTQ1ODQ_6158933e-eb00-41ef-8a8b-d27222e1e0e2">860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTUtMS0xLTEtMTQ1ODQ_3554c312-3304-4198-af6d-a4676caf3293">31,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTUtMy0xLTEtMTQ1ODQ_847034eb-1c94-4ee0-acb1-c13d2c20ff0b">25,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTctMS0xLTEtMTQ1ODQ_7f3c0502-2c71-40fc-9487-544c1ef06d32">165,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTctMy0xLTEtMTQ1ODQ_c8b74892-a8f2-4a09-9ef9-42b1e5b9b806">176,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LIABILITIES AND SHAREHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjItMS0xLTEtMTQ1ODQ_80ee1361-3da5-4b15-9fc2-b4cd2ce6dbf3">24,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjItMy0xLTEtMTQ1ODQ_72121eff-b528-4cb5-8324-de72ed92cc83">27,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="pets:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjMtMS0xLTEtMTQ1ODQ_d76d6fbe-624c-4454-a0dc-1383ba206bc0">6,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="pets:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjMtMy0xLTEtMTQ1ODQ_4dae2074-c292-4101-bddb-1f70f628bf31">5,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjQtMS0xLTEtMTQ1ODQ_bcd8fd66-9023-4e4b-b5cd-111c3df180bc">31,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjQtMy0xLTEtMTQ1ODQ_08399a16-612a-4e03-af15-6e6e6a9e436e">33,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjYtMS0xLTEtMTQ1ODQ_dc9a483d-9d22-4512-90a7-a13a862d9334">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjYtMy0xLTEtMTQ1ODQ_731f1a7f-7b29-481f-b741-16d28cdd988f">936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjgtMS0xLTEtMTQ1ODQ_afdcf30a-b0ea-48ab-ba39-8329b4c9c87e">31,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjgtMy0xLTEtMTQ1ODQ_47f88042-dd17-420e-bca6-4fcf971d52e6">34,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzAtMS0xLTEtMTQ1ODQ_5ae494ec-1a16-4775-9bb9-e676706a8a0e"></ix:nonFraction>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzAtMy0xLTEtMTQ1ODQ_751b8568-c5ba-481e-befc-8b23caa1ecbc"></ix:nonFraction>&#160;</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM18yMQ_51c0cbc9-0fa8-4183-9066-238a40a6ef38"><ix:nonFraction unitRef="usdPerShare" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM18yMQ_5877a793-9884-40dd-ab58-eb96760a67b8">.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM18zNQ_1b62b5b7-40ac-405b-9938-b7c139166d7f"><ix:nonFraction unitRef="shares" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM18zNQ_26cab3e0-4e80-4dfa-82f2-0759009b4366">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM181Nw_102e597e-95fa-42a0-93c3-e908e4c28d03"><ix:nonFraction unitRef="shares" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM181Nw_16da285a-2af6-4c93-8bae-7efba404ecb5"><ix:nonFraction unitRef="shares" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM181Nw_4fbf3d18-7c12-45f7-b85d-f57862c629b1"><ix:nonFraction unitRef="shares" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM181Nw_f14dd083-cd1d-4b99-86e3-755d86a44723">3</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> convertible shares issued and outstanding with a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM18xMzU_8e2f02f7-b3a4-4019-9b80-c7888de3b507"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM18xMzU_e4b63587-98b5-48b5-b648-14fa74d261cb">4</ix:nonFraction></ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMS0xLTEtMTQ1ODQ_cda48314-8520-41f9-b1f7-6634b26aac9c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMy0xLTEtMTQ1ODQ_5dd23073-8323-485d-9e34-676627ea413c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl8xOA_9322711f-663f-4b94-b490-dd179d5f432f"><ix:nonFraction unitRef="usdPerShare" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl8xOA_ef1d3ab4-c442-46ae-bc28-10c6135f7a95">.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl8zMg_2099cb68-44a7-4a69-b932-95bdaadac26c"><ix:nonFraction unitRef="shares" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl8zMg_3b4f2a55-f9be-4d17-a76b-167436e28d7a">40,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl81NA_2e73a370-97f5-4cbf-9d20-ad72a818e1f1"><ix:nonFraction unitRef="shares" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl81NA_f86c78c8-96cd-402c-88c1-df71441b43cc">21,077</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl82MQ_28054368-16bf-4021-b53f-b8e1f4c59b66"><ix:nonFraction unitRef="shares" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl82MQ_53547a62-f469-4281-a16d-0bf46ce5e106">20,979</ix:nonFraction></ix:nonFraction> shares issued and outstanding, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMS0xLTEtMTQ1ODQ_a3699ee5-4ccf-4ed8-9ccd-4e0e14b9b9a9">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMy0xLTEtMTQ1ODQ_9677d485-4b94-4b21-b971-b304f1dc6d00">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzUtMS0xLTEtMTQ1ODQ_5e99374c-4b00-4b0a-a6f5-f6840007c7c6">16,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzUtMy0xLTEtMTQ1ODQ_8b67314b-5d53-44bd-b49d-38373ca7e048">11,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzYtMS0xLTEtMTQ1ODQ_28fa31b5-c344-46e4-92d5-826a9fd09f74">116,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzYtMy0xLTEtMTQ1ODQ_7aa664db-7b85-43b5-bbdc-92e447baf7b6">130,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total shareholders' equity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzgtMS0xLTEtMTQ1ODQ_d367d3d6-97b6-4485-9f60-b4280b0f65d0">133,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzgtMy0xLTEtMTQ1ODQ_927090e6-5a7f-4acc-873d-ee19c4d66634">142,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities and shareholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNDAtMS0xLTEtMTQ1ODQ_d655d368-88b5-4569-bae1-002782e8f974">165,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNDAtMy0xLTEtMTQ1ODQ_2c4d2f1a-843a-45ef-99f6-2ed5b01c1736">176,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1</span></div></div></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except for per share amounts) (Unaudited)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMy0xLTEtMS0xNDU4NA_b0a66f67-57de-48ac-8b40-16af3fb8cc09">58,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMy0zLTEtMS0xNDU4NA_3cb72e4f-aa10-44af-87dd-c5e15592e7f1">60,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMy01LTEtMS0xNDU4NA_bdad8a87-8752-47a6-b873-e51bc9951838">194,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMy03LTEtMS0xNDU4NA_ef6662a1-732a-4e89-9700-2b53e73534ca">207,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNC0xLTEtMS0xNDU4NA_087e6fe2-c8e1-435f-acce-ac0a84fdc0de">43,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNC0zLTEtMS0xNDU4NA_c00f24fa-431b-44bd-a338-dee854464a76">42,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNC01LTEtMS0xNDU4NA_48c3444f-d7a4-4e96-bdaa-2e8ed572c014">140,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNC03LTEtMS0xNDU4NA_ceaa11ca-9a28-47f9-acfa-6848955f3fd5">148,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNi0xLTEtMS0xNDU4NA_302efe27-dfbb-4b45-8535-bdb0f4160bc2">15,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNi0zLTEtMS0xNDU4NA_7a00ccc7-1ba4-46e5-be70-8d88757c5ae5">17,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNi01LTEtMS0xNDU4NA_6d015052-db8d-456b-a8d6-c6fb49599a3b">53,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNi03LTEtMS0xNDU4NA_853dde09-8a6e-4f09-8cbb-cbf3c924f93d">58,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfOS0xLTEtMS0xNDU4NA_cedf6048-0897-4fa8-8cd5-24dfd6d740a2">10,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfOS0zLTEtMS0xNDU4NA_8e82a774-0736-4de1-b674-31a7e8505398">7,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfOS01LTEtMS0xNDU4NA_3ce6c0da-7863-4b73-9030-7928129ef490">30,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfOS03LTEtMS0xNDU4NA_6f660d6c-5963-4c64-9bb9-e9ce4182887b">22,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTAtMS0xLTEtMTQ1ODQ_3ad344a4-4d2b-4100-9181-98d97573f031">4,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTAtMy0xLTEtMTQ1ODQ_27b14d66-ef8b-469a-97ad-77735d4756ce">4,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTAtNS0xLTEtMTQ1ODQ_51d8ba4f-d42e-47ee-860b-cff55ae95e93">14,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTAtNy0xLTEtMTQ1ODQ_eab9b5ce-a4b7-4d86-b7b3-d93b04eed4d2">15,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTEtMS0xLTEtMTQ1ODQ_e6e2edd5-49fe-48a5-8d48-14f6e1d626d6">941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTEtMy0xLTEtMTQ1ODQ_4751d030-2c6a-4b91-af55-320358e06819">710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTEtNS0xLTEtMTQ1ODQ_14f032be-bf06-4c4b-9813-c1d2cc71343b">2,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTEtNy0xLTEtMTQ1ODQ_99a6892c-1a7d-4f22-abcd-a6143e98da56">2,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTItMS0xLTEtMTQ1ODQ_7b67faad-c784-483f-a589-d2c59ddcff03">16,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTItMy0xLTEtMTQ1ODQ_81104ee8-6c02-443b-9b3c-52f3f8c2a208">12,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTItNS0xLTEtMTQ1ODQ_a7f7551e-cd5b-462f-bf43-c88720991ae2">47,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTItNy0xLTEtMTQ1ODQ_f6040bbd-d3a3-480c-98ad-91362b8e27c6">40,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTQtMS0xLTEtMTQ1ODQ_ddd4dcbf-c0ff-41c9-b6c6-f5c2f874266a">769</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTQtMy0xLTEtMTQ1ODQ_168759d5-99c7-4bd5-b095-7864620d8b18">5,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTQtNS0xLTEtMTQ1ODQ_5dfbaf5d-4871-4bb6-8cf9-2d74b5c2cd62">5,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTQtNy0xLTEtMTQ1ODQ_5bbc11fa-04d0-4c4a-8e15-94fa8b60bc13">18,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTctMS0xLTEtMTQ1ODQ_1e46c926-427d-40fb-a085-823c190957c2">708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTctMy0xLTEtMTQ1ODQ_044fe8d4-d263-40a0-b78e-11509e93a469">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTctNS0xLTEtMTQ1ODQ_d70fbcd9-56e6-4bf4-b23d-ad061bba251d">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTctNy0xLTEtMTQ1ODQ_60e2751f-594a-4636-800f-2bbc65329e63">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTgtMS0xLTEtMTQ1ODQ_344d82bc-ca5b-4d85-a923-1bd61a0f54a6">259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTgtMy0xLTEtMTQ1ODQ_7d0b60e3-5149-4e32-a562-2af38b3f1804">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTgtNS0xLTEtMTQ1ODQ_06d477ea-4521-4727-9a21-4e0e9c576ee1">718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTgtNy0xLTEtMTQ1ODQ_98d7ab80-2427-40bc-839b-aad04fb3d682">741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTktMS0xLTEtMTQ1ODQ_3b9472cd-364c-49b8-bfc3-e6e9b7dc92f0">967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTktMy0xLTEtMTQ1ODQ_314be9f7-dd67-4cd7-b2af-94a97ee16885">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTktNS0xLTEtMTQ1ODQ_abbc1136-a4a0-47ad-8e53-d932d71c739c">1,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTktNy0xLTEtMTQ1ODQ_6cf2e6d4-d7ca-4ec8-9cec-10b82dfe5ece">984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjEtMS0xLTEtMTQ1ODQ_0b261518-a8bb-4c8d-adc2-4731ce546e9a">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjEtMy0xLTEtMTQ1ODQ_585faaa0-e300-48dc-8b58-b9d8deacc435">5,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjEtNS0xLTEtMTQ1ODQ_33a97415-a51e-413c-b5f6-a5d13500c51e">7,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjEtNy0xLTEtMTQ1ODQ_98a94899-f464-46e2-a277-c9572fda4a25">19,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjMtMS0xLTEtMTQ1ODQ_5b2dc46e-61a6-482f-a944-02d8bc144bb1">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjMtMy0xLTEtMTQ1ODQ_28303b5e-040c-4cc8-8f0b-93ee36ed35e1">1,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjMtNS0xLTEtMTQ1ODQ_dad521f2-d1e5-487b-91a9-c879b19e2879">2,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjMtNy0xLTEtMTQ1ODQ_78c6a888-07f2-4194-859c-675ab829f321">4,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjUtMS0xLTEtMTQ1ODQ_043b6e6d-6633-499d-8912-b7d738ee885e">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjUtMy0xLTEtMTQ1ODQ_b525be4b-69c9-4af5-a719-2c6f92ebe1fd">4,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjUtNS0xLTEtMTQ1ODQ_ff23c7ac-82be-4d72-aa5f-48436720b215">5,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjUtNy0xLTEtMTQ1ODQ_34e92726-6fb7-44a5-b66c-42df9402aeed">15,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjgtMS0xLTEtMTQ1ODQ_448e998f-4b29-45e0-8903-e8e0d572f5e5">0.00</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjgtMy0xLTEtMTQ1ODQ_108f83e3-d8c9-46eb-8b11-8da732e012db">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjgtNS0xLTEtMTQ1ODQ_17f48c72-a018-4cc4-b02d-0e2bf01b351e">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjgtNy0xLTEtMTQ1ODQ_2da201dd-7990-4153-812f-0c8401b111eb">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjktMS0xLTEtMTQ1ODQ_cf21bb57-a08c-4110-830c-36fe6ac19173">0.00</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjktMy0xLTEtMTQ1ODQ_c57a8352-ab3e-4d1a-a7e1-f8452ab67ba5">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjktNS0xLTEtMTQ1ODQ_e5291d45-f72e-4fa5-b667-e0e8c71e93d7">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjktNy0xLTEtMTQ1ODQ_ac83e7b5-5887-424c-9451-6e47f836a1f2">0.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average number of common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzItMS0xLTEtMTQ1ODQ_6c1139c8-cf52-4c15-8a54-fea37004cb04">20,301</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzItMy0xLTEtMTQ1ODQ_955a1157-6370-4ba5-8c8e-a922cd8c3915">20,208</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzItNS0xLTEtMTQ1ODQ_271c0d38-201d-48ab-a010-b52529d46f81">20,257</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzItNy0xLTEtMTQ1ODQ_1019072b-5782-4d3b-adaa-89c5e61005f0">20,165</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzMtMS0xLTEtMTQ1ODQ_ae347e7a-2529-44fe-bffb-d474e0e0cb02">20,301</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzMtMy0xLTEtMTQ1ODQ_082a0945-1dde-4b31-82d2-894d19c89ab2">20,329</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzMtNS0xLTEtMTQ1ODQ_f8638f61-03ea-4b95-aa90-7d55e84e8472">20,339</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzMtNy0xLTEtMTQ1ODQ_f3ae9640-4706-4235-ba9e-9fdb8bb71f10">20,365</ix:nonFraction></span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash dividends declared per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzUtMS0xLTEtMTQ1ODQ_5c58084f-9ac3-4ba8-be62-3ca1a9fc3ef3">0.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzUtMy0xLTEtMTQ1ODQ_fe2f767a-5733-470f-a428-fec7409f32a2">0.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzUtNS0xLTEtMTQ1ODQ_902594e0-337c-47ce-ae5e-b56568df0b04">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzUtNy0xLTEtMTQ1ODQ_4d54ec7c-9063-4c17-abfa-905403c2148b">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands) (Unaudited)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMy0xLTEtMS0xNDU4NA_5953bce9-2e76-466a-ac1c-84e958924da5">5,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMy0zLTEtMS0xNDU4NA_4978b123-7da6-42db-8d36-0d09b0de290e">15,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfNS0xLTEtMS0xNDU4NA_9f4919df-0262-4755-bf9b-3a3e1cdfb9ec">2,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfNS0zLTEtMS0xNDU4NA_be803e4b-46df-42bc-be39-5cb8d1cba64c">2,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfNi0xLTEtMS0xNDU4NA_e88ad683-3dce-479f-b801-4099664a8fd8">4,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfNi0zLTEtMS0xNDU4NA_d2d6509c-d842-411d-8a9c-a114b2a11d9c">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfNy0xLTEtMS0xNDU4NA_c5f951f3-39ac-48cb-8ff5-cc5aff79dc50">471</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfNy0zLTEtMS0xNDU4NA_b3da7465-0999-4266-b0f7-2a90e3188c39">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bad debt expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfOC0xLTEtMS0xNDU4NA_6f25c8a3-6b03-4117-aba4-6568af9a010d">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfOC0zLTEtMS0xNDU4NA_0c4c25df-8c4a-408d-b036-03899efe4c30">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Increase) decrease in operating assets and increase (decrease) in operating liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTAtMS0xLTEtMTQ1ODQ_b0dd75da-5b1a-43a1-a64d-202e0354517b">324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTAtMy0xLTEtMTQ1ODQ_57baec50-e285-4508-82be-b0d07c165a07">1,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories - finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTEtMS0xLTEtMTQ1ODQ_86b69901-e997-42bb-a16e-6fc6c97585bf">10,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTEtMy0xLTEtMTQ1ODQ_d00b1cb5-b6d8-496c-a4d2-8105d5344aec">6,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTItMS0xLTEtMTQ1ODQ_d1089286-e04a-4c60-8397-ba919547de29">927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTItMy0xLTEtMTQ1ODQ_42bdf411-cf98-4407-9a44-e5fbebc2c590">911</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTMtMS0xLTEtMTQ1ODQ_456bdb7b-6500-4750-b7a5-1ed3614e579c">771</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTMtMy0xLTEtMTQ1ODQ_9bce8acb-d942-4776-a699-fe7a57b20b66">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTQtMS0xLTEtMTQ1ODQ_045b7f60-e8b0-44b8-acd5-5ca19e03e84b">3,183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTQtMy0xLTEtMTQ1ODQ_c3208e8e-4c7b-4cc4-bae3-2b108f0baba4">17,613</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTUtMS0xLTEtMTQ1ODQ_5ad39f95-0e8f-4d38-94c9-02ffbf6eaa92">536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTUtMy0xLTEtMTQ1ODQ_0b507c9e-53b3-49d2-9c98-bcd94626e7aa">1,188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTYtMS0xLTEtMTQ1ODQ_518acc4d-ab5d-4f5a-aaf5-ea43e8904c45">18,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTYtMy0xLTEtMTQ1ODQ_9be8942d-590c-4366-9b54-61195f5c024e">9,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of minority interest investment in Vetster</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTktMS0xLTEtMTQ1ODQ_88372d9c-3963-443a-927a-6a26519b4a02">5,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTktMy0xLTEtMTQ1ODQ_f6b84028-ce91-402f-92a9-f689f67f0d13">-</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjAtMS0xLTEtMTQ1ODQ_435561e4-515a-4e15-b1d4-d06ab00ecc93">3,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjAtMy0xLTEtMTQ1ODQ_ecc6ea4a-e855-41e4-a116-eb1c40d378b6">1,266</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjEtMS0xLTEtMTQ1ODQ_7a3b52a0-f6fe-4990-95a8-4161d5362932">8,329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjEtMy0xLTEtMTQ1ODQ_4034f524-f0ca-462a-ab2b-2b3e2b2bc963">1,266</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjQtMS0xLTEtMTQ1ODQ_9e20c130-cff6-4fae-bad0-6fae4a3f5a95">18,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjQtMy0xLTEtMTQ1ODQ_2fec67c5-b4fc-4867-aceb-a1e563e88495">18,322</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjUtMS0xLTEtMTQ1ODQ_abcf961b-f15b-4243-a6be-0adab2854983">18,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjUtMy0xLTEtMTQ1ODQ_cae26aae-40ff-4263-b6e4-0451785c929b">18,322</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjctMS0xLTEtMTQ1ODQ_c9e008de-8849-470a-8725-e68e89de6a88">8,652</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjctMy0xLTEtMTQ1ODQ_315ea141-7818-4416-9def-989148882500">9,807</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents, at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjgtMS0xLTEtMTQ1ODQ_861783b7-9126-4106-8dee-6d2880997c20">111,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i67ee1fba64a441af905ddeb1f446539b_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjgtMy0xLTEtMTQ1ODQ_f9e8efa6-ea03-470b-b235-f052c2fa7bf2">118,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents, at end of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMzAtMS0xLTEtMTQ1ODQ_152d3ff1-7d6a-43c6-8b91-c28daaf5f617">102,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iddd375a412244dc48910945ff35d18c3_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMzAtMy0xLTEtMTQ1ODQ_9ab4ae55-39d0-451e-a0a5-0734bab51386">108,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMzQtMS0xLTEtMTQ1ODQ_c5fad1a2-0ba1-4092-8145-a0a18f802435">3,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMzQtMy0xLTEtMTQ1ODQ_66c819b6-ec85-41aa-9493-dc5f6fa1f206">5,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends payable in accrued expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:LiabilitiesAssumed1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMzYtMS0xLTEtMTQ1ODQ_949c1c5c-67b8-4212-845e-6cfad4b9f059">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:LiabilitiesAssumed1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMzYtMy0xLTEtMTQ1ODQ_b8cb2849-8085-4bb5-bb1e-373baaba72ae">329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_25"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yNS9mcmFnOmYzYjZmMzk2YzQ2NDQ3NTY4OTkwZTMzYTZhODlkNjAxL3RleHRyZWdpb246ZjNiNmYzOTZjNDY0NDc1Njg5OTBlMzNhNmE4OWQ2MDFfMzQwOA_2f63af4f-fc18-485a-a6fe-db7ddf2bc28b" continuedAt="i183ae8523e214e7ea59fad1a3647cd93" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i183ae8523e214e7ea59fad1a3647cd93" continuedAt="i8c184b20c8364ac6863b73ed4d223ca7"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Organization</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PetMed Express, Inc. and subsidiaries, d/b/a PetMeds&#174; (the &#8220;Company&#8221;), is a leading nationwide pet pharmacy and Your Trusted Pet Health Expert</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs, cats, and horses, directly to the consumer. The Company offers consumers an attractive alternative for obtaining pet medications in terms of expertise, convenience, price, speed of delivery and valued customer service. The Company markets its products through advertising and promotional campaigns, which aim to increase the recognition of the &#8220;PetMeds&#174;&#8221; brand name, increase traffic on its website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, acquire new customers, and maximize repeat purchases. Virtually all of the Company&#8217;s sales are to customers in the United States. The Company&#8217;s corporate headquarters and distribution facility is located in Delray Beach, Florida. The Company&#8217;s fiscal year end is March&#160;31, and references herein to fiscal 2023 or fiscal 2022 refer to the Company's fiscal years ending March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="pets:BasisOfPresentationAndConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yNS9mcmFnOmYzYjZmMzk2YzQ2NDQ3NTY4OTkwZTMzYTZhODlkNjAxL3RleHRyZWdpb246ZjNiNmYzOTZjNDY0NDc1Njg5OTBlMzNhNmE4OWQ2MDFfMzQwOQ_a057147f-38e5-4824-a837-ff3ad407c90c" continuedAt="i065e097f939945489089120c8f54a0b3" escape="true">Basis of Presentation and Consolidation</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i065e097f939945489089120c8f54a0b3">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and, therefore, do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, the accompanying Condensed Consolidated Financial Statements contain all adjustments, consisting of normal recurring accruals, necessary to present fairly the financial position of the Company at December&#160;31, 2022, the Statements of Income for the three and nine months ended December&#160;31, 2022 and 2021, and Cash Flows for the nine months ended December&#160;31, 2022 and 2021. The results of operations for the three and nine months ended December&#160;31, 2022 are not necessarily indicative of the operating results expected for the fiscal year ending March&#160;31, 2023. These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022. The Condensed Consolidated Financial Statements include the accounts of PetMed Express, Inc. and its wholly owned subsidiaries. All significant intercompany transactions have been eliminated upon consolidation.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yNS9mcmFnOmYzYjZmMzk2YzQ2NDQ3NTY4OTkwZTMzYTZhODlkNjAxL3RleHRyZWdpb246ZjNiNmYzOTZjNDY0NDc1Njg5OTBlMzNhNmE4OWQ2MDFfMzQwNQ_dd8fbc8a-ff02-452c-85ba-e45ec79d3fa3" continuedAt="if84b70bcf9a94753be543788ca3e2bd4" escape="true">Use of Estimates </ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if84b70bcf9a94753be543788ca3e2bd4">The preparation of Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yNS9mcmFnOmYzYjZmMzk2YzQ2NDQ3NTY4OTkwZTMzYTZhODlkNjAxL3RleHRyZWdpb246ZjNiNmYzOTZjNDY0NDc1Njg5OTBlMzNhNmE4OWQ2MDFfMzQwNg_89cfaadb-2957-48e5-a3b4-7f06c3ebb56a" continuedAt="ia3f704ec32eb42e096c974132899bcc1" escape="true">Fair Value of Financial Instruments </ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia3f704ec32eb42e096c974132899bcc1">The carrying amounts of the Company's cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yNS9mcmFnOmYzYjZmMzk2YzQ2NDQ3NTY4OTkwZTMzYTZhODlkNjAxL3RleHRyZWdpb246ZjNiNmYzOTZjNDY0NDc1Njg5OTBlMzNhNmE4OWQ2MDFfMzQwNw_534dab07-ab71-41c1-947c-113f15851bc3" continuedAt="i54a738a8792e49428360b80230c2ec5c" escape="true">Recent Accounting Pronouncements </ix:nonNumeric></span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8c184b20c8364ac6863b73ed4d223ca7"><ix:continuation id="i54a738a8792e49428360b80230c2ec5c">The Company does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on the Company's consolidated financial position, results of operations, or cash flows.</ix:continuation></ix:continuation> </span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_28"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RleHRyZWdpb246OTQ2NTNkMGRmM2QyNDU5ODg5MDQ2OWUxNGM5NTQ2Y2JfMjY5MA_0c571c31-165a-4749-b6bc-5c340e043b4e" continuedAt="i55e4891bfc614a05b1b30b345822a116" escape="true">Revenue Recognition</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i55e4891bfc614a05b1b30b345822a116" continuedAt="i451cd4d0b5c74225b909b10d4166509f">The Company generates revenue by selling pet medication products and pet supplies mainly to retail customers. Certain pet supplies offered on the Company&#8217;s website are drop shipped to customers. The Company considers itself the principal in the arrangement because the Company controls the specified good before it is transferred to the customer. Revenue contracts contain one performance obligation, which is delivery of the product. Customer care and support is deemed not to be a material right to the contract. The transaction price is adjusted at the date of sale for any applicable sales discounts and an estimate of product returns, which are based on historical patterns, however this is not considered a key </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i451cd4d0b5c74225b909b10d4166509f"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">judgment. Revenue is recognized when control transfers to the customer at the point in time at which the shipment of the product occurs. This key judgment is determined as the shipping point, which represents the point in time when the Company has a present right to payment, title has transferred to the customer, and the customer has assumed the risks and rewards of ownership.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outbound shipping and handling fees are an accounting policy election and are included in sales as the Company considers itself the principal in the arrangement given its responsibility for supplier selection and discretion over pricing. Shipping costs associated with outbound freight after control over a product has transferred to a customer are an accounting policy election and are accounted for as fulfillment costs and are included in cost of sales.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates sales in the following two categories: (1) reorder sales vs new order sales, and (2) internet sales vs. contact center sales. <ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RleHRyZWdpb246OTQ2NTNkMGRmM2QyNDU5ODg5MDQ2OWUxNGM5NTQ2Y2JfMjY5MQ_b9d9a41f-96d0-4fe1-b911-0d67844116d1" continuedAt="iafc6f4730d8f484897e2fe042aca4820" escape="true">The following table illustrates sales by various classifications:</ix:nonNumeric></span></div><ix:continuation id="iafc6f4730d8f484897e2fe042aca4820"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue (In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reorder sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7bcec245ba8f4bca88ec8b71bb599cdf_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMy0yLTEtMS0xNDU4NA_6affb3b9-8fbc-4019-ba52-15e973c28e19">53,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i7bcec245ba8f4bca88ec8b71bb599cdf_D20221001-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMy00LTEtMS0xNDU4NA_ee5afe4f-e1ae-48c5-9e64-622c84738012">90.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65bde03e5d464408a705348a0a0f41cc_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMy02LTEtMS0xNDU4NA_3900be29-b09e-4767-b9dc-b98c8eb849a1">55,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i65bde03e5d464408a705348a0a0f41cc_D20211001-20211231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMy04LTEtMS0xNDU4NA_aa24fc0f-2e21-4e25-b267-52e287249b96">91.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7bcec245ba8f4bca88ec8b71bb599cdf_D20221001-20221231" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMy0xMC0xLTEtMTQ1ODQ_044631bf-e8df-4125-988d-19bd14edbb3b">1,943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="i7bcec245ba8f4bca88ec8b71bb599cdf_D20221001-20221231" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMy0xMi0xLTEtMTQ1ODQ_f63a6a7d-cc3e-4103-b001-fcad511a8b14">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New order sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if68375ef4a7542af96e74af2ada80410_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNC0yLTEtMS0xNDU4NA_22343543-9d91-42f2-992f-2fb52b5bef0f">5,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="if68375ef4a7542af96e74af2ada80410_D20221001-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNC00LTEtMS0xNDU4NA_26a10c4e-aeea-4cba-baa5-5f5d7648c129">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9f0f687e16e445ef9491c6c0fccac673_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNC02LTEtMS0xNDU4NA_896920a1-82f1-401f-a475-99242f0d54ff">5,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i9f0f687e16e445ef9491c6c0fccac673_D20211001-20211231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNC04LTEtMS0xNDU4NA_f47bfce2-000b-446d-83ce-09c81ed2ffe2">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if68375ef4a7542af96e74af2ada80410_D20221001-20221231" decimals="-3" name="pets:RevenueFromContractWithCustomerVariance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNC0xMC0xLTEtMTQ1ODQ_e8aeb585-5d18-442f-91c8-49b523265983">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="if68375ef4a7542af96e74af2ada80410_D20221001-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNC0xMi0xLTEtMTQ1ODQ_61c1e933-5678-4cc6-92d9-b899fdf6f43d">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNi0yLTEtMS0xNDU4NA_514ad690-2bca-4488-a711-1e8bb6dcc696">58,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNi00LTEtMS0xNDU4NA_879a52b9-ee34-4766-ba7a-1de2f077b3d4">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNi02LTEtMS0xNDU4NA_28eef62b-5267-4952-bff8-884dd2d3cb20">60,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNi04LTEtMS0xNDU4NA_d5a18bd1-0137-45d1-a75a-7817cda716d4">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNi0xMC0xLTEtMTQ1ODQ_13f9fc1a-d793-4ec4-883c-ea6fdcf810ae">1,847</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNi0xMi0xLTEtMTQ1ODQ_36ab6cf7-3b70-469f-914a-7ad061ed5413">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internet sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8150fab077f042849b44c3d66cd1be01_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOC0yLTEtMS0xNDU4NA_c54246e1-e77b-410c-8665-2246d2533964">51,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i8150fab077f042849b44c3d66cd1be01_D20221001-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOC00LTEtMS0xNDU4NA_a817e49f-e3f3-40cd-a8e9-2895e1e134ed">86.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8424940f0f714f6bb29ebc7cef78ee72_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOC02LTEtMS0xNDU4NA_0241f18c-dbe5-47fd-b472-247e740137cf">51,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i8424940f0f714f6bb29ebc7cef78ee72_D20211001-20211231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOC04LTEtMS0xNDU4NA_e54078b5-e71a-4cc6-9b1a-b2b64c72aa2d">84.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i8150fab077f042849b44c3d66cd1be01_D20221001-20221231" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOC0xMC0xLTEtMTQ1ODQ_00050d4b-0b9a-40fb-86a7-205967659e41">196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="i8150fab077f042849b44c3d66cd1be01_D20221001-20221231" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOC0xMi0xLTEtMTQ1ODQ_0a989ab1-5d53-47df-8600-58423d605249">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contact center sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6e261220a35145458a0bb7962680a283_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOS0yLTEtMS0xNDU4NA_16be1cc8-ca34-46be-9347-0f4a655a99f1">7,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i6e261220a35145458a0bb7962680a283_D20221001-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOS00LTEtMS0xNDU4NA_585db33c-85a5-4d7a-ae8d-b8c602f87efb">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib5c88edd5dd84e9abd3087efd2f42496_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOS02LTEtMS0xNDU4NA_4fc30db7-5e6e-4066-b3a3-abbea1f63db7">9,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ib5c88edd5dd84e9abd3087efd2f42496_D20211001-20211231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOS04LTEtMS0xNDU4NA_720170bb-2493-44e1-83c2-a62495607263">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6e261220a35145458a0bb7962680a283_D20221001-20221231" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOS0xMC0xLTEtMTQ1ODQ_9e3c8ca3-b709-4b23-8f8d-03f9c1a71133">1,651</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="i6e261220a35145458a0bb7962680a283_D20221001-20221231" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOS0xMi0xLTEtMTQ1ODQ_c1e258cc-389a-4e9b-869f-f2b6b95f2509">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMTEtMi0xLTEtMTQ1ODQ_fcbae4e4-f945-4bf5-92fd-1b1e2a62c099">58,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMTEtNC0xLTEtMTQ1ODQ_67ef0ed3-5ce4-4ca0-8f3b-eb922b4567c6">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMTEtNi0xLTEtMTQ1ODQ_f35f6851-9f04-43a3-bb85-dfdfd2dc7b17">60,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMTEtOC0xLTEtMTQ1ODQ_33ae2ccb-f214-434c-bc3e-08827ee2e81b">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMTEtMTAtMS0xLTE0NTg0_2a322ff4-f94e-429e-a588-2ad7ab5e9ec4">1,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMTEtMTItMS0xLTE0NTg0_5cc5dea7-cb18-45d9-9b97-86d675c4378f">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue (In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reorder sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6c58fb706aaa4b1e98d81a7a0bfea1a7_D20220401-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMy0yLTEtMS0xNDU4NA_1f1f3942-7d2a-4481-b595-0a2ba5c51b72">176,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i6c58fb706aaa4b1e98d81a7a0bfea1a7_D20220401-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMy00LTEtMS0xNDU4NA_1c972ae7-f792-4a50-8474-01aed1a5b703">90.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idaadbc1c61234f73a3bb5e185c89cf4c_D20210401-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMy02LTEtMS0xNDU4NA_3d1c0774-d98e-4ea9-983d-8c18fa6c541d">184,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="idaadbc1c61234f73a3bb5e185c89cf4c_D20210401-20211231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMy04LTEtMS0xNDU4NA_51093c92-c2c8-4532-838b-e7d00ed43be9">89.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6c58fb706aaa4b1e98d81a7a0bfea1a7_D20220401-20221231" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMy0xMC0xLTEtMTQ1ODQ_6b04c662-54e8-4372-a361-a48dc07be2ca">8,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="i6c58fb706aaa4b1e98d81a7a0bfea1a7_D20220401-20221231" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMy0xMi0xLTEtMTQ1ODQ_2ab56acc-68da-4892-ad3c-aec559f30d96">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New order sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia0e4320425bc46a0a1fea6b2994f5d9f_D20220401-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNC0yLTEtMS0xNDU4NA_991048c7-3016-440b-a07c-f744b9e7c0c3">18,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ia0e4320425bc46a0a1fea6b2994f5d9f_D20220401-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNC00LTEtMS0xNDU4NA_9541ebca-f72a-4871-95e2-de12edc84b14">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6dff8f4be4934a6c8be36b9f8a2211ba_D20210401-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNC02LTEtMS0xNDU4NA_0dabfb48-d338-4d6e-b61a-600ea624223a">22,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i6dff8f4be4934a6c8be36b9f8a2211ba_D20210401-20211231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNC04LTEtMS0xNDU4NA_adbaf0b6-1b3a-44b6-9f82-39d04a1aee5e">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia0e4320425bc46a0a1fea6b2994f5d9f_D20220401-20221231" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNC0xMC0xLTEtMTQ1ODQ_216e344d-0242-4f6d-8873-5b293d29fe50">4,741</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="ia0e4320425bc46a0a1fea6b2994f5d9f_D20220401-20221231" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNC0xMi0xLTEtMTQ1ODQ_e625d778-36eb-4ddb-a416-50cedc0a78a4">20.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNi0yLTEtMS0xNDU4NA_199e78cc-8bf5-4ce8-9936-902f1387cd32">194,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNi00LTEtMS0xNDU4NA_e1e277b6-9ef5-4f3b-bca7-3091240c4d99">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNi02LTEtMS0xNDU4NA_dee9b9ed-55e9-440e-a5f3-072c16280dd9">207,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNi04LTEtMS0xNDU4NA_86f046f5-ef6e-43b2-82c6-688998cd4279">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNi0xMC0xLTEtMTQ1ODQ_e2b240eb-2ff0-408c-b126-9dbadfe0801d">12,964</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNi0xMi0xLTEtMTQ1ODQ_f5b4353b-1c49-4cd6-b138-eef86a9863b6">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internet sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if63c295485f4407fa7e066bf30570500_D20220401-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOC0yLTEtMS0xNDU4NA_82587391-4883-485d-82d1-b7b2d37a3bdb">167,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="if63c295485f4407fa7e066bf30570500_D20220401-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOC00LTEtMS0xNDU4NA_e0849661-6aa2-4ca9-82c5-5fb2d871aef1">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic2bc6f8fae324212a7cadd450f94abe5_D20210401-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOC02LTEtMS0xNDU4NA_1a5b20ae-a94b-4bc3-9341-b46697d2266a">173,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ic2bc6f8fae324212a7cadd450f94abe5_D20210401-20211231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOC04LTEtMS0xNDU4NA_5c864ecb-947e-485f-8553-b6edb9f56ac0">83.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="if63c295485f4407fa7e066bf30570500_D20220401-20221231" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOC0xMC0xLTEtMTQ1ODQ_5de896e1-baa7-4bae-aec7-86ac91f89183">5,761</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="if63c295485f4407fa7e066bf30570500_D20220401-20221231" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOC0xMi0xLTEtMTQ1ODQ_0c0c99c2-b6c7-4340-b2f6-ffd41db60c64">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contact center sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib4c9b15003614ac8a3226d1f0a7f6ee0_D20220401-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOS0yLTEtMS0xNDU4NA_526f2a4b-168d-4196-aa68-6761f3c21b6c">26,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ib4c9b15003614ac8a3226d1f0a7f6ee0_D20220401-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOS00LTEtMS0xNDU4NA_a0cecf37-64bf-40f2-aaa4-6e59f87b6c78">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85db176f3142452d8eb6189c15ae2cd2_D20210401-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOS02LTEtMS0xNDU4NA_278bac27-e234-4683-bda0-2d00ab1f1051">33,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i85db176f3142452d8eb6189c15ae2cd2_D20210401-20211231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOS04LTEtMS0xNDU4NA_fca83525-40f1-462d-80f2-c96e55702127">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib4c9b15003614ac8a3226d1f0a7f6ee0_D20220401-20221231" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOS0xMC0xLTEtMTQ1ODQ_6c909360-a342-4c37-a39a-34bf427cf754">7,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="ib4c9b15003614ac8a3226d1f0a7f6ee0_D20220401-20221231" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOS0xMi0xLTEtMTQ1ODQ_b7db084d-9087-46ef-b178-e271fd7d4b62">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMTEtMi0xLTEtMTQ1ODQ_748715f5-1294-4f16-8593-76bdb14110cc">194,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMTEtNC0xLTEtMTQ1ODQ_8fd62819-dbca-454d-a6a0-becfb87e8e7d">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMTEtNi0xLTEtMTQ1ODQ_fe5c5fde-d400-4c3f-8ae9-01b6fb8b0087">207,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMTEtOC0xLTEtMTQ1ODQ_d8442576-5fab-46c4-9294-d1c24f1b48f8">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMTEtMTAtMS0xLTE0NTg0_f5d0b7ef-6f1d-42e8-b3fb-ed59b67e5d92">12,964</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMTEtMTItMS0xLTE0NTg0_51c3f236-a4d1-4060-b6fb-b5a94c9a329e">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:continuation><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company changed the definition of a new customer on April 1, 2022, to include anyone who has not ordered over the past thirty-six months. The reorder and new order sales amounts for the three and nine  months ended December&#160;31, 2022, and the reorder and new order sales amounts for the three and nine  months ended December&#160;31, 2021 reflect this new customer definition change. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the previous definition of a new customer, reorder and new order sales were $<ix:nonFraction unitRef="usd" contextRef="i8877e07cd58945f6bbc7b58579686efe_D20211001-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RleHRyZWdpb246OTQ2NTNkMGRmM2QyNDU5ODg5MDQ2OWUxNGM5NTQ2Y2JfMjIzMg_352c576d-f31c-45ae-b878-74700f858909">56.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2f7d9324da564d5386147bd5643fe51f_D20211001-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RleHRyZWdpb246OTQ2NTNkMGRmM2QyNDU5ODg5MDQ2OWUxNGM5NTQ2Y2JfMjIzOQ_2b166a9d-6e85-4e20-92c3-72493fab42d0">4.4</ix:nonFraction> million, respectively, for the three months ended December 31, 2021. Under the previous definition of a new customer, reorder and new order sales were $<ix:nonFraction unitRef="usd" contextRef="i2a6c5dc1cfd04bad979e42463356b32b_D20210401-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RleHRyZWdpb246OTQ2NTNkMGRmM2QyNDU5ODg5MDQ2OWUxNGM5NTQ2Y2JfMjM1MQ_52c9955f-4e82-4bd6-a62e-541bfb1ddaa9">189.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i41a9cc96267d4f77b87be8a4fba4c3c2_D20210401-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RleHRyZWdpb246OTQ2NTNkMGRmM2QyNDU5ODg5MDQ2OWUxNGM5NTQ2Y2JfMjM1OA_d839f919-cb12-4dfa-8d71-5eddb0ef1cf9">18.2</ix:nonFraction> million, respectively, for the nine months ended December 31, 2021. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Virtually all the Company&#8217;s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days. Credit card sales minimize the accounts receivable balances relative to sales. The Company had no material contract asset or liability balances as of December&#160;31, 2022 or March&#160;31, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfMTE3MA_4244af6a-149f-47fe-ac4e-f9931ebfee13" continuedAt="if2c37f7368f647f192d1d3926f2289c3" escape="true">Net Income Per Share</ix:nonNumeric></span></div><ix:continuation id="if2c37f7368f647f192d1d3926f2289c3"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of Accounting Standards Codification (&#8220;ASC&#8221;) Topic 260 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) basic net income per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted net income per common share includes the dilutive effect of potential restricted stock and the effects of the potential conversion of preferred shares, calculated using the treasury stock method. Unvested restricted stock and convertible preferred shares issued by the Company represent the only dilutive effect reflected in the diluted weighted average shares outstanding.</span></div><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfMTE3MQ_17273241-3dd6-40c8-8232-ab17451e8a5a" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented (in thousands, except for per share amounts):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.005%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) (numerator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMy0xLTEtMS0xNDU4NA_c7f9239c-bcfa-4804-8383-f55bcf3d002b">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMy0zLTEtMS0xNDU4NA_ab0acd3b-b137-4df2-bf9a-0a899fde6874">4,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMy01LTEtMS0xNDU4NA_7ae244ab-9359-4bbe-9709-9e5ab99b147a">5,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMy03LTEtMS0xNDU4NA_d00c4216-b815-43d3-aba8-3758a735bccf">15,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares (denominator):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average number of common shares outstanding used in basic computation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNi0xLTEtMS0xNDU4NA_ba2dd836-0e96-40a0-8a82-467621122362">20,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNi0zLTEtMS0xNDU4NA_ced96a17-b18c-4621-a95e-1e01c6284100">20,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNi01LTEtMS0xNDU4NA_80f9faf3-d990-4694-b4f9-e9ec804ea219">20,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNi03LTEtMS0xNDU4NA_cf3fe28f-e559-491c-b8c4-f1c7d1e64956">20,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common shares issuable upon vesting of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNy0xLTEtMS0xNDU4NA_3dab28c6-3190-4d83-b65f-bb31cfa23167">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNy0zLTEtMS0xNDU4NA_dc760823-2978-42c1-9957-c780dcce7a4f">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNy01LTEtMS0xNDU4NA_d12b6919-ea12-464f-8b3f-6e1185228235">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNy03LTEtMS0xNDU4NA_b864fcfe-df2c-4f13-bda1-a2433f92189e">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common shares issuable upon conversion of preferred shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOC0xLTEtMS0xNDU4NA_6c679c30-c0fd-4248-ad01-6078f9c76eaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOC0zLTEtMS0xNDU4NA_93b755f6-d1a1-4fd2-98bf-9277d3800530">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOC01LTEtMS0xNDU4NA_6eef437d-4604-4d6f-afc3-5e807f427b7c">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOC03LTEtMS0xNDU4NA_a2afe9c4-c86d-4e38-8c25-9e27e8d09f4e">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares used in diluted computation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOS0xLTEtMS0xNDU4NA_8673aa65-70e5-4396-90ca-3e0dbdc94356">20,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOS0zLTEtMS0xNDU4NA_4df60eef-900d-415a-a271-0cdd43e84ae6">20,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOS01LTEtMS0xNDU4NA_806cd7fb-a698-4553-a59a-e496bef9b8ae">20,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOS03LTEtMS0xNDU4NA_e0d3dcf5-cd3c-4c05-b137-880c59267630">20,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTMtMS0xLTEtMTQ1ODQ_b3c0c3f9-c325-44a9-a80d-37e35a2fea30">0.00</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTMtMy0xLTEtMTQ1ODQ_6e4a222d-aeae-4938-9a0c-bea952e35ccc">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTMtNS0xLTEtMTQ1ODQ_195fa14f-f8df-4ea2-aeb7-35211aef1a9d">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTMtNy0xLTEtMTQ1ODQ_f20e6738-fe4e-4966-816d-2b922f711cd1">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTQtMS0xLTEtMTQ1ODQ_47fc473c-a3f7-4772-af11-c6ae0a0ce404">0.00</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTQtMy0xLTEtMTQ1ODQ_fb577d06-535d-4a8f-95ca-feeccb385d0b">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTQtNS0xLTEtMTQ1ODQ_0af952e1-cb87-490a-bd1b-64e3a23f1a00">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTQtNy0xLTEtMTQ1ODQ_1b9aac8c-f9dd-4484-bbef-bf30ab8d85ed">0.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine  months ended December&#160;31, 2022 and 2021, <ix:nonFraction unitRef="shares" contextRef="iad23aff6e73f4936ae99c55a2a704298_D20221001-20221231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfOTM5_4f10788b-4757-40d0-bf16-53d16c3da1d8"><ix:nonFraction unitRef="shares" contextRef="icaf0a8da7b2e4c5bb6b4975bba8d57ca_D20220401-20221231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfOTM5_8f0ca0f6-6116-49e2-982a-d6c875f5fe93">243,604</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i8fe4a15e0e42437d808ed2840f2e171f_D20211001-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfOTQ2_0c6dc483-5ebc-4835-8684-20979b3da336"><ix:nonFraction unitRef="shares" contextRef="i37ab1b450b194b00bf3e03586f0f9a1f_D20210401-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfOTQ2_758e39c8-3e0b-4dca-8456-467b34450e1b">205,219</ix:nonFraction></ix:nonFraction> shares of common restricted stock, respectively, were excluded from the computations of diluted net income per common share, as their inclusion would have had an anti-dilutive effect on diluted net income per common share. For the three months ended December 31, 2022, <ix:nonFraction unitRef="shares" contextRef="i7d7fa3fa4a984a9283d58153706677c9_D20221001-20221231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfNTQ5NzU1ODE1MDg3_d27670c3-96f4-4d6b-8c54-9b506c529e58">71</ix:nonFraction> shares issuable upon vesting of restricted stock and <ix:nonFraction unitRef="shares" contextRef="i6fd0d3f40e08458eb598ab1db5019057_D20221001-20221231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfNTQ5NzU1ODE1MTUz_78a21e2d-b3f1-42e7-a135-2ca20c017cda">10</ix:nonFraction> shares issuable upon conversion of preferred shares were excluded from the computation of diluted net income per common share, as their inclusion would have had an anti-dilutive effect on diluted net income per common share.</span></div></ix:continuation><div id="i7a10caab6f5047e1a02f0366bdb90d7a_34"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfNDAxMw_41d57593-d973-458b-84da-e56eee992aca" continuedAt="i11e408695f194de4847951f65baf1d56" escape="true">Accounting for Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="i11e408695f194de4847951f65baf1d56" continuedAt="iaff3632fc378417bbdfd0f948b889da2"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records compensation expense associated with restricted stock in accordance with ASC Topic 718 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Based Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) (ASU 2016-09). The Company had <ix:nonFraction unitRef="shares" contextRef="iad28657a6a0b4952ba10608b59c49e38_D20220401-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjE1_9b4fa31a-c1e1-43ed-b34a-8bdda94e9673">959,548</ix:nonFraction> common shares issued under the 2016 Employee Equity Compensation Restricted Stock Plan (&#8220;2016 Employee Plan&#8221;), and <ix:nonFraction unitRef="shares" contextRef="i2f5c94e1389f4483aa7c73b4b9c00e93_D20220401-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzMz_5c20c982-501a-4369-a1c6-d0b3b7140574">240,755</ix:nonFraction> common shares issued under the 2015 Outside Director Equity Compensation Restricted Stock Plan (&#8220;2015 Director Plan&#8221;) at December&#160;31, 2022, all shares of which were issued subject to a restriction or forfeiture period that lapses ratably on the first, second, and third anniversaries of the date of grant, and the fair value of which is being amortized over the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfNjgz_191b9281-4145-40ce-abe4-217b2cb8eccc">one</span> to <ix:nonNumeric contextRef="i8b31dfb51bb44783b638d191bbc7a980_D20220401-20221231" name="pets:RestrictionPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfNDAxMQ_228ef9ce-386e-4555-870b-1daf1acf9ce3">three-year</ix:nonNumeric> restriction period, with the exception of performance restricted shares which were issued to the Chief Executive Officer and Chief Financial Officer.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company issued <ix:nonFraction unitRef="shares" contextRef="ie7442254753449318736ecb33c3c2b59_D20210801-20210831" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfODgy_2fc652d2-ce54-4bc1-91be-181c752a13c7">90,000</ix:nonFraction> restricted shares and <ix:nonFraction unitRef="shares" contextRef="i0d8b91f663f3474c99076e130bb65446_D20210801-20210831" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfOTA3_c0236ceb-2021-498a-b559-8fa13b141a0e">510,000</ix:nonFraction> performance restricted shares to the Company&#8217;s CEO, in accordance with the CEO&#8217;s employment agreement, under the 2016 Employee Plan.  The performance restricted shares are based on achieving absolute stock hurdles with the three-year period from the grant date. If the shares meet the absolute stock price hurdle, they will only vest on the third anniversary of the date of grant. As of December&#160;31, 2022, none of the performance stock hurdles were met.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iaff3632fc378417bbdfd0f948b889da2"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company issued <ix:nonFraction unitRef="shares" contextRef="i5e6712ee77de4a729affbf86d32800d4_D20220803-20220803" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMTczNQ_d6cea414-d70e-4029-ab2f-0d07a37f564e">13,000</ix:nonFraction> restricted shares and <ix:nonFraction unitRef="shares" contextRef="i974cd15bc1f84107b36c802dfb84787d_D20220803-20220803" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMTc2Ng_ece22c7d-b1a2-4cb1-92d0-a65a907d7f24">3,000</ix:nonFraction> performance restricted shares to the Company's new CFO, in accordance with the CFO's employment agreement, under the 2016 Employee Plan. The performance restricted shares are based on the attainment of performance criteria equally weighted between adjusted EBITDA and revenue. The shares for each grant will be released from restriction equally over a three (<ix:nonNumeric contextRef="i2d506cc607c04a3ebf6a185593e1dc41_D20220803-20220803" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMTA5OTUxMTYzMTgzMQ_21973ad1-7e8e-4b49-bde5-e6b29a8492bd">3</ix:nonNumeric>) year period on the anniversary of the grant date, and in the case of the performance restricted shares, subject to the attainment of performance criteria .</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued <ix:nonFraction unitRef="shares" contextRef="i7d5cbb72af874387884242be4246de02_D20221001-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjE5Nw_1487106e-8f21-40ab-ab41-e5958119534a">550</ix:nonFraction> shares of restricted stock, net of forfeitures, to certain employees under the 2016 Employee Plan during the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quarter ended December&#160;31, 2022. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the quarters ended December&#160;31, 2022 and 2021, the Company recognized </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ibe371187742843408787486f68f274b3_D20221001-20221231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjUyOQ_26169b35-7b4f-4a39-817b-9982a0fb6d6c">1.8</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="ida28de54333842baae92c105ccb153e2_D20211001-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjUzNg_7e201e43-0b1e-4eee-a8e2-bb2b4e91f919">1.4</ix:nonFraction> million, respectively, of compensation expense related to the 2016 Employee Plan and 2015 Director Plan. For the nine months ended December&#160;31, 2022 and 2021, the Company recognized </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i53207e2d9eb14013aa52bab22358b457_D20220401-20221231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjY4MQ_0676678a-5cd2-4e49-bbe6-cd52893f337f">5.0</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i97cda5016db34ee48cec4f2f8a6755f2_D20210401-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjY4OA_f0ed5687-aeac-45ec-8986-057af1915d8f">3.0</ix:nonFraction> million, respectively, of compensation expense related to the 2016 Employee Plan and 2015 Director Plan. At December&#160;31, 2022 and 2021 there was $<ix:nonFraction unitRef="usd" contextRef="i1a336deb41434c5ea068a787ed8d62e9_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjgxMQ_430bf593-c00d-4b5a-9f1e-2f4c0a6365f3">10.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3bdd189cee1942858b848f337aac4919_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjgxOA_dc6f5ce8-bc4f-4343-8cca-ba22e8ae6f95">14.4</ix:nonFraction> million of unrecognized compensation cost related to the non-vested restricted stock awards, respectively, which is expected to be recognized over the next <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjk2OQ_1aaf0ccb-d1a0-41ef-bb85-02c3837aae7b">one</span> to <ix:nonNumeric contextRef="i802698039a084839a3f7f1d98357ba6e_D20220401-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjk3NQ_40dd5c41-b86e-4265-bf98-64afcc0bbef9">three years</ix:nonNumeric>. All stock-based compensation expense is recognized as a payroll-related expense and it is included within the general and administrative expenses line item within the Company&#8217;s Consolidated Statements of Income , and the offset is included in the additional paid-in capital line item of the Company&#8217;s Consolidated Balance Sheets. On December&#160;31, 2022 and 2021, there were <ix:nonFraction unitRef="shares" contextRef="i1a336deb41434c5ea068a787ed8d62e9_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzMwMg_c8444f0d-4844-4df1-a81c-5992c645ef4c">759,204</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i3bdd189cee1942858b848f337aac4919_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzMwOQ_806606a0-15a0-4a71-9c3a-19616be520f0">749,219</ix:nonFraction> non-vested restricted shares issued and outstanding, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Company&#8217;s 2022 Employee Equity Compensation Restricted Stock Plan (&#8220;2022 Employee Plan&#8221;) became effective upon the approval of the plan by the Company&#8217;s shareholders. The 2022 Employee Plan authorizes <ix:nonFraction unitRef="shares" contextRef="i7ed1086383e343e69ff226fd59a926d5_I20220731" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzU5OA_11fe8f84-4e7e-417c-8969-b39666b04bb9">1,000,000</ix:nonFraction> shares of the Company's common stock available for issuance.  The value of the restricted stock is determined based on the market value of the stock at the issuance date.  The restriction period or forfeiture period is determined by the Company&#8217;s Compensation Committee and is to be no less than <ix:nonNumeric contextRef="ic43fa5ecc4024171ad3cc5adcab3dead_D20220701-20220731" name="pets:RestrictionPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzkwOA_6addc3ae-247d-47fe-8e81-98cbb26c468c">1</ix:nonNumeric> year and no more than <ix:nonNumeric contextRef="ia5c6583bec134c2b919d20f2ac9ffdd8_D20220701-20220731" name="pets:RestrictionPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzkyOA_776b4c4f-92ac-49da-af1d-4a30595ca9ac">ten years</ix:nonNumeric>, unless otherwise specified by the Compensation Committee. <ix:nonFraction unitRef="shares" contextRef="i436e706c942c451990e2aa84cb93940f_D20220701-20221231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzkzMg_9c1292a5-09fe-4e39-9140-04b96ebcbcb1">No</ix:nonFraction> shares had been issued under the 2022 Employee Plan as of December&#160;31, 2022.</span></div></ix:continuation><div id="i7a10caab6f5047e1a02f0366bdb90d7a_37"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNy9mcmFnOmYxN2EyZDI4OTAxYjQ1YTJiYzZjMTI1NDg1NWYzOTI1L3RleHRyZWdpb246ZjE3YTJkMjg5MDFiNDVhMmJjNmMxMjU0ODU1ZjM5MjVfMTI3NQ_6968a8ed-93da-4ab7-aa2c-026449ec4c34" continuedAt="i308b4938554048f6bfeaf30f3542f140" escape="true">Fair Value</ix:nonNumeric></span></div><ix:continuation id="i308b4938554048f6bfeaf30f3542f140"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company carries cash and cash equivalents at fair value in the Condensed Consolidated Balance Sheets. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. ASC Topic 820 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) establishes a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs which are supported by little or no market activity.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. At December&#160;31, 2022, the Company had invested the majority of its $<ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNy9mcmFnOmYxN2EyZDI4OTAxYjQ1YTJiYzZjMTI1NDg1NWYzOTI1L3RleHRyZWdpb246ZjE3YTJkMjg5MDFiNDVhMmJjNmMxMjU0ODU1ZjM5MjVfMTE4MQ_854571a4-406f-42ee-a81f-6c0dbeef638d">102.4</ix:nonFraction> million cash and cash equivalents balance in money market funds which are classified within Level 1.</span></div></ix:continuation><div id="i7a10caab6f5047e1a02f0366bdb90d7a_40"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80MC9mcmFnOmMwNjA1NzdiNDBmODQzODI5YTZlMDNlNjBiN2FjYzJlL3RleHRyZWdpb246YzA2MDU3N2I0MGY4NDM4MjlhNmUwM2U2MGI3YWNjMmVfMzUzNw_02a9cc3f-540e-4865-9ea2-746ede206f02" continuedAt="i2a033035de254b2b9c56ec90e9b2ef4d" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i2a033035de254b2b9c56ec90e9b2ef4d" continuedAt="i3e4c690234e644b8a478f7f6a2d3dbe7"><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Legal Matters and Routine Proceedings</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has settled complaints that had been filed with various states&#8217; pharmacy boards in the past. There can be no assurances made that other states will not attempt to take similar actions against the Company in the future. The Company also intends to vigorously defend its trade or service marks. There can be no assurance that the Company will be successful in protecting its trade or service marks. Legal costs related to the above matters are expensed as incurred .From time to time, the Company may be involved in and subject to disputes and legal proceedings, as well as demands, claims and threatened litigation that arise in the ordinary course of its business. These proceedings may include allegations involving business practices, infringement of intellectual property, employment or other matters. The ultimate outcome of any legal proceeding is often uncertain, there can be no assurance that the Company will be successful in any legal proceeding, and unfavorable outcomes could have a negative impact on our results of operations and financial condition. In accordance with ASC Topic 450-20 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"), the Company records a liability in its financial statements for these matters when a loss is known or considered probable and the amount can be reasonably estimated. The Company reviews the status of each significant matter each accounting period as additional information is known and adjusts the loss </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3e4c690234e644b8a478f7f6a2d3dbe7" continuedAt="i627889cad8f04133b412ca66b3160681"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provision when appropriate. If a matter is both probable to result in a liability and the amounts of loss can be reasonably estimated, the Company estimates and discloses the possible loss or range of loss to the extent necessary to make the financial statements not misleading. If the loss is not probable and cannot be reasonably estimated, a liability is not recorded in the Company&#8217;s financial statements. Gain contingencies are not recorded until they are realized. Legal costs related to any legal matters are expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates contingencies on an ongoing basis and has established loss provisions for matters in which losses are probable and the amount of the loss can be reasonably estimated and is not currently a party to any legal proceeding that management believes could have a material adverse effect on our results of operations. Based upon an assessment for sales tax received by the Company, an accrual in the amount of $<ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-5" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80MC9mcmFnOmMwNjA1NzdiNDBmODQzODI5YTZlMDNlNjBiN2FjYzJlL3RleHRyZWdpb246YzA2MDU3N2I0MGY4NDM4MjlhNmUwM2U2MGI3YWNjMmVfMjM5NQ_d74ac557-5e47-4050-a310-ed6d7fff2611">0.9</ix:nonFraction>&#160;million is included in the "Accrued expenses and other current liabilities" line item on the Condensed Consolidated Balance Sheets as of December&#160;31, 2022 and the offsetting expense was recognized in the "General and administrative" line item within the Condensed Consolidated Statements of Income for the nine months ended December&#160;31, 2022. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon the assessment received, the Company initiated a process to evaluate the potential for further sales tax contingencies, The effect of such evaluation of potential sales tax exposure, which the Company expects to complete in the fourth quarter ending March&#160;31, 2023, could have a material effect on the results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Separation Agreement</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i627889cad8f04133b412ca66b3160681">In connection with the separation of the Company's former Chief Financial Officer, the Company has accrued $<ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-3" name="pets:AccruedSeveranceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80MC9mcmFnOmMwNjA1NzdiNDBmODQzODI5YTZlMDNlNjBiN2FjYzJlL3RleHRyZWdpb246YzA2MDU3N2I0MGY4NDM4MjlhNmUwM2U2MGI3YWNjMmVfMzQyNA_0e5de752-e149-469d-b0a1-755cce32d39a">364</ix:nonFraction>&#160;thousand with respect to the severance, pursuant to the CFO Transition and Separation Agreement, included in "Accrued expenses and other current liabilities" on the Condensed Consolidated Balance Sheet as of December&#160;31, 2022.</ix:continuation> </span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_43"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RleHRyZWdpb246ODJlZjkxYTk4NzA1NGFjMGFmYTU5MDRiMGVkNjMzY2RfNDI2_ed1fa1cf-cc68-4335-b9a1-2f0e86d05872" continuedAt="ic1266b27c94147c3bb28e005649dca51" escape="true">Changes in Shareholders</ix:nonNumeric></span><ix:continuation id="ic1266b27c94147c3bb28e005649dca51" continuedAt="id0c716cd9c8d435986efdc9b1d0983fb"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Equity:</span></ix:continuation></div><ix:continuation id="id0c716cd9c8d435986efdc9b1d0983fb" continuedAt="i461468e9d37a4108899823d7f354facd"><ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RleHRyZWdpb246ODJlZjkxYTk4NzA1NGFjMGFmYTU5MDRiMGVkNjMzY2RfNDI3_e0656581-ae02-4e4f-8665-69197e2f89a8" continuedAt="iea142ac8737f44ed9bda6dcdd795d67b" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Shareholders&#8217; Equity for the nine months ended December&#160;31, 2022 is summarized below (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retained<br/>Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance at March 31, 2022:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i864561553fdf4df0ac1140a600d033a4_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMS0xLTEtMS0xNDU4NA_7aa2c666-2ca8-473f-8160-59e6b6b7a65b">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i46fd83d710f74df093e8b4c8bcb39594_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMS0zLTEtMS0xNDU4NA_6a65ee47-3c29-493a-b4cf-2fef3e784f09">11,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idc9aeeb29c4742208591d84ff5c3f38f_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMS01LTEtMS0xNDU4NA_ff419629-f463-4cd0-a50c-30f7da99ac87">130,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia3726f4e149f4c17892e094ff0d250d3_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMi0zLTEtMS0xNDU4NA_cfbe2569-8eda-456a-8d54-79896e1a559a">1,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7a965f8b26994fc58ac8950bbd13c3d8_D20220401-20220630" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMy01LTEtMS0xNDU4NA_2d2345cf-9521-497e-a9e1-de0270f38d34">6,297</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a965f8b26994fc58ac8950bbd13c3d8_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfNC01LTEtMS0xNDU4NA_9e3c4f42-9f55-49fe-b035-acdbc43af854">2,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i90c28b24bd8c465fba8956a43b6b42ba_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfNS0xLTEtMS0xNDU4NA_469c9b34-4f9f-4c70-b8a8-5768f8b4279e">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifca299ce29fa401f9edd0c4cc2d16abb_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfNS0zLTEtMS0xNDU4NA_8c5a101c-5db0-4f69-8621-0ea684eedf46">13,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia6e858548b03478893794331fd102d06_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfNS01LTEtMS0xNDU4NA_03e69530-7122-4ea6-a30e-120a5e62dae1">126,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares Issued</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic6e22b4c43d942b8968fdc0f92828472_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfNy0zLTEtMS0xNDU4NA_2511c344-f88a-4bc9-9ac2-d99728cea020">1,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icc4d4debbecb42c6a5c7bf76f83cfd04_D20220701-20220930" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfOC01LTEtMS0xNDU4NA_2e9e6840-426e-4920-941f-214323632d22">6,307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icc4d4debbecb42c6a5c7bf76f83cfd04_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfOS01LTEtMS0xNDU4NA_96cf3396-c557-4290-b169-c917e3109e8f">2,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at September  30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if04a59c0e21b4165abb829478afa536e_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTAtMS0xLTEtMjAwNDk_f0051515-031a-4887-bd6d-03cd6ad8349e">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id0616732cc964c29af2566aecd430715_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTAtMy0xLTEtMjAwNTc_9b3d4238-07d1-4da4-a319-9693a636e7ff">14,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib30acdba9294412b8455cee53c346bbc_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTAtNS0xLTEtMjAwNjU_ce0bf050-3c36-49be-9644-1e1c1b2479f7">123,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i49e30612ead546a68ffa3cc45d3f0c77_D20221001-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTEtMy0xLTEtMjAxMjg_ac9e4528-52ac-4038-99fb-a5fe514760fb">1,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i46d17e7cf38c48cca155dcb2ddb012cc_D20221001-20221231" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTItNS0xLTEtMjAxNTM_d35acecb-dc93-4ace-918e-cdf6992bad48">6,319</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i46d17e7cf38c48cca155dcb2ddb012cc_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTMtNS0xLTEtMjAxNjE_385e68ab-fbac-4a90-b3f3-142b9d19cebe">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at December 31, 2022:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iae5e3adc0e244df78831aead28031b7c_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTAtMS0xLTEtMTQ1ODQ_83cc1610-2327-49ea-9f80-522cda264e7b">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iedd0a502d0114c6b9a8e7b297688cbcf_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTAtMy0xLTEtMTQ1ODQ_1c05cde9-09b2-44c3-987c-0e61f8674e26">16,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i28a4779f6fab4613b28885ae9cac19e6_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTAtNS0xLTEtMTQ1ODQ_ac1e8d8b-37fa-491f-b0e9-beab3dc2f6fb">116,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i461468e9d37a4108899823d7f354facd"><ix:continuation id="iea142ac8737f44ed9bda6dcdd795d67b"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Shareholders&#8217; Equity for the nine months ended December&#160;31, 2021 is summarized below (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retained<br/>Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance at March 31, 2021:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib7ae2226e077465abd6ae8cf00b6f532_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMS0xLTEtMS0xNDU4NA_ae19f47f-39be-4bc0-91a3-58453b9fd314">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i562c11f99bb548b69e78e029f0d65860_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMS0zLTEtMS0xNDU4NA_c7e756d8-b01b-4302-88e6-9b11dd14cd75">7,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if1dae6dbb35c4a6da152924d34b0365d_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMS01LTEtMS0xNDU4NA_c0b61d5d-edf7-43b9-8c92-c10b9545f848">134,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icc4da35a89ae49178deb59c2d6bb3d07_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMi0zLTEtMS0xNDU4NA_fd000d53-878f-49d0-8c63-e710bb85eb56">718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i0ffa3d3f184241dabcf76d81522ac2d2_D20210401-20210630" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMy01LTEtMS0xNDU4NA_1754fee5-5512-4425-8929-175f97e2fe2d">6,080</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ffa3d3f184241dabcf76d81522ac2d2_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfNC01LTEtMS0xNDU4NA_c45da009-0126-4ee7-a25e-7172a8c4eda9">4,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icfb6fe66922848658885a8bc6e9481e9_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfNS0xLTEtMS0xNDU4NA_10e985b4-f0ee-4262-a8eb-14816577c2c8">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i35f0d7d912c3464e849f72990a167356_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfNS0zLTEtMS0xNDU4NA_124dd89e-d7fd-410d-8e88-733e360eb615">7,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5acf5cd16dff4f088c9398f33c3cddca_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfNS01LTEtMS0xNDU4NA_80348e85-ace4-4647-8988-694fff078e99">132,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares Issued</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8c67a17e20334c189d487ee28cf75bf1_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfNi0xLTEtMS0xNDU4NA_46ace039-67a8-473c-afd8-67dd3b891852">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9a920eeb13942fe81148b446dcc66cf_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfNy0zLTEtMS0xNDU4NA_59e0263e-b6a0-4168-a8bd-78c53a413712">882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i128c8af1cec14be1ae200b38a29fd0a9_D20210701-20210930" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfOC01LTEtMS0xNDU4NA_f71c287d-17be-4971-a2c1-dfc8a432983a">6,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i128c8af1cec14be1ae200b38a29fd0a9_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfOS01LTEtMS0xNDU4NA_2a27b1b4-adc2-4cc2-a3df-9d0dfd879fa1">6,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at September  30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic12b54a9ab4242d5a1dca7c82eba46df_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTAtMS0xLTEtMjAyNTQ_bc022ea2-cadd-4702-b847-9582dad97806">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5d10742b5f544f5594cb0909107de875_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTAtMy0xLTEtMjAyNjI_85a5231f-5c25-4264-9ce0-4b59469f1855">8,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i75d4eab0c05241e793a7d11cdc5e2f2a_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTAtNS0xLTEtMjA1MDU_489ddb8c-d5fc-4f85-b919-9bc774f4e03e">132,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i88fc8739d1ab480e97d26ea983b689de_D20211001-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTEtMy0xLTEtMjAzMzE_b952026b-fb4c-4953-8225-4d9b51b57b59">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i26b4c5393a8c4e5092769bb380417953_D20211001-20211231" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTItNS0xLTEtMjAzNjM_d4ae1b73-4f63-40fb-85a5-563517674152">6,282</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i26b4c5393a8c4e5092769bb380417953_D20211001-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTMtNS0xLTEtMjAzNzE_7519e234-3339-4ef5-81f9-2ffaa721c556">4,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at December 31, 2021:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib6f47c348e3745359b8952cad7998881_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTAtMS0xLTEtMTQ1ODQ_12aa6835-ae66-42f4-936d-d7bcf6fe4abd">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3794039ab2794369b1521e3a036acaab_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTAtMy0xLTEtMTQ1ODQ_db7f9853-e701-4401-838b-08e61c8f0459">10,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6978944526c3459c9248ffc7c6ca9745_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTAtNS0xLTEtMTQ1ODQ_dfb8e04f-aa6a-49a1-92b9-65c2a9c3ff90">130,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RleHRyZWdpb246ODJlZjkxYTk4NzA1NGFjMGFmYTU5MDRiMGVkNjMzY2RfMjU0_25247c8e-50d2-4019-bb0e-03dc0fb5459d"><ix:nonFraction unitRef="shares" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RleHRyZWdpb246ODJlZjkxYTk4NzA1NGFjMGFmYTU5MDRiMGVkNjMzY2RfMjU0_45922e20-bfc4-4d34-a037-f2e9a2609004">no</ix:nonFraction></ix:nonFraction> shares of common stock that were purchased or retired in the nine months ended December&#160;31, 2022 or 2021. At December&#160;31, 2022, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i137fc368100c4411981905d28135f59f_I20221231" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RleHRyZWdpb246ODJlZjkxYTk4NzA1NGFjMGFmYTU5MDRiMGVkNjMzY2RfMzY4_ae8f34e2-9ddd-497e-90de-a7055e96ceae">28.7</ix:nonFraction> million remaining under the Company&#8217;s share repurchase plan.</span></div></ix:continuation><div id="i7a10caab6f5047e1a02f0366bdb90d7a_46"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfNjYy_7f5212cc-734d-4dbe-853c-e0b3a9ccd637" continuedAt="i251f6ea2c34941f3b49653f977d3ac69" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i251f6ea2c34941f3b49653f977d3ac69">For the quarters ended December&#160;31, 2022 and 2021, the Company recorded an income tax provision of approximately $<ix:nonFraction unitRef="usd" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfMTIy_f6f24b9c-e2fe-4bdb-b616-2ff0b853c8ea">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfMTI5_8c984194-d023-4e17-b21d-4d21adfbb75a">1.3</ix:nonFraction> million, respectively, and for the nine months ended December&#160;31, 2022 and 2021 the Company recorded an income tax provision of approximately $<ix:nonFraction unitRef="usd" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfMjM0_035d622a-215f-4d8f-a204-0420a8513b27">2.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfMjQx_4339dc42-7810-4d7a-8c4e-419239ab35cf">4.6</ix:nonFraction> million, respectively. The decrease in the tax provision for the three and nine  months ended December&#160;31, 2022 is related to a decrease in operating income during the periods. The effective tax rate for the quarter ended December&#160;31, 2022 was approximately <ix:nonFraction unitRef="number" contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfMzI1_36527148-22d2-4a61-a5cc-6d457b67e873">109.6</ix:nonFraction>%, compared to approximately <ix:nonFraction unitRef="number" contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfMzU1_7dd61248-6c25-4bbb-aa91-99454636e6a0">22.9</ix:nonFraction>% for the quarter ended December&#160;31, 2021, and the effective tax rate for the nine months ended December&#160;31, 2022 was approximately <ix:nonFraction unitRef="number" contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfNDQz_b8c07f2f-7a6c-4ead-8be4-c39eea2e5187">29.9</ix:nonFraction>% compared to approximately <ix:nonFraction unitRef="number" contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfNDcy_31c33f3f-9d27-41fe-8e37-da9a2c83170b">23.4</ix:nonFraction>% for the nine months ended December&#160;31, 2021. The increase to the effective tax rate for the three and nine  months ended December&#160;31, 2022 can be attributed to more non-deductible expenses and an increase in state tax due to the extension of the Company's business operations.</ix:continuation> </span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_52"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81Mi9mcmFnOjI1YWEyZmNiM2NmNjQxOWI5MDBlNDIzMWQ2YmFmZTg5L3RleHRyZWdpb246MjVhYTJmY2IzY2Y2NDE5YjkwMGU0MjMxZDZiYWZlODlfNzEx_e82f7bda-c015-4235-8d8d-c206531e0840" continuedAt="ic6ea2afb98db4b22b988dac487596c68" escape="true">Minority Interest Investment in Vetster</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic6ea2afb98db4b22b988dac487596c68" continuedAt="if95dad43a48b472786882187713d757a">On April&#160;19, 2022, the Company engaged in a <ix:nonNumeric contextRef="iab14d6c222714d4fa9eeef808f9de70c_D20220419-20220419" name="pets:TermOfAgreement" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81Mi9mcmFnOjI1YWEyZmNiM2NmNjQxOWI5MDBlNDIzMWQ2YmFmZTg5L3RleHRyZWdpb246MjVhYTJmY2IzY2Y2NDE5YjkwMGU0MjMxZDZiYWZlODlfNzEy_ebf5f006-5251-401c-81a5-6e8139522e38">three-year</ix:nonNumeric> partnership agreement with Vetster Inc. (&#8220;Vetster&#8221;), a veterinary telehealth Canadian company. The Company also purchased a <ix:nonFraction unitRef="number" contextRef="i443214d583e24ab29051706bdba05419_I20220419" decimals="2" name="pets:NoncontrollingInterestOwnershipPercentagePurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81Mi9mcmFnOjI1YWEyZmNiM2NmNjQxOWI5MDBlNDIzMWQ2YmFmZTg5L3RleHRyZWdpb246MjVhYTJmY2IzY2Y2NDE5YjkwMGU0MjMxZDZiYWZlODlfMjE4_c9f2241f-0ff5-4b84-b5cf-57e29feb32b1">5</ix:nonFraction>% minority interest in Vetster in the amount of $<ix:nonFraction unitRef="usd" contextRef="i443214d583e24ab29051706bdba05419_I20220419" decimals="-5" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81Mi9mcmFnOjI1YWEyZmNiM2NmNjQxOWI5MDBlNDIzMWQ2YmFmZTg5L3RleHRyZWdpb246MjVhYTJmY2IzY2Y2NDE5YjkwMGU0MjMxZDZiYWZlODlfMjY3_1a5e15fc-0f31-44b4-a65c-d7366c1f4ff5">5.0</ix:nonFraction> million and received warrants for additional equity in Vetster, which are tied to future performance milestones. Under the terms of the agreement, the Company became the exclusive e-commerce provider for Vetster, and Vetster became the exclusive provider of telehealth and telemedicine services to the Company. The minority interest investment is being valued on the </ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if95dad43a48b472786882187713d757a">cost basis and the investment will be evaluated periodically for any impairment.</ix:continuation> </span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_55"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81NS9mcmFnOjc5Nzk3NTc1ZWFmNzQ0ZjJhZDA2NDY1YjVmMmNjMGY4L3RleHRyZWdpb246Nzk3OTc1NzVlYWY3NDRmMmFkMDY0NjViNWYyY2MwZjhfNDE2_205463c9-8566-4b35-b599-84408bb8750a" continuedAt="i430728ec3ea04da884cd45ba94b50156" escape="true">Subsequent Events</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i430728ec3ea04da884cd45ba94b50156" continuedAt="i997a278f57564867bf01412c625d6fe2">On January&#160;13, 2023, the Company entered into an Agreement and Plan of Merger to acquire PetCareRx, Inc. ("PetCareRx"), a leading supplier of pet medications, food, and supplies, for an aggregate consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="iba0d1147b871412bb5ee913ee43a4458_D20230113-20230113" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81NS9mcmFnOjc5Nzk3NTc1ZWFmNzQ0ZjJhZDA2NDY1YjVmMmNjMGY4L3RleHRyZWdpb246Nzk3OTc1NzVlYWY3NDRmMmFkMDY0NjViNWYyY2MwZjhfMTA5OTUxMTYzMTM4OQ_205aa45d-a906-4c38-bf86-c259d73da9b7">36.0</ix:nonFraction>&#160;million in cash, subject to adjustment. The closing of the transaction is subject to customary closing conditions and certain state pharmacy license and permit filings related to the change of control of PetCareRx. The transaction has been approved by the Board of Directors of both the Company and PetCareRx, and the stockholders of PetCareRx, and is expected to close in the fourth quarter of fiscal year 2023. Upon completion of the acquisition, PetCareRx will become a wholly-owned subsidiary of the Company.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i997a278f57564867bf01412c625d6fe2"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;6, 2023, the Board of Directors declared a quarterly dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i193309c747ed4183bc1fc06e289d1aba_D20230206-20230206" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81NS9mcmFnOjc5Nzk3NTc1ZWFmNzQ0ZjJhZDA2NDY1YjVmMmNjMGY4L3RleHRyZWdpb246Nzk3OTc1NzVlYWY3NDRmMmFkMDY0NjViNWYyY2MwZjhfOTU_bb153880-dbf7-45e9-bb0e-1bed303fd506">0.30</ix:nonFraction> per share. The Board established a February&#160;20, 2023 record date and a February&#160;27, 2023 payment date. Based on the outstanding share balance as of February&#160;7, 2023 the Company estimates the dividend payable to be approximately $<ix:nonFraction unitRef="usd" contextRef="if721328002364681bee1ba0655718256_I20230207" decimals="-5" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81NS9mcmFnOjc5Nzk3NTc1ZWFmNzQ0ZjJhZDA2NDY1YjVmMmNjMGY4L3RleHRyZWdpb246Nzk3OTc1NzVlYWY3NDRmMmFkMDY0NjViNWYyY2MwZjhfMjgy_72af1345-b697-473b-af13-62971201e841">6.3</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2022, the Board of Directors approved and issued <ix:nonFraction unitRef="shares" contextRef="ib5ac5ca2e988435eaad69a43bc5b154f_D20230101-20230207" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81NS9mcmFnOjc5Nzk3NTc1ZWFmNzQ0ZjJhZDA2NDY1YjVmMmNjMGY4L3RleHRyZWdpb246Nzk3OTc1NzVlYWY3NDRmMmFkMDY0NjViNWYyY2MwZjhfMzQ3_20be111c-cf29-449f-a57f-0483ac0f83eb">1,200</ix:nonFraction> restricted </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares to employees pursuant to the 2016 Employee Plan. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2022, the Board of Directors approved and issued <ix:nonFraction unitRef="shares" contextRef="ia7ef6fce92814d58987c014afa0ebf0d_D20230101-20230207" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81NS9mcmFnOjc5Nzk3NTc1ZWFmNzQ0ZjJhZDA2NDY1YjVmMmNjMGY4L3RleHRyZWdpb246Nzk3OTc1NzVlYWY3NDRmMmFkMDY0NjViNWYyY2MwZjhfNTQ5NzU1ODE4NDI5_0d11e129-e307-42d8-8917-569e86904692">6,000</ix:nonFraction> restricted shares to MZHCI, LLC pursuant to an Investor Relations Consulting Agreement.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_58"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;MANAGEMENT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_61"></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following discussion and analysis should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes thereto included elsewhere in this Quarterly Report on Form 10-Q for the quarterly period ended December&#160;31, 2022 and our Annual Report on Form 10-K for the year ended March&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information in this Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You can identify these forward-looking statements by the words "believes," "intends," "expects," "may," "will," "should," "plans," "projects," "contemplates," "intends," "budgets," "predicts," "estimates," "anticipates," or similar expressions. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties, and assumptions. Actual future results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended March&#160;31, 2022 under the heading &#8220;Risk Factors.&#8221; A reader, whether investing in our common stock or not, should not place undue reliance on these forward-looking statements, which apply only as of the date of this Quarterly Report on Form 10-Q. We assume no obligation to revise or update any forward-looking statements for any reason, except as required by law. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When used in this Quarterly Report on Form 10-Q, "PetMed Express," "1-800-PetMeds," "PetMeds," "PetMed," "PetMeds.com," &#8220;1800PetMeds.com,&#8221; "PetMed.com," "PetMed Express.com," "the Company," "we," "our," and "us" refers to PetMed Express, Inc. and our subsidiaries.</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_64"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PetMed Express was incorporated in the state of Florida in January 1996. Our common stock is traded on the NASDAQ Global Select Market under the symbol &#8220;PETS&#8221;. We began selling pet medications and other pet health products in September 1996. In March 2010 we started offering for sale additional pet supplies on our website, and these additional items are drop shipped to customers by third party vendors. Presently, our product line includes approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 4,350 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SKUs of the most popular pet medications, health products, and supplies for dogs, cats, and horses.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market our products through advertising and promotional campaigns which aim to increase the recognition of the &#8220;PetMeds&#174;&#8221; brand name, increase traffic on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, acquire new customers, and maximize repeat purchases. Approximately 87% of all sales were generated via the Internet for the quarter ended December&#160;31, 2022, compared to 84% for the quarter ended December&#160;31, 2021. Our sales consist of products sold mainly to retail consumers. The average purchase was approximately $90 and $89 for the quarters ended December&#160;31, 2022 and 2021, respectively, and approximately $93 and $92 for the nine months ended December&#160;31, 2022 and 2021, respectively.</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_67"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of our financial condition and the results of our operations contained herein are based upon our condensed consolidated financial statements and the data used to prepare them. Our condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. On an ongoing basis we re-evaluate our judgments and estimates including those related to product returns, bad debts, inventories, and income taxes. We base our estimates and judgments on our historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. Actual results may differ from these estimates under different assumptions or conditions. Our estimates are guided by observing the following critical accounting policies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognition</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for revenue under ASC Topic 606 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers")</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and  generate revenue by selling pet medication products and pet supplies mainly to retail customers. Certain pet supplies offered on our website are drop shipped to customers. We considers ourself the principal in the arrangement because we control the specified good before it is transferred to the customer. Revenue contracts contain one performance obligation, which is delivery of the product; customer care and support is deemed not to be a material right to the contract. The transaction price is adjusted at the date of sale for any applicable sales discounts and an estimate of product returns, which are estimated based on historical patterns, however this is not considered a key judgment. There are no amounts excluded from the variable </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consideration. Revenue is recognized when control transfers to the customer at the point in time in which the shipment of the product occurs. This key judgment is determined as the shipping point, which represents the point in time where we have a present right to payment, title has transferred to the customer, and the customer has assumed the risks and rewards of ownership.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outbound shipping and handling fees are an accounting policy election and are included in sales as we considers ourself the principal in the arrangement given responsibility for supplier selection and discretion over pricing. Shipping costs associated with outbound freight after control over a product has transferred to a customer are an accounting policy election and are accounted for as fulfillment costs and are included in cost of sales. Virtually all of our sales are paid by credit cards and we usually receive the cash settlement in two to three banking days. Credit card sales minimize the accounts receivable balances relative to sales.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for doubtful accounts for losses that we estimate will arise from customers&#8217; inability to make required payments, arising from either credit card chargebacks or insufficient funds checks. We determine our estimates of the uncollectibility of accounts receivable by analyzing historical and current bad debts and economic trends. The allowance for doubtful accounts was approximately $40 thousand at December&#160;31, 2022, compared to $39 thousand at March&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation of inventory</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or net realizable value using a weighted average cost method. We write down our inventory for estimated obsolescence. The inventory reserve was approximately $56 thousand at December&#160;31, 2022 compared to $81 thousand at March&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our advertising expense consists primarily of Internet marketing, direct mail/print, and television advertising. Internet costs are expensed in the month incurred and direct mail/print advertising costs are expensed when the related brochures and postcards are produced, distributed, or superseded. Television advertising costs are expensed in the month advertisements are televised.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting for income taxes</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes under the provisions of ASC Topic 740 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which generally requires recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in our condensed consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following should be read in conjunction with our condensed consolidated financial statements and the related notes thereto included elsewhere herein. The following table sets forth, as a percentage of sales, certain operating data appearing in our condensed consolidated statements of income:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_73"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EBITDA </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To provide investors and the market with additional information regarding our financial results, we have disclosed (see below) adjusted EBITDA, a non-GAAP financial measure that we calculate as net income excluding share-based compensation expense; depreciation and amortization; income tax provision; interest income (expense); and other non-operational expenses. We have provided reconciliations below of adjusted EBITDA to net income, the most directly comparable GAAP financial measures.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have included adjusted EBITDA, herein, because it is a key measure used by our management and Board of Directors to evaluate our operating performance, generate future operating plans, and make strategic decisions regarding the allocation of capital. In particular, the exclusion of certain expenses in calculating adjusted EBITDA facilitates operating performance comparability across reporting periods by removing the effect of non-cash expenses and other expenses. Accordingly, we believe that adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and Board of Directors.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe it is useful to exclude non-cash charges, such as share-based compensation expense, depreciation and amortization from our adjusted EBITDA because the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations. We believe it is useful to exclude income tax provision and interest income (expense</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s neither are components of our core business operations. We also believe that it is useful to exclude other expenses, including the investment banking fee related to the Vetster partnership, acquisition costs related </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to PetCareRx, employee severance and estimated state sales tax accrual as these items are not indicative of our ongoing operations. Adjusted EBITDA has limitations as a financial measure, and these non-GAAP measures should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:</span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future and adjusted EBITDA does not reflect capital expenditure requirements for such replacements or for new capital expenditures;</span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect share-based compensation. Share-based compensation has been, and will continue to be for the foreseeable future, a material recurring expense in our business and an important part of our compensation strategy;</span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect interest income (expense), net; or changes in, or cash requirements for, our working capital;</span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect transaction related costs and other items which are either not representative of our underlying operations or are incremental costs that result from an actual or planned transaction and include litigation matters, integration consulting fees, internal salaries and wages (to the extent the individuals are assigned full-time to integration and transformation activities) and certain costs related to integrating and converging IT systems; </span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect certain non-operating expenses including the employee severance which reduces cash available to us; </span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect certain expenses including the estimated state sales tax accrual which reduces cash available to us.</span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other companies, including companies in our industry, may calculate adjusted EBITDA differently, which reduces the measures usefulness as comparative measures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of these and other limitations, adjusted EBITDA should only be considered as supplemental to, and alongside with other GAAP based financial performance measures, including various cash flow metrics, net income, net margin, and our other GAAP results.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of net income, the most directly comparable GAAP measure to adjusted EBITDA for each of the periods indicated:</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of Non-GAAP Measures</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PetMed Express, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in thousands, except percentages)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change</span></div></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Reconciliation of GAAP Net Income to Adjusted EBITDA:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Add (subtract):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based Compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,044)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest (Income)/Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition and Partnership Transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State Sales Accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,584&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,844)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(64)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span><br/></span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_76"></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in thousands, except percentages)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$<br/>Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%<br/>Change</span></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Reconciliation of GAAP Net Income to Adjusted EBITDA:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Add (subtract):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based Compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,987&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest (Income)/Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(970)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition and Partnership Transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State Sales Accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/m</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,122&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,363)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:10pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended December 31, 2022 Compared With Three Months Ended December 31, 2021 and Nine Months Ended December 31, 2022 Compared With Nine Months Ended December 31, 2021</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">COVID-19</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are dedicated to making every effort to ensure our customers&#8217; pets receive the medications they need. We are also dedicated to making every effort to ensure the health and safety of our employees. We have continued with working from home where possible and enhanced disinfection and social distancing within our workplace. We have been open during our normal business hours without any material disruptions to our operations. We have not seen any major disruptions in our supply chain; however, we have experienced some delays in the delivery of some inventory items. The COVID-19 pandemic or any future surges, including as a result of new variants and subvariants of the virus, may have adverse effects on our business, operations, and financial results and condition, including, among other things, as a result of adverse impacts on labor availability, our fulfillment center operations, supply chain and logistics disruptions, consumer behaviors, and on the overall economy, including recent high inflation levels impacting consumer spending. While most areas of the United States have reduced most or all COVID-19 restrictions, as the pandemic continues and if new outbreaks emerge, there is uncertainty regarding the magnitude and duration of the economic and social effects of the COVID-19 pandemic, and therefore, we cannot predict the COVID-19 pandemic full extent of impact on the broader economy or the positive or negative impacts the pandemic will have on our business, operations, and financial results and condition in future periods. See risk factors &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">The recent outbreak of the COVID-19 global pandemic and related government, private sector and individual consumer responsive actions may adversely affect our business operations, employee availability, financial performance, liquidity and cash flow for an unknown period of time</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Shipping is a critical part of our business and any changes in, or disruptions to, our shipping arrangements could adversely affect our business, financial condition, and results of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in Part I, Item 1A of our Form 10-K for the year ended March&#160;31, 2022 for further discussion regarding risks associated with the COVID-19 pandemic.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Sales</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales decreased by approximately $1.8 million, or 3.0%, to approximately $58.9 million for the quarter ended December&#160;31, 2022, compared to approximately $60.7 million for the quarter ended December&#160;31, 2021. The decrease in sales for the three months ended December&#160;31, 2022 was mainly due to higher seasonal discounts and competitive pressures. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     Sales decreased by approximately $13.0 million, or 6.3%, to approximately $194.5 million for the nine months ended December&#160;31, 2022, compared to approximately $207.4 million for the nine months ended December&#160;31, 2021. The decrease in sales for the nine months ended December&#160;31, 2022 was mainly due to the increased cost to acquire new customers and competitive pressures. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     We acquired approximately 72,000 new customers for the quarter ended December&#160;31, 2022 compared to approximately 66,000  new customers for the quarter ended December&#160;31, 2021. We acquired approximately 202,000 new customers for the nine months ended December&#160;31, 2022, compared to approximately 260,000  new customers for the nine months ended December&#160;31, 2021. Financial data in the tables below reflects the new 36-month definition of new customers. Prior year new and reorder customers and sales have been recalculated utilizing the new 36-month definition of a new customer (described below). The following tables illustrates sales by various sales classifications:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,943)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New order sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,458</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,847)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contact center sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,651)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,847)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">176,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New order sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,808</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,741)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,964)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contact center sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194,451&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,964)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that we changed the definition of a new customer on April 1, 2022, to include anyone who has not ordered over the past thirty-six months. The reorder and new order sales amounts for three and nine  months ended December&#160;31, 2022 and reorder and new order sales for the three and nine  months ended December&#160;31, 2021 reflect this new customer definition change. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the previous definition of a new customer, reorder and new order sales were $56.3 million and $4.4 million, respectively, and acquired new customers were approximately 53,000, for the three months ended December 31, 2021. Under the previous definition of a new customer, reorder and new order sales were $189.3 million and $18.2 million, respectively, and acquired new customers were approximately 210,000, for the nine months ended December 31, 2021.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021 we launched the new AutoShip &amp; Save subscription program (&#8220;AutoShip&#8221;) on our website. AutoShip is a new convenient way for our loyal customer base to have future pet medication orders delivered directly to them without the need to place an order each time. During the quarter ended June 30, 2022 we made a change to the methodology on how we calculate the percentage of our revenue that was generated by our AutoShip program. We now report AutoShip sales, as a percent of sales, net of discounts and credits for the entire quarter. Previously, we reported AutoShip sales as a percent of total sales on the last month in the quarter. This change to the calculation resulted in a decrease to the AutoShip percentage that was previously reported by only a few percentage points. We believe that this change reflects a more accurate representation of our subscription business for stakeholders to gauge our performance.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are encouraged by the adoption of our AutoShip program and have seen an increasingly positive trend over the last several quarters since we launched this program. For example, our quarterly AutoShip percentage was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42% of net sales for the most recent quarter ended December&#160;31, 2022, up from 20% of net sales for the same period last year and up from 39% of net sales sequentially in the prior quarter. We have set a goal of generating approximately 50% of our net sales via the AutoShip program in fiscal 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Going forward sales may be adversely affected due to increased competition and consumers giving more consideration to price. The changes in consumer behavior post pandemic makes future sales somewhat challenging to predict. No guarantees can be made that sales will grow in the future. The majority of our product sales are affected by the seasons, due to the seasonality of mainly flea and tick and heartworm medications. For the quarters ended June 30, September 30, December 31, and March 31 of fiscal 2022, our sales were approximately 29%, 25%, 22%, and 24%, respectively, as a percentage of annual sales.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cost of sales</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales increased by approximately $0.6 million, or 1.5%, to approximately $43.6 million for the quarter ended December&#160;31, 2022, from approximately $43.0 million for the quarter ended December&#160;31, 2021. The cost of sales increase was due to changes in accrual from our rewards program of $0.5 million  and higher freight expense, partially offset by the impact  from lower sales. As a percentage of sales, cost of sales was 74.1% and 70.8% for the quarters ended December&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended December 31, 2022, cost of sales decreased by approximately $7.9 million, or 5.3%, to approximately $140.8 million for the nine months ended December 31, 2022, from approximately $148.7 million for the nine months ended December 31, 2021. The cost of sales decrease can be directly related to the decrease in sales during </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended December 31, 2022. As a percentage of sales, cost of sales was 72.4% and 71.7% for the nine months ended December 31, 2022 and 2021, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Gross profit</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit decreased by approximately $2.5 million, or 14.0%, to approximately $15.2 million for the quarter ended December&#160;31, 2022, from approximately $17.7 million for the quarter ended December&#160;31, 2021. Gross profit as a percentage of sales was 25.9% and 29.2% for the quarters ended December&#160;31, 2022 and 2021, respectively. The gross profit and gross profit percentage decrease for the quarter ended December&#160;31, 2022 compared to previous period was primarily due </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to higher promotions and changes in our rewards program accrual.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended December 31, 2022 gross profit decreased by approximately $5.0 million, or 8.6%, to approximately $53.6 million for the nine months ended December 31, 2022, from approximately $58.7 million for the nine months ended December 31, 2021.  Gross profit as a percentage of sales for the nine months ended December 31, 2022 and 2021, respectively, was 27.6% and 28.3%. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross profit and gross profit percentage decreased for the nine months ended December&#160;31, 2022 compared to the previous period was primarily due to lower manufacturer rebates .</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">General and administrative expenses </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by approximately $2.9 million, or 38.2%, to approximately $10.4 million for the quarter ended December&#160;31, 2022, from approximately $7.5 million for the quarter ended December&#160;31, 2021. The increase to general and administrative expenses for the quarter ended December&#160;31, 2022 was due to a $1.8 million increase in purposeful investments in people and systems, of which $0.3 million is from increased stock compensation, and an additional $1.0 million of professional fees of which $0.5 million were transaction related expenses.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended December 31, 2022 general and administrative expenses increased by approximately $8.0 million, or 35.4%, to approximately $30.5 million for the nine months ended December 31, 2022, from approximately $22.5 million for the nine months ended December 31, 2021. The increase to general and administrative expenses for the the nine months ended December 31, 2022 was due to a $4.5 million increase in payroll expenses, of which $1.9 million is from increased stock compensation and $0.4M from accrued severance, as well as a $1.0 million increase of professional fees, and $0.7 million of software and systems investment. In addition, general and administrative expenses increased in the nine months ended December 31, 2022 due to a $0.9 million sales tax accrual and $0.9 million of acquisition related expenses. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Advertising expenses</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising expenses increased by approximately $0.3 million, or 7.3%, to approximately $4.6 million for the quarter ended December&#160;31, 2022, from approximately $4.3 million for the quarter ended December&#160;31, 2021. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall advertising spending for the quarter increased compared to the same quarter the prior year, due to increased media costs and increased agency fees. The advertising costs of acquiring a new customer, defined as total advertising costs divided by new customers acquired, was $64 for the quarter ended December&#160;31, 2022 compared to $66 for the quarter ended December&#160;31, 2021, per the new definition of new customers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in advertising costs of acquiring a new customer for the quarter ended December&#160;31, 2022 can be mainly attributed to increased conversion due to higher promotions. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a percentage of sales, advertising expense was 7.9% and 7.1% for the quarters ended December&#160;31, 2022 and 2021, respectively. The advertising percentage will fluctuate quarter to quarter due to seasonality and advertising availability.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended December 31, 2022 advertising expenses decreased by approximately $0.6 million, or 3.7%, to approximately $14.9 million for the nine months ended December 31, 2022, from approximately $15.4 million for the nine months ended December 31, 2021. The decrease was primarily due to lower media spend compared to the same period in the prior year. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advertising costs of acquiring a new customer was $74 and $59 for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the nine months ended December 31, 2022 and 2021, respectively</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The increase in advertising costs of acquiring a new customer for the period can be mainly attributed to increased media costs and competitive pressures. As a percentage of sales, advertising expense was relatively flat, at 7.6% and 7.5% for the nine months ended December&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Depreciation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $0.9 million and $0.7 million for the quarters ended December&#160;31, 2022 and December&#160;31, 2021, respectively. Depreciation expense was $2.6 million and $2.1 million for the nine months ended December 31, 2022 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2021, respectively. This increase to depreciation expense for the the quarter and nine months ended December 31, 2022 can be attributed to new property and equipment additions subsequent to the prior period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other income</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income increased to approximately $1.0 million for the quarter ended December&#160;31, 2022 compared to approximately $0.4 million for the quarter ended December&#160;31, 2021. Other income increased to approximately $1.9 million for the nine months ended December 31, 2022 compared to approximately $1.0 million for the nine months ended December 31, 2021. The increase to other income for the quarter and nine months was primarily related to increased interest income as a result of increased interest rates. Interest income may decrease in the future as we utilize our cash balances on any quarterly dividend payment, on future investments or partnerships, on our operating activities, or on our share repurchase plan, which has approximately $28.7 million remaining as of December&#160;31, 2022.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Provision for income taxes</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarters ended December&#160;31, 2022 and 2021, the Company recorded an income tax provision of approximately $0.2 million and $1.3 million, respectively, and for the nine months ended December&#160;31, 2022 and 2021 the Company recorded an income tax provision of approximately $2.3 million and $4.6 million, respectively. The decrease in the tax provision for the three and nine  months ended December&#160;31, 2022 is related to a decrease in operating income during the periods. The effective tax rate for the quarter ended December&#160;31, 2022 was approximately 109.6%, compared to approximately 22.9% for the quarter ended December&#160;31, 2021, and the effective tax rate for the nine months ended December&#160;31, 2022 was approximately 29.9% compared to approximately 23.4% for the nine months ended December&#160;31, 2021. The increase to the effective tax rate for the three and nine  months ended December&#160;31, 2022 can be attributed to more non-deductible expenses and an increase in state tax due to the extension of the Company's business operations. </span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_82"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our working capital at December&#160;31, 2022 and March&#160;31, 2022 was $102.9 million and $117.8 million, respectively. The $14.9 million decrease in working capital was primarily attributable to a decrease in cash to fund the Vetster partnership and infrastructure investment, and $5 million ownership investment in Vetster. Net cash provided by operating activities was $18.1 million for the nine months ended December 31, 2022, compared to cash provided by operating activities of $9.8 million for the nine months ended December 31, 2021. This change is due to a greater reduction in accounts payable and inventory in the nine months ended December&#160;31, 2022 than in the same period the prior year, partially offset by a decrease to net income. Net cash used in investing activities was $8.3 million for the nine months ended December 31, 2022, compared to $1.3 million used in investing activities for the nine months ended December 31, 2021. This change in investing activities is related to the Vetster partnership and investment, and increased property and equipment additions acquired in the nine months ended December&#160;31, 2022. Net cash used in financing activities was $18.4 million for the nine months ended December 31, 2022 compared to $18.3 million for the nine months ended December 31, 2021, due to the declaration of an aggregate of $0.90 and $0.90 per share dividend during the nine months ended December 31, 2022 and 2021, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had approximately $28.7 million remaining under our share repurchase plan. On February&#160;6, 2023 our Board of Directors declared a $0.30 per share dividend. The Board of Directors established a February&#160;20, 2023 record date and a February&#160;27, 2023 payment date for the quarterly dividend. Depending on future market conditions we may utilize our cash and cash equivalents on quarterly dividends, on our operating activities, or on the remaining balance of our current share repurchase plan.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had no material outstanding lease commitments. We are not currently bound by any long- or short-term agreements for the purchase or lease of capital expenditures. Any material amounts expended for capital expenditures would be the result of an increase in the capacity needed to adequately provide for any increase in our business. To date we have paid for any needed additions to our capital equipment infrastructure from working capital funds and anticipate this being the case in the future. Our primary source of working capital is cash from operations. We presently have no need for alternative sources of working capital and have no commitments.</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_85"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk generally represents the risk that losses may occur in the value of financial instruments as a result of movements in interest rates, foreign currency exchange rates, and commodity prices. Our financial instruments include cash and cash equivalents, accounts receivable, and accounts payable. The book values of cash equivalents, accounts receivable, and accounts payable are considered to be representative of fair value because of the short maturity of these </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">instruments. Interest rates affect our return on excess cash and cash equivalents. At December&#160;31, 2022, we had $102.4 million in cash and cash equivalents, and the majority of our cash and cash equivalents generate interest income based on prevailing interest rates. A significant change in interest rates would impact the amount of interest income generated from our excess cash and cash equivalents. It would also impact the market value of our cash and cash equivalents. Our cash and cash equivalents are subject to market risk, primarily interest rate and credit risk. Our cash and cash equivalents are managed by a limited number of outside professional managers within investment guidelines set by our Board of Directors. Such guidelines include security type, credit quality, and maturity, and are intended to limit market risk by restricting our cash and cash equivalents to high-quality cash and cash equivalents with both short- and long-term maturities. We do not hold any derivative financial instruments that could expose us to significant market risk. At December&#160;31, 2022, we had no debt obligations.</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_88"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial and accounting officer), has conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a&#8209;15 and 15d-15 promulgated under the Securities Exchange Act of 1934, as amended ("Exchange Act"), as of the quarter ended December&#160;31, 2022, the end of the period covered by this report (the "Evaluation Date"). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded as of the Evaluation Date, that our disclosure controls and procedures are effective such that the information relating to us, including our consolidated subsidiaries, required to be disclosed by us in reports that we file or submit under the Exchange Act: (1) is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and (2) is accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_94"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS.</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_97"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and financial results are subject to various risks and uncertainties that could adversely affect our business, financial condition, results of operations, and trading price of our common stock. Please refer to our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022 for additional information concerning these and other uncertainties that could negatively impact the Company.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional risk factor disclosure </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxing authorities may successfully assert that we should have collected, or in the future should collect, sales and use, value added, or similar taxes, and any such assessments could adversely affect our business, financial condition, and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the past several years states have adopted laws that attempt to impose tax collection obligations on out-of-state companies. Additionally, the Supreme Court of the United States ("Supreme Court") ruled in South Dakota v. Wayfair, Inc. et al, or Wayfair, that online sellers can be required to collect sales and use tax despite not having a physical presence in the buyer&#8217;s state. In response to Wayfair, or otherwise, states or local governments may adopt, or begin to enforce, laws requiring us to calculate, collect, and remit taxes on sales in their jurisdictions. While we currently collect and remit applicable sales taxes to the extent required in all states in which we sell, a successful assertion by one or more states seeing to tax us on sales that occurred in prior tax years, or to collect more taxes in a jurisdiction in which we currently do collect some taxes, could result in substantial tax liabilities, including taxes on past sales, as well as penalties and interest. The imposition by state governments or local governments of sales tax collection obligations on out-of-state sellers could also create additional administrative burdens for us, put us at a competitive disadvantage if they do not impose similar obligations on our competitors, and decrease our future sales, which could have a material adverse effect on our business and results of operations. New legislation or regulations, the application of laws and regulations from jurisdictions, or the application of existing laws and regulations to the Internet and commercial online services could similarly result in significant additional taxes on our business. For instance, the Supreme Court&#8217;s decision and the enactment and enforcement of laws resulting therefrom could also impact where we are required to file state income taxes. As a result, our effective income tax rate as well as the cost and growth of our business could be materially and adversely affected, which could in turn have a material adverse effect on our financial condition and results of operations. In addition, because the Company&#8217;s products and services are available over the Internet, states may claim that the Company is required to do business as a foreign corporation in one or more of those jurisdictions. Failure to qualify as a foreign corporation in a jurisdiction where the Company is required to do so could subject it to taxes and penalties, and such jurisdictions may charge the Company with violations of local laws.</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_100"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_103"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;DEFAULTS UPON SENIOR SECURITIES.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_106"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_109"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;&#160;&#160;OTHER INFORMATION.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-20221231xexx311.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-20221231xexx312.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-20221231xexx321.htm">Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 </a></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.INS*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.SCH*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.CAL*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.DEF*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.LAB*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.PRE*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Filed herewith..</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      **&#160;&#160;&#160;&#160;Furnished herewith. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</span></div></div></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC.</span></div><div><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: February&#160;7, 2023</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;/s/ Mathew N. Hulett</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Mathew N. Hulett</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Executive Officer and President</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;/s/ Christine Chambers</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Christine Chambers</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Financial and Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</span></div></div></div><div id="i7a10caab6f5047e1a02f0366bdb90d7a_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:35pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:30pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC</span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:30pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q </span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOR THE QUARTER ENDED:</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DECEMBER&#160;31, 2022</span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:30pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBITS</span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>pets-20221231xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i20eb6ce801b44b8584e7c767d47bc9f0_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mathew N. Hulett, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this report on Form 10-Q for the quarter ended December&#160;31, 2022 of PetMed Express, Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s Board of Directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 7, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; </font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mathew N. Hulett</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mathew N. Hulett</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>pets-20221231xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ica6b0d53ed22484a962ea5dee72c4939_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christine Chambers, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this report on Form 10-Q for the quarter ended December&#160;31, 2022 of PetMed Express, Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s Board of Directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 7, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; </font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christine Chambers</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Chambers</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>pets-20221231xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7cd5dafb7c2345e399eb51f8f68ab1b5_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mathew N. Hulett, and I, Christine Chambers, each certify to the best of our knowledge, based upon a review of the report on Form 10-Q for the quarter ended December&#160;31, 2022 (the &#8220;Report&#8221;) of the Registrant, that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the information contained in the Report, fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; February&#160;7, 2023</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#47;s&#47; Mathew N. Hulett</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mathew N. Hulett</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; </font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#47;s&#47; Christine Chambers</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Chambers</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>pets-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:66cb9e58-a04f-48d4-a0bc-a601d74b20f7,g:93132296-a4cf-4603-975d-122774d1cfdf-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pets="http://www.1800petmeds.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.1800petmeds.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.1800petmeds.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncome" roleURI="http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome">
        <link:definition>0000004 - Statement - Condensed Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000006 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.1800petmeds.com/role/RevenueRecognition">
        <link:definition>0000007 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://www.1800petmeds.com/role/NetIncomePerShare">
        <link:definition>0000008 - Disclosure - Net Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingforStockBasedCompensation" roleURI="http://www.1800petmeds.com/role/AccountingforStockBasedCompensation">
        <link:definition>0000009 - Disclosure - Accounting for Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.1800petmeds.com/role/FairValue">
        <link:definition>0000010 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.1800petmeds.com/role/CommitmentsandContingencies">
        <link:definition>0000011 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinShareholdersEquity" roleURI="http://www.1800petmeds.com/role/ChangesinShareholdersEquity">
        <link:definition>0000012 - Disclosure - Changes in Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.1800petmeds.com/role/IncomeTaxes">
        <link:definition>0000013 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MinorityInterestInvestmentinVetster" roleURI="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster">
        <link:definition>0000014 - Disclosure - Minority Interest Investment in Vetster</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.1800petmeds.com/role/SubsequentEvents">
        <link:definition>0000015 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000016 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.1800petmeds.com/role/RevenueRecognitionTables">
        <link:definition>0000017 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.1800petmeds.com/role/NetIncomePerShareTables">
        <link:definition>0000018 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinShareholdersEquityTables" roleURI="http://www.1800petmeds.com/role/ChangesinShareholdersEquityTables">
        <link:definition>0000019 - Disclosure - Changes in Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionSummaryofDisaggregationofRevenueDetails" roleURI="http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails">
        <link:definition>0000020 - Disclosure - Revenue Recognition - Summary of Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionNarrativeDetails" roleURI="http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails">
        <link:definition>0000021 - Disclosure - Revenue Recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareScheduleofEarningsPerShareDetails" roleURI="http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails">
        <link:definition>0000022 - Disclosure - Net Income Per Share - Schedule of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareNarrativeDetails" roleURI="http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails">
        <link:definition>0000023 - Disclosure - Net Income Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingforStockBasedCompensationDetails" roleURI="http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails">
        <link:definition>0000024 - Disclosure - Accounting for Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueDetails" roleURI="http://www.1800petmeds.com/role/FairValueDetails">
        <link:definition>0000025 - Disclosure - Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000026 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails" roleURI="http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails">
        <link:definition>0000027 - Disclosure - Changes in Shareholders' Equity - Schedule of Changes in Shareholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinShareholdersEquityNarrativeDetails" roleURI="http://www.1800petmeds.com/role/ChangesinShareholdersEquityNarrativeDetails">
        <link:definition>0000028 - Disclosure - Changes in Shareholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.1800petmeds.com/role/IncomeTaxesDetails">
        <link:definition>0000029 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MinorityInterestInvestmentinVetsterDetails" roleURI="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails">
        <link:definition>0000030 - Disclosure - Minority Interest Investment in Vetster (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.1800petmeds.com/role/SubsequentEventsDetails">
        <link:definition>0000031 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="pets_ContactCenterMember" abstract="true" name="ContactCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_QuarterlyDividendMember" abstract="false" name="QuarterlyDividendMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_AccruedExpensesAndOtherCurrentLiabilities" abstract="false" name="AccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" abstract="true" name="TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_NewOrderMember" abstract="true" name="NewOrderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_MZHCILLCInvestorRelationsConsultingAgreementMember" abstract="true" name="MZHCILLCInvestorRelationsConsultingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_TermOfAgreement" abstract="false" name="TermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_EmployeeAndDirectorPlansMember" abstract="true" name="EmployeeAndDirectorPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_AccruedSeveranceCosts" abstract="false" name="AccruedSeveranceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_PetCareRxMember" abstract="true" name="PetCareRxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_IntangibleAndOtherAssets" abstract="false" name="IntangibleAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_ReorderMember" abstract="true" name="ReorderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_PartnershipAgreementWithVetsterMember" abstract="true" name="PartnershipAgreementWithVetsterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_RevenueFromContractWithCustomerVariancePercentage" abstract="false" name="RevenueFromContractWithCustomerVariancePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pets_RevenueFromContractWithCustomerVariance" abstract="false" name="RevenueFromContractWithCustomerVariance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_InternetMember" abstract="true" name="InternetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_RestrictionPeriod" abstract="false" name="RestrictionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_NoncontrollingInterestOwnershipPercentagePurchased" abstract="false" name="NoncontrollingInterestOwnershipPercentagePurchased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" abstract="true" name="OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" abstract="true" name="The2016EmployeeEquityCompensationRestrictedStockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_A2022EmployeePlanMember" abstract="true" name="A2022EmployeePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_NetIncomePerCommonShareBasicAndDilutedAbstract" abstract="true" name="NetIncomePerCommonShareBasicAndDilutedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pets_RevenueFromContractWithCustomerPercentage" abstract="false" name="RevenueFromContractWithCustomerPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pets_BasisOfPresentationAndConsolidationPolicyTextBlock" abstract="false" name="BasisOfPresentationAndConsolidationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pets_SharesIssuableUponVestingOfRestrictedStockMember" abstract="true" name="SharesIssuableUponVestingOfRestrictedStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_PerformanceRestrictedStockMember" abstract="true" name="PerformanceRestrictedStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>pets-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:66cb9e58-a04f-48d4-a0bc-a601d74b20f7,g:93132296-a4cf-4603-975d-122774d1cfdf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pets-20221231.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2802ec51-3a5d-4c5b-935d-7a6e4e0aea7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_96bde3d3-a4df-406e-83eb-9614a791e353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2802ec51-3a5d-4c5b-935d-7a6e4e0aea7b" xlink:to="loc_us-gaap_Liabilities_96bde3d3-a4df-406e-83eb-9614a791e353" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_049b3124-0898-412d-99ea-e85b5623fed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2802ec51-3a5d-4c5b-935d-7a6e4e0aea7b" xlink:to="loc_us-gaap_StockholdersEquity_049b3124-0898-412d-99ea-e85b5623fed9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_37151512-729a-4c99-b857-33c753aa9497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2802ec51-3a5d-4c5b-935d-7a6e4e0aea7b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_37151512-729a-4c99-b857-33c753aa9497" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_cb9122ef-55a4-4d53-92ea-543df4d4c037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3148abb6-c34d-4ba0-a0ac-9db372ac2d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_cb9122ef-55a4-4d53-92ea-543df4d4c037" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3148abb6-c34d-4ba0-a0ac-9db372ac2d6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_IntangibleAndOtherAssets_d5b1cade-daad-45f5-bd3a-48bc7f905c99" xlink:href="pets-20221231.xsd#pets_IntangibleAndOtherAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_cb9122ef-55a4-4d53-92ea-543df4d4c037" xlink:to="loc_pets_IntangibleAndOtherAssets_d5b1cade-daad-45f5-bd3a-48bc7f905c99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cba0a403-ac26-43c4-b635-6b91d708501a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_20bd9ebd-dc2d-4a83-aee3-e865a72dcc33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_cba0a403-ac26-43c4-b635-6b91d708501a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_20bd9ebd-dc2d-4a83-aee3-e865a72dcc33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6e62294e-b499-430d-80f4-62edbfad1e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_cba0a403-ac26-43c4-b635-6b91d708501a" xlink:to="loc_us-gaap_LiabilitiesCurrent_6e62294e-b499-430d-80f4-62edbfad1e0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_490569c4-bde9-423c-82f8-c094980554b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8eeb70ad-4d06-47ac-abc2-ab4121b14d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_490569c4-bde9-423c-82f8-c094980554b5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8eeb70ad-4d06-47ac-abc2-ab4121b14d0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d3b115e5-1e38-4cc4-be8c-0633a8740876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_490569c4-bde9-423c-82f8-c094980554b5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d3b115e5-1e38-4cc4-be8c-0633a8740876" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e04ab696-4dc3-4696-883b-16ff3d2c906f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_490569c4-bde9-423c-82f8-c094980554b5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e04ab696-4dc3-4696-883b-16ff3d2c906f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_4f8c32a5-f8fa-45ca-b306-88a0ffadb5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_490569c4-bde9-423c-82f8-c094980554b5" xlink:to="loc_us-gaap_PrepaidTaxes_4f8c32a5-f8fa-45ca-b306-88a0ffadb5b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_55f6a560-0411-465b-9d76-a4e6cb502d71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_490569c4-bde9-423c-82f8-c094980554b5" xlink:to="loc_us-gaap_InventoryFinishedGoods_55f6a560-0411-465b-9d76-a4e6cb502d71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6aaf65d0-a539-4a7e-a039-305152c29362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_810ca5c3-ea73-461e-9cbc-66a82f9d2657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6aaf65d0-a539-4a7e-a039-305152c29362" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_810ca5c3-ea73-461e-9cbc-66a82f9d2657" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_bf270acd-ce6d-4240-9d4f-edd59c4214c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6aaf65d0-a539-4a7e-a039-305152c29362" xlink:to="loc_us-gaap_AdditionalPaidInCapital_bf270acd-ce6d-4240-9d4f-edd59c4214c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2a392774-627c-4a98-93c7-bf54335d8d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6aaf65d0-a539-4a7e-a039-305152c29362" xlink:to="loc_us-gaap_PreferredStockValue_2a392774-627c-4a98-93c7-bf54335d8d5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_864a6814-8b84-446a-b086-7f42ea5253e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6aaf65d0-a539-4a7e-a039-305152c29362" xlink:to="loc_us-gaap_CommonStockValue_864a6814-8b84-446a-b086-7f42ea5253e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9dedbfd6-0162-4bad-9d23-56653a9da921" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d18f6795-1404-41c5-b82a-3614ca92e404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9dedbfd6-0162-4bad-9d23-56653a9da921" xlink:to="loc_us-gaap_AccountsPayableCurrent_d18f6795-1404-41c5-b82a-3614ca92e404" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_30e507b1-ef4a-4d64-8154-fdf6fbd92a4b" xlink:href="pets-20221231.xsd#pets_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9dedbfd6-0162-4bad-9d23-56653a9da921" xlink:to="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_30e507b1-ef4a-4d64-8154-fdf6fbd92a4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_acdef104-f16c-4375-84b9-eb6f22dbd428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a2a458f7-a6f9-4061-9ace-a176ce448096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_acdef104-f16c-4375-84b9-eb6f22dbd428" xlink:to="loc_us-gaap_AssetsCurrent_a2a458f7-a6f9-4061-9ace-a176ce448096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_77b5434a-fa06-4b8f-916e-c6869f989b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_acdef104-f16c-4375-84b9-eb6f22dbd428" xlink:to="loc_us-gaap_AssetsNoncurrent_77b5434a-fa06-4b8f-916e-c6869f989b2e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="pets-20221231.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_073bbeea-9067-443f-8e91-8e73dc34b66d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_42310255-0b5a-4e7d-b118-a4de23203838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_073bbeea-9067-443f-8e91-8e73dc34b66d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_42310255-0b5a-4e7d-b118-a4de23203838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_68ddd088-8f15-421b-bad8-bba0fb5a2145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_073bbeea-9067-443f-8e91-8e73dc34b66d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_68ddd088-8f15-421b-bad8-bba0fb5a2145" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_758e8221-32b6-47c7-8891-ad7ae17cab76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d6adca4b-6f57-48cb-b162-8470e88ec662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_758e8221-32b6-47c7-8891-ad7ae17cab76" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d6adca4b-6f57-48cb-b162-8470e88ec662" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_782fae7a-2c75-4e3f-92e3-b366125073cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_758e8221-32b6-47c7-8891-ad7ae17cab76" xlink:to="loc_us-gaap_OperatingIncomeLoss_782fae7a-2c75-4e3f-92e3-b366125073cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_958deb16-b8f0-4da1-91d7-a690a42f8e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_990b45b2-ba45-4e26-a2c3-03189d27c9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_958deb16-b8f0-4da1-91d7-a690a42f8e23" xlink:to="loc_us-gaap_OperatingExpenses_990b45b2-ba45-4e26-a2c3-03189d27c9cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_187d764d-5fb4-45f0-8c15-f302b8cc64b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_958deb16-b8f0-4da1-91d7-a690a42f8e23" xlink:to="loc_us-gaap_GrossProfit_187d764d-5fb4-45f0-8c15-f302b8cc64b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8201c62b-6768-46ff-b7b3-e7afa719c129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c60530ba-6741-43bc-952a-500ab8cbc1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8201c62b-6768-46ff-b7b3-e7afa719c129" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c60530ba-6741-43bc-952a-500ab8cbc1a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_607786a9-9266-48d5-b786-436475d2abcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8201c62b-6768-46ff-b7b3-e7afa719c129" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_607786a9-9266-48d5-b786-436475d2abcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7fc34fc7-ecbd-46c5-8d34-5b33fd9d0f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_d2882e80-dfe3-4f05-b79a-4da664f18cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7fc34fc7-ecbd-46c5-8d34-5b33fd9d0f17" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_d2882e80-dfe3-4f05-b79a-4da664f18cb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_23f8d133-66cd-400c-86fe-cd874787bef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7fc34fc7-ecbd-46c5-8d34-5b33fd9d0f17" xlink:to="loc_us-gaap_Depreciation_23f8d133-66cd-400c-86fe-cd874787bef0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_2000da08-a943-4f04-8f5f-c855323f076f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7fc34fc7-ecbd-46c5-8d34-5b33fd9d0f17" xlink:to="loc_us-gaap_AdvertisingExpense_2000da08-a943-4f04-8f5f-c855323f076f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_cfda69a2-124a-4b76-8eca-6ae4aa354d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_068f71dc-23d8-494b-83ec-2bbd02243c95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_cfda69a2-124a-4b76-8eca-6ae4aa354d2b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_068f71dc-23d8-494b-83ec-2bbd02243c95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1b37dcf8-1374-44a0-999b-3e3d669e5f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_cfda69a2-124a-4b76-8eca-6ae4aa354d2b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1b37dcf8-1374-44a0-999b-3e3d669e5f4b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pets-20221231.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec91fd28-3aab-4f44-a573-ee8e6c14ac3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_331bc527-b71d-46ea-8d8e-af1bff702b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec91fd28-3aab-4f44-a573-ee8e6c14ac3b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_331bc527-b71d-46ea-8d8e-af1bff702b80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_34e500d4-f69e-4e3c-9a0e-bb6922cf8080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec91fd28-3aab-4f44-a573-ee8e6c14ac3b" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_34e500d4-f69e-4e3c-9a0e-bb6922cf8080" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_663b3e0f-9975-4222-8b0c-1cba9639571e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_446bd13b-0a58-4ef0-b90d-3a6d263ff462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_663b3e0f-9975-4222-8b0c-1cba9639571e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_446bd13b-0a58-4ef0-b90d-3a6d263ff462" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7f8770bc-092a-4c0b-a87b-84ef100f2fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_663b3e0f-9975-4222-8b0c-1cba9639571e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7f8770bc-092a-4c0b-a87b-84ef100f2fb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f4d2a743-9776-4274-9ec7-2f990087e0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_663b3e0f-9975-4222-8b0c-1cba9639571e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f4d2a743-9776-4274-9ec7-2f990087e0e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3de5d2f1-1aea-43be-83d1-782f18d73634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d53542d6-9792-490b-8bad-4dbf6b395f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3de5d2f1-1aea-43be-83d1-782f18d73634" xlink:to="loc_us-gaap_NetIncomeLoss_d53542d6-9792-490b-8bad-4dbf6b395f2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0d49e79a-9beb-4ffd-8501-00825588dfec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3de5d2f1-1aea-43be-83d1-782f18d73634" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0d49e79a-9beb-4ffd-8501-00825588dfec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_79ff05a9-1a6c-43da-9485-34cdab4e697a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3de5d2f1-1aea-43be-83d1-782f18d73634" xlink:to="loc_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_79ff05a9-1a6c-43da-9485-34cdab4e697a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_d2855dd8-1fb9-4fca-bde3-cf7dec80afbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3de5d2f1-1aea-43be-83d1-782f18d73634" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_d2855dd8-1fb9-4fca-bde3-cf7dec80afbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b4a85648-e421-42a0-9eba-040af5b15229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3de5d2f1-1aea-43be-83d1-782f18d73634" xlink:to="loc_us-gaap_Depreciation_b4a85648-e421-42a0-9eba-040af5b15229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_99ce19b3-a137-40b9-89bc-612f9890065d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3de5d2f1-1aea-43be-83d1-782f18d73634" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_99ce19b3-a137-40b9-89bc-612f9890065d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_53e6dd05-8a5c-47bb-af32-c4da251406e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3de5d2f1-1aea-43be-83d1-782f18d73634" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_53e6dd05-8a5c-47bb-af32-c4da251406e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4af90946-4664-485c-9d21-3dd2b97b24b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3de5d2f1-1aea-43be-83d1-782f18d73634" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4af90946-4664-485c-9d21-3dd2b97b24b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_914297f6-bbdd-4fe5-a681-335ec5d52f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3de5d2f1-1aea-43be-83d1-782f18d73634" xlink:to="loc_us-gaap_ShareBasedCompensation_914297f6-bbdd-4fe5-a681-335ec5d52f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9f9f6e9a-0500-4054-93eb-97cc5ec16e30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3de5d2f1-1aea-43be-83d1-782f18d73634" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_9f9f6e9a-0500-4054-93eb-97cc5ec16e30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d5c6181e-9da8-4f46-abd7-0678eb852bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3de5d2f1-1aea-43be-83d1-782f18d73634" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d5c6181e-9da8-4f46-abd7-0678eb852bb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b48e648d-3763-4f99-a0e3-29687a3b721a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_4a31c4b4-3a62-471b-8452-6b7b22eb3259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b48e648d-3763-4f99-a0e3-29687a3b721a" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_4a31c4b4-3a62-471b-8452-6b7b22eb3259" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#NetIncomePerShareScheduleofEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_98637051-dfa6-4001-ba93-4d4a208fd431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7684a5fc-7efb-4d0b-9321-77fac59d9f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_98637051-dfa6-4001-ba93-4d4a208fd431" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7684a5fc-7efb-4d0b-9321-77fac59d9f05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b5c7da2e-81cd-4859-8425-6123fb69800d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_98637051-dfa6-4001-ba93-4d4a208fd431" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b5c7da2e-81cd-4859-8425-6123fb69800d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_a9baf925-f1f1-4d67-b393-0e117348d294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_98637051-dfa6-4001-ba93-4d4a208fd431" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_a9baf925-f1f1-4d67-b393-0e117348d294" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>pets-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:66cb9e58-a04f-48d4-a0bc-a601d74b20f7,g:93132296-a4cf-4603-975d-122774d1cfdf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#RevenueRecognitionSummaryofDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails" xlink:type="extended" id="if630e2a5218f4e069ec28991bcd73dbd_RevenueRecognitionSummaryofDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9e532de3-e217-4149-971e-56fafae27140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_da9f9e30-68e8-478b-bca9-cbe3be6400e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e532de3-e217-4149-971e-56fafae27140" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_da9f9e30-68e8-478b-bca9-cbe3be6400e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerPercentage_d6e4e66e-3309-4ac4-91f6-6c70ed56cf5e" xlink:href="pets-20221231.xsd#pets_RevenueFromContractWithCustomerPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e532de3-e217-4149-971e-56fafae27140" xlink:to="loc_pets_RevenueFromContractWithCustomerPercentage_d6e4e66e-3309-4ac4-91f6-6c70ed56cf5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerVariance_b05a1656-7c1d-40af-b1aa-cafcc980960f" xlink:href="pets-20221231.xsd#pets_RevenueFromContractWithCustomerVariance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e532de3-e217-4149-971e-56fafae27140" xlink:to="loc_pets_RevenueFromContractWithCustomerVariance_b05a1656-7c1d-40af-b1aa-cafcc980960f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerVariancePercentage_85ef9ccf-3c52-47df-bba8-fd0411e05ea0" xlink:href="pets-20221231.xsd#pets_RevenueFromContractWithCustomerVariancePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e532de3-e217-4149-971e-56fafae27140" xlink:to="loc_pets_RevenueFromContractWithCustomerVariancePercentage_85ef9ccf-3c52-47df-bba8-fd0411e05ea0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_08e3a772-d2aa-4b7f-9a4c-4ee5e350860e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e532de3-e217-4149-971e-56fafae27140" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_08e3a772-d2aa-4b7f-9a4c-4ee5e350860e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_55b3101b-9985-4489-884f-867fa09c1e99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_08e3a772-d2aa-4b7f-9a4c-4ee5e350860e" xlink:to="loc_srt_MajorCustomersAxis_55b3101b-9985-4489-884f-867fa09c1e99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_55b3101b-9985-4489-884f-867fa09c1e99_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_55b3101b-9985-4489-884f-867fa09c1e99" xlink:to="loc_srt_NameOfMajorCustomerDomain_55b3101b-9985-4489-884f-867fa09c1e99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e47ac69d-a44c-4f41-b10e-9ced10fa0235" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_55b3101b-9985-4489-884f-867fa09c1e99" xlink:to="loc_srt_NameOfMajorCustomerDomain_e47ac69d-a44c-4f41-b10e-9ced10fa0235" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ReorderMember_25fd990e-321c-4f14-b75f-a9f87ffc7fce" xlink:href="pets-20221231.xsd#pets_ReorderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e47ac69d-a44c-4f41-b10e-9ced10fa0235" xlink:to="loc_pets_ReorderMember_25fd990e-321c-4f14-b75f-a9f87ffc7fce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NewOrderMember_1a00fd19-56f2-48b5-97d1-cf795c3965f6" xlink:href="pets-20221231.xsd#pets_NewOrderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e47ac69d-a44c-4f41-b10e-9ced10fa0235" xlink:to="loc_pets_NewOrderMember_1a00fd19-56f2-48b5-97d1-cf795c3965f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_27ef4b0f-872f-4f75-92bb-bade375ce310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_08e3a772-d2aa-4b7f-9a4c-4ee5e350860e" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_27ef4b0f-872f-4f75-92bb-bade375ce310" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_27ef4b0f-872f-4f75-92bb-bade375ce310_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_27ef4b0f-872f-4f75-92bb-bade375ce310" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_27ef4b0f-872f-4f75-92bb-bade375ce310_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_377dddb7-380b-431a-b522-7387dd3f37ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_27ef4b0f-872f-4f75-92bb-bade375ce310" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_377dddb7-380b-431a-b522-7387dd3f37ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_InternetMember_b1bf768e-e89a-48b0-b71f-41f3ad2c5acb" xlink:href="pets-20221231.xsd#pets_InternetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_377dddb7-380b-431a-b522-7387dd3f37ea" xlink:to="loc_pets_InternetMember_b1bf768e-e89a-48b0-b71f-41f3ad2c5acb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ContactCenterMember_d2275fc1-60e1-4f53-87ec-91250a6ebea5" xlink:href="pets-20221231.xsd#pets_ContactCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_377dddb7-380b-431a-b522-7387dd3f37ea" xlink:to="loc_pets_ContactCenterMember_d2275fc1-60e1-4f53-87ec-91250a6ebea5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended" id="i841d1c5897e94990b9ab82bd8b77b4aa_RevenueRecognitionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2a3ce191-1572-45f4-8850-d275043d52f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_33dbc047-baf5-4b05-b597-08145294a436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2a3ce191-1572-45f4-8850-d275043d52f9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_33dbc047-baf5-4b05-b597-08145294a436" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_66445e8c-7923-4712-beb7-1f2d045436fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2a3ce191-1572-45f4-8850-d275043d52f9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_66445e8c-7923-4712-beb7-1f2d045436fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_8bdf76cc-0a13-490a-bb83-fc207ff65a40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_66445e8c-7923-4712-beb7-1f2d045436fb" xlink:to="loc_srt_MajorCustomersAxis_8bdf76cc-0a13-490a-bb83-fc207ff65a40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8bdf76cc-0a13-490a-bb83-fc207ff65a40_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_8bdf76cc-0a13-490a-bb83-fc207ff65a40" xlink:to="loc_srt_NameOfMajorCustomerDomain_8bdf76cc-0a13-490a-bb83-fc207ff65a40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e84f7294-6697-46c2-9c15-f6cfd32fd7f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_8bdf76cc-0a13-490a-bb83-fc207ff65a40" xlink:to="loc_srt_NameOfMajorCustomerDomain_e84f7294-6697-46c2-9c15-f6cfd32fd7f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ReorderMember_2e508cf4-fc36-46c3-822c-f39e8b5c84b5" xlink:href="pets-20221231.xsd#pets_ReorderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e84f7294-6697-46c2-9c15-f6cfd32fd7f8" xlink:to="loc_pets_ReorderMember_2e508cf4-fc36-46c3-822c-f39e8b5c84b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NewOrderMember_23bdf96e-856e-40e1-9bfb-4ffc4860d17f" xlink:href="pets-20221231.xsd#pets_NewOrderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e84f7294-6697-46c2-9c15-f6cfd32fd7f8" xlink:to="loc_pets_NewOrderMember_23bdf96e-856e-40e1-9bfb-4ffc4860d17f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_7f09dbe5-6911-44a6-b8e9-6d7d7d84c2f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_66445e8c-7923-4712-beb7-1f2d045436fb" xlink:to="loc_srt_RestatementAxis_7f09dbe5-6911-44a6-b8e9-6d7d7d84c2f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7f09dbe5-6911-44a6-b8e9-6d7d7d84c2f8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_7f09dbe5-6911-44a6-b8e9-6d7d7d84c2f8" xlink:to="loc_srt_RestatementDomain_7f09dbe5-6911-44a6-b8e9-6d7d7d84c2f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_30bc7d11-7f0f-4460-8e50-bf620ccaf400" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_7f09dbe5-6911-44a6-b8e9-6d7d7d84c2f8" xlink:to="loc_srt_RestatementDomain_30bc7d11-7f0f-4460-8e50-bf620ccaf400" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_6c8f6908-9202-453a-a187-9ffaa7f2c347" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_30bc7d11-7f0f-4460-8e50-bf620ccaf400" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_6c8f6908-9202-453a-a187-9ffaa7f2c347" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#NetIncomePerShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails" xlink:type="extended" id="i58046205465942d6a0c6b312be500c80_NetIncomePerShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_504c7f74-0892-4c6c-a86b-bc3b5fa5558e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d8572ebb-7955-4ac3-ac89-951489f8a4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_504c7f74-0892-4c6c-a86b-bc3b5fa5558e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d8572ebb-7955-4ac3-ac89-951489f8a4ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_278ed635-deb5-41d2-a883-fe6b304f01dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_504c7f74-0892-4c6c-a86b-bc3b5fa5558e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_278ed635-deb5-41d2-a883-fe6b304f01dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9492813f-8d80-43b1-b110-29592c6a6e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_278ed635-deb5-41d2-a883-fe6b304f01dc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9492813f-8d80-43b1-b110-29592c6a6e91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9492813f-8d80-43b1-b110-29592c6a6e91_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9492813f-8d80-43b1-b110-29592c6a6e91" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9492813f-8d80-43b1-b110-29592c6a6e91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8f84fa29-9092-4847-97db-376adb120eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9492813f-8d80-43b1-b110-29592c6a6e91" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8f84fa29-9092-4847-97db-376adb120eaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_d1e4f499-7bf6-462c-8677-02f8a0a32651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8f84fa29-9092-4847-97db-376adb120eaa" xlink:to="loc_us-gaap_RestrictedStockMember_d1e4f499-7bf6-462c-8677-02f8a0a32651" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SharesIssuableUponVestingOfRestrictedStockMember_f58d3c15-82ef-49e2-8b1a-03384659d594" xlink:href="pets-20221231.xsd#pets_SharesIssuableUponVestingOfRestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8f84fa29-9092-4847-97db-376adb120eaa" xlink:to="loc_pets_SharesIssuableUponVestingOfRestrictedStockMember_f58d3c15-82ef-49e2-8b1a-03384659d594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_8e6c3f5b-f43f-4eeb-a839-f6de48a31454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8f84fa29-9092-4847-97db-376adb120eaa" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_8e6c3f5b-f43f-4eeb-a839-f6de48a31454" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#AccountingforStockBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails" xlink:type="extended" id="i789dc2939092447a923a72b83dc5f417_AccountingforStockBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_ea4db874-4ed1-44b0-bb07-322b9621e97a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_ea4db874-4ed1-44b0-bb07-322b9621e97a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RestrictionPeriod_874c2c68-6fe6-46b7-b25b-f98410836484" xlink:href="pets-20221231.xsd#pets_RestrictionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_pets_RestrictionPeriod_874c2c68-6fe6-46b7-b25b-f98410836484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_24f8e591-00f4-4407-a390-d4e101316f67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_24f8e591-00f4-4407-a390-d4e101316f67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1f1b4bc4-4bfa-42a8-969d-c7d7c601b8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1f1b4bc4-4bfa-42a8-969d-c7d7c601b8a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3fbb1e56-6eb7-4ab3-a77c-67c5d5e818ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3fbb1e56-6eb7-4ab3-a77c-67c5d5e818ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7379a597-7fa5-454a-bec1-c839bf0344bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7379a597-7fa5-454a-bec1-c839bf0344bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e7a04209-8d0e-4bc4-9ba4-97b4505e2b05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e7a04209-8d0e-4bc4-9ba4-97b4505e2b05" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b9585b1e-90e5-409f-b09d-7251657c6739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b9585b1e-90e5-409f-b09d-7251657c6739" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7867d3c6-4b58-4874-9c3e-b655635065be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7867d3c6-4b58-4874-9c3e-b655635065be" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ba8ca6da-916f-41bb-80d2-c3b453054470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:to="loc_us-gaap_PlanNameAxis_ba8ca6da-916f-41bb-80d2-c3b453054470" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ba8ca6da-916f-41bb-80d2-c3b453054470_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ba8ca6da-916f-41bb-80d2-c3b453054470" xlink:to="loc_us-gaap_PlanNameDomain_ba8ca6da-916f-41bb-80d2-c3b453054470_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ba8ca6da-916f-41bb-80d2-c3b453054470" xlink:to="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_ecc8ab53-9ebd-401a-a9ae-8a0437521a9d" xlink:href="pets-20221231.xsd#pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:to="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_ecc8ab53-9ebd-401a-a9ae-8a0437521a9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_c7ed857e-6dc7-4a4a-a857-88c1897ee7a9" xlink:href="pets-20221231.xsd#pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:to="loc_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_c7ed857e-6dc7-4a4a-a857-88c1897ee7a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmployeeAndDirectorPlansMember_c00811a3-fda6-49a0-b4c7-d3438435a032" xlink:href="pets-20221231.xsd#pets_EmployeeAndDirectorPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:to="loc_pets_EmployeeAndDirectorPlansMember_c00811a3-fda6-49a0-b4c7-d3438435a032" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_9716b34a-99a3-4b2a-b4f2-dc064f6a9d71" xlink:href="pets-20221231.xsd#pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:to="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_9716b34a-99a3-4b2a-b4f2-dc064f6a9d71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_A2022EmployeePlanMember_98751569-9bf8-4908-97c0-0b135cf5abc8" xlink:href="pets-20221231.xsd#pets_A2022EmployeePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:to="loc_pets_A2022EmployeePlanMember_98751569-9bf8-4908-97c0-0b135cf5abc8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_aecce266-f7f2-4f8c-b20a-8f19eeabd89f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:to="loc_us-gaap_AwardTypeAxis_aecce266-f7f2-4f8c-b20a-8f19eeabd89f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aecce266-f7f2-4f8c-b20a-8f19eeabd89f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_aecce266-f7f2-4f8c-b20a-8f19eeabd89f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aecce266-f7f2-4f8c-b20a-8f19eeabd89f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e594f456-d563-4885-a96a-d916df044a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_aecce266-f7f2-4f8c-b20a-8f19eeabd89f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e594f456-d563-4885-a96a-d916df044a71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e23d738b-1ee0-43d4-8de0-8b1ac8ad7664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e594f456-d563-4885-a96a-d916df044a71" xlink:to="loc_us-gaap_RestrictedStockMember_e23d738b-1ee0-43d4-8de0-8b1ac8ad7664" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockMember_0e2d18a0-7f22-4240-9abe-282c64846001" xlink:href="pets-20221231.xsd#pets_PerformanceRestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e594f456-d563-4885-a96a-d916df044a71" xlink:to="loc_pets_PerformanceRestrictedStockMember_0e2d18a0-7f22-4240-9abe-282c64846001" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d06119e4-028d-43b8-a4a8-2d0e15224997" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:to="loc_srt_RangeAxis_d06119e4-028d-43b8-a4a8-2d0e15224997" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d06119e4-028d-43b8-a4a8-2d0e15224997_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d06119e4-028d-43b8-a4a8-2d0e15224997" xlink:to="loc_srt_RangeMember_d06119e4-028d-43b8-a4a8-2d0e15224997_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2857bf1b-dbc6-43a9-96bf-d8bf2fe9c61f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d06119e4-028d-43b8-a4a8-2d0e15224997" xlink:to="loc_srt_RangeMember_2857bf1b-dbc6-43a9-96bf-d8bf2fe9c61f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_156c97e1-cff1-4b8d-b533-75cfc7257570" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2857bf1b-dbc6-43a9-96bf-d8bf2fe9c61f" xlink:to="loc_srt_MinimumMember_156c97e1-cff1-4b8d-b533-75cfc7257570" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a268e4c7-95e2-4add-8d25-74ff5cd07fb3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2857bf1b-dbc6-43a9-96bf-d8bf2fe9c61f" xlink:to="loc_srt_MaximumMember_a268e4c7-95e2-4add-8d25-74ff5cd07fb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_62a1c7cb-8e1c-441a-9872-090a4ac85f7e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:to="loc_srt_TitleOfIndividualAxis_62a1c7cb-8e1c-441a-9872-090a4ac85f7e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_62a1c7cb-8e1c-441a-9872-090a4ac85f7e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_62a1c7cb-8e1c-441a-9872-090a4ac85f7e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_62a1c7cb-8e1c-441a-9872-090a4ac85f7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46e12e47-9eca-471d-8c3f-9bd323e3f307" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_62a1c7cb-8e1c-441a-9872-090a4ac85f7e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46e12e47-9eca-471d-8c3f-9bd323e3f307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_67d5d489-5f7f-4a94-a9c9-49c40b935d2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46e12e47-9eca-471d-8c3f-9bd323e3f307" xlink:to="loc_srt_ChiefExecutiveOfficerMember_67d5d489-5f7f-4a94-a9c9-49c40b935d2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefFinancialOfficerMember_d512678d-6c8a-4741-8354-d5b650dda16d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46e12e47-9eca-471d-8c3f-9bd323e3f307" xlink:to="loc_srt_ChiefFinancialOfficerMember_d512678d-6c8a-4741-8354-d5b650dda16d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails" xlink:type="extended" id="i18a1f0ae86cc429183a7bf03c2c6afd2_ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_685bf676-0df5-4aff-bf3f-d18d7b597ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_685bf676-0df5-4aff-bf3f-d18d7b597ebb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_99fe7cfe-243f-405e-bce5-8af3289881a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:to="loc_us-gaap_StockholdersEquity_99fe7cfe-243f-405e-bce5-8af3289881a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a87fc32c-09ce-4633-b664-22a77dd8e61b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a87fc32c-09ce-4633-b664-22a77dd8e61b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcd4d334-54fa-4fab-976b-323bbe6dc80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcd4d334-54fa-4fab-976b-323bbe6dc80b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_5ba3f4b3-7477-44f6-bc73-1be8145e732f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:to="loc_us-gaap_DividendsCommonStock_5ba3f4b3-7477-44f6-bc73-1be8145e732f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a19d135f-c399-4b7f-8790-a49d7684cd74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:to="loc_us-gaap_NetIncomeLoss_a19d135f-c399-4b7f-8790-a49d7684cd74" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_aaef41e1-e8d8-40a8-a3c6-4dd69437bf82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a5e0affa-1575-4bd7-b06b-5269bada3100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_685bf676-0df5-4aff-bf3f-d18d7b597ebb" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a5e0affa-1575-4bd7-b06b-5269bada3100" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d9e718e2-a966-46a8-9560-f394c23537dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a5e0affa-1575-4bd7-b06b-5269bada3100" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d9e718e2-a966-46a8-9560-f394c23537dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d9e718e2-a966-46a8-9560-f394c23537dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9e718e2-a966-46a8-9560-f394c23537dd" xlink:to="loc_us-gaap_EquityComponentDomain_d9e718e2-a966-46a8-9560-f394c23537dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7fb7753d-57db-49b6-8de0-ece24fede810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9e718e2-a966-46a8-9560-f394c23537dd" xlink:to="loc_us-gaap_EquityComponentDomain_7fb7753d-57db-49b6-8de0-ece24fede810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a0484920-005e-4207-83b3-c8c5207080e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7fb7753d-57db-49b6-8de0-ece24fede810" xlink:to="loc_us-gaap_CommonStockMember_a0484920-005e-4207-83b3-c8c5207080e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b6c7af8d-23b9-4333-a354-523573e4d8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7fb7753d-57db-49b6-8de0-ece24fede810" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b6c7af8d-23b9-4333-a354-523573e4d8c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a7506393-e707-429b-af03-38d6053a0383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7fb7753d-57db-49b6-8de0-ece24fede810" xlink:to="loc_us-gaap_RetainedEarningsMember_a7506393-e707-429b-af03-38d6053a0383" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#MinorityInterestInvestmentinVetsterDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails" xlink:type="extended" id="i8e58e7048f8e478daf2a3ea955e4de1f_MinorityInterestInvestmentinVetsterDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_c71d19ed-7fd8-4737-954e-6e2e8fbaf8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TermOfAgreement_1d8a6230-046e-475c-9ba6-a397476470ee" xlink:href="pets-20221231.xsd#pets_TermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c71d19ed-7fd8-4737-954e-6e2e8fbaf8b7" xlink:to="loc_pets_TermOfAgreement_1d8a6230-046e-475c-9ba6-a397476470ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NoncontrollingInterestOwnershipPercentagePurchased_14c20662-db5a-4768-9ac8-9f415bf1aade" xlink:href="pets-20221231.xsd#pets_NoncontrollingInterestOwnershipPercentagePurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c71d19ed-7fd8-4737-954e-6e2e8fbaf8b7" xlink:to="loc_pets_NoncontrollingInterestOwnershipPercentagePurchased_14c20662-db5a-4768-9ac8-9f415bf1aade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_15502b32-9300-412a-9e49-b5f2f4a217f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_c71d19ed-7fd8-4737-954e-6e2e8fbaf8b7" xlink:to="loc_us-gaap_Investments_15502b32-9300-412a-9e49-b5f2f4a217f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_e50b7894-d93f-4b7f-ba82-11e2c8836258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_c71d19ed-7fd8-4737-954e-6e2e8fbaf8b7" xlink:to="loc_us-gaap_MinorityInterestTable_e50b7894-d93f-4b7f-ba82-11e2c8836258" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_f559aaee-465f-4d8f-9820-a2d06964f646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_e50b7894-d93f-4b7f-ba82-11e2c8836258" xlink:to="loc_us-gaap_TypeOfArrangementAxis_f559aaee-465f-4d8f-9820-a2d06964f646" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f559aaee-465f-4d8f-9820-a2d06964f646_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f559aaee-465f-4d8f-9820-a2d06964f646" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f559aaee-465f-4d8f-9820-a2d06964f646_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a67ea7ca-c4fa-4370-af26-110c4ef3079f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f559aaee-465f-4d8f-9820-a2d06964f646" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a67ea7ca-c4fa-4370-af26-110c4ef3079f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PartnershipAgreementWithVetsterMember_6a40cb7f-e1e0-4a59-bcb8-403bc08629db" xlink:href="pets-20221231.xsd#pets_PartnershipAgreementWithVetsterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a67ea7ca-c4fa-4370-af26-110c4ef3079f" xlink:to="loc_pets_PartnershipAgreementWithVetsterMember_6a40cb7f-e1e0-4a59-bcb8-403bc08629db" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/SubsequentEventsDetails" xlink:type="extended" id="i24fea6c650654d47a9e87ad91896f303_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_f1281c1a-1cfd-4ef6-8e3f-e8f67ee91165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ada45f38-6232-4e17-b2f8-01c448635b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1281c1a-1cfd-4ef6-8e3f-e8f67ee91165" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ada45f38-6232-4e17-b2f8-01c448635b99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_d18e7b5a-f0d3-4335-b031-e10828f3386f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1281c1a-1cfd-4ef6-8e3f-e8f67ee91165" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_d18e7b5a-f0d3-4335-b031-e10828f3386f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_1c8cd736-76c5-4e3e-a8f8-94311e114ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1281c1a-1cfd-4ef6-8e3f-e8f67ee91165" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_1c8cd736-76c5-4e3e-a8f8-94311e114ea0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6f4b4e4e-0b34-403a-99e6-edde495d6335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1281c1a-1cfd-4ef6-8e3f-e8f67ee91165" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6f4b4e4e-0b34-403a-99e6-edde495d6335" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1281c1a-1cfd-4ef6-8e3f-e8f67ee91165" xlink:to="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_08a8f0ca-56b8-4f31-9810-9c18f17341fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_08a8f0ca-56b8-4f31-9810-9c18f17341fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_08a8f0ca-56b8-4f31-9810-9c18f17341fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_08a8f0ca-56b8-4f31-9810-9c18f17341fb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_08a8f0ca-56b8-4f31-9810-9c18f17341fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_315ee0e8-621b-44e4-ac43-e055d6c4411f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_08a8f0ca-56b8-4f31-9810-9c18f17341fb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_315ee0e8-621b-44e4-ac43-e055d6c4411f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b4730616-0f34-4a4b-b15d-4ebaeca2fa41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_315ee0e8-621b-44e4-ac43-e055d6c4411f" xlink:to="loc_us-gaap_SubsequentEventMember_b4730616-0f34-4a4b-b15d-4ebaeca2fa41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a5533ad1-4277-4af5-9b02-5c6ce7cd76b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:to="loc_us-gaap_AwardTypeAxis_a5533ad1-4277-4af5-9b02-5c6ce7cd76b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5533ad1-4277-4af5-9b02-5c6ce7cd76b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a5533ad1-4277-4af5-9b02-5c6ce7cd76b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5533ad1-4277-4af5-9b02-5c6ce7cd76b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93e1ae7b-2cbf-412c-a41f-7e739847face" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a5533ad1-4277-4af5-9b02-5c6ce7cd76b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93e1ae7b-2cbf-412c-a41f-7e739847face" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8b127ee4-59f7-4381-8351-098b33d5426e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93e1ae7b-2cbf-412c-a41f-7e739847face" xlink:to="loc_us-gaap_CommonStockMember_8b127ee4-59f7-4381-8351-098b33d5426e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_b5c4497f-981a-4b49-9f6a-e983a4aff25d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93e1ae7b-2cbf-412c-a41f-7e739847face" xlink:to="loc_us-gaap_EmployeeStockMember_b5c4497f-981a-4b49-9f6a-e983a4aff25d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_13dc21a5-fc86-491f-918d-0920461930e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93e1ae7b-2cbf-412c-a41f-7e739847face" xlink:to="loc_us-gaap_RestrictedStockMember_13dc21a5-fc86-491f-918d-0920461930e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_849eaafc-2d37-4bfd-9955-6103391bdad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:to="loc_us-gaap_PlanNameAxis_849eaafc-2d37-4bfd-9955-6103391bdad6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_849eaafc-2d37-4bfd-9955-6103391bdad6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_849eaafc-2d37-4bfd-9955-6103391bdad6" xlink:to="loc_us-gaap_PlanNameDomain_849eaafc-2d37-4bfd-9955-6103391bdad6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_84942ea6-2798-420c-b997-380159c273ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_849eaafc-2d37-4bfd-9955-6103391bdad6" xlink:to="loc_us-gaap_PlanNameDomain_84942ea6-2798-420c-b997-380159c273ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_1cd1e900-8820-47cc-a798-5790f467bbb2" xlink:href="pets-20221231.xsd#pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_84942ea6-2798-420c-b997-380159c273ab" xlink:to="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_1cd1e900-8820-47cc-a798-5790f467bbb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_MZHCILLCInvestorRelationsConsultingAgreementMember_37b19dc5-5b34-4e7b-bb0f-42f49602d174" xlink:href="pets-20221231.xsd#pets_MZHCILLCInvestorRelationsConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_84942ea6-2798-420c-b997-380159c273ab" xlink:to="loc_pets_MZHCILLCInvestorRelationsConsultingAgreementMember_37b19dc5-5b34-4e7b-bb0f-42f49602d174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_cb1aa849-c9e0-458a-9640-e3aaa408b8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:to="loc_us-gaap_DividendsAxis_cb1aa849-c9e0-458a-9640-e3aaa408b8af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_cb1aa849-c9e0-458a-9640-e3aaa408b8af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DividendsAxis_cb1aa849-c9e0-458a-9640-e3aaa408b8af" xlink:to="loc_us-gaap_DividendsDomain_cb1aa849-c9e0-458a-9640-e3aaa408b8af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_b17bf129-d44d-4eaa-b8cd-faf515ea951c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DividendsAxis_cb1aa849-c9e0-458a-9640-e3aaa408b8af" xlink:to="loc_us-gaap_DividendsDomain_b17bf129-d44d-4eaa-b8cd-faf515ea951c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_QuarterlyDividendMember_fb25d644-0f25-479a-8de0-a0b8995b2c44" xlink:href="pets-20221231.xsd#pets_QuarterlyDividendMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_b17bf129-d44d-4eaa-b8cd-faf515ea951c" xlink:to="loc_pets_QuarterlyDividendMember_fb25d644-0f25-479a-8de0-a0b8995b2c44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5ff7deaf-d989-40ba-95b0-fb27fc46dc2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5ff7deaf-d989-40ba-95b0-fb27fc46dc2d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5ff7deaf-d989-40ba-95b0-fb27fc46dc2d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5ff7deaf-d989-40ba-95b0-fb27fc46dc2d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5ff7deaf-d989-40ba-95b0-fb27fc46dc2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cd75289-56d4-48cf-af69-4a698d669972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5ff7deaf-d989-40ba-95b0-fb27fc46dc2d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cd75289-56d4-48cf-af69-4a698d669972" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PetCareRxMember_163ba8d6-c5e8-4920-a48c-031fe96d4532" xlink:href="pets-20221231.xsd#pets_PetCareRxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cd75289-56d4-48cf-af69-4a698d669972" xlink:to="loc_pets_PetCareRxMember_163ba8d6-c5e8-4920-a48c-031fe96d4532" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>pets-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:66cb9e58-a04f-48d4-a0bc-a601d74b20f7,g:93132296-a4cf-4603-975d-122774d1cfdf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_47fcc899-a42b-4f08-8abd-29735c319fbe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_b114c9f3-3ff0-4a02-bafb-d0705357d78f_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ab93098d-833e-4f20-b4d5-d64457f65a36_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_57a91aca-be8a-4267-a2e7-70c550c20ae4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_affee099-7d7d-4e99-ab00-ea0d8d8f261f_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_bee11e8e-2014-4953-b624-78c2c828c7c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_e3571c8e-6c9a-4632-bab5-700adc4d202a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_70f0a01d-d3b7-4ab8-b5a4-f6d84777afc1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_57a25e85-6673-41b7-8213-a8437cc44ba8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_RestrictionPeriod_f74e594f-96f5-454c-8cea-318ca89c2eac_terseLabel_en-US" xlink:label="lab_pets_RestrictionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restriction period</link:label>
    <link:label id="lab_pets_RestrictionPeriod_label_en-US" xlink:label="lab_pets_RestrictionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restriction Period</link:label>
    <link:label id="lab_pets_RestrictionPeriod_documentation_en-US" xlink:label="lab_pets_RestrictionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of restriction of forfeiture.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RestrictionPeriod" xlink:href="pets-20221231.xsd#pets_RestrictionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_RestrictionPeriod" xlink:to="lab_pets_RestrictionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6f7fb5b6-02f1-4d39-95ac-b085c52d0943_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1c229579-0756-484a-9cbc-9d2e95249e6b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_dd8e8b64-f047-48eb-85d8-040535956c48_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_02dc209a-ad12-4636-8288-49cd97402480_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_563685b5-445f-4c5c-804e-59f60ba85c6c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5515a79c-cf37-426c-9f7b-275202bcb0bb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_64e47fd1-12c2-4cb9-9275-625d80c55408_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in diluted computation (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_704c515e-5474-4297-a0e4-9db27cfcc7a4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_85660c00-1c57-4e9c-ab80-c3a2d0b21286_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable in accrued expenses</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_ca826514-a744-4aaf-b3b9-08042eecf4b0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f62b2678-4f16-43d2-be4c-04e4541f3097_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_411c1ee6-b81a-40b9-a2ed-a02dc01ed192_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority interest purchased, amount</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_ecc26fcf-1b0a-4f82-a026-91ab72257c7c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_bd6527df-6a97-473b-8992-c62fc60013e2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $.001 par value, 40,000 shares authorized; 21,077 and 20,979 shares issued and outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_03d63460-a7f5-4df7-99dc-91f16eda05c5_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_88d19791-9215-4cd5-bf72-63f518aa6fb5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_5592e1fd-91ab-408e-9c28-fcc8c4914848_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_5b5c3821-73a3-4332-8fd0-f11d0134fdc9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted common shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_f161cf2f-c919-4623-a3f6-b74b43dc4360_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased_b9e269c4-01d2-4f7d-bb7d-9bfcb01254e4_terseLabel_en-US" xlink:label="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority interest purchased, percent</link:label>
    <link:label id="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased_label_en-US" xlink:label="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Ownership Percentage Purchased</link:label>
    <link:label id="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased_documentation_en-US" xlink:label="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents minority interest purchased.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NoncontrollingInterestOwnershipPercentagePurchased" xlink:href="pets-20221231.xsd#pets_NoncontrollingInterestOwnershipPercentagePurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_NoncontrollingInterestOwnershipPercentagePurchased" xlink:to="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_6ff663df-e93d-4416-be9f-81ec914f77c7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b4f9635b-9c0e-487d-b4ca-b70b0e29126e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0776881d-8c6d-4194-abac-5eaaeaa77711_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c0f99b54-5276-4c81-a3cc-f507707a3690_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_fa438b07-7bd3-4fba-aa19-bc959cbd4c7f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_f1881ceb-281d-4e51-ad06-a047fd7de806_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_ca5fde29-5cf7-4ad2-a776-55e823a079d8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_207621cc-5d4a-4196-9fcb-93c5bf9bcb50_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories - finished goods</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Finished Goods and Work in Process Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_66e83507-4d63-496b-8927-239a50367a86_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_f2a876e8-c480-404d-b0b7-8ae8f16ac210_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_db5aa62f-fd4e-41ef-8de5-db5aa4276a3c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0efded0-74a5-4bb0-b9f5-e467be3f4178_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4b15e2cd-ce37-4a67-bdd8-ff3294509400_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_6663350a-235a-4727-be60-7198356cbd38_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_SharesIssuableUponVestingOfRestrictedStockMember_362e538e-fa10-4c3f-8cfa-148ab9d9a04d_terseLabel_en-US" xlink:label="lab_pets_SharesIssuableUponVestingOfRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issuable Upon Vesting of Restricted Stock</link:label>
    <link:label id="lab_pets_SharesIssuableUponVestingOfRestrictedStockMember_label_en-US" xlink:label="lab_pets_SharesIssuableUponVestingOfRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issuable Upon Vesting Of Restricted Stock [Member]</link:label>
    <link:label id="lab_pets_SharesIssuableUponVestingOfRestrictedStockMember_documentation_en-US" xlink:label="lab_pets_SharesIssuableUponVestingOfRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issuable Upon Vesting Of Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SharesIssuableUponVestingOfRestrictedStockMember" xlink:href="pets-20221231.xsd#pets_SharesIssuableUponVestingOfRestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_SharesIssuableUponVestingOfRestrictedStockMember" xlink:to="lab_pets_SharesIssuableUponVestingOfRestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_0c4e3fc8-4778-4a61-8260-a78824ef26bd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_503241c1-a0bd-473e-ba14-a7264c7c4670_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_49a42652-3198-49b6-be01-3de5369db01e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_71e5fdbc-4392-48e5-b3ca-d6fc10c7a046_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_51441056-8412-4f4e-8121-b01108110310_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_5c2aec4e-ab61-4856-8da8-2110a4222dd0_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_A2022EmployeePlanMember_2221391a-a937-4bfa-bf28-edc02fbbf2fc_terseLabel_en-US" xlink:label="lab_pets_A2022EmployeePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Employee Plan</link:label>
    <link:label id="lab_pets_A2022EmployeePlanMember_label_en-US" xlink:label="lab_pets_A2022EmployeePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Employee Plan [Member]</link:label>
    <link:label id="lab_pets_A2022EmployeePlanMember_documentation_en-US" xlink:label="lab_pets_A2022EmployeePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Employee Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_A2022EmployeePlanMember" xlink:href="pets-20221231.xsd#pets_A2022EmployeePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_A2022EmployeePlanMember" xlink:to="lab_pets_A2022EmployeePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_714d201b-b7de-495a-90c4-4f9282ab399b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_a986ae4e-bb97-4301-a911-80612456ad4c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_3c01b34d-bb24-4a50-bbab-d89ce6747e85_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_7137613e-ab0e-4ceb-8be2-7b9662098efe_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_TermOfAgreement_70b97ea6-b01d-425f-bc9e-5548a91b2af1_terseLabel_en-US" xlink:label="lab_pets_TermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of agreement</link:label>
    <link:label id="lab_pets_TermOfAgreement_label_en-US" xlink:label="lab_pets_TermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Of Agreement</link:label>
    <link:label id="lab_pets_TermOfAgreement_documentation_en-US" xlink:label="lab_pets_TermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents term of agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TermOfAgreement" xlink:href="pets-20221231.xsd#pets_TermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_TermOfAgreement" xlink:to="lab_pets_TermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_fd29387a-629e-4577-b12a-72356c02dd37_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_79c080a3-5245-43e2-85b4-cdb96f406329_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_76b3c054-bbce-4581-ae38-4473c6444816_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_6117dee4-f1ec-4367-95bc-2b8ff6ff9e8f_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_270f0473-1616-408d-aa33-3de5204f32a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_d1d0f3e9-59a6-4598-b789-bafd6765292c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_eb2f2ccb-babd-40f2-9feb-d371c9f88aaa_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4ede8ff5-9e78-4bc9-bc68-04ea7106ada1_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7e64ccab-6157-49b4-ba68-57ca9e63a875_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_EmployeeAndDirectorPlansMember_82b54ff1-c232-404d-a7ad-b7f7f6db398f_terseLabel_en-US" xlink:label="lab_pets_EmployeeAndDirectorPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Employee Plan and 2015 Director Plan</link:label>
    <link:label id="lab_pets_EmployeeAndDirectorPlansMember_label_en-US" xlink:label="lab_pets_EmployeeAndDirectorPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee and Director Plans [Member]</link:label>
    <link:label id="lab_pets_EmployeeAndDirectorPlansMember_documentation_en-US" xlink:label="lab_pets_EmployeeAndDirectorPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refers to information regarding employee and director plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmployeeAndDirectorPlansMember" xlink:href="pets-20221231.xsd#pets_EmployeeAndDirectorPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_EmployeeAndDirectorPlansMember" xlink:to="lab_pets_EmployeeAndDirectorPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bd87b5e8-24ff-402c-bd60-2e4000eabbff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_56442030-fa3c-40a3-a6a1-1b65552b4cde_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_894ac153-d9ff-4955-a1b7-60027275d9ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_148b2138-8eec-466f-b23c-6340d0dfb6c9_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e26e7c9b-1216-47a9-8bf4-781f50503885_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_3989ed8f-d33a-42b1-92a3-1a8c2c092791_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State sales tax assessment accruals</link:label>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Taxes Other than Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ea9a86b0-019e-4035-ac34-b0bb70c1e4e9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_487b1aaa-124c-4457-a820-0be0c0a8925a_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_396c8609-6beb-426b-b108-5b865870474e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2401ce2f-7b6d-4257-9e2d-3a9e05203a84_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_01a6d488-0f3b-4d93-a87d-1c301eeabbef_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_2d392817-ef7b-4c0b-96f0-a34c86d7febb_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_709251aa-f03d-4cb6-9d47-223e271b8b20_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0cae8028-2ad6-4f6f-93ef-83d8022399cb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_97aa3572-e25a-4456-8193-cb0d0d10a668_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8e02aae5-9b79-4488-a42c-1a22da66acce_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_83fa3da8-1440-4bb8-9827-13debfb29322_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_8eb6acfb-5bd3-487f-ad90-2e460d2fbc25_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_730890c8-1381-4e59-b05a-ca492c0a925f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0f11189c-bab7-4dca-89c0-abfe64e04348_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_46746c4e-b7cf-4ba4-8abc-4571613cf49a_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_522c68a8-ff13-4c67-a9da-b5d742769e51_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cdeb8000-d94d-4f78-b654-d4e279126778_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_f25185be-d74d-46a6-8cdb-e4be4753cdf3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_557816ef-98f8-4844-9c48-9bd9ee3fee01_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b747df58-c95d-4612-b209-e95d7dd30d26_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_d4e50b1f-c8d9-43f5-aea6-f0013ee62cf1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_99dca07d-fb9c-4545-b50e-0de09f3674ab_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased and retired (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_6aefc5f7-459a-4c7e-8e41-58968118b93e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b1776593-5479-4648-ab23-7dcb8dc8d611_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_5eddf194-f908-4679-a79a-9a6aa39add0d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_2dee37df-24d3-4c7c-82ca-891b23f77489_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_89d3036b-f5ba-47d5-92a9-cc69177f9c05_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_dfb1da5f-f32a-4739-a0cc-d014cd729959_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_4d5b7fd5-13ed-4d27-95fe-d30fb23d24a7_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e578e4ad-d726-4f86-a72e-4a2660e0dbbb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_f37165c3-bedc-4a1f-a10e-da3725684786_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_433b8a31-53b5-424e-a10f-d59ad1828c26_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0899bf53-f7ce-4a0f-b4ea-2b50ec7c44aa_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_857d6033-333e-4b97-98ab-b5a042a18275_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_c3dcd456-d186-4b25-8a2e-744697c9a7bc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, liquidation preference (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreference" xlink:to="lab_us-gaap_PreferredStockLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_a0ef944b-a59c-4181-be13-e3b761157438_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fba8dafb-9f03-4748-9a27-c0456dd4485a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares (denominator):</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_e4fbac5b-c892-45bc-8093-24f3a9dc5474_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_AccruedExpensesAndOtherCurrentLiabilities_0ba5103d-100e-4f04-9a6f-543dd364044e_terseLabel_en-US" xlink:label="lab_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_pets_AccruedExpensesAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_pets_AccruedExpensesAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:href="pets-20221231.xsd#pets_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_778330f1-4c56-49fa-a1bf-29f54f5d0aff_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a09740df-5d93-43b9-994a-8a4a94ff7bee_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_f9a73803-7eaa-43b0-936f-ea66b3ec1c0e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5517675c-f5ad-489f-85a7-40e536442867_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_9dcbf653-fa6a-4785-bfaf-5bcd1dbb74e0_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority Interest Investment in Vetster</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_bfb5f152-e9b4-4d81-abd4-1dbc06b6c7ab_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_87dafb1c-1859-402a-9755-687440e47ac3_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_ReorderMember_4a7363b4-062a-486b-ac58-4c74bf5d175d_terseLabel_en-US" xlink:label="lab_pets_ReorderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorder sales</link:label>
    <link:label id="lab_pets_ReorderMember_label_en-US" xlink:label="lab_pets_ReorderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorder Customer [Member]</link:label>
    <link:label id="lab_pets_ReorderMember_documentation_en-US" xlink:label="lab_pets_ReorderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disaggregate of revenue in reorder sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ReorderMember" xlink:href="pets-20221231.xsd#pets_ReorderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_ReorderMember" xlink:to="lab_pets_ReorderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_RevenueFromContractWithCustomerVariancePercentage_85692bae-cf95-45f6-9393-d7a9ff668f5d_terseLabel_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerVariancePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues, variance, percentage</link:label>
    <link:label id="lab_pets_RevenueFromContractWithCustomerVariancePercentage_label_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerVariancePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Variance Percentage</link:label>
    <link:label id="lab_pets_RevenueFromContractWithCustomerVariancePercentage_documentation_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerVariancePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of changes in revenue in current period comparing to the same period in the previous year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerVariancePercentage" xlink:href="pets-20221231.xsd#pets_RevenueFromContractWithCustomerVariancePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_RevenueFromContractWithCustomerVariancePercentage" xlink:to="lab_pets_RevenueFromContractWithCustomerVariancePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ba87c23d-bb05-4791-bd52-79e8ec9b38b7_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b83b1587-7339-48bf-85ca-9f132fa232c0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_89e4c212-7545-466c-9605-fcda38e8cc9e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding used in basic computation (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3206c10-d7bd-455f-9cc2-13fb61bdc61f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PetCareRxMember_68737cfc-9d6b-4974-a950-b06baf9ea07f_terseLabel_en-US" xlink:label="lab_pets_PetCareRxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PetCareRx</link:label>
    <link:label id="lab_pets_PetCareRxMember_label_en-US" xlink:label="lab_pets_PetCareRxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PetCareRx [Member]</link:label>
    <link:label id="lab_pets_PetCareRxMember_documentation_en-US" xlink:label="lab_pets_PetCareRxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PetCareRx</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PetCareRxMember" xlink:href="pets-20221231.xsd#pets_PetCareRxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PetCareRxMember" xlink:to="lab_pets_PetCareRxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1d1c010d-f0cc-4e28-8e71-67e0edd713ed_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_b89b459b-b247-4308-adef-2cc361aa3793_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories - finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_f9013c72-1103-40ed-b558-147c7212c408_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_91dac914-71f8-4562-9dcd-f57a9656a3ad_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_343baaed-4afa-46b8-abe1-f61fd7c8d637_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_26aaa99e-f4dd-42aa-a47d-be5ac5b55c1d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ca059a0f-bd80-4af9-897a-4a142a552558_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_73abc906-702c-49dd-b3fb-34ebe3dfd303_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_bb54004a-deea-4261-b732-8d374b4e3aba_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_6b0aa65a-a3c1-4fa6-8678-6e56a87dd162_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_74f3177d-78d5-4944-989b-31e65ee550ad_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_14a00fea-192c-4dde-a1da-f204c3e5e1bb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_fbad7201-d105-48be-bd09-3fb3bd98926e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDomain_b7979d3c-41d0-476c-90d7-380851be92e2_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Domain]</link:label>
    <link:label id="lab_us-gaap_DividendsDomain_label_en-US" xlink:label="lab_us-gaap_DividendsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDomain" xlink:to="lab_us-gaap_DividendsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_04d75c04-4746-45e5-a13e-538670057505_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_f561e7d1-44d7-4953-8c04-5ba100fbf519_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_7afeee55-7c22-4e8e-b765-6405095280ec_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total noncurrent assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_e3f9f916-5082-433e-9a19-0f7b3c13d050_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d940777a-ce28-4e7a-b706-c2c530218946_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_56078535-0a64-492b-a3eb-1d0349c22d75_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_4e9da181-a950-4fb9-ac7d-4758b3e2ff65_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issuable upon conversion of preferred shares (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_f85cc2ec-f224-443f-a39d-c1513a15d883_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_3a03b335-fa1d-4b08-9584-fd30448e30ad_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ee412d66-4419-460a-837a-fca2c03192a9_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_91b40df9-7774-46ea-bc39-c7d8e0bdbf5a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_1fe42ae6-5b7d-4604-a75a-a069b4f2f671_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_ContactCenterMember_f88f4263-5cac-44dc-a55e-ba05756509ff_terseLabel_en-US" xlink:label="lab_pets_ContactCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact center sales</link:label>
    <link:label id="lab_pets_ContactCenterMember_label_en-US" xlink:label="lab_pets_ContactCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Center [Member]</link:label>
    <link:label id="lab_pets_ContactCenterMember_documentation_en-US" xlink:label="lab_pets_ContactCenterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disaggregate of revenue in contact center sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ContactCenterMember" xlink:href="pets-20221231.xsd#pets_ContactCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_ContactCenterMember" xlink:to="lab_pets_ContactCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a61dd77e-2580-4659-87fc-a7f041e8886e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b87246db-53c2-4493-89f0-846b3b938c45_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_23180ff2-4855-43f0-9f11-8d161142def6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_b589ec1b-a3e5-42a3-8fac-ca13d7034e00_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_eb28365f-fe3a-4c01-b24b-c947024880d4_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0fd26970-11fb-4591-9050-1505a8cd0960_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issuable upon vesting of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_888de8ac-3d87-4bea-b716-76c194c0627c_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fe1c9a1c-50e8-4d85-84f7-7dc956e6c02d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued restricted shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6c714d0c-7973-44c0-8ae5-dc2ad139575a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate, percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_7f9d3804-7bad-4b9b-a27c-12d5b04056b3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_12def4c3-30fd-41eb-a20d-7bf329022ee7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_df9a271a-d691-4f70-8a49-747ea75c1948_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4f4b61d4-701c-4b09-a9e2-7505dc7da58e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant release restriction period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_1a8db235-8899-4985-a1c6-9711f957ced1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_946f06bc-5420-438c-a7d1-17d4cd1a3521_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_4e049cd2-7a8c-4205-92b0-9de0dbe20c65_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_136ad797-de1c-4aee-a532-93f6745a090b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_3e1cbe8f-9d5f-4c0f-a5d1-6b280837da77_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_MZHCILLCInvestorRelationsConsultingAgreementMember_81cbd827-fc03-4275-801c-5245776f2999_terseLabel_en-US" xlink:label="lab_pets_MZHCILLCInvestorRelationsConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MZHCI LLC Investor Relations Consulting Agreement</link:label>
    <link:label id="lab_pets_MZHCILLCInvestorRelationsConsultingAgreementMember_label_en-US" xlink:label="lab_pets_MZHCILLCInvestorRelationsConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MZHCI LLC Investor Relations Consulting Agreement [Member]</link:label>
    <link:label id="lab_pets_MZHCILLCInvestorRelationsConsultingAgreementMember_documentation_en-US" xlink:label="lab_pets_MZHCILLCInvestorRelationsConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MZHCI LLC Investor Relations Consulting Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_MZHCILLCInvestorRelationsConsultingAgreementMember" xlink:href="pets-20221231.xsd#pets_MZHCILLCInvestorRelationsConsultingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_MZHCILLCInvestorRelationsConsultingAgreementMember" xlink:to="lab_pets_MZHCILLCInvestorRelationsConsultingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_NewOrderMember_a835471f-361d-4426-b3f3-bcaab4c65da4_terseLabel_en-US" xlink:label="lab_pets_NewOrderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New order sales</link:label>
    <link:label id="lab_pets_NewOrderMember_label_en-US" xlink:label="lab_pets_NewOrderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Order Customer [Member]</link:label>
    <link:label id="lab_pets_NewOrderMember_documentation_en-US" xlink:label="lab_pets_NewOrderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disaggregate of revenue in new order sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NewOrderMember" xlink:href="pets-20221231.xsd#pets_NewOrderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_NewOrderMember" xlink:to="lab_pets_NewOrderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_IntangibleAndOtherAssets_91cd48c1-9be1-4564-b264-6f210a0360de_terseLabel_en-US" xlink:label="lab_pets_IntangibleAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and other assets</link:label>
    <link:label id="lab_pets_IntangibleAndOtherAssets_label_en-US" xlink:label="lab_pets_IntangibleAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible And Other Assets</link:label>
    <link:label id="lab_pets_IntangibleAndOtherAssets_documentation_en-US" xlink:label="lab_pets_IntangibleAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible And Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_IntangibleAndOtherAssets" xlink:href="pets-20221231.xsd#pets_IntangibleAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_IntangibleAndOtherAssets" xlink:to="lab_pets_IntangibleAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_AccruedSeveranceCosts_e121f9e0-1e5b-4a0c-ad83-23e33c196545_terseLabel_en-US" xlink:label="lab_pets_AccruedSeveranceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued severance costs</link:label>
    <link:label id="lab_pets_AccruedSeveranceCosts_label_en-US" xlink:label="lab_pets_AccruedSeveranceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance Costs</link:label>
    <link:label id="lab_pets_AccruedSeveranceCosts_documentation_en-US" xlink:label="lab_pets_AccruedSeveranceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedSeveranceCosts" xlink:href="pets-20221231.xsd#pets_AccruedSeveranceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_AccruedSeveranceCosts" xlink:to="lab_pets_AccruedSeveranceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_498fc22e-65c8-4190-a0b4-b8a35c4dfc79_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_30f4b2c2-d887-4e5b-b799-23e996e791f5_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_5a3c181a-b256-4f48-9744-b189d3ebcd0f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_760fbe06-ffd5-4ae9-ad7a-35ddd4041ad5_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2c4722a6-ee3f-48f8-a03c-61e54fc014f2_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ca53692c-7f84-43d5-8191-54d9c775ca86_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_QuarterlyDividendMember_3629caeb-297f-4d0e-a68c-79f141fca312_terseLabel_en-US" xlink:label="lab_pets_QuarterlyDividendMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Dividend</link:label>
    <link:label id="lab_pets_QuarterlyDividendMember_label_en-US" xlink:label="lab_pets_QuarterlyDividendMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Dividend [Member]</link:label>
    <link:label id="lab_pets_QuarterlyDividendMember_documentation_en-US" xlink:label="lab_pets_QuarterlyDividendMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents quarterly dividend.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_QuarterlyDividendMember" xlink:href="pets-20221231.xsd#pets_QuarterlyDividendMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_QuarterlyDividendMember" xlink:to="lab_pets_QuarterlyDividendMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_e618508b-cc62-4198-bf23-2acbd0948c62_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_ec8b7c19-47d5-44e2-aed0-489932831a57_terseLabel_en-US" xlink:label="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Employee Equity Compensation Restricted Stock Plan</link:label>
    <link:label id="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_label_en-US" xlink:label="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Employee Equity Compensation Restricted Stock Plan [Member]</link:label>
    <link:label id="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_documentation_en-US" xlink:label="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the 2016 Employee Equity Compensation Restricted Stock Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" xlink:href="pets-20221231.xsd#pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" xlink:to="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_5faef535-c879-4b71-8e5e-bbb4fe070058_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_ae3ba234-1d99-4979-a1ea-688705e622ae_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_RevenueFromContractWithCustomerPercentage_30047e1e-e544-4d75-873c-c24d21c9525a_terseLabel_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues, percentage</link:label>
    <link:label id="lab_pets_RevenueFromContractWithCustomerPercentage_label_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Percentage</link:label>
    <link:label id="lab_pets_RevenueFromContractWithCustomerPercentage_documentation_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenue from the specified category to the total revenue during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerPercentage" xlink:href="pets-20221231.xsd#pets_RevenueFromContractWithCustomerPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_RevenueFromContractWithCustomerPercentage" xlink:to="lab_pets_RevenueFromContractWithCustomerPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c108d1f8-9b4e-4f7f-a24e-1c0dad1e2918_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase) decrease in operating assets and increase (decrease) in operating liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_b5f89e85-acae-4133-86e6-6b6d1fe60f19_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) (numerator):</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_18f90373-4293-4562-9854-24109c4d7121_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_186ab114-b472-4c4a-afed-352655777dc0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_344f6f1c-5764-49a1-80bf-2efbc55067b0_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_0604ae30-ba40-4604-995d-88d8d007bf9e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PerformanceRestrictedStockMember_7e97093f-26a2-4caa-b7f1-04ef7a14d9cb_terseLabel_en-US" xlink:label="lab_pets_PerformanceRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockMember_label_en-US" xlink:label="lab_pets_PerformanceRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock [Member]</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockMember_documentation_en-US" xlink:label="lab_pets_PerformanceRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents performance restricted stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockMember" xlink:href="pets-20221231.xsd#pets_PerformanceRestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PerformanceRestrictedStockMember" xlink:to="lab_pets_PerformanceRestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_RevenueFromContractWithCustomerVariance_c34a8d7e-7511-4fd0-ae89-54cfa4247a2d_terseLabel_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerVariance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues, variance</link:label>
    <link:label id="lab_pets_RevenueFromContractWithCustomerVariance_label_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerVariance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Variance</link:label>
    <link:label id="lab_pets_RevenueFromContractWithCustomerVariance_documentation_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerVariance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of changes in revenue in current period comparing to the same period in the previous year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerVariance" xlink:href="pets-20221231.xsd#pets_RevenueFromContractWithCustomerVariance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_RevenueFromContractWithCustomerVariance" xlink:to="lab_pets_RevenueFromContractWithCustomerVariance" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_BasisOfPresentationAndConsolidationPolicyTextBlock_950e3408-acb0-4f38-8d91-17c47f285e75_terseLabel_en-US" xlink:label="lab_pets_BasisOfPresentationAndConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation and Consolidation</link:label>
    <link:label id="lab_pets_BasisOfPresentationAndConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_pets_BasisOfPresentationAndConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation and Consolidation [Policy Text Block]</link:label>
    <link:label id="lab_pets_BasisOfPresentationAndConsolidationPolicyTextBlock_documentation_en-US" xlink:label="lab_pets_BasisOfPresentationAndConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for basis of accounting, or basis of presentation and , used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Also consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_BasisOfPresentationAndConsolidationPolicyTextBlock" xlink:href="pets-20221231.xsd#pets_BasisOfPresentationAndConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_BasisOfPresentationAndConsolidationPolicyTextBlock" xlink:to="lab_pets_BasisOfPresentationAndConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_1030eebc-53da-43f7-b8da-c747a445771c_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_7af8f31e-cf00-4262-9a15-10e792801b0a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_0a2e04d1-ca26-4592-bc07-ae35277d15ca_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_47268ca8-bc54-4fde-94e8-a843c5000d5e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ae377f9f-f762-45dc-8c30-bf94b053f534_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_21c3b453-73c3-4ee4-aacf-fff9fedd5143_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_InternetMember_ea2e09b8-fca9-4265-a0b6-1b68fc9c00b6_terseLabel_en-US" xlink:label="lab_pets_InternetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internet sales</link:label>
    <link:label id="lab_pets_InternetMember_label_en-US" xlink:label="lab_pets_InternetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internet [Member]</link:label>
    <link:label id="lab_pets_InternetMember_documentation_en-US" xlink:label="lab_pets_InternetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disaggregate of revenue in internet sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_InternetMember" xlink:href="pets-20221231.xsd#pets_InternetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_InternetMember" xlink:to="lab_pets_InternetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_1d7a3eff-20ff-4c6f-9bbc-2083673a2fac_terseLabel_en-US" xlink:label="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Director Plan</link:label>
    <link:label id="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_label_en-US" xlink:label="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Outside Director Equity Compensation Restricted Stock Plan ("2015 Director Plan") [Member]</link:label>
    <link:label id="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_documentation_en-US" xlink:label="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refers to information regarding 2015 Outside Director Equity Compensation Restricted Stock Plan ("2015 Director Plan").</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" xlink:href="pets-20221231.xsd#pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" xlink:to="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_458cf765-726e-40da-8b4b-a7b1a38099cf_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_52088dba-dc66-46eb-8858-c23fa2401dfa_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less allowance for doubtful accounts of $40 and $39, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b4746889-ff5d-4ffb-8da4-7466f2a96a08_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_1bedb912-07dc-4e6e-8c3d-426f27d485f3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3ca46001-c18f-48e3-a6e7-bb9332463d9b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_1f1ff9d0-f7c4-40b9-b7a6-dac61f6ff5d1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4fe12e75-d84b-47ea-9efd-d1cd3ddad785_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_7809d9dd-805f-4097-89cf-4f70475ca0c6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_0ebe3233-1870-45a2-a379-8f673838be07_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4b3b1c68-4c4c-48a7-8779-ab29d4789c2c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ba1026c9-b0cf-4a50-8d71-f927cfd2722e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b5c733cd-90c0-4bb8-9f04-63552d424329_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefFinancialOfficerMember_314ee78b-8905-4e41-b239-5a4ac233fcbb_terseLabel_en-US" xlink:label="lab_srt_ChiefFinancialOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Financial Officer</link:label>
    <link:label id="lab_srt_ChiefFinancialOfficerMember_label_en-US" xlink:label="lab_srt_ChiefFinancialOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Financial Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefFinancialOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefFinancialOfficerMember" xlink:to="lab_srt_ChiefFinancialOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_2a88ab8b-b4da-4e3a-8098-323e6803bdf0_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2f05e632-7214-4dc9-bb75-fcc0abbb5b39_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1db2832a-5aa3-4139-a4bc-f0b994dc8914_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted shares issued and outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_a1c69d82-6f48-4fab-954f-a621592a395e_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsAxis_ca840715-0e76-40e4-8057-c164bacc013b_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Axis]</link:label>
    <link:label id="lab_us-gaap_DividendsAxis_label_en-US" xlink:label="lab_us-gaap_DividendsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsAxis" xlink:to="lab_us-gaap_DividendsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf662a46-6fdb-4dd1-b555-2c1994bd5449_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PartnershipAgreementWithVetsterMember_955196b2-4944-404b-9063-db429a362b83_terseLabel_en-US" xlink:label="lab_pets_PartnershipAgreementWithVetsterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement with Vetster</link:label>
    <link:label id="lab_pets_PartnershipAgreementWithVetsterMember_label_en-US" xlink:label="lab_pets_PartnershipAgreementWithVetsterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement with Vetster [Member]</link:label>
    <link:label id="lab_pets_PartnershipAgreementWithVetsterMember_documentation_en-US" xlink:label="lab_pets_PartnershipAgreementWithVetsterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents partnership agreement with Vestster.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PartnershipAgreementWithVetsterMember" xlink:href="pets-20221231.xsd#pets_PartnershipAgreementWithVetsterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PartnershipAgreementWithVetsterMember" xlink:to="lab_pets_PartnershipAgreementWithVetsterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_bc1df312-fe05-43dd-9547-bb6844a2374c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_NetIncomePerCommonShareBasicAndDilutedAbstract_3e8cbf9b-e485-489c-997f-2a5ee43fccfa_terseLabel_en-US" xlink:label="lab_pets_NetIncomePerCommonShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per common share:</link:label>
    <link:label id="lab_pets_NetIncomePerCommonShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_pets_NetIncomePerCommonShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Common Share, Basic And Diluted [Abstract]</link:label>
    <link:label id="lab_pets_NetIncomePerCommonShareBasicAndDilutedAbstract_documentation_en-US" xlink:label="lab_pets_NetIncomePerCommonShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Common Share, Basic And Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NetIncomePerCommonShareBasicAndDilutedAbstract" xlink:href="pets-20221231.xsd#pets_NetIncomePerCommonShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_NetIncomePerCommonShareBasicAndDilutedAbstract" xlink:to="lab_pets_NetIncomePerCommonShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_5db1d5d4-dc71-4246-8034-2e71375a3e17_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_642d412b-5c2f-474f-9807-56892c3a2ee2_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_57224a8f-fea2-472b-b3db-8c75afeeb580_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_629b1d99-1dfb-4628-ae1b-df583c2851e1_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_6b345fc5-6449-4a73-baa7-a4c2a7d5732a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e887d8a9-05c7-4d93-81bb-dad3a8c2685b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a07d2ee1-dc7e-4212-ad44-e180f1f81aa1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_92e4ee57-17e0-4c9b-981b-93d3eaaef140_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f639c841-31ec-4e70-b946-85594776c9c5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_b62d8bbe-d3c7-4c34-803f-bd295255be3b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of minority interest investment in Vetster</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_c11f49cb-fd04-4a04-bcb6-f4de8abc84b8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_de1b35c4-c636-4cc2-b2b8-1d302ec36cb1_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_97fc7312-d931-48b8-b196-fd18f0f54994_terseLabel_en-US" xlink:label="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Employee Plan</link:label>
    <link:label id="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_label_en-US" xlink:label="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2016 Employee Equity Compensation Restricted Stock Plan [Member]</link:label>
    <link:label id="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_documentation_en-US" xlink:label="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">represents the 2016 Employee Equity Compensation Restricted Stock Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" xlink:href="pets-20221231.xsd#pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" xlink:to="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_86a18de6-0e9d-475f-83f2-287a7e4aa4ea_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>pets-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:66cb9e58-a04f-48d4-a0bc-a601d74b20f7,g:93132296-a4cf-4603-975d-122774d1cfdf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.1800petmeds.com/role/Cover" xlink:type="simple" xlink:href="pets-20221231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c6776811-ad44-475f-84b7-b9c1842bdeff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_DocumentType_c6776811-ad44-475f-84b7-b9c1842bdeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_8e197128-56f4-4dd9-91d8-3ba2d770db2a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_DocumentQuarterlyReport_8e197128-56f4-4dd9-91d8-3ba2d770db2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f7c618b7-fa19-4c77-a96a-47049c692245" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_DocumentPeriodEndDate_f7c618b7-fa19-4c77-a96a-47049c692245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_c31af719-57c1-49b4-a850-77b21d239df0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_DocumentTransitionReport_c31af719-57c1-49b4-a850-77b21d239df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b00e4cd7-d3c8-4d91-a8c8-91cf617bf280" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityFileNumber_b00e4cd7-d3c8-4d91-a8c8-91cf617bf280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_78ce2f12-88ec-4020-97c7-aa1701657fc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityRegistrantName_78ce2f12-88ec-4020-97c7-aa1701657fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_efed7fcb-0694-44a9-8385-437acf1162db" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityIncorporationStateCountryCode_efed7fcb-0694-44a9-8385-437acf1162db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f47797fe-68a0-4890-8c68-967dcb459cca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityTaxIdentificationNumber_f47797fe-68a0-4890-8c68-967dcb459cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2671fdff-a07e-48f1-816b-eded1836f584" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityAddressAddressLine1_2671fdff-a07e-48f1-816b-eded1836f584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a5b90ba7-f37e-4aa0-ba2b-40c8d2281b12" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityAddressCityOrTown_a5b90ba7-f37e-4aa0-ba2b-40c8d2281b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0c303570-78c5-4e4d-bd78-2e92ab7100a2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityAddressStateOrProvince_0c303570-78c5-4e4d-bd78-2e92ab7100a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8938ebb7-bcaf-47ca-99c1-5abc000be9aa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityAddressPostalZipCode_8938ebb7-bcaf-47ca-99c1-5abc000be9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e2a45ca9-7b30-491c-9eaf-eb50c928236a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_CityAreaCode_e2a45ca9-7b30-491c-9eaf-eb50c928236a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_021c1ec7-3f78-4c01-ad54-51d059174f41" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_LocalPhoneNumber_021c1ec7-3f78-4c01-ad54-51d059174f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ac4ee60a-cf01-42eb-819e-4d7fa494a293" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_Security12bTitle_ac4ee60a-cf01-42eb-819e-4d7fa494a293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_26502f75-4e6d-4baf-af0e-8f3d7d42283c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_TradingSymbol_26502f75-4e6d-4baf-af0e-8f3d7d42283c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_8feb553d-e86e-4a79-a5e5-c71eedceb96b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_SecurityExchangeName_8feb553d-e86e-4a79-a5e5-c71eedceb96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8294827d-0e7a-47e4-9c72-94d0d3da4c40" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityCurrentReportingStatus_8294827d-0e7a-47e4-9c72-94d0d3da4c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_73e7b677-3223-4a6e-8f25-b9cec96067a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityInteractiveDataCurrent_73e7b677-3223-4a6e-8f25-b9cec96067a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_741acef3-015c-4d68-9f7c-ba8a3a9e43bf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityFilerCategory_741acef3-015c-4d68-9f7c-ba8a3a9e43bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_426ec5f7-990b-47a3-96fe-251882753af0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntitySmallBusiness_426ec5f7-990b-47a3-96fe-251882753af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_fff68640-f0ac-4656-a52f-306f4723f57d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityEmergingGrowthCompany_fff68640-f0ac-4656-a52f-306f4723f57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a789003b-e725-44d4-90a6-caee0cec1606" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityShellCompany_a789003b-e725-44d4-90a6-caee0cec1606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_defb141b-b78f-4fbd-b182-46b7b73ef2fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_defb141b-b78f-4fbd-b182-46b7b73ef2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_41e626bb-e4f4-45f8-9399-94e9f625d5b3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_EntityCentralIndexKey_41e626bb-e4f4-45f8-9399-94e9f625d5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_ab38d27b-9196-4725-a357-f38650177250" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_CurrentFiscalYearEndDate_ab38d27b-9196-4725-a357-f38650177250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_ad498a9e-30cd-4f12-b988-bc057473adf9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_DocumentFiscalYearFocus_ad498a9e-30cd-4f12-b988-bc057473adf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d4dac10c-220f-4d8d-991f-28acb0f7f86b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d4dac10c-220f-4d8d-991f-28acb0f7f86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6b9cb675-3694-4350-be51-117725d56111" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fda0d41d-1131-407b-8613-9aafe8ec4995" xlink:to="loc_dei_AmendmentFlag_6b9cb675-3694-4350-be51-117725d56111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pets-20221231.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3cf874bb-fb43-49b1-a480-4f100fbd802f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ee067532-4222-4ab9-b70e-484489c90acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3cf874bb-fb43-49b1-a480-4f100fbd802f" xlink:to="loc_us-gaap_AssetsAbstract_ee067532-4222-4ab9-b70e-484489c90acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f644509a-b5a2-4ce4-9d3b-c31013e86c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ee067532-4222-4ab9-b70e-484489c90acc" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f644509a-b5a2-4ce4-9d3b-c31013e86c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e4526c88-475d-45f0-a762-210dd46e8319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f644509a-b5a2-4ce4-9d3b-c31013e86c59" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e4526c88-475d-45f0-a762-210dd46e8319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_48270ffc-ff3f-4d80-807b-18c8052751eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f644509a-b5a2-4ce4-9d3b-c31013e86c59" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_48270ffc-ff3f-4d80-807b-18c8052751eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_2094f870-0ad4-4059-baae-25812c339ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f644509a-b5a2-4ce4-9d3b-c31013e86c59" xlink:to="loc_us-gaap_InventoryFinishedGoods_2094f870-0ad4-4059-baae-25812c339ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2a118e1d-7eb1-4e38-9b2a-6bfd6a1bbe81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f644509a-b5a2-4ce4-9d3b-c31013e86c59" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2a118e1d-7eb1-4e38-9b2a-6bfd6a1bbe81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_8d81f2fa-df34-476d-b9ff-49b36d349563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f644509a-b5a2-4ce4-9d3b-c31013e86c59" xlink:to="loc_us-gaap_PrepaidTaxes_8d81f2fa-df34-476d-b9ff-49b36d349563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_be34d91c-f0e0-4136-8af5-5660d976b00a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f644509a-b5a2-4ce4-9d3b-c31013e86c59" xlink:to="loc_us-gaap_AssetsCurrent_be34d91c-f0e0-4136-8af5-5660d976b00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_f02d7c6f-6a0c-4ea3-bb83-5257819ed8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ee067532-4222-4ab9-b70e-484489c90acc" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_f02d7c6f-6a0c-4ea3-bb83-5257819ed8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_abfebe2d-6606-4704-96bc-44b8dd777ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_f02d7c6f-6a0c-4ea3-bb83-5257819ed8f3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_abfebe2d-6606-4704-96bc-44b8dd777ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_IntangibleAndOtherAssets_0ccf2196-53c0-4819-bdb2-95be2b32aa52" xlink:href="pets-20221231.xsd#pets_IntangibleAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_f02d7c6f-6a0c-4ea3-bb83-5257819ed8f3" xlink:to="loc_pets_IntangibleAndOtherAssets_0ccf2196-53c0-4819-bdb2-95be2b32aa52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_f81b26d7-4436-4b5c-a9c4-f4bc3f67376f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_f02d7c6f-6a0c-4ea3-bb83-5257819ed8f3" xlink:to="loc_us-gaap_AssetsNoncurrent_f81b26d7-4436-4b5c-a9c4-f4bc3f67376f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2c4ce4de-2df7-44b4-9d6a-7919b8af8540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ee067532-4222-4ab9-b70e-484489c90acc" xlink:to="loc_us-gaap_Assets_2c4ce4de-2df7-44b4-9d6a-7919b8af8540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7152ef4d-6610-42de-bf7c-852c7e6403f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3cf874bb-fb43-49b1-a480-4f100fbd802f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7152ef4d-6610-42de-bf7c-852c7e6403f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_7fbb4976-0cce-4662-af82-0b3660e30b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7152ef4d-6610-42de-bf7c-852c7e6403f8" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_7fbb4976-0cce-4662-af82-0b3660e30b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e26a6414-0bb3-44d0-9a0f-20bb68b3e38d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7fbb4976-0cce-4662-af82-0b3660e30b45" xlink:to="loc_us-gaap_AccountsPayableCurrent_e26a6414-0bb3-44d0-9a0f-20bb68b3e38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_4627b690-226e-40ea-84b8-b3d863418489" xlink:href="pets-20221231.xsd#pets_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7fbb4976-0cce-4662-af82-0b3660e30b45" xlink:to="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_4627b690-226e-40ea-84b8-b3d863418489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7cf1d208-717a-4ca4-9b10-03e53b5c719a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7fbb4976-0cce-4662-af82-0b3660e30b45" xlink:to="loc_us-gaap_LiabilitiesCurrent_7cf1d208-717a-4ca4-9b10-03e53b5c719a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5dfdabe1-809c-4967-9b53-77838dcb8eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7152ef4d-6610-42de-bf7c-852c7e6403f8" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5dfdabe1-809c-4967-9b53-77838dcb8eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a79090b0-c673-4683-9b8d-147806055ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7152ef4d-6610-42de-bf7c-852c7e6403f8" xlink:to="loc_us-gaap_Liabilities_a79090b0-c673-4683-9b8d-147806055ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2f8d91d1-ed10-469d-ac04-f3006cd3b18a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7152ef4d-6610-42de-bf7c-852c7e6403f8" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2f8d91d1-ed10-469d-ac04-f3006cd3b18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_055a7deb-723a-4636-a930-1db68606eec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7152ef4d-6610-42de-bf7c-852c7e6403f8" xlink:to="loc_us-gaap_StockholdersEquityAbstract_055a7deb-723a-4636-a930-1db68606eec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_85e521ef-bd39-4f95-8323-fb9677216b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_055a7deb-723a-4636-a930-1db68606eec6" xlink:to="loc_us-gaap_PreferredStockValue_85e521ef-bd39-4f95-8323-fb9677216b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9ad05a46-9b68-4a18-9229-744efd91f606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_055a7deb-723a-4636-a930-1db68606eec6" xlink:to="loc_us-gaap_CommonStockValue_9ad05a46-9b68-4a18-9229-744efd91f606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_2e2b3ab5-c478-47b3-8c15-7324b627fc94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_055a7deb-723a-4636-a930-1db68606eec6" xlink:to="loc_us-gaap_AdditionalPaidInCapital_2e2b3ab5-c478-47b3-8c15-7324b627fc94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05123546-b6fe-40e1-a79c-20ef9d62206c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_055a7deb-723a-4636-a930-1db68606eec6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05123546-b6fe-40e1-a79c-20ef9d62206c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b3ab1115-ea1b-42c8-a181-387ce6b6ce2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_055a7deb-723a-4636-a930-1db68606eec6" xlink:to="loc_us-gaap_StockholdersEquity_b3ab1115-ea1b-42c8-a181-387ce6b6ce2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ca811c7c-6744-4975-a424-48d92f4a144b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7152ef4d-6610-42de-bf7c-852c7e6403f8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_ca811c7c-6744-4975-a424-48d92f4a144b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="pets-20221231.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4f7d865c-2a4f-44c0-b334-148b5e512df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d5f06aa7-1048-4351-a2ea-b5956fd45fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f7d865c-2a4f-44c0-b334-148b5e512df5" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d5f06aa7-1048-4351-a2ea-b5956fd45fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4cdbf3f7-f35a-44e7-ab35-9437147459d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f7d865c-2a4f-44c0-b334-148b5e512df5" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4cdbf3f7-f35a-44e7-ab35-9437147459d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b3f9cd01-439d-48f0-bad3-01f1a0d17d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f7d865c-2a4f-44c0-b334-148b5e512df5" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b3f9cd01-439d-48f0-bad3-01f1a0d17d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_9c7d763b-5d74-4b99-9944-272a337faa8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f7d865c-2a4f-44c0-b334-148b5e512df5" xlink:to="loc_us-gaap_PreferredStockSharesIssued_9c7d763b-5d74-4b99-9944-272a337faa8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_515b2155-e549-4a56-a33d-5a1db20414bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f7d865c-2a4f-44c0-b334-148b5e512df5" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_515b2155-e549-4a56-a33d-5a1db20414bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_7993c3aa-0502-4d0a-9df9-43fd2a26c411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f7d865c-2a4f-44c0-b334-148b5e512df5" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_7993c3aa-0502-4d0a-9df9-43fd2a26c411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ed4630fe-738f-49e1-801a-16ab1c5bf453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f7d865c-2a4f-44c0-b334-148b5e512df5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ed4630fe-738f-49e1-801a-16ab1c5bf453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_aee4acb1-4e81-47f6-a02d-8106a8dc3e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f7d865c-2a4f-44c0-b334-148b5e512df5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_aee4acb1-4e81-47f6-a02d-8106a8dc3e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8c6b9c34-85f2-46b6-9e69-1334d7e49435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f7d865c-2a4f-44c0-b334-148b5e512df5" xlink:to="loc_us-gaap_CommonStockSharesIssued_8c6b9c34-85f2-46b6-9e69-1334d7e49435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e5690949-5b46-40d0-b8b5-bc9f13ae4fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4f7d865c-2a4f-44c0-b334-148b5e512df5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e5690949-5b46-40d0-b8b5-bc9f13ae4fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="pets-20221231.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2a46e5b2-dbfe-4b0a-8a0e-0f7a0d7ab3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2a46e5b2-dbfe-4b0a-8a0e-0f7a0d7ab3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_b492255c-2850-42ca-a4a8-911e16094d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_b492255c-2850-42ca-a4a8-911e16094d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_fc25ebd8-d245-4ed7-99c3-26f9d09689cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:to="loc_us-gaap_GrossProfit_fc25ebd8-d245-4ed7-99c3-26f9d09689cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_467df001-3084-4653-b55b-a71f5fc51c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:to="loc_us-gaap_OperatingExpensesAbstract_467df001-3084-4653-b55b-a71f5fc51c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_913ad48f-aae4-4708-81cf-2efb9728229c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_467df001-3084-4653-b55b-a71f5fc51c6d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_913ad48f-aae4-4708-81cf-2efb9728229c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_6110285b-4f3a-4030-ad68-3f89cbcb97c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_467df001-3084-4653-b55b-a71f5fc51c6d" xlink:to="loc_us-gaap_AdvertisingExpense_6110285b-4f3a-4030-ad68-3f89cbcb97c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_931780b0-bd5e-4e5c-b093-2641491e49fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_467df001-3084-4653-b55b-a71f5fc51c6d" xlink:to="loc_us-gaap_Depreciation_931780b0-bd5e-4e5c-b093-2641491e49fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9249d4dd-59fb-4f9e-8b7c-7a77bf7b3c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_467df001-3084-4653-b55b-a71f5fc51c6d" xlink:to="loc_us-gaap_OperatingExpenses_9249d4dd-59fb-4f9e-8b7c-7a77bf7b3c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1c764292-ece8-4289-ab82-96e03b9cd9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:to="loc_us-gaap_OperatingIncomeLoss_1c764292-ece8-4289-ab82-96e03b9cd9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_238e945b-09f2-4a89-be47-ffb1b34c5cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_238e945b-09f2-4a89-be47-ffb1b34c5cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_8318e086-2a63-4c30-9fd3-1c0c904a6aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_238e945b-09f2-4a89-be47-ffb1b34c5cb3" xlink:to="loc_us-gaap_InvestmentIncomeInterest_8318e086-2a63-4c30-9fd3-1c0c904a6aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a13f8c08-bf13-4131-ae41-8c59e34a48c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_238e945b-09f2-4a89-be47-ffb1b34c5cb3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a13f8c08-bf13-4131-ae41-8c59e34a48c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3bea3239-521e-4f6c-a380-512a7f8333ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_238e945b-09f2-4a89-be47-ffb1b34c5cb3" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_3bea3239-521e-4f6c-a380-512a7f8333ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_31a6418b-69b9-4f1d-891b-fec82b4a0ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_31a6418b-69b9-4f1d-891b-fec82b4a0ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0bb35da8-8abd-47d1-bef7-578f27e57681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0bb35da8-8abd-47d1-bef7-578f27e57681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7d88ffe0-7b78-4fbf-8dcd-fd493a3680a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:to="loc_us-gaap_NetIncomeLoss_7d88ffe0-7b78-4fbf-8dcd-fd493a3680a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_355c11ea-9d28-4f22-a126-22605cc32ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:to="loc_us-gaap_EarningsPerShareAbstract_355c11ea-9d28-4f22-a126-22605cc32ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8b30d7ca-2b81-4e9c-b477-41bd20b5d302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_355c11ea-9d28-4f22-a126-22605cc32ce9" xlink:to="loc_us-gaap_EarningsPerShareBasic_8b30d7ca-2b81-4e9c-b477-41bd20b5d302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_63f7988f-d1eb-4424-a8c5-3f6e6f016ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_355c11ea-9d28-4f22-a126-22605cc32ce9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_63f7988f-d1eb-4424-a8c5-3f6e6f016ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_558a5e88-e5df-4ef3-96c0-0f7114911066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_558a5e88-e5df-4ef3-96c0-0f7114911066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_98b807e2-fd04-4781-9be5-9c7d2d1454fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_558a5e88-e5df-4ef3-96c0-0f7114911066" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_98b807e2-fd04-4781-9be5-9c7d2d1454fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_60b0dfef-87a9-4292-9a0d-aec8c0cfe42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_558a5e88-e5df-4ef3-96c0-0f7114911066" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_60b0dfef-87a9-4292-9a0d-aec8c0cfe42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1585c594-e5d0-46e8-a0d6-61c8c589b8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4d0346-965d-4947-ac73-759b1a049fb2" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1585c594-e5d0-46e8-a0d6-61c8c589b8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pets-20221231.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_3d6a6e7e-6cf0-4eff-8ba9-6a91fe6df3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c7ad1a14-d876-4243-9d19-e2a230916982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3d6a6e7e-6cf0-4eff-8ba9-6a91fe6df3c9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c7ad1a14-d876-4243-9d19-e2a230916982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_456f46ce-a13f-4f40-a9d4-17cf243d2bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c7ad1a14-d876-4243-9d19-e2a230916982" xlink:to="loc_us-gaap_NetIncomeLoss_456f46ce-a13f-4f40-a9d4-17cf243d2bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a113b339-f42e-4db9-9dc8-611f8ddd22b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c7ad1a14-d876-4243-9d19-e2a230916982" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a113b339-f42e-4db9-9dc8-611f8ddd22b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_122c2c39-1253-44b6-9379-13833ada731c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a113b339-f42e-4db9-9dc8-611f8ddd22b9" xlink:to="loc_us-gaap_Depreciation_122c2c39-1253-44b6-9379-13833ada731c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c143b9ef-bbfe-4c01-aadd-6c3892b87409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a113b339-f42e-4db9-9dc8-611f8ddd22b9" xlink:to="loc_us-gaap_ShareBasedCompensation_c143b9ef-bbfe-4c01-aadd-6c3892b87409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_be88694e-d412-46c8-8565-82773a7d6b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a113b339-f42e-4db9-9dc8-611f8ddd22b9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_be88694e-d412-46c8-8565-82773a7d6b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_e305e5b4-82a4-498e-9add-ed2b2cbc4ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a113b339-f42e-4db9-9dc8-611f8ddd22b9" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_e305e5b4-82a4-498e-9add-ed2b2cbc4ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36834db7-2b24-4398-a183-798224c471f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c7ad1a14-d876-4243-9d19-e2a230916982" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36834db7-2b24-4398-a183-798224c471f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4fe6dcd5-e088-4e6d-b635-1b165fcac7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36834db7-2b24-4398-a183-798224c471f1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4fe6dcd5-e088-4e6d-b635-1b165fcac7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_629b06b1-769c-4597-8168-d0f874f142f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36834db7-2b24-4398-a183-798224c471f1" xlink:to="loc_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_629b06b1-769c-4597-8168-d0f874f142f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_91ea0820-6a92-4afe-920a-73354b0bcc23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36834db7-2b24-4398-a183-798224c471f1" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_91ea0820-6a92-4afe-920a-73354b0bcc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c2b6cced-5721-4899-b5cf-63476011a3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36834db7-2b24-4398-a183-798224c471f1" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c2b6cced-5721-4899-b5cf-63476011a3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_85afc9d7-d5a0-42cd-8cb3-7dff85ff63ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36834db7-2b24-4398-a183-798224c471f1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_85afc9d7-d5a0-42cd-8cb3-7dff85ff63ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_68b29e28-a008-422d-84e8-6698e733578d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36834db7-2b24-4398-a183-798224c471f1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_68b29e28-a008-422d-84e8-6698e733578d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_af12f436-05e3-4f26-808b-51555975c058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c7ad1a14-d876-4243-9d19-e2a230916982" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_af12f436-05e3-4f26-808b-51555975c058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7cc9eb3b-b860-421a-a104-421b26514553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3d6a6e7e-6cf0-4eff-8ba9-6a91fe6df3c9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7cc9eb3b-b860-421a-a104-421b26514553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_afd36fb8-47f5-4b65-bdab-066afb10cfa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7cc9eb3b-b860-421a-a104-421b26514553" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_afd36fb8-47f5-4b65-bdab-066afb10cfa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_39015256-1c7e-4d10-aded-ab6779efdc84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7cc9eb3b-b860-421a-a104-421b26514553" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_39015256-1c7e-4d10-aded-ab6779efdc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a42a2527-b9c5-49f0-a187-1d07f5d4f758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7cc9eb3b-b860-421a-a104-421b26514553" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a42a2527-b9c5-49f0-a187-1d07f5d4f758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d32b585d-8cd4-4c38-8a27-5769d333a940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3d6a6e7e-6cf0-4eff-8ba9-6a91fe6df3c9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d32b585d-8cd4-4c38-8a27-5769d333a940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_660b15ef-44f5-4c95-9311-5438018031d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d32b585d-8cd4-4c38-8a27-5769d333a940" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_660b15ef-44f5-4c95-9311-5438018031d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_747f0e77-6b1e-4d05-b332-afd2f722c825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d32b585d-8cd4-4c38-8a27-5769d333a940" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_747f0e77-6b1e-4d05-b332-afd2f722c825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_11cb72f6-d6b6-4526-89bb-661fea05d339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3d6a6e7e-6cf0-4eff-8ba9-6a91fe6df3c9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_11cb72f6-d6b6-4526-89bb-661fea05d339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ba56d1b-3578-4737-af95-56be552f8d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3d6a6e7e-6cf0-4eff-8ba9-6a91fe6df3c9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ba56d1b-3578-4737-af95-56be552f8d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_07a988aa-b631-4efd-a9aa-b31e7289ca52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3d6a6e7e-6cf0-4eff-8ba9-6a91fe6df3c9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_07a988aa-b631-4efd-a9aa-b31e7289ca52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_ac26773d-cc25-496a-84b9-0349e6256eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3d6a6e7e-6cf0-4eff-8ba9-6a91fe6df3c9" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_ac26773d-cc25-496a-84b9-0349e6256eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_3b15a2df-f445-4930-9936-c75811e08f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_ac26773d-cc25-496a-84b9-0349e6256eaa" xlink:to="loc_us-gaap_IncomeTaxesPaid_3b15a2df-f445-4930-9936-c75811e08f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_75d34816-9024-41f7-a107-76de819ee15d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_ac26773d-cc25-496a-84b9-0349e6256eaa" xlink:to="loc_us-gaap_LiabilitiesAssumed1_75d34816-9024-41f7-a107-76de819ee15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="pets-20221231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2153859e-6995-4ff3-8dd4-a70cda0214f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_30f71eef-b557-4412-bfa5-c8f625c11d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2153859e-6995-4ff3-8dd4-a70cda0214f3" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_30f71eef-b557-4412-bfa5-c8f625c11d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RevenueRecognition" xlink:type="simple" xlink:href="pets-20221231.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_477841ca-a1e5-4177-8454-5b626f34a3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5b55814a-abee-4a8d-9c00-14dd852752b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_477841ca-a1e5-4177-8454-5b626f34a3fa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5b55814a-abee-4a8d-9c00-14dd852752b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="pets-20221231.xsd#NetIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8217fac9-296b-4227-af29-7d37114f6b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_f28259e2-5fd3-475f-8c51-e9014496414f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8217fac9-296b-4227-af29-7d37114f6b24" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_f28259e2-5fd3-475f-8c51-e9014496414f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/AccountingforStockBasedCompensation" xlink:type="simple" xlink:href="pets-20221231.xsd#AccountingforStockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/AccountingforStockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b3d94c4-4ca9-4ace-be07-d4bfd258cfb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a3d57a0b-3aed-4c96-87a4-84d103084011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b3d94c4-4ca9-4ace-be07-d4bfd258cfb1" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a3d57a0b-3aed-4c96-87a4-84d103084011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/FairValue" xlink:type="simple" xlink:href="pets-20221231.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8399e1ed-81fc-4462-beb2-e27c3c042a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_99018adc-3d76-46c2-96f1-e3897697d7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8399e1ed-81fc-4462-beb2-e27c3c042a50" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_99018adc-3d76-46c2-96f1-e3897697d7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="pets-20221231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_839a1f4e-aa3f-4ac4-9576-510784b65914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_483bc102-b12c-4b13-afc0-2938131af037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_839a1f4e-aa3f-4ac4-9576-510784b65914" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_483bc102-b12c-4b13-afc0-2938131af037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ChangesinShareholdersEquity" xlink:type="simple" xlink:href="pets-20221231.xsd#ChangesinShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ChangesinShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d7055607-040a-44c1-961b-3e239e4c7519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cec69f31-579d-4c5a-8664-39ec04ad84b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d7055607-040a-44c1-961b-3e239e4c7519" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cec69f31-579d-4c5a-8664-39ec04ad84b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxes" xlink:type="simple" xlink:href="pets-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_542d9e69-635a-42b0-9f65-7cebb1636f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_2df694c4-24fd-4cce-a599-56b8bf79bc73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_542d9e69-635a-42b0-9f65-7cebb1636f07" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_2df694c4-24fd-4cce-a599-56b8bf79bc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster" xlink:type="simple" xlink:href="pets-20221231.xsd#MinorityInterestInvestmentinVetster"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_e6313d6a-a556-486c-a064-fc8826a55033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_78fe9d88-65b8-4b03-9e78-3964e1ea997b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_e6313d6a-a556-486c-a064-fc8826a55033" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_78fe9d88-65b8-4b03-9e78-3964e1ea997b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SubsequentEvents" xlink:type="simple" xlink:href="pets-20221231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_ad3f0e6b-843c-45d4-a8e6-53b09898d7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_3e5e4592-00e8-4a54-90a7-e5064e4fa3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_ad3f0e6b-843c-45d4-a8e6-53b09898d7e0" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_3e5e4592-00e8-4a54-90a7-e5064e4fa3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="pets-20221231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2f651224-f05d-47c2-a951-6bc940a644a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_BasisOfPresentationAndConsolidationPolicyTextBlock_4da68314-742c-49e5-8c9f-8d4ef9749c6a" xlink:href="pets-20221231.xsd#pets_BasisOfPresentationAndConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2f651224-f05d-47c2-a951-6bc940a644a5" xlink:to="loc_pets_BasisOfPresentationAndConsolidationPolicyTextBlock_4da68314-742c-49e5-8c9f-8d4ef9749c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_7f885b09-30ee-4c40-b759-1d7f93b38d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2f651224-f05d-47c2-a951-6bc940a644a5" xlink:to="loc_us-gaap_UseOfEstimates_7f885b09-30ee-4c40-b759-1d7f93b38d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_dfabe183-bff4-4ee4-bab5-f4391e969159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2f651224-f05d-47c2-a951-6bc940a644a5" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_dfabe183-bff4-4ee4-bab5-f4391e969159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0cc62ae8-2306-42bc-a6d7-49eb7c1d3d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2f651224-f05d-47c2-a951-6bc940a644a5" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0cc62ae8-2306-42bc-a6d7-49eb7c1d3d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="pets-20221231.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a059da7e-30e4-4f41-ab53-53953858b1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c2fa7ed6-c0c5-49b5-b735-d1bfeb5904f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a059da7e-30e4-4f41-ab53-53953858b1a3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c2fa7ed6-c0c5-49b5-b735-d1bfeb5904f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="pets-20221231.xsd#NetIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8462c5d6-5ff3-4305-9609-c7506056704e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2e8bb331-f94a-4f73-94af-19ca00739b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8462c5d6-5ff3-4305-9609-c7506056704e" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2e8bb331-f94a-4f73-94af-19ca00739b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ChangesinShareholdersEquityTables" xlink:type="simple" xlink:href="pets-20221231.xsd#ChangesinShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ChangesinShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c01a4025-aa22-4621-8f0d-85ee1efef4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_316e46ba-c808-430e-8829-1b40649dd78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c01a4025-aa22-4621-8f0d-85ee1efef4e1" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_316e46ba-c808-430e-8829-1b40649dd78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#RevenueRecognitionSummaryofDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9339484e-6062-48c0-97c5-8ffcef19bdc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_08e3a772-d2aa-4b7f-9a4c-4ee5e350860e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9339484e-6062-48c0-97c5-8ffcef19bdc7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_08e3a772-d2aa-4b7f-9a4c-4ee5e350860e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_55b3101b-9985-4489-884f-867fa09c1e99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_08e3a772-d2aa-4b7f-9a4c-4ee5e350860e" xlink:to="loc_srt_MajorCustomersAxis_55b3101b-9985-4489-884f-867fa09c1e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e47ac69d-a44c-4f41-b10e-9ced10fa0235" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_55b3101b-9985-4489-884f-867fa09c1e99" xlink:to="loc_srt_NameOfMajorCustomerDomain_e47ac69d-a44c-4f41-b10e-9ced10fa0235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ReorderMember_25fd990e-321c-4f14-b75f-a9f87ffc7fce" xlink:href="pets-20221231.xsd#pets_ReorderMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e47ac69d-a44c-4f41-b10e-9ced10fa0235" xlink:to="loc_pets_ReorderMember_25fd990e-321c-4f14-b75f-a9f87ffc7fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NewOrderMember_1a00fd19-56f2-48b5-97d1-cf795c3965f6" xlink:href="pets-20221231.xsd#pets_NewOrderMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e47ac69d-a44c-4f41-b10e-9ced10fa0235" xlink:to="loc_pets_NewOrderMember_1a00fd19-56f2-48b5-97d1-cf795c3965f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_27ef4b0f-872f-4f75-92bb-bade375ce310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_08e3a772-d2aa-4b7f-9a4c-4ee5e350860e" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_27ef4b0f-872f-4f75-92bb-bade375ce310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_377dddb7-380b-431a-b522-7387dd3f37ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_27ef4b0f-872f-4f75-92bb-bade375ce310" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_377dddb7-380b-431a-b522-7387dd3f37ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_InternetMember_b1bf768e-e89a-48b0-b71f-41f3ad2c5acb" xlink:href="pets-20221231.xsd#pets_InternetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_377dddb7-380b-431a-b522-7387dd3f37ea" xlink:to="loc_pets_InternetMember_b1bf768e-e89a-48b0-b71f-41f3ad2c5acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ContactCenterMember_d2275fc1-60e1-4f53-87ec-91250a6ebea5" xlink:href="pets-20221231.xsd#pets_ContactCenterMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_377dddb7-380b-431a-b522-7387dd3f37ea" xlink:to="loc_pets_ContactCenterMember_d2275fc1-60e1-4f53-87ec-91250a6ebea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9e532de3-e217-4149-971e-56fafae27140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_08e3a772-d2aa-4b7f-9a4c-4ee5e350860e" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_9e532de3-e217-4149-971e-56fafae27140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_da9f9e30-68e8-478b-bca9-cbe3be6400e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e532de3-e217-4149-971e-56fafae27140" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_da9f9e30-68e8-478b-bca9-cbe3be6400e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerPercentage_d6e4e66e-3309-4ac4-91f6-6c70ed56cf5e" xlink:href="pets-20221231.xsd#pets_RevenueFromContractWithCustomerPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e532de3-e217-4149-971e-56fafae27140" xlink:to="loc_pets_RevenueFromContractWithCustomerPercentage_d6e4e66e-3309-4ac4-91f6-6c70ed56cf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerVariance_b05a1656-7c1d-40af-b1aa-cafcc980960f" xlink:href="pets-20221231.xsd#pets_RevenueFromContractWithCustomerVariance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e532de3-e217-4149-971e-56fafae27140" xlink:to="loc_pets_RevenueFromContractWithCustomerVariance_b05a1656-7c1d-40af-b1aa-cafcc980960f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerVariancePercentage_85ef9ccf-3c52-47df-bba8-fd0411e05ea0" xlink:href="pets-20221231.xsd#pets_RevenueFromContractWithCustomerVariancePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9e532de3-e217-4149-971e-56fafae27140" xlink:to="loc_pets_RevenueFromContractWithCustomerVariancePercentage_85ef9ccf-3c52-47df-bba8-fd0411e05ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2f96e9fa-8d2f-4dba-bf45-abcfc64a7ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_66445e8c-7923-4712-beb7-1f2d045436fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2f96e9fa-8d2f-4dba-bf45-abcfc64a7ad7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_66445e8c-7923-4712-beb7-1f2d045436fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_8bdf76cc-0a13-490a-bb83-fc207ff65a40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_66445e8c-7923-4712-beb7-1f2d045436fb" xlink:to="loc_srt_MajorCustomersAxis_8bdf76cc-0a13-490a-bb83-fc207ff65a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e84f7294-6697-46c2-9c15-f6cfd32fd7f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_8bdf76cc-0a13-490a-bb83-fc207ff65a40" xlink:to="loc_srt_NameOfMajorCustomerDomain_e84f7294-6697-46c2-9c15-f6cfd32fd7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ReorderMember_2e508cf4-fc36-46c3-822c-f39e8b5c84b5" xlink:href="pets-20221231.xsd#pets_ReorderMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e84f7294-6697-46c2-9c15-f6cfd32fd7f8" xlink:to="loc_pets_ReorderMember_2e508cf4-fc36-46c3-822c-f39e8b5c84b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NewOrderMember_23bdf96e-856e-40e1-9bfb-4ffc4860d17f" xlink:href="pets-20221231.xsd#pets_NewOrderMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e84f7294-6697-46c2-9c15-f6cfd32fd7f8" xlink:to="loc_pets_NewOrderMember_23bdf96e-856e-40e1-9bfb-4ffc4860d17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_7f09dbe5-6911-44a6-b8e9-6d7d7d84c2f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_66445e8c-7923-4712-beb7-1f2d045436fb" xlink:to="loc_srt_RestatementAxis_7f09dbe5-6911-44a6-b8e9-6d7d7d84c2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_30bc7d11-7f0f-4460-8e50-bf620ccaf400" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_7f09dbe5-6911-44a6-b8e9-6d7d7d84c2f8" xlink:to="loc_srt_RestatementDomain_30bc7d11-7f0f-4460-8e50-bf620ccaf400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_6c8f6908-9202-453a-a187-9ffaa7f2c347" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_30bc7d11-7f0f-4460-8e50-bf620ccaf400" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_6c8f6908-9202-453a-a187-9ffaa7f2c347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2a3ce191-1572-45f4-8850-d275043d52f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_66445e8c-7923-4712-beb7-1f2d045436fb" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_2a3ce191-1572-45f4-8850-d275043d52f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_33dbc047-baf5-4b05-b597-08145294a436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2a3ce191-1572-45f4-8850-d275043d52f9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_33dbc047-baf5-4b05-b597-08145294a436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#NetIncomePerShareScheduleofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_55457702-2923-4e18-9480-443b804f785a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_a4728752-0d4a-4b3e-914a-9138c38baba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_55457702-2923-4e18-9480-443b804f785a" xlink:to="loc_us-gaap_NetIncomeLossAbstract_a4728752-0d4a-4b3e-914a-9138c38baba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bb948309-c6a9-47d9-ade2-886e96b7e6af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_a4728752-0d4a-4b3e-914a-9138c38baba2" xlink:to="loc_us-gaap_NetIncomeLoss_bb948309-c6a9-47d9-ade2-886e96b7e6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2141e55f-b71b-4187-9f99-ca7a017a2ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_55457702-2923-4e18-9480-443b804f785a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2141e55f-b71b-4187-9f99-ca7a017a2ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1283d3f6-6148-4e2a-b4fb-0df13cb0b641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2141e55f-b71b-4187-9f99-ca7a017a2ea6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1283d3f6-6148-4e2a-b4fb-0df13cb0b641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1ba221b3-c082-4a05-be64-f269f99577b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2141e55f-b71b-4187-9f99-ca7a017a2ea6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1ba221b3-c082-4a05-be64-f269f99577b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_9c0ed897-77d1-4c4d-aabc-ec627f57eb22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2141e55f-b71b-4187-9f99-ca7a017a2ea6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_9c0ed897-77d1-4c4d-aabc-ec627f57eb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4bf338c2-acfc-4768-8c75-2968b2a3976a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2141e55f-b71b-4187-9f99-ca7a017a2ea6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4bf338c2-acfc-4768-8c75-2968b2a3976a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NetIncomePerCommonShareBasicAndDilutedAbstract_856db55b-4e29-44fd-9f99-66281dc7d495" xlink:href="pets-20221231.xsd#pets_NetIncomePerCommonShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_55457702-2923-4e18-9480-443b804f785a" xlink:to="loc_pets_NetIncomePerCommonShareBasicAndDilutedAbstract_856db55b-4e29-44fd-9f99-66281dc7d495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f11a0a12-96c9-4e0f-b92d-08fe7ec7b5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pets_NetIncomePerCommonShareBasicAndDilutedAbstract_856db55b-4e29-44fd-9f99-66281dc7d495" xlink:to="loc_us-gaap_EarningsPerShareBasic_f11a0a12-96c9-4e0f-b92d-08fe7ec7b5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3b13b32d-a57a-4e39-ac27-ea692c2f382b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pets_NetIncomePerCommonShareBasicAndDilutedAbstract_856db55b-4e29-44fd-9f99-66281dc7d495" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3b13b32d-a57a-4e39-ac27-ea692c2f382b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#NetIncomePerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9ddf1443-98f7-4d3c-9911-9d99a84157a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_278ed635-deb5-41d2-a883-fe6b304f01dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9ddf1443-98f7-4d3c-9911-9d99a84157a2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_278ed635-deb5-41d2-a883-fe6b304f01dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9492813f-8d80-43b1-b110-29592c6a6e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_278ed635-deb5-41d2-a883-fe6b304f01dc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9492813f-8d80-43b1-b110-29592c6a6e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8f84fa29-9092-4847-97db-376adb120eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9492813f-8d80-43b1-b110-29592c6a6e91" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8f84fa29-9092-4847-97db-376adb120eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_d1e4f499-7bf6-462c-8677-02f8a0a32651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8f84fa29-9092-4847-97db-376adb120eaa" xlink:to="loc_us-gaap_RestrictedStockMember_d1e4f499-7bf6-462c-8677-02f8a0a32651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SharesIssuableUponVestingOfRestrictedStockMember_f58d3c15-82ef-49e2-8b1a-03384659d594" xlink:href="pets-20221231.xsd#pets_SharesIssuableUponVestingOfRestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8f84fa29-9092-4847-97db-376adb120eaa" xlink:to="loc_pets_SharesIssuableUponVestingOfRestrictedStockMember_f58d3c15-82ef-49e2-8b1a-03384659d594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_8e6c3f5b-f43f-4eeb-a839-f6de48a31454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8f84fa29-9092-4847-97db-376adb120eaa" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_8e6c3f5b-f43f-4eeb-a839-f6de48a31454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_504c7f74-0892-4c6c-a86b-bc3b5fa5558e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_278ed635-deb5-41d2-a883-fe6b304f01dc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_504c7f74-0892-4c6c-a86b-bc3b5fa5558e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d8572ebb-7955-4ac3-ac89-951489f8a4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_504c7f74-0892-4c6c-a86b-bc3b5fa5558e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d8572ebb-7955-4ac3-ac89-951489f8a4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#AccountingforStockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1cdd543-208a-4d80-9a44-85fbb7fbcdbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1cdd543-208a-4d80-9a44-85fbb7fbcdbc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ba8ca6da-916f-41bb-80d2-c3b453054470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:to="loc_us-gaap_PlanNameAxis_ba8ca6da-916f-41bb-80d2-c3b453054470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ba8ca6da-916f-41bb-80d2-c3b453054470" xlink:to="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_ecc8ab53-9ebd-401a-a9ae-8a0437521a9d" xlink:href="pets-20221231.xsd#pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:to="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_ecc8ab53-9ebd-401a-a9ae-8a0437521a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_c7ed857e-6dc7-4a4a-a857-88c1897ee7a9" xlink:href="pets-20221231.xsd#pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:to="loc_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_c7ed857e-6dc7-4a4a-a857-88c1897ee7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmployeeAndDirectorPlansMember_c00811a3-fda6-49a0-b4c7-d3438435a032" xlink:href="pets-20221231.xsd#pets_EmployeeAndDirectorPlansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:to="loc_pets_EmployeeAndDirectorPlansMember_c00811a3-fda6-49a0-b4c7-d3438435a032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_9716b34a-99a3-4b2a-b4f2-dc064f6a9d71" xlink:href="pets-20221231.xsd#pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:to="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_9716b34a-99a3-4b2a-b4f2-dc064f6a9d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_A2022EmployeePlanMember_98751569-9bf8-4908-97c0-0b135cf5abc8" xlink:href="pets-20221231.xsd#pets_A2022EmployeePlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_504c3d99-dd66-4f10-b3b3-c9e5cdc23adb" xlink:to="loc_pets_A2022EmployeePlanMember_98751569-9bf8-4908-97c0-0b135cf5abc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_aecce266-f7f2-4f8c-b20a-8f19eeabd89f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:to="loc_us-gaap_AwardTypeAxis_aecce266-f7f2-4f8c-b20a-8f19eeabd89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e594f456-d563-4885-a96a-d916df044a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_aecce266-f7f2-4f8c-b20a-8f19eeabd89f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e594f456-d563-4885-a96a-d916df044a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e23d738b-1ee0-43d4-8de0-8b1ac8ad7664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e594f456-d563-4885-a96a-d916df044a71" xlink:to="loc_us-gaap_RestrictedStockMember_e23d738b-1ee0-43d4-8de0-8b1ac8ad7664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockMember_0e2d18a0-7f22-4240-9abe-282c64846001" xlink:href="pets-20221231.xsd#pets_PerformanceRestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e594f456-d563-4885-a96a-d916df044a71" xlink:to="loc_pets_PerformanceRestrictedStockMember_0e2d18a0-7f22-4240-9abe-282c64846001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d06119e4-028d-43b8-a4a8-2d0e15224997" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:to="loc_srt_RangeAxis_d06119e4-028d-43b8-a4a8-2d0e15224997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2857bf1b-dbc6-43a9-96bf-d8bf2fe9c61f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d06119e4-028d-43b8-a4a8-2d0e15224997" xlink:to="loc_srt_RangeMember_2857bf1b-dbc6-43a9-96bf-d8bf2fe9c61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_156c97e1-cff1-4b8d-b533-75cfc7257570" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2857bf1b-dbc6-43a9-96bf-d8bf2fe9c61f" xlink:to="loc_srt_MinimumMember_156c97e1-cff1-4b8d-b533-75cfc7257570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a268e4c7-95e2-4add-8d25-74ff5cd07fb3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2857bf1b-dbc6-43a9-96bf-d8bf2fe9c61f" xlink:to="loc_srt_MaximumMember_a268e4c7-95e2-4add-8d25-74ff5cd07fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_62a1c7cb-8e1c-441a-9872-090a4ac85f7e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:to="loc_srt_TitleOfIndividualAxis_62a1c7cb-8e1c-441a-9872-090a4ac85f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46e12e47-9eca-471d-8c3f-9bd323e3f307" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_62a1c7cb-8e1c-441a-9872-090a4ac85f7e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46e12e47-9eca-471d-8c3f-9bd323e3f307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_67d5d489-5f7f-4a94-a9c9-49c40b935d2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46e12e47-9eca-471d-8c3f-9bd323e3f307" xlink:to="loc_srt_ChiefExecutiveOfficerMember_67d5d489-5f7f-4a94-a9c9-49c40b935d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefFinancialOfficerMember_d512678d-6c8a-4741-8354-d5b650dda16d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_46e12e47-9eca-471d-8c3f-9bd323e3f307" xlink:to="loc_srt_ChiefFinancialOfficerMember_d512678d-6c8a-4741-8354-d5b650dda16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5edf393a-d16f-4f1c-a72b-f50cb27e43ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_ea4db874-4ed1-44b0-bb07-322b9621e97a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_ea4db874-4ed1-44b0-bb07-322b9621e97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RestrictionPeriod_874c2c68-6fe6-46b7-b25b-f98410836484" xlink:href="pets-20221231.xsd#pets_RestrictionPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_pets_RestrictionPeriod_874c2c68-6fe6-46b7-b25b-f98410836484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_24f8e591-00f4-4407-a390-d4e101316f67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_24f8e591-00f4-4407-a390-d4e101316f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1f1b4bc4-4bfa-42a8-969d-c7d7c601b8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1f1b4bc4-4bfa-42a8-969d-c7d7c601b8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3fbb1e56-6eb7-4ab3-a77c-67c5d5e818ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3fbb1e56-6eb7-4ab3-a77c-67c5d5e818ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7379a597-7fa5-454a-bec1-c839bf0344bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7379a597-7fa5-454a-bec1-c839bf0344bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e7a04209-8d0e-4bc4-9ba4-97b4505e2b05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e7a04209-8d0e-4bc4-9ba4-97b4505e2b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b9585b1e-90e5-409f-b09d-7251657c6739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b9585b1e-90e5-409f-b09d-7251657c6739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7867d3c6-4b58-4874-9c3e-b655635065be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8b8324e-1630-431b-b4be-903c00d60dc0" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7867d3c6-4b58-4874-9c3e-b655635065be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/FairValueDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#FairValueDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/FairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_91d46b4c-0673-4ccf-9041-86912385fe10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_23059172-2858-4e3f-b78e-4795b6dbc492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_91d46b4c-0673-4ccf-9041-86912385fe10" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_23059172-2858-4e3f-b78e-4795b6dbc492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3a602628-afe1-454d-8283-b5dfec530078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_cd04fc1c-3c16-42c0-876f-9e9aa390f4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3a602628-afe1-454d-8283-b5dfec530078" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_cd04fc1c-3c16-42c0-876f-9e9aa390f4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedSeveranceCosts_8ee20c56-3b85-4fa1-aaa9-b89153bc459c" xlink:href="pets-20221231.xsd#pets_AccruedSeveranceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3a602628-afe1-454d-8283-b5dfec530078" xlink:to="loc_pets_AccruedSeveranceCosts_8ee20c56-3b85-4fa1-aaa9-b89153bc459c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_60a29114-6542-487d-846f-8b89f8d22439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a5e0affa-1575-4bd7-b06b-5269bada3100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_60a29114-6542-487d-846f-8b89f8d22439" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a5e0affa-1575-4bd7-b06b-5269bada3100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d9e718e2-a966-46a8-9560-f394c23537dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a5e0affa-1575-4bd7-b06b-5269bada3100" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d9e718e2-a966-46a8-9560-f394c23537dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7fb7753d-57db-49b6-8de0-ece24fede810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9e718e2-a966-46a8-9560-f394c23537dd" xlink:to="loc_us-gaap_EquityComponentDomain_7fb7753d-57db-49b6-8de0-ece24fede810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a0484920-005e-4207-83b3-c8c5207080e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7fb7753d-57db-49b6-8de0-ece24fede810" xlink:to="loc_us-gaap_CommonStockMember_a0484920-005e-4207-83b3-c8c5207080e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b6c7af8d-23b9-4333-a354-523573e4d8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7fb7753d-57db-49b6-8de0-ece24fede810" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b6c7af8d-23b9-4333-a354-523573e4d8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a7506393-e707-429b-af03-38d6053a0383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7fb7753d-57db-49b6-8de0-ece24fede810" xlink:to="loc_us-gaap_RetainedEarningsMember_a7506393-e707-429b-af03-38d6053a0383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_685bf676-0df5-4aff-bf3f-d18d7b597ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a5e0affa-1575-4bd7-b06b-5269bada3100" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_685bf676-0df5-4aff-bf3f-d18d7b597ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_685bf676-0df5-4aff-bf3f-d18d7b597ebb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_99fe7cfe-243f-405e-bce5-8af3289881a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:to="loc_us-gaap_StockholdersEquity_99fe7cfe-243f-405e-bce5-8af3289881a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a87fc32c-09ce-4633-b664-22a77dd8e61b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a87fc32c-09ce-4633-b664-22a77dd8e61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcd4d334-54fa-4fab-976b-323bbe6dc80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcd4d334-54fa-4fab-976b-323bbe6dc80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_5ba3f4b3-7477-44f6-bc73-1be8145e732f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:to="loc_us-gaap_DividendsCommonStock_5ba3f4b3-7477-44f6-bc73-1be8145e732f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a19d135f-c399-4b7f-8790-a49d7684cd74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:to="loc_us-gaap_NetIncomeLoss_a19d135f-c399-4b7f-8790-a49d7684cd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_aaef41e1-e8d8-40a8-a3c6-4dd69437bf82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e224d409-870d-44ff-aab5-83dd8b453661" xlink:to="loc_us-gaap_StockholdersEquity_aaef41e1-e8d8-40a8-a3c6-4dd69437bf82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ChangesinShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#ChangesinShareholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ChangesinShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d4898c13-c0a9-4ab8-9a24-a0f65ab9d2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_97df34fc-a304-4233-8afa-d091e0079521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d4898c13-c0a9-4ab8-9a24-a0f65ab9d2c7" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_97df34fc-a304-4233-8afa-d091e0079521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7fbecd1b-09f1-427e-be23-92648c67c46c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d4898c13-c0a9-4ab8-9a24-a0f65ab9d2c7" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7fbecd1b-09f1-427e-be23-92648c67c46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2bd7a50a-cbc0-467a-ac18-b50ee3082660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_68608e92-12bd-41c5-9c56-4d5d6d09972b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2bd7a50a-cbc0-467a-ac18-b50ee3082660" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_68608e92-12bd-41c5-9c56-4d5d6d09972b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_31a46fb2-90be-47cc-82da-fa256300ec1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2bd7a50a-cbc0-467a-ac18-b50ee3082660" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_31a46fb2-90be-47cc-82da-fa256300ec1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#MinorityInterestInvestmentinVetsterDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_90811cdc-e8ec-4754-b51e-f783c6462230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_e50b7894-d93f-4b7f-ba82-11e2c8836258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_90811cdc-e8ec-4754-b51e-f783c6462230" xlink:to="loc_us-gaap_MinorityInterestTable_e50b7894-d93f-4b7f-ba82-11e2c8836258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_f559aaee-465f-4d8f-9820-a2d06964f646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_e50b7894-d93f-4b7f-ba82-11e2c8836258" xlink:to="loc_us-gaap_TypeOfArrangementAxis_f559aaee-465f-4d8f-9820-a2d06964f646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a67ea7ca-c4fa-4370-af26-110c4ef3079f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f559aaee-465f-4d8f-9820-a2d06964f646" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a67ea7ca-c4fa-4370-af26-110c4ef3079f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PartnershipAgreementWithVetsterMember_6a40cb7f-e1e0-4a59-bcb8-403bc08629db" xlink:href="pets-20221231.xsd#pets_PartnershipAgreementWithVetsterMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a67ea7ca-c4fa-4370-af26-110c4ef3079f" xlink:to="loc_pets_PartnershipAgreementWithVetsterMember_6a40cb7f-e1e0-4a59-bcb8-403bc08629db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_c71d19ed-7fd8-4737-954e-6e2e8fbaf8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_e50b7894-d93f-4b7f-ba82-11e2c8836258" xlink:to="loc_us-gaap_MinorityInterestLineItems_c71d19ed-7fd8-4737-954e-6e2e8fbaf8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TermOfAgreement_1d8a6230-046e-475c-9ba6-a397476470ee" xlink:href="pets-20221231.xsd#pets_TermOfAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c71d19ed-7fd8-4737-954e-6e2e8fbaf8b7" xlink:to="loc_pets_TermOfAgreement_1d8a6230-046e-475c-9ba6-a397476470ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NoncontrollingInterestOwnershipPercentagePurchased_14c20662-db5a-4768-9ac8-9f415bf1aade" xlink:href="pets-20221231.xsd#pets_NoncontrollingInterestOwnershipPercentagePurchased"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c71d19ed-7fd8-4737-954e-6e2e8fbaf8b7" xlink:to="loc_pets_NoncontrollingInterestOwnershipPercentagePurchased_14c20662-db5a-4768-9ac8-9f415bf1aade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_15502b32-9300-412a-9e49-b5f2f4a217f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_c71d19ed-7fd8-4737-954e-6e2e8fbaf8b7" xlink:to="loc_us-gaap_Investments_15502b32-9300-412a-9e49-b5f2f4a217f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="pets-20221231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_67a1a5cb-3226-4d2b-9968-a57c58deb22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_67a1a5cb-3226-4d2b-9968-a57c58deb22a" xlink:to="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_08a8f0ca-56b8-4f31-9810-9c18f17341fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_08a8f0ca-56b8-4f31-9810-9c18f17341fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_315ee0e8-621b-44e4-ac43-e055d6c4411f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_08a8f0ca-56b8-4f31-9810-9c18f17341fb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_315ee0e8-621b-44e4-ac43-e055d6c4411f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b4730616-0f34-4a4b-b15d-4ebaeca2fa41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_315ee0e8-621b-44e4-ac43-e055d6c4411f" xlink:to="loc_us-gaap_SubsequentEventMember_b4730616-0f34-4a4b-b15d-4ebaeca2fa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a5533ad1-4277-4af5-9b02-5c6ce7cd76b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:to="loc_us-gaap_AwardTypeAxis_a5533ad1-4277-4af5-9b02-5c6ce7cd76b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93e1ae7b-2cbf-412c-a41f-7e739847face" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a5533ad1-4277-4af5-9b02-5c6ce7cd76b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93e1ae7b-2cbf-412c-a41f-7e739847face" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8b127ee4-59f7-4381-8351-098b33d5426e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93e1ae7b-2cbf-412c-a41f-7e739847face" xlink:to="loc_us-gaap_CommonStockMember_8b127ee4-59f7-4381-8351-098b33d5426e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_b5c4497f-981a-4b49-9f6a-e983a4aff25d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93e1ae7b-2cbf-412c-a41f-7e739847face" xlink:to="loc_us-gaap_EmployeeStockMember_b5c4497f-981a-4b49-9f6a-e983a4aff25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_13dc21a5-fc86-491f-918d-0920461930e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93e1ae7b-2cbf-412c-a41f-7e739847face" xlink:to="loc_us-gaap_RestrictedStockMember_13dc21a5-fc86-491f-918d-0920461930e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_849eaafc-2d37-4bfd-9955-6103391bdad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:to="loc_us-gaap_PlanNameAxis_849eaafc-2d37-4bfd-9955-6103391bdad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_84942ea6-2798-420c-b997-380159c273ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_849eaafc-2d37-4bfd-9955-6103391bdad6" xlink:to="loc_us-gaap_PlanNameDomain_84942ea6-2798-420c-b997-380159c273ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_1cd1e900-8820-47cc-a798-5790f467bbb2" xlink:href="pets-20221231.xsd#pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_84942ea6-2798-420c-b997-380159c273ab" xlink:to="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_1cd1e900-8820-47cc-a798-5790f467bbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_MZHCILLCInvestorRelationsConsultingAgreementMember_37b19dc5-5b34-4e7b-bb0f-42f49602d174" xlink:href="pets-20221231.xsd#pets_MZHCILLCInvestorRelationsConsultingAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_84942ea6-2798-420c-b997-380159c273ab" xlink:to="loc_pets_MZHCILLCInvestorRelationsConsultingAgreementMember_37b19dc5-5b34-4e7b-bb0f-42f49602d174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_cb1aa849-c9e0-458a-9640-e3aaa408b8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:to="loc_us-gaap_DividendsAxis_cb1aa849-c9e0-458a-9640-e3aaa408b8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_b17bf129-d44d-4eaa-b8cd-faf515ea951c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsAxis_cb1aa849-c9e0-458a-9640-e3aaa408b8af" xlink:to="loc_us-gaap_DividendsDomain_b17bf129-d44d-4eaa-b8cd-faf515ea951c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_QuarterlyDividendMember_fb25d644-0f25-479a-8de0-a0b8995b2c44" xlink:href="pets-20221231.xsd#pets_QuarterlyDividendMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_b17bf129-d44d-4eaa-b8cd-faf515ea951c" xlink:to="loc_pets_QuarterlyDividendMember_fb25d644-0f25-479a-8de0-a0b8995b2c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5ff7deaf-d989-40ba-95b0-fb27fc46dc2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5ff7deaf-d989-40ba-95b0-fb27fc46dc2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cd75289-56d4-48cf-af69-4a698d669972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5ff7deaf-d989-40ba-95b0-fb27fc46dc2d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cd75289-56d4-48cf-af69-4a698d669972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PetCareRxMember_163ba8d6-c5e8-4920-a48c-031fe96d4532" xlink:href="pets-20221231.xsd#pets_PetCareRxMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cd75289-56d4-48cf-af69-4a698d669972" xlink:to="loc_pets_PetCareRxMember_163ba8d6-c5e8-4920-a48c-031fe96d4532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_f1281c1a-1cfd-4ef6-8e3f-e8f67ee91165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_22ccc627-4e10-4ac4-b314-e3232fbddd2c" xlink:to="loc_us-gaap_SubsequentEventLineItems_f1281c1a-1cfd-4ef6-8e3f-e8f67ee91165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ada45f38-6232-4e17-b2f8-01c448635b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1281c1a-1cfd-4ef6-8e3f-e8f67ee91165" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ada45f38-6232-4e17-b2f8-01c448635b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_d18e7b5a-f0d3-4335-b031-e10828f3386f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1281c1a-1cfd-4ef6-8e3f-e8f67ee91165" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_d18e7b5a-f0d3-4335-b031-e10828f3386f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_1c8cd736-76c5-4e3e-a8f8-94311e114ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1281c1a-1cfd-4ef6-8e3f-e8f67ee91165" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_1c8cd736-76c5-4e3e-a8f8-94311e114ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6f4b4e4e-0b34-403a-99e6-edde495d6335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f1281c1a-1cfd-4ef6-8e3f-e8f67ee91165" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6f4b4e4e-0b34-403a-99e6-edde495d6335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585779475440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 07, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-28827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PETMED EXPRESS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0680967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">420 South Congress Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Delray Beach<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">526-4444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PETS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,084,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001040130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585778135632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 102,428<span></span>
</td>
<td class="nump">$ 111,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less allowance for doubtful accounts of $40 and $39, respectively</a></td>
<td class="nump">1,944<span></span>
</td>
<td class="nump">1,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Inventories - finished goods</a></td>
<td class="nump">22,402<span></span>
</td>
<td class="nump">32,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">5,637<span></span>
</td>
<td class="nump">4,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">1,608<span></span>
</td>
<td class="nump">681<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">134,019<span></span>
</td>
<td class="nump">150,995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Noncurrent assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">25,242<span></span>
</td>
<td class="nump">24,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_IntangibleAndOtherAssets', window );">Intangible and other assets</a></td>
<td class="nump">5,860<span></span>
</td>
<td class="nump">860<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total noncurrent assets</a></td>
<td class="nump">31,102<span></span>
</td>
<td class="nump">25,324<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">165,121<span></span>
</td>
<td class="nump">176,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">24,317<span></span>
</td>
<td class="nump">27,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">6,754<span></span>
</td>
<td class="nump">5,697<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">31,071<span></span>
</td>
<td class="nump">33,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">465<span></span>
</td>
<td class="nump">936<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">31,536<span></span>
</td>
<td class="nump">34,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.001 par value, 40,000 shares authorized; 21,077 and 20,979 shares issued and outstanding, respectively</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">16,647<span></span>
</td>
<td class="nump">11,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">116,908<span></span>
</td>
<td class="nump">130,496<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">133,585<span></span>
</td>
<td class="nump">142,186<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 165,121<span></span>
</td>
<td class="nump">$ 176,319<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_AccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_AccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_IntangibleAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible And Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_IntangibleAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585779430768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred stock, liquidation preference (in dollars per share)</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">21,077<span></span>
</td>
<td class="nump">20,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">21,077<span></span>
</td>
<td class="nump">20,979<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585778170000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 58,870<span></span>
</td>
<td class="nump">$ 60,717<span></span>
</td>
<td class="nump">$ 194,451<span></span>
</td>
<td class="nump">$ 207,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">43,632<span></span>
</td>
<td class="nump">42,992<span></span>
</td>
<td class="nump">140,819<span></span>
</td>
<td class="nump">148,736<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">15,238<span></span>
</td>
<td class="nump">17,725<span></span>
</td>
<td class="nump">53,632<span></span>
</td>
<td class="nump">58,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">10,425<span></span>
</td>
<td class="nump">7,541<span></span>
</td>
<td class="nump">30,529<span></span>
</td>
<td class="nump">22,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising</a></td>
<td class="nump">4,641<span></span>
</td>
<td class="nump">4,327<span></span>
</td>
<td class="nump">14,869<span></span>
</td>
<td class="nump">15,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">710<span></span>
</td>
<td class="nump">2,552<span></span>
</td>
<td class="nump">2,051<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">16,007<span></span>
</td>
<td class="nump">12,578<span></span>
</td>
<td class="nump">47,950<span></span>
</td>
<td class="nump">40,026<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="num">(769)<span></span>
</td>
<td class="nump">5,147<span></span>
</td>
<td class="nump">5,682<span></span>
</td>
<td class="nump">18,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income, net</a></td>
<td class="nump">708<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="nump">718<span></span>
</td>
<td class="nump">741<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="nump">967<span></span>
</td>
<td class="nump">371<span></span>
</td>
<td class="nump">1,931<span></span>
</td>
<td class="nump">984<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">5,518<span></span>
</td>
<td class="nump">7,613<span></span>
</td>
<td class="nump">19,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">1,261<span></span>
</td>
<td class="nump">2,278<span></span>
</td>
<td class="nump">4,603<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (19)<span></span>
</td>
<td class="nump">$ 4,257<span></span>
</td>
<td class="nump">$ 5,335<span></span>
</td>
<td class="nump">$ 15,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">20,301<span></span>
</td>
<td class="nump">20,208<span></span>
</td>
<td class="nump">20,257<span></span>
</td>
<td class="nump">20,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">20,301<span></span>
</td>
<td class="nump">20,329<span></span>
</td>
<td class="nump">20,339<span></span>
</td>
<td class="nump">20,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585779324880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 5,335<span></span>
</td>
<td class="nump">$ 15,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">2,552<span></span>
</td>
<td class="nump">2,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="nump">4,987<span></span>
</td>
<td class="nump">3,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(471)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>(Increase) decrease in operating assets and increase (decrease) in operating liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(324)<span></span>
</td>
<td class="nump">1,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories', window );">Inventories - finished goods</a></td>
<td class="nump">10,053<span></span>
</td>
<td class="nump">6,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="num">(927)<span></span>
</td>
<td class="num">(911)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(771)<span></span>
</td>
<td class="nump">1,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(3,183)<span></span>
</td>
<td class="num">(17,613)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">536<span></span>
</td>
<td class="num">(1,188)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">18,079<span></span>
</td>
<td class="nump">9,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Purchase of minority interest investment in Vetster</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(3,329)<span></span>
</td>
<td class="num">(1,266)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(8,329)<span></span>
</td>
<td class="num">(1,266)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(18,402)<span></span>
</td>
<td class="num">(18,322)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(18,402)<span></span>
</td>
<td class="num">(18,322)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="num">(8,652)<span></span>
</td>
<td class="num">(9,807)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, at beginning of period</a></td>
<td class="nump">111,080<span></span>
</td>
<td class="nump">118,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, at end of period</a></td>
<td class="nump">102,428<span></span>
</td>
<td class="nump">108,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">3,870<span></span>
</td>
<td class="nump">5,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Dividends payable in accrued expenses</a></td>
<td class="nump">$ 1,079<span></span>
</td>
<td class="nump">$ 329<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the book value of finished goods inventory and work in process inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585776752672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Organization</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PetMed Express, Inc. and subsidiaries, d/b/a PetMeds&#174; (the &#8220;Company&#8221;), is a leading nationwide pet pharmacy and Your Trusted Pet Health Expert</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs, cats, and horses, directly to the consumer. The Company offers consumers an attractive alternative for obtaining pet medications in terms of expertise, convenience, price, speed of delivery and valued customer service. The Company markets its products through advertising and promotional campaigns, which aim to increase the recognition of the &#8220;PetMeds&#174;&#8221; brand name, increase traffic on its website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, acquire new customers, and maximize repeat purchases. Virtually all of the Company&#8217;s sales are to customers in the United States. The Company&#8217;s corporate headquarters and distribution facility is located in Delray Beach, Florida. The Company&#8217;s fiscal year end is March&#160;31, and references herein to fiscal 2023 or fiscal 2022 refer to the Company's fiscal years ending March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and, therefore, do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, the accompanying Condensed Consolidated Financial Statements contain all adjustments, consisting of normal recurring accruals, necessary to present fairly the financial position of the Company at December&#160;31, 2022, the Statements of Income for the three and nine months ended December&#160;31, 2022 and 2021, and Cash Flows for the nine months ended December&#160;31, 2022 and 2021. The results of operations for the three and nine months ended December&#160;31, 2022 are not necessarily indicative of the operating results expected for the fiscal year ending March&#160;31, 2023. These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022. The Condensed Consolidated Financial Statements include the accounts of PetMed Express, Inc. and its wholly owned subsidiaries. All significant intercompany transactions have been eliminated upon consolidation. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Use of Estimates </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair Value of Financial Instruments </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the Company's cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent Accounting Pronouncements </span></div>The Company does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on the Company's consolidated financial position, results of operations, or cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585777386288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue RecognitionThe Company generates revenue by selling pet medication products and pet supplies mainly to retail customers. Certain pet supplies offered on the Company&#8217;s website are drop shipped to customers. The Company considers itself the principal in the arrangement because the Company controls the specified good before it is transferred to the customer. Revenue contracts contain one performance obligation, which is delivery of the product. Customer care and support is deemed not to be a material right to the contract. The transaction price is adjusted at the date of sale for any applicable sales discounts and an estimate of product returns, which are based on historical patterns, however this is not considered a key <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">judgment. Revenue is recognized when control transfers to the customer at the point in time at which the shipment of the product occurs. This key judgment is determined as the shipping point, which represents the point in time when the Company has a present right to payment, title has transferred to the customer, and the customer has assumed the risks and rewards of ownership.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outbound shipping and handling fees are an accounting policy election and are included in sales as the Company considers itself the principal in the arrangement given its responsibility for supplier selection and discretion over pricing. Shipping costs associated with outbound freight after control over a product has transferred to a customer are an accounting policy election and are accounted for as fulfillment costs and are included in cost of sales.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates sales in the following two categories: (1) reorder sales vs new order sales, and (2) internet sales vs. contact center sales. The following table illustrates sales by various classifications:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue (In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reorder sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,943)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New order sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,847)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internet sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contact center sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,651)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,847)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue (In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reorder sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">176,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New order sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,741)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,964)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internet sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contact center sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194,451&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,964)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company changed the definition of a new customer on April 1, 2022, to include anyone who has not ordered over the past thirty-six months. The reorder and new order sales amounts for the three and nine  months ended December&#160;31, 2022, and the reorder and new order sales amounts for the three and nine  months ended December&#160;31, 2021 reflect this new customer definition change. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the previous definition of a new customer, reorder and new order sales were $56.3 million and $4.4 million, respectively, for the three months ended December 31, 2021. Under the previous definition of a new customer, reorder and new order sales were $189.3 million and $18.2 million, respectively, for the nine months ended December 31, 2021. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Virtually all the Company&#8217;s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days. Credit card sales minimize the accounts receivable balances relative to sales. The Company had no material contract asset or liability balances as of December&#160;31, 2022 or March&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585778047008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share</a></td>
<td class="text">Net Income Per Share<div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of Accounting Standards Codification (&#8220;ASC&#8221;) Topic 260 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) basic net income per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted net income per common share includes the dilutive effect of potential restricted stock and the effects of the potential conversion of preferred shares, calculated using the treasury stock method. Unvested restricted stock and convertible preferred shares issued by the Company represent the only dilutive effect reflected in the diluted weighted average shares outstanding.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented (in thousands, except for per share amounts):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.005%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) (numerator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares (denominator):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average number of common shares outstanding used in basic computation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common shares issuable upon vesting of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common shares issuable upon conversion of preferred shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares used in diluted computation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,301&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,329&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,339&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.00)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.00)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.74&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine  months ended December&#160;31, 2022 and 2021, 243,604 and 205,219 shares of common restricted stock, respectively, were excluded from the computations of diluted net income per common share, as their inclusion would have had an anti-dilutive effect on diluted net income per common share. For the three months ended December 31, 2022, 71 shares issuable upon vesting of restricted stock and 10 shares issuable upon conversion of preferred shares were excluded from the computation of diluted net income per common share, as their inclusion would have had an anti-dilutive effect on diluted net income per common share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585784635200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting for Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Accounting for Stock-Based Compensation</a></td>
<td class="text">Accounting for Stock-Based Compensation<div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records compensation expense associated with restricted stock in accordance with ASC Topic 718 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Based Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) (ASU 2016-09). The Company had 959,548 common shares issued under the 2016 Employee Equity Compensation Restricted Stock Plan (&#8220;2016 Employee Plan&#8221;), and 240,755 common shares issued under the 2015 Outside Director Equity Compensation Restricted Stock Plan (&#8220;2015 Director Plan&#8221;) at December&#160;31, 2022, all shares of which were issued subject to a restriction or forfeiture period that lapses ratably on the first, second, and third anniversaries of the date of grant, and the fair value of which is being amortized over the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfNjgz_191b9281-4145-40ce-abe4-217b2cb8eccc">one</span> to three-year restriction period, with the exception of performance restricted shares which were issued to the Chief Executive Officer and Chief Financial Officer.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company issued 90,000 restricted shares and 510,000 performance restricted shares to the Company&#8217;s CEO, in accordance with the CEO&#8217;s employment agreement, under the 2016 Employee Plan.  The performance restricted shares are based on achieving absolute stock hurdles with the three-year period from the grant date. If the shares meet the absolute stock price hurdle, they will only vest on the third anniversary of the date of grant. As of December&#160;31, 2022, none of the performance stock hurdles were met.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company issued 13,000 restricted shares and 3,000 performance restricted shares to the Company's new CFO, in accordance with the CFO's employment agreement, under the 2016 Employee Plan. The performance restricted shares are based on the attainment of performance criteria equally weighted between adjusted EBITDA and revenue. The shares for each grant will be released from restriction equally over a three (3) year period on the anniversary of the grant date, and in the case of the performance restricted shares, subject to the attainment of performance criteria .</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued 550 shares of restricted stock, net of forfeitures, to certain employees under the 2016 Employee Plan during the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quarter ended December&#160;31, 2022. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the quarters ended December&#160;31, 2022 and 2021, the Company recognized </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.8 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $1.4 million, respectively, of compensation expense related to the 2016 Employee Plan and 2015 Director Plan. For the nine months ended December&#160;31, 2022 and 2021, the Company recognized </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.0 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $3.0 million, respectively, of compensation expense related to the 2016 Employee Plan and 2015 Director Plan. At December&#160;31, 2022 and 2021 there was $10.6 million and $14.4 million of unrecognized compensation cost related to the non-vested restricted stock awards, respectively, which is expected to be recognized over the next <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjk2OQ_1aaf0ccb-d1a0-41ef-bb85-02c3837aae7b">one</span> to three years. All stock-based compensation expense is recognized as a payroll-related expense and it is included within the general and administrative expenses line item within the Company&#8217;s Consolidated Statements of Income , and the offset is included in the additional paid-in capital line item of the Company&#8217;s Consolidated Balance Sheets. On December&#160;31, 2022 and 2021, there were 759,204 and 749,219 non-vested restricted shares issued and outstanding, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Company&#8217;s 2022 Employee Equity Compensation Restricted Stock Plan (&#8220;2022 Employee Plan&#8221;) became effective upon the approval of the plan by the Company&#8217;s shareholders. The 2022 Employee Plan authorizes 1,000,000 shares of the Company's common stock available for issuance.  The value of the restricted stock is determined based on the market value of the stock at the issuance date.  The restriction period or forfeiture period is determined by the Company&#8217;s Compensation Committee and is to be no less than 1 year and no more than ten years, unless otherwise specified by the Compensation Committee. No shares had been issued under the 2022 Employee Plan as of December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585777512592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company carries cash and cash equivalents at fair value in the Condensed Consolidated Balance Sheets. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. ASC Topic 820 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) establishes a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs which are supported by little or no market activity.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. At December&#160;31, 2022, the Company had invested the majority of its $102.4 million cash and cash equivalents balance in money market funds which are classified within Level 1.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585781017024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Legal Matters and Routine Proceedings</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has settled complaints that had been filed with various states&#8217; pharmacy boards in the past. There can be no assurances made that other states will not attempt to take similar actions against the Company in the future. The Company also intends to vigorously defend its trade or service marks. There can be no assurance that the Company will be successful in protecting its trade or service marks. Legal costs related to the above matters are expensed as incurred .From time to time, the Company may be involved in and subject to disputes and legal proceedings, as well as demands, claims and threatened litigation that arise in the ordinary course of its business. These proceedings may include allegations involving business practices, infringement of intellectual property, employment or other matters. The ultimate outcome of any legal proceeding is often uncertain, there can be no assurance that the Company will be successful in any legal proceeding, and unfavorable outcomes could have a negative impact on our results of operations and financial condition. In accordance with ASC Topic 450-20 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"), the Company records a liability in its financial statements for these matters when a loss is known or considered probable and the amount can be reasonably estimated. The Company reviews the status of each significant matter each accounting period as additional information is known and adjusts the loss </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provision when appropriate. If a matter is both probable to result in a liability and the amounts of loss can be reasonably estimated, the Company estimates and discloses the possible loss or range of loss to the extent necessary to make the financial statements not misleading. If the loss is not probable and cannot be reasonably estimated, a liability is not recorded in the Company&#8217;s financial statements. Gain contingencies are not recorded until they are realized. Legal costs related to any legal matters are expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates contingencies on an ongoing basis and has established loss provisions for matters in which losses are probable and the amount of the loss can be reasonably estimated and is not currently a party to any legal proceeding that management believes could have a material adverse effect on our results of operations. Based upon an assessment for sales tax received by the Company, an accrual in the amount of $0.9&#160;million is included in the "Accrued expenses and other current liabilities" line item on the Condensed Consolidated Balance Sheets as of December&#160;31, 2022 and the offsetting expense was recognized in the "General and administrative" line item within the Condensed Consolidated Statements of Income for the nine months ended December&#160;31, 2022. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon the assessment received, the Company initiated a process to evaluate the potential for further sales tax contingencies, The effect of such evaluation of potential sales tax exposure, which the Company expects to complete in the fourth quarter ending March&#160;31, 2023, could have a material effect on the results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Separation Agreement</span></div>In connection with the separation of the Company's former Chief Financial Officer, the Company has accrued $364&#160;thousand with respect to the severance, pursuant to the CFO Transition and Separation Agreement, included in "Accrued expenses and other current liabilities" on the Condensed Consolidated Balance Sheet as of December&#160;31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585777597968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Changes in Shareholders' Equity</a></td>
<td class="text">Changes in Shareholders<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Equity:</span><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Shareholders&#8217; Equity for the nine months ended December&#160;31, 2022 is summarized below (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retained<br/>Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance at March 31, 2022:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,297)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares Issued</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at September  30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,877&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at December 31, 2022:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,647&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116,908&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Shareholders&#8217; Equity for the nine months ended December&#160;31, 2021 is summarized below (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retained<br/>Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance at March 31, 2021:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,080)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132,489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares Issued</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at September  30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132,746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at December 31, 2021:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130,721&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no shares of common stock that were purchased or retired in the nine months ended December&#160;31, 2022 or 2021. At December&#160;31, 2022, the Company had approximately $28.7 million remaining under the Company&#8217;s share repurchase plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585777516112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income TaxesFor the quarters ended December&#160;31, 2022 and 2021, the Company recorded an income tax provision of approximately $0.2 million and $1.3 million, respectively, and for the nine months ended December&#160;31, 2022 and 2021 the Company recorded an income tax provision of approximately $2.3 million and $4.6 million, respectively. The decrease in the tax provision for the three and nine  months ended December&#160;31, 2022 is related to a decrease in operating income during the periods. The effective tax rate for the quarter ended December&#160;31, 2022 was approximately 109.6%, compared to approximately 22.9% for the quarter ended December&#160;31, 2021, and the effective tax rate for the nine months ended December&#160;31, 2022 was approximately 29.9% compared to approximately 23.4% for the nine months ended December&#160;31, 2021. The increase to the effective tax rate for the three and nine  months ended December&#160;31, 2022 can be attributed to more non-deductible expenses and an increase in state tax due to the extension of the Company's business operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585800321968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Minority Interest Investment in Vetster<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Minority Interest Investment in Vetster</a></td>
<td class="text">Minority Interest Investment in VetsterOn April&#160;19, 2022, the Company engaged in a three-year partnership agreement with Vetster Inc. (&#8220;Vetster&#8221;), a veterinary telehealth Canadian company. The Company also purchased a 5% minority interest in Vetster in the amount of $5.0 million and received warrants for additional equity in Vetster, which are tied to future performance milestones. Under the terms of the agreement, the Company became the exclusive e-commerce provider for Vetster, and Vetster became the exclusive provider of telehealth and telemedicine services to the Company. The minority interest investment is being valued on the cost basis and the investment will be evaluated periodically for any impairment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585781176832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent EventsOn January&#160;13, 2023, the Company entered into an Agreement and Plan of Merger to acquire PetCareRx, Inc. ("PetCareRx"), a leading supplier of pet medications, food, and supplies, for an aggregate consideration of approximately $36.0&#160;million in cash, subject to adjustment. The closing of the transaction is subject to customary closing conditions and certain state pharmacy license and permit filings related to the change of control of PetCareRx. The transaction has been approved by the Board of Directors of both the Company and PetCareRx, and the stockholders of PetCareRx, and is expected to close in the fourth quarter of fiscal year 2023. Upon completion of the acquisition, PetCareRx will become a wholly-owned subsidiary of the Company.<div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;6, 2023, the Board of Directors declared a quarterly dividend of $0.30 per share. The Board established a February&#160;20, 2023 record date and a February&#160;27, 2023 payment date. Based on the outstanding share balance as of February&#160;7, 2023 the Company estimates the dividend payable to be approximately $6.3 million.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2022, the Board of Directors approved and issued 1,200 restricted </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares to employees pursuant to the 2016 Employee Plan. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2022, the Board of Directors approved and issued 6,000 restricted shares to MZHCI, LLC pursuant to an Investor Relations Consulting Agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585778158592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_BasisOfPresentationAndConsolidationPolicyTextBlock', window );">Basis Of Presentation and Consolidation</a></td>
<td class="text">Basis of Presentation and ConsolidationThe accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and, therefore, do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, the accompanying Condensed Consolidated Financial Statements contain all adjustments, consisting of normal recurring accruals, necessary to present fairly the financial position of the Company at December&#160;31, 2022, the Statements of Income for the three and nine months ended December&#160;31, 2022 and 2021, and Cash Flows for the nine months ended December&#160;31, 2022 and 2021. The results of operations for the three and nine months ended December&#160;31, 2022 are not necessarily indicative of the operating results expected for the fiscal year ending March&#160;31, 2023. These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022. The Condensed Consolidated Financial Statements include the accounts of PetMed Express, Inc. and its wholly owned subsidiaries. All significant intercompany transactions have been eliminated upon consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of Estimates The preparation of Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value of Financial Instruments The carrying amounts of the Company's cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text">Recent Accounting Pronouncements The Company does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on the Company's consolidated financial position, results of operations, or cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_BasisOfPresentationAndConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation and , used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Also consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_BasisOfPresentationAndConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585781176832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Summary of Disaggregation of Revenue</a></td>
<td class="text">The following table illustrates sales by various classifications:<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue (In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reorder sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,943)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New order sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,847)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internet sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contact center sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,651)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,847)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue (In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reorder sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">176,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New order sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,741)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,964)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internet sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contact center sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194,451&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,964)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585777512592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented (in thousands, except for per share amounts):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.005%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) (numerator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares (denominator):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average number of common shares outstanding used in basic computation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common shares issuable upon vesting of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common shares issuable upon conversion of preferred shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares used in diluted computation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,301&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,329&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,339&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.00)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.00)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.74&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585776729552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Changes in Shareholders' Equity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Shareholders&#8217; Equity for the nine months ended December&#160;31, 2022 is summarized below (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retained<br/>Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance at March 31, 2022:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,297)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares Issued</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at September  30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,877&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at December 31, 2022:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,647&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116,908&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Shareholders&#8217; Equity for the nine months ended December&#160;31, 2021 is summarized below (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retained<br/>Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance at March 31, 2021:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,080)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132,489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares Issued</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at September  30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132,746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends declared</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance at December 31, 2021:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130,721&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585700606160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Summary of Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 58,870<span></span>
</td>
<td class="nump">$ 60,717<span></span>
</td>
<td class="nump">$ 194,451<span></span>
</td>
<td class="nump">$ 207,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerPercentage', window );">Revenues, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariance', window );">Revenues, variance</a></td>
<td class="num">$ (1,847)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,964)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariancePercentage', window );">Revenues, variance, percentage</a></td>
<td class="num">(3.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=pets_InternetMember', window );">Internet sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 51,109<span></span>
</td>
<td class="nump">$ 51,305<span></span>
</td>
<td class="nump">$ 167,952<span></span>
</td>
<td class="nump">$ 173,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerPercentage', window );">Revenues, percentage</a></td>
<td class="nump">86.80%<span></span>
</td>
<td class="nump">84.50%<span></span>
</td>
<td class="nump">86.40%<span></span>
</td>
<td class="nump">83.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariance', window );">Revenues, variance</a></td>
<td class="num">$ (196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,761)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariancePercentage', window );">Revenues, variance, percentage</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=pets_ContactCenterMember', window );">Contact center sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 7,761<span></span>
</td>
<td class="nump">$ 9,412<span></span>
</td>
<td class="nump">$ 26,499<span></span>
</td>
<td class="nump">$ 33,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerPercentage', window );">Revenues, percentage</a></td>
<td class="nump">13.20%<span></span>
</td>
<td class="nump">15.50%<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
<td class="nump">16.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariance', window );">Revenues, variance</a></td>
<td class="num">$ (1,651)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariancePercentage', window );">Revenues, variance, percentage</a></td>
<td class="num">(17.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=pets_ReorderMember', window );">Reorder sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 53,316<span></span>
</td>
<td class="nump">$ 55,259<span></span>
</td>
<td class="nump">$ 176,384<span></span>
</td>
<td class="nump">$ 184,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerPercentage', window );">Revenues, percentage</a></td>
<td class="nump">90.60%<span></span>
</td>
<td class="nump">91.00%<span></span>
</td>
<td class="nump">90.70%<span></span>
</td>
<td class="nump">89.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariance', window );">Revenues, variance</a></td>
<td class="num">$ (1,943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,223)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariancePercentage', window );">Revenues, variance, percentage</a></td>
<td class="num">(3.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=pets_NewOrderMember', window );">New order sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 5,554<span></span>
</td>
<td class="nump">$ 5,458<span></span>
</td>
<td class="nump">$ 18,067<span></span>
</td>
<td class="nump">$ 22,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerPercentage', window );">Revenues, percentage</a></td>
<td class="nump">9.40%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">9.30%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariance', window );">Revenues, variance</a></td>
<td class="nump">$ 96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,741)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariancePercentage', window );">Revenues, variance, percentage</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_RevenueFromContractWithCustomerPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenue from the specified category to the total revenue during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_RevenueFromContractWithCustomerPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_RevenueFromContractWithCustomerVariance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of changes in revenue in current period comparing to the same period in the previous year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_RevenueFromContractWithCustomerVariance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_RevenueFromContractWithCustomerVariancePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of changes in revenue in current period comparing to the same period in the previous year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_RevenueFromContractWithCustomerVariancePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=pets_InternetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=pets_InternetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=pets_ContactCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=pets_ContactCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pets_ReorderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pets_ReorderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pets_NewOrderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pets_NewOrderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585773439424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 58,870<span></span>
</td>
<td class="nump">$ 60,717<span></span>
</td>
<td class="nump">$ 194,451<span></span>
</td>
<td class="nump">$ 207,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=pets_ReorderMember', window );">Reorder sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">53,316<span></span>
</td>
<td class="nump">55,259<span></span>
</td>
<td class="nump">176,384<span></span>
</td>
<td class="nump">184,607<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=pets_ReorderMember', window );">Reorder sales | Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=pets_NewOrderMember', window );">New order sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 5,554<span></span>
</td>
<td class="nump">5,458<span></span>
</td>
<td class="nump">$ 18,067<span></span>
</td>
<td class="nump">22,808<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=pets_NewOrderMember', window );">New order sales | Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pets_ReorderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pets_ReorderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pets_NewOrderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pets_NewOrderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585778174928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Schedule of Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Net income (loss) (numerator):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (19)<span></span>
</td>
<td class="nump">$ 4,257<span></span>
</td>
<td class="nump">$ 5,335<span></span>
</td>
<td class="nump">$ 15,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Shares (denominator):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding used in basic computation (in shares)</a></td>
<td class="nump">20,301<span></span>
</td>
<td class="nump">20,208<span></span>
</td>
<td class="nump">20,257<span></span>
</td>
<td class="nump">20,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Common shares issuable upon vesting of restricted stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Common shares issuable upon conversion of preferred shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in diluted computation (in shares)</a></td>
<td class="nump">20,301<span></span>
</td>
<td class="nump">20,329<span></span>
</td>
<td class="nump">20,339<span></span>
</td>
<td class="nump">20,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_NetIncomePerCommonShareBasicAndDilutedAbstract', window );"><strong>Net income (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_NetIncomePerCommonShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income Per Common Share, Basic And Diluted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_NetIncomePerCommonShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585778095296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">243,604<span></span>
</td>
<td class="nump">205,219<span></span>
</td>
<td class="nump">243,604<span></span>
</td>
<td class="nump">205,219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=pets_SharesIssuableUponVestingOfRestrictedStockMember', window );">Shares Issuable Upon Vesting of Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=pets_SharesIssuableUponVestingOfRestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=pets_SharesIssuableUponVestingOfRestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585772866944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting for Stock-Based Compensation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 03, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember', window );">2016 Employee Plan | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted common shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">959,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember', window );">2016 Employee Plan | Restricted Stock | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Issued restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember', window );">2016 Employee Plan | Restricted Stock | Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Issued restricted shares (in shares)</a></td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember', window );">2016 Employee Plan | Performance Restricted Stock | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Issued restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember', window );">2016 Employee Plan | Performance Restricted Stock | Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Issued restricted shares (in shares)</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember', window );">2015 Director Plan | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted common shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember', window );">2015 Director Plan | Restricted Stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RestrictionPeriod', window );">Restriction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember', window );">2015 Director Plan | Restricted Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RestrictionPeriod', window );">Restriction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_EmployeeAndDirectorPlansMember', window );">2016 Employee Plan and 2015 Director Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_EmployeeAndDirectorPlansMember', window );">2016 Employee Plan and 2015 Director Plan | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.6<span></span>
</td>
<td class="nump">$ 14.4<span></span>
</td>
<td class="nump">$ 10.6<span></span>
</td>
<td class="nump">$ 10.6<span></span>
</td>
<td class="nump">$ 14.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested restricted shares issued and outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">759,204<span></span>
</td>
<td class="nump">749,219<span></span>
</td>
<td class="nump">759,204<span></span>
</td>
<td class="nump">759,204<span></span>
</td>
<td class="nump">749,219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_EmployeeAndDirectorPlansMember', window );">2016 Employee Plan and 2015 Director Plan | Restricted Stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_EmployeeAndDirectorPlansMember', window );">2016 Employee Plan and 2015 Director Plan | Restricted Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember', window );">2016 Employee Equity Compensation Restricted Stock Plan | Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Grant release restriction period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_A2022EmployeePlanMember', window );">2022 Employee Plan | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted common shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_A2022EmployeePlanMember', window );">2022 Employee Plan | Restricted Stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RestrictionPeriod', window );">Restriction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_A2022EmployeePlanMember', window );">2022 Employee Plan | Restricted Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RestrictionPeriod', window );">Restriction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_RestrictionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of restriction of forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_RestrictionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_EmployeeAndDirectorPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_EmployeeAndDirectorPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_A2022EmployeePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_A2022EmployeePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585776722976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 102,428<span></span>
</td>
<td class="nump">$ 111,080<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585778415264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent', window );">State sales tax assessment accruals</a></td>
<td class="nump">$ 900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_AccruedSeveranceCosts', window );">Accrued severance costs</a></td>
<td class="nump">$ 364<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_AccruedSeveranceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Severance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_AccruedSeveranceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585773375008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Shareholders' Equity - Schedule of Changes in Shareholders' Equity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,335<span></span>
</td>
<td class="nump">$ 15,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">133,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">14,877<span></span>
</td>
<td class="nump">13,196<span></span>
</td>
<td class="nump">11,660<span></span>
</td>
<td class="nump">8,711<span></span>
</td>
<td class="nump">7,829<span></span>
</td>
<td class="nump">7,111<span></span>
</td>
<td class="nump">11,660<span></span>
</td>
<td class="nump">7,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation</a></td>
<td class="nump">1,770<span></span>
</td>
<td class="nump">1,681<span></span>
</td>
<td class="nump">1,536<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
<td class="nump">882<span></span>
</td>
<td class="nump">718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">16,647<span></span>
</td>
<td class="nump">14,877<span></span>
</td>
<td class="nump">13,196<span></span>
</td>
<td class="nump">10,151<span></span>
</td>
<td class="nump">8,711<span></span>
</td>
<td class="nump">7,829<span></span>
</td>
<td class="nump">16,647<span></span>
</td>
<td class="nump">10,151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">123,246<span></span>
</td>
<td class="nump">126,974<span></span>
</td>
<td class="nump">130,496<span></span>
</td>
<td class="nump">132,746<span></span>
</td>
<td class="nump">132,489<span></span>
</td>
<td class="nump">134,141<span></span>
</td>
<td class="nump">130,496<span></span>
</td>
<td class="nump">134,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared</a></td>
<td class="num">(6,319)<span></span>
</td>
<td class="num">(6,307)<span></span>
</td>
<td class="num">(6,297)<span></span>
</td>
<td class="num">(6,282)<span></span>
</td>
<td class="num">(6,092)<span></span>
</td>
<td class="num">(6,080)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">2,579<span></span>
</td>
<td class="nump">2,775<span></span>
</td>
<td class="nump">4,257<span></span>
</td>
<td class="nump">6,349<span></span>
</td>
<td class="nump">4,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 116,908<span></span>
</td>
<td class="nump">$ 123,246<span></span>
</td>
<td class="nump">$ 126,974<span></span>
</td>
<td class="nump">$ 130,721<span></span>
</td>
<td class="nump">$ 132,746<span></span>
</td>
<td class="nump">$ 132,489<span></span>
</td>
<td class="nump">$ 116,908<span></span>
</td>
<td class="nump">$ 130,721<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585779299152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Shareholders' Equity - Narrative (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased and retired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount</a></td>
<td class="nump">$ 28.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585778176608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">$ 1,261<span></span>
</td>
<td class="nump">$ 2,278<span></span>
</td>
<td class="nump">$ 4,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate, percent</a></td>
<td class="nump">109.60%<span></span>
</td>
<td class="nump">22.90%<span></span>
</td>
<td class="nump">29.90%<span></span>
</td>
<td class="nump">23.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585779257088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Minority Interest Investment in Vetster (Details) - Partnership Agreement with Vetster<br> $ in Millions</strong></div></th>
<th class="th">
<div>Apr. 19, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_TermOfAgreement', window );">Term of agreement</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_NoncontrollingInterestOwnershipPercentagePurchased', window );">Minority interest purchased, percent</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Minority interest purchased, amount</a></td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_NoncontrollingInterestOwnershipPercentagePurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents minority interest purchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_NoncontrollingInterestOwnershipPercentagePurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_TermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents term of agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_TermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=pets_PartnershipAgreementWithVetsterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=pets_PartnershipAgreementWithVetsterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140585778250368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 06, 2023</div></th>
<th class="th"><div>Jan. 13, 2023</div></th>
<th class="th"><div>Feb. 07, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | PetCareRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Quarterly Dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Employee Stock | 2016 Employee Equity Compensation Restricted Stock Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Issued restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Restricted Stock | MZHCI LLC Investor Relations Consulting Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Issued restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pets_PetCareRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pets_PetCareRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=pets_QuarterlyDividendMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=pets_QuarterlyDividendMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_MZHCILLCInvestorRelationsConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_MZHCILLCInvestorRelationsConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>pets-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pets="http://www.1800petmeds.com/20221231"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="pets-20221231.xsd" xlink:type="simple"/>
    <context id="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib6ac52f3534e4298b31908c876c060eb_I20230207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2023-02-07</instant>
        </period>
    </context>
    <context id="i137fc368100c4411981905d28135f59f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf36910fa826464cac0a33af2dcec06b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i67ee1fba64a441af905ddeb1f446539b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iddd375a412244dc48910945ff35d18c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7bcec245ba8f4bca88ec8b71bb599cdf_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i65bde03e5d464408a705348a0a0f41cc_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if68375ef4a7542af96e74af2ada80410_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9f0f687e16e445ef9491c6c0fccac673_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8150fab077f042849b44c3d66cd1be01_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8424940f0f714f6bb29ebc7cef78ee72_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6e261220a35145458a0bb7962680a283_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib5c88edd5dd84e9abd3087efd2f42496_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6c58fb706aaa4b1e98d81a7a0bfea1a7_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idaadbc1c61234f73a3bb5e185c89cf4c_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia0e4320425bc46a0a1fea6b2994f5d9f_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6dff8f4be4934a6c8be36b9f8a2211ba_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if63c295485f4407fa7e066bf30570500_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic2bc6f8fae324212a7cadd450f94abe5_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib4c9b15003614ac8a3226d1f0a7f6ee0_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i85db176f3142452d8eb6189c15ae2cd2_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8877e07cd58945f6bbc7b58579686efe_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2f7d9324da564d5386147bd5643fe51f_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2a6c5dc1cfd04bad979e42463356b32b_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i41a9cc96267d4f77b87be8a4fba4c3c2_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iad23aff6e73f4936ae99c55a2a704298_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icaf0a8da7b2e4c5bb6b4975bba8d57ca_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8fe4a15e0e42437d808ed2840f2e171f_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i37ab1b450b194b00bf3e03586f0f9a1f_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7d7fa3fa4a984a9283d58153706677c9_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">pets:SharesIssuableUponVestingOfRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6fd0d3f40e08458eb598ab1db5019057_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iad28657a6a0b4952ba10608b59c49e38_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2f5c94e1389f4483aa7c73b4b9c00e93_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8c2ce15d936e45dd931cb405b5d2ef93_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8b31dfb51bb44783b638d191bbc7a980_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie7442254753449318736ecb33c3c2b59_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i0d8b91f663f3474c99076e130bb65446_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i5e6712ee77de4a729affbf86d32800d4_D20220803-20220803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-03</startDate>
            <endDate>2022-08-03</endDate>
        </period>
    </context>
    <context id="i974cd15bc1f84107b36c802dfb84787d_D20220803-20220803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-03</startDate>
            <endDate>2022-08-03</endDate>
        </period>
    </context>
    <context id="i2d506cc607c04a3ebf6a185593e1dc41_D20220803-20220803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-03</startDate>
            <endDate>2022-08-03</endDate>
        </period>
    </context>
    <context id="i7d5cbb72af874387884242be4246de02_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibe371187742843408787486f68f274b3_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ida28de54333842baae92c105ccb153e2_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i53207e2d9eb14013aa52bab22358b457_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i97cda5016db34ee48cec4f2f8a6755f2_D20210401-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1a336deb41434c5ea068a787ed8d62e9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3bdd189cee1942858b848f337aac4919_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib29dce32b1424514860c1e7e96b95363_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i802698039a084839a3f7f1d98357ba6e_D20220401-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7ed1086383e343e69ff226fd59a926d5_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="ic43fa5ecc4024171ad3cc5adcab3dead_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="ia5c6583bec134c2b919d20f2ac9ffdd8_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i436e706c942c451990e2aa84cb93940f_D20220701-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i864561553fdf4df0ac1140a600d033a4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i46fd83d710f74df093e8b4c8bcb39594_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idc9aeeb29c4742208591d84ff5c3f38f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia3726f4e149f4c17892e094ff0d250d3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7a965f8b26994fc58ac8950bbd13c3d8_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i90c28b24bd8c465fba8956a43b6b42ba_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifca299ce29fa401f9edd0c4cc2d16abb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia6e858548b03478893794331fd102d06_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic6e22b4c43d942b8968fdc0f92828472_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icc4d4debbecb42c6a5c7bf76f83cfd04_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if04a59c0e21b4165abb829478afa536e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id0616732cc964c29af2566aecd430715_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib30acdba9294412b8455cee53c346bbc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i49e30612ead546a68ffa3cc45d3f0c77_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i46d17e7cf38c48cca155dcb2ddb012cc_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iae5e3adc0e244df78831aead28031b7c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iedd0a502d0114c6b9a8e7b297688cbcf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i28a4779f6fab4613b28885ae9cac19e6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib7ae2226e077465abd6ae8cf00b6f532_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i562c11f99bb548b69e78e029f0d65860_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if1dae6dbb35c4a6da152924d34b0365d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icc4da35a89ae49178deb59c2d6bb3d07_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0ffa3d3f184241dabcf76d81522ac2d2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icfb6fe66922848658885a8bc6e9481e9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i35f0d7d912c3464e849f72990a167356_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5acf5cd16dff4f088c9398f33c3cddca_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8c67a17e20334c189d487ee28cf75bf1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia9a920eeb13942fe81148b446dcc66cf_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i128c8af1cec14be1ae200b38a29fd0a9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic12b54a9ab4242d5a1dca7c82eba46df_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5d10742b5f544f5594cb0909107de875_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i75d4eab0c05241e793a7d11cdc5e2f2a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i88fc8739d1ab480e97d26ea983b689de_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i26b4c5393a8c4e5092769bb380417953_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib6f47c348e3745359b8952cad7998881_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3794039ab2794369b1521e3a036acaab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6978944526c3459c9248ffc7c6ca9745_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab14d6c222714d4fa9eeef808f9de70c_D20220419-20220419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pets:PartnershipAgreementWithVetsterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-19</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="i443214d583e24ab29051706bdba05419_I20220419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pets:PartnershipAgreementWithVetsterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-19</instant>
        </period>
    </context>
    <context id="iba0d1147b871412bb5ee913ee43a4458_D20230113-20230113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pets:PetCareRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-13</startDate>
            <endDate>2023-01-13</endDate>
        </period>
    </context>
    <context id="i193309c747ed4183bc1fc06e289d1aba_D20230206-20230206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">pets:QuarterlyDividendMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-06</startDate>
            <endDate>2023-02-06</endDate>
        </period>
    </context>
    <context id="if721328002364681bee1ba0655718256_I20230207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">pets:QuarterlyDividendMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-07</instant>
        </period>
    </context>
    <context id="ib5ac5ca2e988435eaad69a43bc5b154f_D20230101-20230207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-02-07</endDate>
        </period>
    </context>
    <context id="ia7ef6fce92814d58987c014afa0ebf0d_D20230101-20230207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:MZHCILLCInvestorRelationsConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-02-07</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80L2ZyYWc6NWYxMWIxZTFmZmMzNGI2NjhlZGY2ZDVmNDgzNDNlZTkvdGFibGU6ODhlZWE0MWU4MzU0NDNjZWI4ZTM2NWViOGIzZmY5NjAvdGFibGVyYW5nZTo4OGVlYTQxZTgzNTQ0M2NlYjhlMzY1ZWI4YjNmZjk2MF8yLTEtMS0xLTE0NTg0_48dec86a-9f0d-4037-b535-a8a71ad25060">0001040130</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80L2ZyYWc6NWYxMWIxZTFmZmMzNGI2NjhlZGY2ZDVmNDgzNDNlZTkvdGFibGU6ODhlZWE0MWU4MzU0NDNjZWI4ZTM2NWViOGIzZmY5NjAvdGFibGVyYW5nZTo4OGVlYTQxZTgzNTQ0M2NlYjhlMzY1ZWI4YjNmZjk2MF8zLTEtMS0xLTE0NTg0_fc397cb3-acc5-4bdb-8374-e5da350a9fac">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80L2ZyYWc6NWYxMWIxZTFmZmMzNGI2NjhlZGY2ZDVmNDgzNDNlZTkvdGFibGU6ODhlZWE0MWU4MzU0NDNjZWI4ZTM2NWViOGIzZmY5NjAvdGFibGVyYW5nZTo4OGVlYTQxZTgzNTQ0M2NlYjhlMzY1ZWI4YjNmZjk2MF80LTEtMS0xLTE0NTg0_a2d5f9ca-0dd6-4998-8fae-4311b596e951">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80L2ZyYWc6NWYxMWIxZTFmZmMzNGI2NjhlZGY2ZDVmNDgzNDNlZTkvdGFibGU6ODhlZWE0MWU4MzU0NDNjZWI4ZTM2NWViOGIzZmY5NjAvdGFibGVyYW5nZTo4OGVlYTQxZTgzNTQ0M2NlYjhlMzY1ZWI4YjNmZjk2MF81LTEtMS0xLTE0NTg0_e0a371d6-578d-42b7-8496-3249a9eced37">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80L2ZyYWc6NWYxMWIxZTFmZmMzNGI2NjhlZGY2ZDVmNDgzNDNlZTkvdGFibGU6ODhlZWE0MWU4MzU0NDNjZWI4ZTM2NWViOGIzZmY5NjAvdGFibGVyYW5nZTo4OGVlYTQxZTgzNTQ0M2NlYjhlMzY1ZWI4YjNmZjk2MF82LTEtMS0xLTE0NTg0_de9eab6a-f5c3-41f4-ac12-f1df422d6fc8">false</dei:AmendmentFlag>
    <pets:RestrictionPeriod
      contextRef="i8c2ce15d936e45dd931cb405b5d2ef93_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfNjgz_191b9281-4145-40ce-abe4-217b2cb8eccc">P1Y</pets:RestrictionPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ib29dce32b1424514860c1e7e96b95363_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjk2OQ_1aaf0ccb-d1a0-41ef-bb85-02c3837aae7b">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <dei:DocumentType
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDMz_f4fceead-bd85-4666-b368-ae76263f5aff">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDM0_de410e5a-065b-4cc3-9af4-79400624b6ce">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV81NDk3NTU4MTYzNTg_bc921079-9132-4a95-98bf-0ae3154a8953">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDI2_05d3c155-dac6-46dc-b23e-99c694481f90">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDEx_f5711434-0c2b-47d7-b6b5-e93a774e4977">000-28827</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDI0_07a79f8c-0248-44c6-bd95-61c4d40d9893">PETMED EXPRESS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MjAwMGJhYTNhMTZhNDAxNmIyNjk2MjViM2MyM2NmNzIvdGFibGVyYW5nZToyMDAwYmFhM2ExNmE0MDE2YjI2OTYyNWIzYzIzY2Y3Ml8wLTAtMS0xLTE0NTg0L3RleHRyZWdpb246OTM0YmNjZjA3MDRhNGU0ZThlODkwODRmN2I5OGViZGZfNA_72d9f488-dc98-4243-b200-b9f1597a0dc1">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MjAwMGJhYTNhMTZhNDAxNmIyNjk2MjViM2MyM2NmNzIvdGFibGVyYW5nZToyMDAwYmFhM2ExNmE0MDE2YjI2OTYyNWIzYzIzY2Y3Ml8wLTEtMS0xLTE0NTg0_62750e04-aa6c-4e7e-a032-146196152943">65-0680967</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDE5_cde2c359-2993-4380-9bb6-1cc0ff84ae8c">420 South Congress Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDEy_a1602d3c-ed1b-413e-90df-b8fb51144360">Delray Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDE2_827d0fa6-2255-4a7f-b2db-92a52e27b52f">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDI5_7a626688-0e4a-4ab1-81c3-cee07e9cc54d">33445</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV82MTc_15cd978b-aeee-41f0-836f-44bf1c052d67">561</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDE3_15dcfe16-bf3e-48b5-bbd1-8b9f62afa5ce">526-4444</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MzNmNDBmMmJhYzFkNDYyZjgyNjE4Yzk1OGM4ODA1YmMvdGFibGVyYW5nZTozM2Y0MGYyYmFjMWQ0NjJmODI2MThjOTU4Yzg4MDViY18xLTAtMS0xLTE0NTg0_547e83d4-15a6-4a14-85e1-779b0d731ce8">Common Stock, par value $.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MzNmNDBmMmJhYzFkNDYyZjgyNjE4Yzk1OGM4ODA1YmMvdGFibGVyYW5nZTozM2Y0MGYyYmFjMWQ0NjJmODI2MThjOTU4Yzg4MDViY18xLTEtMS0xLTE0NTg0_b8b539a9-aad5-4dc9-bfca-228a0336314e">PETS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MzNmNDBmMmJhYzFkNDYyZjgyNjE4Yzk1OGM4ODA1YmMvdGFibGVyYW5nZTozM2Y0MGYyYmFjMWQ0NjJmODI2MThjOTU4Yzg4MDViY18xLTItMS0xLTE0NTg0_876a6bb9-2d64-42aa-8e81-8b76859e919e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDMw_2d56fd86-b776-4c7e-a0c1-dd7ee9517aab">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDI4_a42268a0-9e87-4c47-8dc7-91757a3d2236">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MTY2MzZhMmFlNGRiNDk3NThmMjg4MTI1NTgzYmVkODMvdGFibGVyYW5nZToxNjYzNmEyYWU0ZGI0OTc1OGYyODgxMjU1ODNiZWQ4M18wLTEtMS0xLTE0NTg0L3RleHRyZWdpb246MDhkNTI1Yzk4Yjk2NGQ4Njk2OGU1MWIwZDBiOWJmZWNfNA_8a917157-825c-4061-8079-e9f38346de7c">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MTY2MzZhMmFlNGRiNDk3NThmMjg4MTI1NTgzYmVkODMvdGFibGVyYW5nZToxNjYzNmEyYWU0ZGI0OTc1OGYyODgxMjU1ODNiZWQ4M18xLTEtMS0xLTE0NTg0_72858b0d-c560-4295-b291-1b7e25a5f6ff">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGFibGU6MTY2MzZhMmFlNGRiNDk3NThmMjg4MTI1NTgzYmVkODMvdGFibGVyYW5nZToxNjYzNmEyYWU0ZGI0OTc1OGYyODgxMjU1ODNiZWQ4M18yLTAtMS0xLTE0NTg0_9bbbd1c8-df29-4ad3-b176-e25636e57736">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yNDMx_b90c78a5-a091-4776-918b-4cfa79726791">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ib6ac52f3534e4298b31908c876c060eb_I20230207"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xL2ZyYWc6YmU4ODM0ZDY2NzZlNDJiM2FhNjhkZjE0ZjYzNGVlYTUvdGV4dHJlZ2lvbjpiZTg4MzRkNjY3NmU0MmIzYWE2OGRmMTRmNjM0ZWVhNV8yMzUy_dfaaa850-e276-43c8-83c6-b696d2d22791"
      unitRef="shares">21084277</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNS0xLTEtMS0xNDU4NA_d666bbbe-9a2f-4915-a5e7-47d4b06a6241"
      unitRef="usd">102428000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNS0zLTEtMS0xNDU4NA_9dd32fc0-0ebc-48c1-8ad5-556d2e6dfaeb"
      unitRef="usd">111080000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNi0wLTEtMS0xNDU4NC90ZXh0cmVnaW9uOmY2ZDcyYTUyNzFiYjQ4MDQ4MGViNDE2YWNkYmMxZTY4XzY1_0e59d75a-0c6d-4753-b2d9-90d715eeaa30"
      unitRef="usd">40000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNi0wLTEtMS0xNDU4NC90ZXh0cmVnaW9uOmY2ZDcyYTUyNzFiYjQ4MDQ4MGViNDE2YWNkYmMxZTY4Xzcy_278cec95-a0b8-418e-a2e4-6807891e05a7"
      unitRef="usd">39000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNi0xLTEtMS0xNDU4NA_ee3eedf6-4aee-4567-be89-23351f9e482a"
      unitRef="usd">1944000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNi0zLTEtMS0xNDU4NA_938ce329-226b-4133-9677-b28d2f2b69a7"
      unitRef="usd">1913000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryFinishedGoods
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNy0xLTEtMS0xNDU4NA_fabe07ab-bb8e-4758-b40c-c0cf060bc6fb"
      unitRef="usd">22402000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNy0zLTEtMS0xNDU4NA_c70d16ee-4960-4ac7-ac6e-54ff9fa5f690"
      unitRef="usd">32455000</us-gaap:InventoryFinishedGoods>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfOC0xLTEtMS0xNDU4NA_bbade7da-700c-43da-8c19-3a228c77d6ee"
      unitRef="usd">5637000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfOC0zLTEtMS0xNDU4NA_53d9db52-a7e5-44c6-b9c5-b9f3be03ebea"
      unitRef="usd">4866000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidTaxes
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfOS0xLTEtMS0xNDU4NA_a7c5d370-11b9-406c-ac7a-b04f1cabf2b3"
      unitRef="usd">1608000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfOS0zLTEtMS0xNDU4NA_e8726d9c-a5e2-4b1c-b250-2c6020d1425c"
      unitRef="usd">681000</us-gaap:PrepaidTaxes>
    <us-gaap:AssetsCurrent
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTAtMS0xLTEtMTQ1ODQ_ca06ded0-a763-4676-9f46-217a4b2ed561"
      unitRef="usd">134019000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTAtMy0xLTEtMTQ1ODQ_b90fa5ed-d253-43c5-98af-cf64a9cc682f"
      unitRef="usd">150995000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTMtMS0xLTEtMTQ1ODQ_9494c33b-271e-481a-ac44-ea9952503642"
      unitRef="usd">25242000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTMtMy0xLTEtMTQ1ODQ_682ffe21-391e-4eda-a07f-c773260c72ce"
      unitRef="usd">24464000</us-gaap:PropertyPlantAndEquipmentNet>
    <pets:IntangibleAndOtherAssets
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTQtMS0xLTEtMTQ1ODQ_33e993f9-6ec3-4ea6-9621-c7da235d0c03"
      unitRef="usd">5860000</pets:IntangibleAndOtherAssets>
    <pets:IntangibleAndOtherAssets
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTQtMy0xLTEtMTQ1ODQ_6158933e-eb00-41ef-8a8b-d27222e1e0e2"
      unitRef="usd">860000</pets:IntangibleAndOtherAssets>
    <us-gaap:AssetsNoncurrent
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTUtMS0xLTEtMTQ1ODQ_3554c312-3304-4198-af6d-a4676caf3293"
      unitRef="usd">31102000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTUtMy0xLTEtMTQ1ODQ_847034eb-1c94-4ee0-acb1-c13d2c20ff0b"
      unitRef="usd">25324000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTctMS0xLTEtMTQ1ODQ_7f3c0502-2c71-40fc-9487-544c1ef06d32"
      unitRef="usd">165121000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMTctMy0xLTEtMTQ1ODQ_c8b74892-a8f2-4a09-9ef9-42b1e5b9b806"
      unitRef="usd">176319000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjItMS0xLTEtMTQ1ODQ_80ee1361-3da5-4b15-9fc2-b4cd2ce6dbf3"
      unitRef="usd">24317000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjItMy0xLTEtMTQ1ODQ_72121eff-b528-4cb5-8324-de72ed92cc83"
      unitRef="usd">27500000</us-gaap:AccountsPayableCurrent>
    <pets:AccruedExpensesAndOtherCurrentLiabilities
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjMtMS0xLTEtMTQ1ODQ_d76d6fbe-624c-4454-a0dc-1383ba206bc0"
      unitRef="usd">6754000</pets:AccruedExpensesAndOtherCurrentLiabilities>
    <pets:AccruedExpensesAndOtherCurrentLiabilities
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjMtMy0xLTEtMTQ1ODQ_4dae2074-c292-4101-bddb-1f70f628bf31"
      unitRef="usd">5697000</pets:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjQtMS0xLTEtMTQ1ODQ_bcd8fd66-9023-4e4b-b5cd-111c3df180bc"
      unitRef="usd">31071000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjQtMy0xLTEtMTQ1ODQ_08399a16-612a-4e03-af15-6e6e6a9e436e"
      unitRef="usd">33197000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjYtMS0xLTEtMTQ1ODQ_dc9a483d-9d22-4512-90a7-a13a862d9334"
      unitRef="usd">465000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjYtMy0xLTEtMTQ1ODQ_731f1a7f-7b29-481f-b741-16d28cdd988f"
      unitRef="usd">936000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjgtMS0xLTEtMTQ1ODQ_afdcf30a-b0ea-48ab-ba39-8329b4c9c87e"
      unitRef="usd">31536000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMjgtMy0xLTEtMTQ1ODQ_47f88042-dd17-420e-bca6-4fcf971d52e6"
      unitRef="usd">34133000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzAtMS0xLTEtMTQ1ODQ_5ae494ec-1a16-4775-9bb9-e676706a8a0e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzAtMy0xLTEtMTQ1ODQ_751b8568-c5ba-481e-befc-8b23caa1ecbc"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM18yMQ_51c0cbc9-0fa8-4183-9066-238a40a6ef38"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM18yMQ_5877a793-9884-40dd-ab58-eb96760a67b8"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM18zNQ_1b62b5b7-40ac-405b-9938-b7c139166d7f"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM18zNQ_26cab3e0-4e80-4dfa-82f2-0759009b4366"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM181Nw_102e597e-95fa-42a0-93c3-e908e4c28d03"
      unitRef="shares">3000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM181Nw_16da285a-2af6-4c93-8bae-7efba404ecb5"
      unitRef="shares">3000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM181Nw_4fbf3d18-7c12-45f7-b85d-f57862c629b1"
      unitRef="shares">3000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM181Nw_f14dd083-cd1d-4b99-86e3-755d86a44723"
      unitRef="shares">3000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM18xMzU_8e2f02f7-b3a4-4019-9b80-c7888de3b507"
      unitRef="usdPerShare">4</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjo1MzJlMGNmYTgzM2Y0OTZhYmI2ZDk4ZjNmYWJlOWJmM18xMzU_e4b63587-98b5-48b5-b648-14fa74d261cb"
      unitRef="usdPerShare">4</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockValue
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMS0xLTEtMTQ1ODQ_cda48314-8520-41f9-b1f7-6634b26aac9c"
      unitRef="usd">9000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzMtMy0xLTEtMTQ1ODQ_5dd23073-8323-485d-9e34-676627ea413c"
      unitRef="usd">9000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl8xOA_9322711f-663f-4b94-b490-dd179d5f432f"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl8xOA_ef1d3ab4-c442-46ae-bc28-10c6135f7a95"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl8zMg_2099cb68-44a7-4a69-b932-95bdaadac26c"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl8zMg_3b4f2a55-f9be-4d17-a76b-167436e28d7a"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl81NA_2e73a370-97f5-4cbf-9d20-ad72a818e1f1"
      unitRef="shares">21077000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl81NA_f86c78c8-96cd-402c-88c1-df71441b43cc"
      unitRef="shares">21077000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl82MQ_28054368-16bf-4021-b53f-b8e1f4c59b66"
      unitRef="shares">20979000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMC0xLTEtMTQ1ODQvdGV4dHJlZ2lvbjplOGE4MWNlNWUwYjY0ZDM2ODhlOGZiZjVmZWEyNmZkNl82MQ_53547a62-f469-4281-a16d-0bf46ce5e106"
      unitRef="shares">20979000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMS0xLTEtMTQ1ODQ_a3699ee5-4ccf-4ed8-9ccd-4e0e14b9b9a9"
      unitRef="usd">21000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzQtMy0xLTEtMTQ1ODQ_9677d485-4b94-4b21-b971-b304f1dc6d00"
      unitRef="usd">21000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzUtMS0xLTEtMTQ1ODQ_5e99374c-4b00-4b0a-a6f5-f6840007c7c6"
      unitRef="usd">16647000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzUtMy0xLTEtMTQ1ODQ_8b67314b-5d53-44bd-b49d-38373ca7e048"
      unitRef="usd">11660000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzYtMS0xLTEtMTQ1ODQ_28fa31b5-c344-46e4-92d5-826a9fd09f74"
      unitRef="usd">116908000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzYtMy0xLTEtMTQ1ODQ_7aa664db-7b85-43b5-bbdc-92e447baf7b6"
      unitRef="usd">130496000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzgtMS0xLTEtMTQ1ODQ_d367d3d6-97b6-4485-9f60-b4280b0f65d0"
      unitRef="usd">133585000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfMzgtMy0xLTEtMTQ1ODQ_927090e6-5a7f-4acc-873d-ee19c4d66634"
      unitRef="usd">142186000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNDAtMS0xLTEtMTQ1ODQ_d655d368-88b5-4569-bae1-002782e8f974"
      unitRef="usd">165121000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xMy9mcmFnOjVkZTYzNzFhYTQzZTRlMTNhMDQxNmU0M2E4YTZkODFiL3RhYmxlOjVkZGU0ZGNmNGMzNzRkYjJiZDlhZmU4MTdlYjIyYWY2L3RhYmxlcmFuZ2U6NWRkZTRkY2Y0YzM3NGRiMmJkOWFmZTgxN2ViMjJhZjZfNDAtMy0xLTEtMTQ1ODQ_2c4d2f1a-843a-45ef-99f6-2ed5b01c1736"
      unitRef="usd">176319000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMy0xLTEtMS0xNDU4NA_b0a66f67-57de-48ac-8b40-16af3fb8cc09"
      unitRef="usd">58870000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMy0zLTEtMS0xNDU4NA_3cb72e4f-aa10-44af-87dd-c5e15592e7f1"
      unitRef="usd">60717000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMy01LTEtMS0xNDU4NA_bdad8a87-8752-47a6-b873-e51bc9951838"
      unitRef="usd">194451000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMy03LTEtMS0xNDU4NA_ef6662a1-732a-4e89-9700-2b53e73534ca"
      unitRef="usd">207415000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNC0xLTEtMS0xNDU4NA_087e6fe2-c8e1-435f-acce-ac0a84fdc0de"
      unitRef="usd">43632000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNC0zLTEtMS0xNDU4NA_c00f24fa-431b-44bd-a338-dee854464a76"
      unitRef="usd">42992000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNC01LTEtMS0xNDU4NA_48c3444f-d7a4-4e96-bdaa-2e8ed572c014"
      unitRef="usd">140819000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNC03LTEtMS0xNDU4NA_ceaa11ca-9a28-47f9-acfa-6848955f3fd5"
      unitRef="usd">148736000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNi0xLTEtMS0xNDU4NA_302efe27-dfbb-4b45-8535-bdb0f4160bc2"
      unitRef="usd">15238000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNi0zLTEtMS0xNDU4NA_7a00ccc7-1ba4-46e5-be70-8d88757c5ae5"
      unitRef="usd">17725000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNi01LTEtMS0xNDU4NA_6d015052-db8d-456b-a8d6-c6fb49599a3b"
      unitRef="usd">53632000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfNi03LTEtMS0xNDU4NA_853dde09-8a6e-4f09-8cbb-cbf3c924f93d"
      unitRef="usd">58679000</us-gaap:GrossProfit>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfOS0xLTEtMS0xNDU4NA_cedf6048-0897-4fa8-8cd5-24dfd6d740a2"
      unitRef="usd">10425000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfOS0zLTEtMS0xNDU4NA_8e82a774-0736-4de1-b674-31a7e8505398"
      unitRef="usd">7541000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfOS01LTEtMS0xNDU4NA_3ce6c0da-7863-4b73-9030-7928129ef490"
      unitRef="usd">30529000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfOS03LTEtMS0xNDU4NA_6f660d6c-5963-4c64-9bb9-e9ce4182887b"
      unitRef="usd">22540000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AdvertisingExpense
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTAtMS0xLTEtMTQ1ODQ_3ad344a4-4d2b-4100-9181-98d97573f031"
      unitRef="usd">4641000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTAtMy0xLTEtMTQ1ODQ_27b14d66-ef8b-469a-97ad-77735d4756ce"
      unitRef="usd">4327000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTAtNS0xLTEtMTQ1ODQ_51d8ba4f-d42e-47ee-860b-cff55ae95e93"
      unitRef="usd">14869000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTAtNy0xLTEtMTQ1ODQ_eab9b5ce-a4b7-4d86-b7b3-d93b04eed4d2"
      unitRef="usd">15435000</us-gaap:AdvertisingExpense>
    <us-gaap:Depreciation
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTEtMS0xLTEtMTQ1ODQ_e6e2edd5-49fe-48a5-8d48-14f6e1d626d6"
      unitRef="usd">941000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTEtMy0xLTEtMTQ1ODQ_4751d030-2c6a-4b91-af55-320358e06819"
      unitRef="usd">710000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTEtNS0xLTEtMTQ1ODQ_14f032be-bf06-4c4b-9813-c1d2cc71343b"
      unitRef="usd">2552000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTEtNy0xLTEtMTQ1ODQ_99a6892c-1a7d-4f22-abcd-a6143e98da56"
      unitRef="usd">2051000</us-gaap:Depreciation>
    <us-gaap:OperatingExpenses
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTItMS0xLTEtMTQ1ODQ_7b67faad-c784-483f-a589-d2c59ddcff03"
      unitRef="usd">16007000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTItMy0xLTEtMTQ1ODQ_81104ee8-6c02-443b-9b3c-52f3f8c2a208"
      unitRef="usd">12578000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTItNS0xLTEtMTQ1ODQ_a7f7551e-cd5b-462f-bf43-c88720991ae2"
      unitRef="usd">47950000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTItNy0xLTEtMTQ1ODQ_f6040bbd-d3a3-480c-98ad-91362b8e27c6"
      unitRef="usd">40026000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTQtMS0xLTEtMTQ1ODQ_ddd4dcbf-c0ff-41c9-b6c6-f5c2f874266a"
      unitRef="usd">-769000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTQtMy0xLTEtMTQ1ODQ_168759d5-99c7-4bd5-b095-7864620d8b18"
      unitRef="usd">5147000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTQtNS0xLTEtMTQ1ODQ_5dfbaf5d-4871-4bb6-8cf9-2d74b5c2cd62"
      unitRef="usd">5682000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTQtNy0xLTEtMTQ1ODQ_5bbc11fa-04d0-4c4a-8e15-94fa8b60bc13"
      unitRef="usd">18653000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTctMS0xLTEtMTQ1ODQ_1e46c926-427d-40fb-a085-823c190957c2"
      unitRef="usd">708000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTctMy0xLTEtMTQ1ODQ_044fe8d4-d263-40a0-b78e-11509e93a469"
      unitRef="usd">84000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTctNS0xLTEtMTQ1ODQ_d70fbcd9-56e6-4bf4-b23d-ad061bba251d"
      unitRef="usd">1213000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTctNy0xLTEtMTQ1ODQ_60e2751f-594a-4636-800f-2bbc65329e63"
      unitRef="usd">243000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTgtMS0xLTEtMTQ1ODQ_344d82bc-ca5b-4d85-a923-1bd61a0f54a6"
      unitRef="usd">259000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTgtMy0xLTEtMTQ1ODQ_7d0b60e3-5149-4e32-a562-2af38b3f1804"
      unitRef="usd">287000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTgtNS0xLTEtMTQ1ODQ_06d477ea-4521-4727-9a21-4e0e9c576ee1"
      unitRef="usd">718000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTgtNy0xLTEtMTQ1ODQ_98d7ab80-2427-40bc-839b-aad04fb3d682"
      unitRef="usd">741000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTktMS0xLTEtMTQ1ODQ_3b9472cd-364c-49b8-bfc3-e6e9b7dc92f0"
      unitRef="usd">967000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTktMy0xLTEtMTQ1ODQ_314be9f7-dd67-4cd7-b2af-94a97ee16885"
      unitRef="usd">371000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTktNS0xLTEtMTQ1ODQ_abbc1136-a4a0-47ad-8e53-d932d71c739c"
      unitRef="usd">1931000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMTktNy0xLTEtMTQ1ODQ_6cf2e6d4-d7ca-4ec8-9cec-10b82dfe5ece"
      unitRef="usd">984000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjEtMS0xLTEtMTQ1ODQ_0b261518-a8bb-4c8d-adc2-4731ce546e9a"
      unitRef="usd">198000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjEtMy0xLTEtMTQ1ODQ_585faaa0-e300-48dc-8b58-b9d8deacc435"
      unitRef="usd">5518000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjEtNS0xLTEtMTQ1ODQ_33a97415-a51e-413c-b5f6-a5d13500c51e"
      unitRef="usd">7613000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjEtNy0xLTEtMTQ1ODQ_98a94899-f464-46e2-a277-c9572fda4a25"
      unitRef="usd">19637000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjMtMS0xLTEtMTQ1ODQ_5b2dc46e-61a6-482f-a944-02d8bc144bb1"
      unitRef="usd">217000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjMtMy0xLTEtMTQ1ODQ_28303b5e-040c-4cc8-8f0b-93ee36ed35e1"
      unitRef="usd">1261000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjMtNS0xLTEtMTQ1ODQ_dad521f2-d1e5-487b-91a9-c879b19e2879"
      unitRef="usd">2278000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjMtNy0xLTEtMTQ1ODQ_78c6a888-07f2-4194-859c-675ab829f321"
      unitRef="usd">4603000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjUtMS0xLTEtMTQ1ODQ_043b6e6d-6633-499d-8912-b7d738ee885e"
      unitRef="usd">-19000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjUtMy0xLTEtMTQ1ODQ_b525be4b-69c9-4af5-a719-2c6f92ebe1fd"
      unitRef="usd">4257000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjUtNS0xLTEtMTQ1ODQ_ff23c7ac-82be-4d72-aa5f-48436720b215"
      unitRef="usd">5335000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjUtNy0xLTEtMTQ1ODQ_34e92726-6fb7-44a5-b66c-42df9402aeed"
      unitRef="usd">15034000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjgtMS0xLTEtMTQ1ODQ_448e998f-4b29-45e0-8903-e8e0d572f5e5"
      unitRef="usdPerShare">-0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjgtMy0xLTEtMTQ1ODQ_108f83e3-d8c9-46eb-8b11-8da732e012db"
      unitRef="usdPerShare">0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjgtNS0xLTEtMTQ1ODQ_17f48c72-a018-4cc4-b02d-0e2bf01b351e"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjgtNy0xLTEtMTQ1ODQ_2da201dd-7990-4153-812f-0c8401b111eb"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjktMS0xLTEtMTQ1ODQ_cf21bb57-a08c-4110-830c-36fe6ac19173"
      unitRef="usdPerShare">-0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjktMy0xLTEtMTQ1ODQ_c57a8352-ab3e-4d1a-a7e1-f8452ab67ba5"
      unitRef="usdPerShare">0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjktNS0xLTEtMTQ1ODQ_e5291d45-f72e-4fa5-b667-e0e8c71e93d7"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMjktNy0xLTEtMTQ1ODQ_ac83e7b5-5887-424c-9451-6e47f836a1f2"
      unitRef="usdPerShare">0.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzItMS0xLTEtMTQ1ODQ_6c1139c8-cf52-4c15-8a54-fea37004cb04"
      unitRef="shares">20301000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzItMy0xLTEtMTQ1ODQ_955a1157-6370-4ba5-8c8e-a922cd8c3915"
      unitRef="shares">20208000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzItNS0xLTEtMTQ1ODQ_271c0d38-201d-48ab-a010-b52529d46f81"
      unitRef="shares">20257000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzItNy0xLTEtMTQ1ODQ_1019072b-5782-4d3b-adaa-89c5e61005f0"
      unitRef="shares">20165000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzMtMS0xLTEtMTQ1ODQ_ae347e7a-2529-44fe-bffb-d474e0e0cb02"
      unitRef="shares">20301000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzMtMy0xLTEtMTQ1ODQ_082a0945-1dde-4b31-82d2-894d19c89ab2"
      unitRef="shares">20329000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzMtNS0xLTEtMTQ1ODQ_f8638f61-03ea-4b95-aa90-7d55e84e8472"
      unitRef="shares">20339000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzMtNy0xLTEtMTQ1ODQ_f3ae9640-4706-4235-ba9e-9fdb8bb71f10"
      unitRef="shares">20365000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzUtMS0xLTEtMTQ1ODQ_5c58084f-9ac3-4ba8-be62-3ca1a9fc3ef3"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzUtMy0xLTEtMTQ1ODQ_fe2f767a-5733-470f-a428-fec7409f32a2"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzUtNS0xLTEtMTQ1ODQ_902594e0-337c-47ce-ae5e-b56568df0b04"
      unitRef="usdPerShare">0.90</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xNi9mcmFnOjIxNDNkYTU5NGIyZDRkZTY5ZWFlY2FiYjUxYTZkZmFkL3RhYmxlOjNlYTMwMTExZTFkMDRjYzdhYjY1MmExMjg2ZGVjMWViL3RhYmxlcmFuZ2U6M2VhMzAxMTFlMWQwNGNjN2FiNjUyYTEyODZkZWMxZWJfMzUtNy0xLTEtMTQ1ODQ_4d54ec7c-9063-4c17-abfa-905403c2148b"
      unitRef="usdPerShare">0.90</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:NetIncomeLoss
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMy0xLTEtMS0xNDU4NA_5953bce9-2e76-466a-ac1c-84e958924da5"
      unitRef="usd">5335000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMy0zLTEtMS0xNDU4NA_4978b123-7da6-42db-8d36-0d09b0de290e"
      unitRef="usd">15034000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfNS0xLTEtMS0xNDU4NA_9f4919df-0262-4755-bf9b-3a3e1cdfb9ec"
      unitRef="usd">2552000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfNS0zLTEtMS0xNDU4NA_be803e4b-46df-42bc-be39-5cb8d1cba64c"
      unitRef="usd">2051000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfNi0xLTEtMS0xNDU4NA_e88ad683-3dce-479f-b801-4099664a8fd8"
      unitRef="usd">4987000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfNi0zLTEtMS0xNDU4NA_d2d6509c-d842-411d-8a9c-a114b2a11d9c"
      unitRef="usd">3040000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfNy0xLTEtMS0xNDU4NA_c5f951f3-39ac-48cb-8ff5-cc5aff79dc50"
      unitRef="usd">-471000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfNy0zLTEtMS0xNDU4NA_b3da7465-0999-4266-b0f7-2a90e3188c39"
      unitRef="usd">-19000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfOC0xLTEtMS0xNDU4NA_6f25c8a3-6b03-4117-aba4-6568af9a010d"
      unitRef="usd">292000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfOC0zLTEtMS0xNDU4NA_0c4c25df-8c4a-408d-b036-03899efe4c30"
      unitRef="usd">104000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTAtMS0xLTEtMTQ1ODQ_b0dd75da-5b1a-43a1-a64d-202e0354517b"
      unitRef="usd">324000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTAtMy0xLTEtMTQ1ODQ_57baec50-e285-4508-82be-b0d07c165a07"
      unitRef="usd">-1216000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTEtMS0xLTEtMTQ1ODQ_86b69901-e997-42bb-a16e-6fc6c97585bf"
      unitRef="usd">-10053000</us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories>
    <us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTEtMy0xLTEtMTQ1ODQ_d00b1cb5-b6d8-496c-a4d2-8105d5344aec"
      unitRef="usd">-6780000</us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTItMS0xLTEtMTQ1ODQ_d1089286-e04a-4c60-8397-ba919547de29"
      unitRef="usd">927000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTItMy0xLTEtMTQ1ODQ_42bdf411-cf98-4407-9a44-e5fbebc2c590"
      unitRef="usd">911000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTMtMS0xLTEtMTQ1ODQ_456bdb7b-6500-4750-b7a5-1ed3614e579c"
      unitRef="usd">771000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTMtMy0xLTEtMTQ1ODQ_9bce8acb-d942-4776-a699-fe7a57b20b66"
      unitRef="usd">-1287000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTQtMS0xLTEtMTQ1ODQ_045b7f60-e8b0-44b8-acd5-5ca19e03e84b"
      unitRef="usd">-3183000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTQtMy0xLTEtMTQ1ODQ_c3208e8e-4c7b-4cc4-bae3-2b108f0baba4"
      unitRef="usd">-17613000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTUtMS0xLTEtMTQ1ODQ_5ad39f95-0e8f-4d38-94c9-02ffbf6eaa92"
      unitRef="usd">536000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTUtMy0xLTEtMTQ1ODQ_0b507c9e-53b3-49d2-9c98-bcd94626e7aa"
      unitRef="usd">-1188000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTYtMS0xLTEtMTQ1ODQ_518acc4d-ab5d-4f5a-aaf5-ea43e8904c45"
      unitRef="usd">18079000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTYtMy0xLTEtMTQ1ODQ_9be8942d-590c-4366-9b54-61195f5c024e"
      unitRef="usd">9781000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTktMS0xLTEtMTQ1ODQ_88372d9c-3963-443a-927a-6a26519b4a02"
      unitRef="usd">5000000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMTktMy0xLTEtMTQ1ODQ_f6b84028-ce91-402f-92a9-f689f67f0d13"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjAtMS0xLTEtMTQ1ODQ_435561e4-515a-4e15-b1d4-d06ab00ecc93"
      unitRef="usd">3329000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjAtMy0xLTEtMTQ1ODQ_ecc6ea4a-e855-41e4-a116-eb1c40d378b6"
      unitRef="usd">1266000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjEtMS0xLTEtMTQ1ODQ_7a3b52a0-f6fe-4990-95a8-4161d5362932"
      unitRef="usd">-8329000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjEtMy0xLTEtMTQ1ODQ_4034f524-f0ca-462a-ab2b-2b3e2b2bc963"
      unitRef="usd">-1266000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjQtMS0xLTEtMTQ1ODQ_9e20c130-cff6-4fae-bad0-6fae4a3f5a95"
      unitRef="usd">18402000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjQtMy0xLTEtMTQ1ODQ_2fec67c5-b4fc-4867-aceb-a1e563e88495"
      unitRef="usd">18322000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjUtMS0xLTEtMTQ1ODQ_abcf961b-f15b-4243-a6be-0adab2854983"
      unitRef="usd">-18402000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjUtMy0xLTEtMTQ1ODQ_cae26aae-40ff-4263-b6e4-0451785c929b"
      unitRef="usd">-18322000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjctMS0xLTEtMTQ1ODQ_c9e008de-8849-470a-8725-e68e89de6a88"
      unitRef="usd">-8652000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjctMy0xLTEtMTQ1ODQ_315ea141-7818-4416-9def-989148882500"
      unitRef="usd">-9807000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iaf36910fa826464cac0a33af2dcec06b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjgtMS0xLTEtMTQ1ODQ_861783b7-9126-4106-8dee-6d2880997c20"
      unitRef="usd">111080000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i67ee1fba64a441af905ddeb1f446539b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMjgtMy0xLTEtMTQ1ODQ_f9e8efa6-ea03-470b-b235-f052c2fa7bf2"
      unitRef="usd">118718000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMzAtMS0xLTEtMTQ1ODQ_152d3ff1-7d6a-43c6-8b91-c28daaf5f617"
      unitRef="usd">102428000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iddd375a412244dc48910945ff35d18c3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMzAtMy0xLTEtMTQ1ODQ_9ab4ae55-39d0-451e-a0a5-0734bab51386"
      unitRef="usd">108911000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMzQtMS0xLTEtMTQ1ODQ_c5fad1a2-0ba1-4092-8145-a0a18f802435"
      unitRef="usd">3870000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMzQtMy0xLTEtMTQ1ODQ_66c819b6-ec85-41aa-9493-dc5f6fa1f206"
      unitRef="usd">5580000</us-gaap:IncomeTaxesPaid>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMzYtMS0xLTEtMTQ1ODQ_949c1c5c-67b8-4212-845e-6cfad4b9f059"
      unitRef="usd">1079000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8xOS9mcmFnOmI4NzkwNTI1ZmMzNjRlNjE4M2MxZDEyYzBjOGU0MzQwL3RhYmxlOmE1ZDhkZjk2MzI3YjRjNjdhNWVhMDcxNWFlMWM5OTQ3L3RhYmxlcmFuZ2U6YTVkOGRmOTYzMjdiNGM2N2E1ZWEwNzE1YWUxYzk5NDdfMzYtMy0xLTEtMTQ1ODQ_b8cb2849-8085-4bb5-bb1e-373baaba72ae"
      unitRef="usd">329000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yNS9mcmFnOmYzYjZmMzk2YzQ2NDQ3NTY4OTkwZTMzYTZhODlkNjAxL3RleHRyZWdpb246ZjNiNmYzOTZjNDY0NDc1Njg5OTBlMzNhNmE4OWQ2MDFfMzQwOA_2f63af4f-fc18-485a-a6fe-db7ddf2bc28b">Summary of Significant Accounting Policies&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Organization&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PetMed Express, Inc. and subsidiaries, d/b/a PetMeds&#xae; (the &#x201c;Company&#x201d;), is a leading nationwide pet pharmacy and Your Trusted Pet Health Expert&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs, cats, and horses, directly to the consumer. The Company offers consumers an attractive alternative for obtaining pet medications in terms of expertise, convenience, price, speed of delivery and valued customer service. The Company markets its products through advertising and promotional campaigns, which aim to increase the recognition of the &#x201c;PetMeds&#xae;&#x201d; brand name, increase traffic on its website at &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;www.petmeds.com&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, acquire new customers, and maximize repeat purchases. Virtually all of the Company&#x2019;s sales are to customers in the United States. The Company&#x2019;s corporate headquarters and distribution facility is located in Delray Beach, Florida. The Company&#x2019;s fiscal year end is March&#160;31, and references herein to fiscal 2023 or fiscal 2022 refer to the Company's fiscal years ending March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basis of Presentation and Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and, therefore, do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, the accompanying Condensed Consolidated Financial Statements contain all adjustments, consisting of normal recurring accruals, necessary to present fairly the financial position of the Company at December&#160;31, 2022, the Statements of Income for the three and nine months ended December&#160;31, 2022 and 2021, and Cash Flows for the nine months ended December&#160;31, 2022 and 2021. The results of operations for the three and nine months ended December&#160;31, 2022 are not necessarily indicative of the operating results expected for the fiscal year ending March&#160;31, 2023. These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022. The Condensed Consolidated Financial Statements include the accounts of PetMed Express, Inc. and its wholly owned subsidiaries. All significant intercompany transactions have been eliminated upon consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair Value of Financial Instruments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of the Company's cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;The Company does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on the Company's consolidated financial position, results of operations, or cash flows.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <pets:BasisOfPresentationAndConsolidationPolicyTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yNS9mcmFnOmYzYjZmMzk2YzQ2NDQ3NTY4OTkwZTMzYTZhODlkNjAxL3RleHRyZWdpb246ZjNiNmYzOTZjNDY0NDc1Njg5OTBlMzNhNmE4OWQ2MDFfMzQwOQ_a057147f-38e5-4824-a837-ff3ad407c90c">Basis of Presentation and ConsolidationThe accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and, therefore, do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, the accompanying Condensed Consolidated Financial Statements contain all adjustments, consisting of normal recurring accruals, necessary to present fairly the financial position of the Company at December&#160;31, 2022, the Statements of Income for the three and nine months ended December&#160;31, 2022 and 2021, and Cash Flows for the nine months ended December&#160;31, 2022 and 2021. The results of operations for the three and nine months ended December&#160;31, 2022 are not necessarily indicative of the operating results expected for the fiscal year ending March&#160;31, 2023. These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022. The Condensed Consolidated Financial Statements include the accounts of PetMed Express, Inc. and its wholly owned subsidiaries. All significant intercompany transactions have been eliminated upon consolidation.</pets:BasisOfPresentationAndConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yNS9mcmFnOmYzYjZmMzk2YzQ2NDQ3NTY4OTkwZTMzYTZhODlkNjAxL3RleHRyZWdpb246ZjNiNmYzOTZjNDY0NDc1Njg5OTBlMzNhNmE4OWQ2MDFfMzQwNQ_dd8fbc8a-ff02-452c-85ba-e45ec79d3fa3">Use of Estimates The preparation of Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yNS9mcmFnOmYzYjZmMzk2YzQ2NDQ3NTY4OTkwZTMzYTZhODlkNjAxL3RleHRyZWdpb246ZjNiNmYzOTZjNDY0NDc1Njg5OTBlMzNhNmE4OWQ2MDFfMzQwNg_89cfaadb-2957-48e5-a3b4-7f06c3ebb56a">Fair Value of Financial Instruments The carrying amounts of the Company's cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yNS9mcmFnOmYzYjZmMzk2YzQ2NDQ3NTY4OTkwZTMzYTZhODlkNjAxL3RleHRyZWdpb246ZjNiNmYzOTZjNDY0NDc1Njg5OTBlMzNhNmE4OWQ2MDFfMzQwNw_534dab07-ab71-41c1-947c-113f15851bc3">Recent Accounting Pronouncements The Company does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on the Company's consolidated financial position, results of operations, or cash flows.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RleHRyZWdpb246OTQ2NTNkMGRmM2QyNDU5ODg5MDQ2OWUxNGM5NTQ2Y2JfMjY5MA_0c571c31-165a-4749-b6bc-5c340e043b4e">Revenue RecognitionThe Company generates revenue by selling pet medication products and pet supplies mainly to retail customers. Certain pet supplies offered on the Company&#x2019;s website are drop shipped to customers. The Company considers itself the principal in the arrangement because the Company controls the specified good before it is transferred to the customer. Revenue contracts contain one performance obligation, which is delivery of the product. Customer care and support is deemed not to be a material right to the contract. The transaction price is adjusted at the date of sale for any applicable sales discounts and an estimate of product returns, which are based on historical patterns, however this is not considered a key &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;judgment. Revenue is recognized when control transfers to the customer at the point in time at which the shipment of the product occurs. This key judgment is determined as the shipping point, which represents the point in time when the Company has a present right to payment, title has transferred to the customer, and the customer has assumed the risks and rewards of ownership.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outbound shipping and handling fees are an accounting policy election and are included in sales as the Company considers itself the principal in the arrangement given its responsibility for supplier selection and discretion over pricing. Shipping costs associated with outbound freight after control over a product has transferred to a customer are an accounting policy election and are accounted for as fulfillment costs and are included in cost of sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disaggregates sales in the following two categories: (1) reorder sales vs new order sales, and (2) internet sales vs. contact center sales. The following table illustrates sales by various classifications:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue (In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$ Variance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;% Variance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reorder sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;New order sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Internet sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;84.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contact center sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue (In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$ Variance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;% Variance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reorder sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;176,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;184,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;89.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;New order sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,741)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;194,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;207,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Internet sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;167,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;173,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;83.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contact center sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;194,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;207,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company changed the definition of a new customer on April 1, 2022, to include anyone who has not ordered over the past thirty-six months. The reorder and new order sales amounts for the three and nine  months ended December&#160;31, 2022, and the reorder and new order sales amounts for the three and nine  months ended December&#160;31, 2021 reflect this new customer definition change. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the previous definition of a new customer, reorder and new order sales were $56.3 million and $4.4 million, respectively, for the three months ended December 31, 2021. Under the previous definition of a new customer, reorder and new order sales were $189.3 million and $18.2 million, respectively, for the nine months ended December 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Virtually all the Company&#x2019;s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days. Credit card sales minimize the accounts receivable balances relative to sales. The Company had no material contract asset or liability balances as of December&#160;31, 2022 or March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RleHRyZWdpb246OTQ2NTNkMGRmM2QyNDU5ODg5MDQ2OWUxNGM5NTQ2Y2JfMjY5MQ_b9d9a41f-96d0-4fe1-b911-0d67844116d1">The following table illustrates sales by various classifications:&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue (In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$ Variance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;% Variance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reorder sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;New order sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Internet sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;84.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contact center sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.021%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Nine Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue (In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$ Variance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;% Variance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reorder sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;176,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;184,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;89.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(8,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;New order sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,741)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;194,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;207,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Internet sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;167,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;173,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;83.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contact center sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;194,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;207,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7bcec245ba8f4bca88ec8b71bb599cdf_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMy0yLTEtMS0xNDU4NA_6affb3b9-8fbc-4019-ba52-15e973c28e19"
      unitRef="usd">53316000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i7bcec245ba8f4bca88ec8b71bb599cdf_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMy00LTEtMS0xNDU4NA_ee5afe4f-e1ae-48c5-9e64-622c84738012"
      unitRef="number">0.906</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i65bde03e5d464408a705348a0a0f41cc_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMy02LTEtMS0xNDU4NA_3900be29-b09e-4767-b9dc-b98c8eb849a1"
      unitRef="usd">55259000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i65bde03e5d464408a705348a0a0f41cc_D20211001-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMy04LTEtMS0xNDU4NA_aa24fc0f-2e21-4e25-b267-52e287249b96"
      unitRef="number">0.910</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i7bcec245ba8f4bca88ec8b71bb599cdf_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMy0xMC0xLTEtMTQ1ODQ_044631bf-e8df-4125-988d-19bd14edbb3b"
      unitRef="usd">-1943000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i7bcec245ba8f4bca88ec8b71bb599cdf_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMy0xMi0xLTEtMTQ1ODQ_f63a6a7d-cc3e-4103-b001-fcad511a8b14"
      unitRef="number">-0.035</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if68375ef4a7542af96e74af2ada80410_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNC0yLTEtMS0xNDU4NA_22343543-9d91-42f2-992f-2fb52b5bef0f"
      unitRef="usd">5554000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="if68375ef4a7542af96e74af2ada80410_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNC00LTEtMS0xNDU4NA_26a10c4e-aeea-4cba-baa5-5f5d7648c129"
      unitRef="number">0.094</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9f0f687e16e445ef9491c6c0fccac673_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNC02LTEtMS0xNDU4NA_896920a1-82f1-401f-a475-99242f0d54ff"
      unitRef="usd">5458000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i9f0f687e16e445ef9491c6c0fccac673_D20211001-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNC04LTEtMS0xNDU4NA_f47bfce2-000b-446d-83ce-09c81ed2ffe2"
      unitRef="number">0.090</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="if68375ef4a7542af96e74af2ada80410_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNC0xMC0xLTEtMTQ1ODQ_e8aeb585-5d18-442f-91c8-49b523265983"
      unitRef="usd">96000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="if68375ef4a7542af96e74af2ada80410_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNC0xMi0xLTEtMTQ1ODQ_61c1e933-5678-4cc6-92d9-b899fdf6f43d"
      unitRef="number">0.018</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNi0yLTEtMS0xNDU4NA_514ad690-2bca-4488-a711-1e8bb6dcc696"
      unitRef="usd">58870000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNi00LTEtMS0xNDU4NA_879a52b9-ee34-4766-ba7a-1de2f077b3d4"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNi02LTEtMS0xNDU4NA_28eef62b-5267-4952-bff8-884dd2d3cb20"
      unitRef="usd">60717000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNi04LTEtMS0xNDU4NA_d5a18bd1-0137-45d1-a75a-7817cda716d4"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNi0xMC0xLTEtMTQ1ODQ_13f9fc1a-d793-4ec4-883c-ea6fdcf810ae"
      unitRef="usd">-1847000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfNi0xMi0xLTEtMTQ1ODQ_36ab6cf7-3b70-469f-914a-7ad061ed5413"
      unitRef="number">-0.030</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8150fab077f042849b44c3d66cd1be01_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOC0yLTEtMS0xNDU4NA_c54246e1-e77b-410c-8665-2246d2533964"
      unitRef="usd">51109000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i8150fab077f042849b44c3d66cd1be01_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOC00LTEtMS0xNDU4NA_a817e49f-e3f3-40cd-a8e9-2895e1e134ed"
      unitRef="number">0.868</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8424940f0f714f6bb29ebc7cef78ee72_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOC02LTEtMS0xNDU4NA_0241f18c-dbe5-47fd-b472-247e740137cf"
      unitRef="usd">51305000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i8424940f0f714f6bb29ebc7cef78ee72_D20211001-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOC04LTEtMS0xNDU4NA_e54078b5-e71a-4cc6-9b1a-b2b64c72aa2d"
      unitRef="number">0.845</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i8150fab077f042849b44c3d66cd1be01_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOC0xMC0xLTEtMTQ1ODQ_00050d4b-0b9a-40fb-86a7-205967659e41"
      unitRef="usd">-196000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i8150fab077f042849b44c3d66cd1be01_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOC0xMi0xLTEtMTQ1ODQ_0a989ab1-5d53-47df-8600-58423d605249"
      unitRef="number">-0.004</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6e261220a35145458a0bb7962680a283_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOS0yLTEtMS0xNDU4NA_16be1cc8-ca34-46be-9347-0f4a655a99f1"
      unitRef="usd">7761000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i6e261220a35145458a0bb7962680a283_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOS00LTEtMS0xNDU4NA_585db33c-85a5-4d7a-ae8d-b8c602f87efb"
      unitRef="number">0.132</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib5c88edd5dd84e9abd3087efd2f42496_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOS02LTEtMS0xNDU4NA_4fc30db7-5e6e-4066-b3a3-abbea1f63db7"
      unitRef="usd">9412000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ib5c88edd5dd84e9abd3087efd2f42496_D20211001-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOS04LTEtMS0xNDU4NA_720170bb-2493-44e1-83c2-a62495607263"
      unitRef="number">0.155</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i6e261220a35145458a0bb7962680a283_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOS0xMC0xLTEtMTQ1ODQ_9e3c8ca3-b709-4b23-8f8d-03f9c1a71133"
      unitRef="usd">-1651000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i6e261220a35145458a0bb7962680a283_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfOS0xMi0xLTEtMTQ1ODQ_c1e258cc-389a-4e9b-869f-f2b6b95f2509"
      unitRef="number">-0.175</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMTEtMi0xLTEtMTQ1ODQ_fcbae4e4-f945-4bf5-92fd-1b1e2a62c099"
      unitRef="usd">58870000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMTEtNC0xLTEtMTQ1ODQ_67ef0ed3-5ce4-4ca0-8f3b-eb922b4567c6"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMTEtNi0xLTEtMTQ1ODQ_f35f6851-9f04-43a3-bb85-dfdfd2dc7b17"
      unitRef="usd">60717000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMTEtOC0xLTEtMTQ1ODQ_33ae2ccb-f214-434c-bc3e-08827ee2e81b"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMTEtMTAtMS0xLTE0NTg0_2a322ff4-f94e-429e-a588-2ad7ab5e9ec4"
      unitRef="usd">-1847000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmEzNDgxNDQ5OWVlNjQ5ODdhMTk4MmZlZGYxNjdlZGQzL3RhYmxlcmFuZ2U6YTM0ODE0NDk5ZWU2NDk4N2ExOTgyZmVkZjE2N2VkZDNfMTEtMTItMS0xLTE0NTg0_5cc5dea7-cb18-45d9-9b97-86d675c4378f"
      unitRef="number">-0.030</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6c58fb706aaa4b1e98d81a7a0bfea1a7_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMy0yLTEtMS0xNDU4NA_1f1f3942-7d2a-4481-b595-0a2ba5c51b72"
      unitRef="usd">176384000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i6c58fb706aaa4b1e98d81a7a0bfea1a7_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMy00LTEtMS0xNDU4NA_1c972ae7-f792-4a50-8474-01aed1a5b703"
      unitRef="number">0.907</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idaadbc1c61234f73a3bb5e185c89cf4c_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMy02LTEtMS0xNDU4NA_3d1c0774-d98e-4ea9-983d-8c18fa6c541d"
      unitRef="usd">184607000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="idaadbc1c61234f73a3bb5e185c89cf4c_D20210401-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMy04LTEtMS0xNDU4NA_51093c92-c2c8-4532-838b-e7d00ed43be9"
      unitRef="number">0.890</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i6c58fb706aaa4b1e98d81a7a0bfea1a7_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMy0xMC0xLTEtMTQ1ODQ_6b04c662-54e8-4372-a361-a48dc07be2ca"
      unitRef="usd">-8223000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i6c58fb706aaa4b1e98d81a7a0bfea1a7_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMy0xMi0xLTEtMTQ1ODQ_2ab56acc-68da-4892-ad3c-aec559f30d96"
      unitRef="number">-0.045</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia0e4320425bc46a0a1fea6b2994f5d9f_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNC0yLTEtMS0xNDU4NA_991048c7-3016-440b-a07c-f744b9e7c0c3"
      unitRef="usd">18067000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ia0e4320425bc46a0a1fea6b2994f5d9f_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNC00LTEtMS0xNDU4NA_9541ebca-f72a-4871-95e2-de12edc84b14"
      unitRef="number">0.093</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6dff8f4be4934a6c8be36b9f8a2211ba_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNC02LTEtMS0xNDU4NA_0dabfb48-d338-4d6e-b61a-600ea624223a"
      unitRef="usd">22808000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i6dff8f4be4934a6c8be36b9f8a2211ba_D20210401-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNC04LTEtMS0xNDU4NA_adbaf0b6-1b3a-44b6-9f82-39d04a1aee5e"
      unitRef="number">0.110</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="ia0e4320425bc46a0a1fea6b2994f5d9f_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNC0xMC0xLTEtMTQ1ODQ_216e344d-0242-4f6d-8873-5b293d29fe50"
      unitRef="usd">-4741000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="ia0e4320425bc46a0a1fea6b2994f5d9f_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNC0xMi0xLTEtMTQ1ODQ_e625d778-36eb-4ddb-a416-50cedc0a78a4"
      unitRef="number">-0.208</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNi0yLTEtMS0xNDU4NA_199e78cc-8bf5-4ce8-9936-902f1387cd32"
      unitRef="usd">194451000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNi00LTEtMS0xNDU4NA_e1e277b6-9ef5-4f3b-bca7-3091240c4d99"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNi02LTEtMS0xNDU4NA_dee9b9ed-55e9-440e-a5f3-072c16280dd9"
      unitRef="usd">207415000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNi04LTEtMS0xNDU4NA_86f046f5-ef6e-43b2-82c6-688998cd4279"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNi0xMC0xLTEtMTQ1ODQ_e2b240eb-2ff0-408c-b126-9dbadfe0801d"
      unitRef="usd">-12964000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfNi0xMi0xLTEtMTQ1ODQ_f5b4353b-1c49-4cd6-b138-eef86a9863b6"
      unitRef="number">-0.063</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if63c295485f4407fa7e066bf30570500_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOC0yLTEtMS0xNDU4NA_82587391-4883-485d-82d1-b7b2d37a3bdb"
      unitRef="usd">167952000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="if63c295485f4407fa7e066bf30570500_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOC00LTEtMS0xNDU4NA_e0849661-6aa2-4ca9-82c5-5fb2d871aef1"
      unitRef="number">0.864</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic2bc6f8fae324212a7cadd450f94abe5_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOC02LTEtMS0xNDU4NA_1a5b20ae-a94b-4bc3-9341-b46697d2266a"
      unitRef="usd">173713000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ic2bc6f8fae324212a7cadd450f94abe5_D20210401-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOC04LTEtMS0xNDU4NA_5c864ecb-947e-485f-8553-b6edb9f56ac0"
      unitRef="number">0.838</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="if63c295485f4407fa7e066bf30570500_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOC0xMC0xLTEtMTQ1ODQ_5de896e1-baa7-4bae-aec7-86ac91f89183"
      unitRef="usd">-5761000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="if63c295485f4407fa7e066bf30570500_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOC0xMi0xLTEtMTQ1ODQ_0c0c99c2-b6c7-4340-b2f6-ffd41db60c64"
      unitRef="number">-0.033</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib4c9b15003614ac8a3226d1f0a7f6ee0_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOS0yLTEtMS0xNDU4NA_526f2a4b-168d-4196-aa68-6761f3c21b6c"
      unitRef="usd">26499000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ib4c9b15003614ac8a3226d1f0a7f6ee0_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOS00LTEtMS0xNDU4NA_a0cecf37-64bf-40f2-aaa4-6e59f87b6c78"
      unitRef="number">0.136</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i85db176f3142452d8eb6189c15ae2cd2_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOS02LTEtMS0xNDU4NA_278bac27-e234-4683-bda0-2d00ab1f1051"
      unitRef="usd">33702000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i85db176f3142452d8eb6189c15ae2cd2_D20210401-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOS04LTEtMS0xNDU4NA_fca83525-40f1-462d-80f2-c96e55702127"
      unitRef="number">0.162</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="ib4c9b15003614ac8a3226d1f0a7f6ee0_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOS0xMC0xLTEtMTQ1ODQ_6c909360-a342-4c37-a39a-34bf427cf754"
      unitRef="usd">-7203000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="ib4c9b15003614ac8a3226d1f0a7f6ee0_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfOS0xMi0xLTEtMTQ1ODQ_b7db084d-9087-46ef-b178-e271fd7d4b62"
      unitRef="number">-0.214</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMTEtMi0xLTEtMTQ1ODQ_748715f5-1294-4f16-8593-76bdb14110cc"
      unitRef="usd">194451000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMTEtNC0xLTEtMTQ1ODQ_8fd62819-dbca-454d-a6a0-becfb87e8e7d"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMTEtNi0xLTEtMTQ1ODQ_fe5c5fde-d400-4c3f-8ae9-01b6fb8b0087"
      unitRef="usd">207415000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMTEtOC0xLTEtMTQ1ODQ_d8442576-5fab-46c4-9294-d1c24f1b48f8"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMTEtMTAtMS0xLTE0NTg0_f5d0b7ef-6f1d-42e8-b3fb-ed59b67e5d92"
      unitRef="usd">-12964000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RhYmxlOmUyZjcyOGZlYTA1MzQ3Njc4YWM1N2RiZjY1YTUxOGZkL3RhYmxlcmFuZ2U6ZTJmNzI4ZmVhMDUzNDc2NzhhYzU3ZGJmNjVhNTE4ZmRfMTEtMTItMS0xLTE0NTg0_51c3f236-a4d1-4060-b6fb-b5a94c9a329e"
      unitRef="number">-0.063</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8877e07cd58945f6bbc7b58579686efe_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RleHRyZWdpb246OTQ2NTNkMGRmM2QyNDU5ODg5MDQ2OWUxNGM5NTQ2Y2JfMjIzMg_352c576d-f31c-45ae-b878-74700f858909"
      unitRef="usd">56300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2f7d9324da564d5386147bd5643fe51f_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RleHRyZWdpb246OTQ2NTNkMGRmM2QyNDU5ODg5MDQ2OWUxNGM5NTQ2Y2JfMjIzOQ_2b166a9d-6e85-4e20-92c3-72493fab42d0"
      unitRef="usd">4400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2a6c5dc1cfd04bad979e42463356b32b_D20210401-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RleHRyZWdpb246OTQ2NTNkMGRmM2QyNDU5ODg5MDQ2OWUxNGM5NTQ2Y2JfMjM1MQ_52c9955f-4e82-4bd6-a62e-541bfb1ddaa9"
      unitRef="usd">189300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i41a9cc96267d4f77b87be8a4fba4c3c2_D20210401-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8yOC9mcmFnOjk0NjUzZDBkZjNkMjQ1OTg4OTA0NjllMTRjOTU0NmNiL3RleHRyZWdpb246OTQ2NTNkMGRmM2QyNDU5ODg5MDQ2OWUxNGM5NTQ2Y2JfMjM1OA_d839f919-cb12-4dfa-8d71-5eddb0ef1cf9"
      unitRef="usd">18200000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfMTE3MA_4244af6a-149f-47fe-ac4e-f9931ebfee13">Net Income Per Share&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the provisions of Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 260 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) basic net income per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted net income per common share includes the dilutive effect of potential restricted stock and the effects of the potential conversion of preferred shares, calculated using the treasury stock method. Unvested restricted stock and convertible preferred shares issued by the Company represent the only dilutive effect reflected in the diluted weighted average shares outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented (in thousands, except for per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Nine Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) (numerator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average number of common shares outstanding used in basic computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common shares issuable upon vesting of restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common shares issuable upon conversion of preferred shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares used in diluted computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.00)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.00)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine  months ended December&#160;31, 2022 and 2021, 243,604 and 205,219 shares of common restricted stock, respectively, were excluded from the computations of diluted net income per common share, as their inclusion would have had an anti-dilutive effect on diluted net income per common share. For the three months ended December 31, 2022, 71 shares issuable upon vesting of restricted stock and 10 shares issuable upon conversion of preferred shares were excluded from the computation of diluted net income per common share, as their inclusion would have had an anti-dilutive effect on diluted net income per common share.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfMTE3MQ_17273241-3dd6-40c8-8232-ab17451e8a5a">&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented (in thousands, except for per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Nine Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) (numerator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average number of common shares outstanding used in basic computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common shares issuable upon vesting of restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common shares issuable upon conversion of preferred shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares used in diluted computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.00)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.00)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMy0xLTEtMS0xNDU4NA_c7f9239c-bcfa-4804-8383-f55bcf3d002b"
      unitRef="usd">-19000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMy0zLTEtMS0xNDU4NA_ab0acd3b-b137-4df2-bf9a-0a899fde6874"
      unitRef="usd">4257000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMy01LTEtMS0xNDU4NA_7ae244ab-9359-4bbe-9709-9e5ab99b147a"
      unitRef="usd">5335000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMy03LTEtMS0xNDU4NA_d00c4216-b815-43d3-aba8-3758a735bccf"
      unitRef="usd">15034000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNi0xLTEtMS0xNDU4NA_ba2dd836-0e96-40a0-8a82-467621122362"
      unitRef="shares">20301000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNi0zLTEtMS0xNDU4NA_ced96a17-b18c-4621-a95e-1e01c6284100"
      unitRef="shares">20208000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNi01LTEtMS0xNDU4NA_80f9faf3-d990-4694-b4f9-e9ec804ea219"
      unitRef="shares">20257000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNi03LTEtMS0xNDU4NA_cf3fe28f-e559-491c-b8c4-f1c7d1e64956"
      unitRef="shares">20165000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNy0xLTEtMS0xNDU4NA_3dab28c6-3190-4d83-b65f-bb31cfa23167"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNy0zLTEtMS0xNDU4NA_dc760823-2978-42c1-9957-c780dcce7a4f"
      unitRef="shares">111000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNy01LTEtMS0xNDU4NA_d12b6919-ea12-464f-8b3f-6e1185228235"
      unitRef="shares">72000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfNy03LTEtMS0xNDU4NA_b864fcfe-df2c-4f13-bda1-a2433f92189e"
      unitRef="shares">190000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOC0xLTEtMS0xNDU4NA_6c679c30-c0fd-4248-ad01-6078f9c76eaa"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOC0zLTEtMS0xNDU4NA_93b755f6-d1a1-4fd2-98bf-9277d3800530"
      unitRef="shares">10000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOC01LTEtMS0xNDU4NA_6eef437d-4604-4d6f-afc3-5e807f427b7c"
      unitRef="shares">10000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOC03LTEtMS0xNDU4NA_a2afe9c4-c86d-4e38-8c25-9e27e8d09f4e"
      unitRef="shares">10000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOS0xLTEtMS0xNDU4NA_8673aa65-70e5-4396-90ca-3e0dbdc94356"
      unitRef="shares">20301000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOS0zLTEtMS0xNDU4NA_4df60eef-900d-415a-a271-0cdd43e84ae6"
      unitRef="shares">20329000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOS01LTEtMS0xNDU4NA_806cd7fb-a698-4553-a59a-e496bef9b8ae"
      unitRef="shares">20339000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfOS03LTEtMS0xNDU4NA_e0d3dcf5-cd3c-4c05-b137-880c59267630"
      unitRef="shares">20365000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTMtMS0xLTEtMTQ1ODQ_b3c0c3f9-c325-44a9-a80d-37e35a2fea30"
      unitRef="usdPerShare">-0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTMtMy0xLTEtMTQ1ODQ_6e4a222d-aeae-4938-9a0c-bea952e35ccc"
      unitRef="usdPerShare">0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTMtNS0xLTEtMTQ1ODQ_195fa14f-f8df-4ea2-aeb7-35211aef1a9d"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTMtNy0xLTEtMTQ1ODQ_f20e6738-fe4e-4966-816d-2b922f711cd1"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTQtMS0xLTEtMTQ1ODQ_47fc473c-a3f7-4772-af11-c6ae0a0ce404"
      unitRef="usdPerShare">-0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTQtMy0xLTEtMTQ1ODQ_fb577d06-535d-4a8f-95ca-feeccb385d0b"
      unitRef="usdPerShare">0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTQtNS0xLTEtMTQ1ODQ_0af952e1-cb87-490a-bd1b-64e3a23f1a00"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RhYmxlOjdhMzY3OTk3ZWY5ZDQ5OTNiNTJmYmYwNTQxNGRkZTk3L3RhYmxlcmFuZ2U6N2EzNjc5OTdlZjlkNDk5M2I1MmZiZjA1NDE0ZGRlOTdfMTQtNy0xLTEtMTQ1ODQ_1b9aac8c-f9dd-4484-bbef-bf30ab8d85ed"
      unitRef="usdPerShare">0.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iad23aff6e73f4936ae99c55a2a704298_D20221001-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfOTM5_4f10788b-4757-40d0-bf16-53d16c3da1d8"
      unitRef="shares">243604</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icaf0a8da7b2e4c5bb6b4975bba8d57ca_D20220401-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfOTM5_8f0ca0f6-6116-49e2-982a-d6c875f5fe93"
      unitRef="shares">243604</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8fe4a15e0e42437d808ed2840f2e171f_D20211001-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfOTQ2_0c6dc483-5ebc-4835-8684-20979b3da336"
      unitRef="shares">205219</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i37ab1b450b194b00bf3e03586f0f9a1f_D20210401-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfOTQ2_758e39c8-3e0b-4dca-8456-467b34450e1b"
      unitRef="shares">205219</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7d7fa3fa4a984a9283d58153706677c9_D20221001-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfNTQ5NzU1ODE1MDg3_d27670c3-96f4-4d6b-8c54-9b506c529e58"
      unitRef="shares">71</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6fd0d3f40e08458eb598ab1db5019057_D20221001-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zMS9mcmFnOjY0NmM2YTQzZGVjYjQzMjY4M2U4YTI5ZDI1YTIxNTlkL3RleHRyZWdpb246NjQ2YzZhNDNkZWNiNDMyNjgzZThhMjlkMjVhMjE1OWRfNTQ5NzU1ODE1MTUz_78a21e2d-b3f1-42e7-a135-2ca20c017cda"
      unitRef="shares">10</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfNDAxMw_41d57593-d973-458b-84da-e56eee992aca">Accounting for Stock-Based Compensation&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records compensation expense associated with restricted stock in accordance with ASC Topic 718 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Based Payment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) (ASU 2016-09). The Company had 959,548 common shares issued under the 2016 Employee Equity Compensation Restricted Stock Plan (&#x201c;2016 Employee Plan&#x201d;), and 240,755 common shares issued under the 2015 Outside Director Equity Compensation Restricted Stock Plan (&#x201c;2015 Director Plan&#x201d;) at December&#160;31, 2022, all shares of which were issued subject to a restriction or forfeiture period that lapses ratably on the first, second, and third anniversaries of the date of grant, and the fair value of which is being amortized over the &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfNjgz_191b9281-4145-40ce-abe4-217b2cb8eccc"&gt;one&lt;/span&gt; to three-year restriction period, with the exception of performance restricted shares which were issued to the Chief Executive Officer and Chief Financial Officer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, the Company issued 90,000 restricted shares and 510,000 performance restricted shares to the Company&#x2019;s CEO, in accordance with the CEO&#x2019;s employment agreement, under the 2016 Employee Plan.  The performance restricted shares are based on achieving absolute stock hurdles with the three-year period from the grant date. If the shares meet the absolute stock price hurdle, they will only vest on the third anniversary of the date of grant. As of December&#160;31, 2022, none of the performance stock hurdles were met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, the Company issued 13,000 restricted shares and 3,000 performance restricted shares to the Company's new CFO, in accordance with the CFO's employment agreement, under the 2016 Employee Plan. The performance restricted shares are based on the attainment of performance criteria equally weighted between adjusted EBITDA and revenue. The shares for each grant will be released from restriction equally over a three (3) year period on the anniversary of the grant date, and in the case of the performance restricted shares, subject to the attainment of performance criteria .&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued 550 shares of restricted stock, net of forfeitures, to certain employees under the 2016 Employee Plan during the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;quarter ended December&#160;31, 2022. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For the quarters ended December&#160;31, 2022 and 2021, the Company recognized &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.8 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $1.4 million, respectively, of compensation expense related to the 2016 Employee Plan and 2015 Director Plan. For the nine months ended December&#160;31, 2022 and 2021, the Company recognized &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.0 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $3.0 million, respectively, of compensation expense related to the 2016 Employee Plan and 2015 Director Plan. At December&#160;31, 2022 and 2021 there was $10.6 million and $14.4 million of unrecognized compensation cost related to the non-vested restricted stock awards, respectively, which is expected to be recognized over the next &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjk2OQ_1aaf0ccb-d1a0-41ef-bb85-02c3837aae7b"&gt;one&lt;/span&gt; to three years. All stock-based compensation expense is recognized as a payroll-related expense and it is included within the general and administrative expenses line item within the Company&#x2019;s Consolidated Statements of Income , and the offset is included in the additional paid-in capital line item of the Company&#x2019;s Consolidated Balance Sheets. On December&#160;31, 2022 and 2021, there were 759,204 and 749,219 non-vested restricted shares issued and outstanding, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2022, the Company&#x2019;s 2022 Employee Equity Compensation Restricted Stock Plan (&#x201c;2022 Employee Plan&#x201d;) became effective upon the approval of the plan by the Company&#x2019;s shareholders. The 2022 Employee Plan authorizes 1,000,000 shares of the Company's common stock available for issuance.  The value of the restricted stock is determined based on the market value of the stock at the issuance date.  The restriction period or forfeiture period is determined by the Company&#x2019;s Compensation Committee and is to be no less than 1 year and no more than ten years, unless otherwise specified by the Compensation Committee. No shares had been issued under the 2022 Employee Plan as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="iad28657a6a0b4952ba10608b59c49e38_D20220401-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjE1_9b4fa31a-c1e1-43ed-b34a-8bdda94e9673"
      unitRef="shares">959548</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i2f5c94e1389f4483aa7c73b4b9c00e93_D20220401-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzMz_5c20c982-501a-4369-a1c6-d0b3b7140574"
      unitRef="shares">240755</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <pets:RestrictionPeriod
      contextRef="i8b31dfb51bb44783b638d191bbc7a980_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfNDAxMQ_228ef9ce-386e-4555-870b-1daf1acf9ce3">P3Y</pets:RestrictionPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie7442254753449318736ecb33c3c2b59_D20210801-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfODgy_2fc652d2-ce54-4bc1-91be-181c752a13c7"
      unitRef="shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0d8b91f663f3474c99076e130bb65446_D20210801-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfOTA3_c0236ceb-2021-498a-b559-8fa13b141a0e"
      unitRef="shares">510000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5e6712ee77de4a729affbf86d32800d4_D20220803-20220803"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMTczNQ_d6cea414-d70e-4029-ab2f-0d07a37f564e"
      unitRef="shares">13000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i974cd15bc1f84107b36c802dfb84787d_D20220803-20220803"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMTc2Ng_ece22c7d-b1a2-4cb1-92d0-a65a907d7f24"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2d506cc607c04a3ebf6a185593e1dc41_D20220803-20220803"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMTA5OTUxMTYzMTgzMQ_21973ad1-7e8e-4b49-bde5-e6b29a8492bd">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i7d5cbb72af874387884242be4246de02_D20221001-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjE5Nw_1487106e-8f21-40ab-ab41-e5958119534a"
      unitRef="shares">550</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibe371187742843408787486f68f274b3_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjUyOQ_26169b35-7b4f-4a39-817b-9982a0fb6d6c"
      unitRef="usd">1800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ida28de54333842baae92c105ccb153e2_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjUzNg_7e201e43-0b1e-4eee-a8e2-bb2b4e91f919"
      unitRef="usd">1400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i53207e2d9eb14013aa52bab22358b457_D20220401-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjY4MQ_0676678a-5cd2-4e49-bbe6-cd52893f337f"
      unitRef="usd">5000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i97cda5016db34ee48cec4f2f8a6755f2_D20210401-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjY4OA_f0ed5687-aeac-45ec-8986-057af1915d8f"
      unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i1a336deb41434c5ea068a787ed8d62e9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjgxMQ_430bf593-c00d-4b5a-9f1e-2f4c0a6365f3"
      unitRef="usd">10600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i3bdd189cee1942858b848f337aac4919_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjgxOA_dc6f5ce8-bc4f-4343-8cca-ba22e8ae6f95"
      unitRef="usd">14400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i802698039a084839a3f7f1d98357ba6e_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMjk3NQ_40dd5c41-b86e-4265-bf98-64afcc0bbef9">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1a336deb41434c5ea068a787ed8d62e9_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzMwMg_c8444f0d-4844-4df1-a81c-5992c645ef4c"
      unitRef="shares">759204</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3bdd189cee1942858b848f337aac4919_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzMwOQ_806606a0-15a0-4a71-9c3a-19616be520f0"
      unitRef="shares">749219</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i7ed1086383e343e69ff226fd59a926d5_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzU5OA_11fe8f84-4e7e-417c-8969-b39666b04bb9"
      unitRef="shares">1000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <pets:RestrictionPeriod
      contextRef="ic43fa5ecc4024171ad3cc5adcab3dead_D20220701-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzkwOA_6addc3ae-247d-47fe-8e81-98cbb26c468c">P1Y</pets:RestrictionPeriod>
    <pets:RestrictionPeriod
      contextRef="ia5c6583bec134c2b919d20f2ac9ffdd8_D20220701-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzkyOA_776b4c4f-92ac-49da-af1d-4a30595ca9ac">P10Y</pets:RestrictionPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i436e706c942c451990e2aa84cb93940f_D20220701-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNC9mcmFnOmZlYmIwYTkwZDU4YzRlYzY5ZTZkMDYyODE5MTgxNGI1L3RleHRyZWdpb246ZmViYjBhOTBkNThjNGVjNjllNmQwNjI4MTkxODE0YjVfMzkzMg_9c1292a5-09fe-4e39-9140-04b96ebcbcb1"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNy9mcmFnOmYxN2EyZDI4OTAxYjQ1YTJiYzZjMTI1NDg1NWYzOTI1L3RleHRyZWdpb246ZjE3YTJkMjg5MDFiNDVhMmJjNmMxMjU0ODU1ZjM5MjVfMTI3NQ_6968a8ed-93da-4ab7-aa2c-026449ec4c34">Fair Value&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company carries cash and cash equivalents at fair value in the Condensed Consolidated Balance Sheets. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. ASC Topic 820 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) establishes a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - Unobservable inputs which are supported by little or no market activity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. At December&#160;31, 2022, the Company had invested the majority of its $102.4 million cash and cash equivalents balance in money market funds which are classified within Level 1.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV8zNy9mcmFnOmYxN2EyZDI4OTAxYjQ1YTJiYzZjMTI1NDg1NWYzOTI1L3RleHRyZWdpb246ZjE3YTJkMjg5MDFiNDVhMmJjNmMxMjU0ODU1ZjM5MjVfMTE4MQ_854571a4-406f-42ee-a81f-6c0dbeef638d"
      unitRef="usd">102400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80MC9mcmFnOmMwNjA1NzdiNDBmODQzODI5YTZlMDNlNjBiN2FjYzJlL3RleHRyZWdpb246YzA2MDU3N2I0MGY4NDM4MjlhNmUwM2U2MGI3YWNjMmVfMzUzNw_02a9cc3f-540e-4865-9ea2-746ede206f02">Commitments and Contingencies&lt;div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt;Legal Matters and Routine Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has settled complaints that had been filed with various states&#x2019; pharmacy boards in the past. There can be no assurances made that other states will not attempt to take similar actions against the Company in the future. The Company also intends to vigorously defend its trade or service marks. There can be no assurance that the Company will be successful in protecting its trade or service marks. Legal costs related to the above matters are expensed as incurred .From time to time, the Company may be involved in and subject to disputes and legal proceedings, as well as demands, claims and threatened litigation that arise in the ordinary course of its business. These proceedings may include allegations involving business practices, infringement of intellectual property, employment or other matters. The ultimate outcome of any legal proceeding is often uncertain, there can be no assurance that the Company will be successful in any legal proceeding, and unfavorable outcomes could have a negative impact on our results of operations and financial condition. In accordance with ASC Topic 450-20 ("&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Loss Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;"), the Company records a liability in its financial statements for these matters when a loss is known or considered probable and the amount can be reasonably estimated. The Company reviews the status of each significant matter each accounting period as additional information is known and adjusts the loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;provision when appropriate. If a matter is both probable to result in a liability and the amounts of loss can be reasonably estimated, the Company estimates and discloses the possible loss or range of loss to the extent necessary to make the financial statements not misleading. If the loss is not probable and cannot be reasonably estimated, a liability is not recorded in the Company&#x2019;s financial statements. Gain contingencies are not recorded until they are realized. Legal costs related to any legal matters are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates contingencies on an ongoing basis and has established loss provisions for matters in which losses are probable and the amount of the loss can be reasonably estimated and is not currently a party to any legal proceeding that management believes could have a material adverse effect on our results of operations. Based upon an assessment for sales tax received by the Company, an accrual in the amount of $0.9&#160;million is included in the "Accrued expenses and other current liabilities" line item on the Condensed Consolidated Balance Sheets as of December&#160;31, 2022 and the offsetting expense was recognized in the "General and administrative" line item within the Condensed Consolidated Statements of Income for the nine months ended December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based upon the assessment received, the Company initiated a process to evaluate the potential for further sales tax contingencies, The effect of such evaluation of potential sales tax exposure, which the Company expects to complete in the fourth quarter ending March&#160;31, 2023, could have a material effect on the results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt;Separation Agreement&lt;/span&gt;&lt;/div&gt;In connection with the separation of the Company's former Chief Financial Officer, the Company has accrued $364&#160;thousand with respect to the severance, pursuant to the CFO Transition and Separation Agreement, included in "Accrued expenses and other current liabilities" on the Condensed Consolidated Balance Sheet as of December&#160;31, 2022.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80MC9mcmFnOmMwNjA1NzdiNDBmODQzODI5YTZlMDNlNjBiN2FjYzJlL3RleHRyZWdpb246YzA2MDU3N2I0MGY4NDM4MjlhNmUwM2U2MGI3YWNjMmVfMjM5NQ_d74ac557-5e47-4050-a310-ed6d7fff2611"
      unitRef="usd">900000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent>
    <pets:AccruedSeveranceCosts
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80MC9mcmFnOmMwNjA1NzdiNDBmODQzODI5YTZlMDNlNjBiN2FjYzJlL3RleHRyZWdpb246YzA2MDU3N2I0MGY4NDM4MjlhNmUwM2U2MGI3YWNjMmVfMzQyNA_0e5de752-e149-469d-b0a1-755cce32d39a"
      unitRef="usd">364000</pets:AccruedSeveranceCosts>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RleHRyZWdpb246ODJlZjkxYTk4NzA1NGFjMGFmYTU5MDRiMGVkNjMzY2RfNDI2_ed1fa1cf-cc68-4335-b9a1-2f0e86d05872">Changes in Shareholders&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Equity:&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in Shareholders&#x2019; Equity for the nine months ended December&#160;31, 2022 is summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Additional&lt;br/&gt;Paid-In&lt;br/&gt;Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance at March 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;130,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;126,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance at September  30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;123,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance at December 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;116,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in Shareholders&#x2019; Equity for the nine months ended December&#160;31, 2021 is summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Additional&lt;br/&gt;Paid-In&lt;br/&gt;Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance at March 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance at September  30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance at December 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;130,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no shares of common stock that were purchased or retired in the nine months ended December&#160;31, 2022 or 2021. At December&#160;31, 2022, the Company had approximately $28.7 million remaining under the Company&#x2019;s share repurchase plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RleHRyZWdpb246ODJlZjkxYTk4NzA1NGFjMGFmYTU5MDRiMGVkNjMzY2RfNDI3_e0656581-ae02-4e4f-8665-69197e2f89a8">&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in Shareholders&#x2019; Equity for the nine months ended December&#160;31, 2022 is summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Additional&lt;br/&gt;Paid-In&lt;br/&gt;Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance at March 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;130,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;126,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance at September  30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;123,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance at December 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;116,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in Shareholders&#x2019; Equity for the nine months ended December&#160;31, 2021 is summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Additional&lt;br/&gt;Paid-In&lt;br/&gt;Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance at March 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance at September  30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends declared&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance at December 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;130,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i864561553fdf4df0ac1140a600d033a4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMS0xLTEtMS0xNDU4NA_7aa2c666-2ca8-473f-8160-59e6b6b7a65b"
      unitRef="usd">21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i46fd83d710f74df093e8b4c8bcb39594_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMS0zLTEtMS0xNDU4NA_6a65ee47-3c29-493a-b4cf-2fef3e784f09"
      unitRef="usd">11660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idc9aeeb29c4742208591d84ff5c3f38f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMS01LTEtMS0xNDU4NA_ff419629-f463-4cd0-a50c-30f7da99ac87"
      unitRef="usd">130496000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia3726f4e149f4c17892e094ff0d250d3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMi0zLTEtMS0xNDU4NA_cfbe2569-8eda-456a-8d54-79896e1a559a"
      unitRef="usd">1536000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsCommonStock
      contextRef="i7a965f8b26994fc58ac8950bbd13c3d8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMy01LTEtMS0xNDU4NA_2d2345cf-9521-497e-a9e1-de0270f38d34"
      unitRef="usd">6297000</us-gaap:DividendsCommonStock>
    <us-gaap:NetIncomeLoss
      contextRef="i7a965f8b26994fc58ac8950bbd13c3d8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfNC01LTEtMS0xNDU4NA_9e3c4f42-9f55-49fe-b035-acdbc43af854"
      unitRef="usd">2775000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="i90c28b24bd8c465fba8956a43b6b42ba_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfNS0xLTEtMS0xNDU4NA_469c9b34-4f9f-4c70-b8a8-5768f8b4279e"
      unitRef="usd">21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifca299ce29fa401f9edd0c4cc2d16abb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfNS0zLTEtMS0xNDU4NA_8c5a101c-5db0-4f69-8621-0ea684eedf46"
      unitRef="usd">13196000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia6e858548b03478893794331fd102d06_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfNS01LTEtMS0xNDU4NA_03e69530-7122-4ea6-a30e-120a5e62dae1"
      unitRef="usd">126974000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic6e22b4c43d942b8968fdc0f92828472_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfNy0zLTEtMS0xNDU4NA_2511c344-f88a-4bc9-9ac2-d99728cea020"
      unitRef="usd">1681000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsCommonStock
      contextRef="icc4d4debbecb42c6a5c7bf76f83cfd04_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfOC01LTEtMS0xNDU4NA_2e9e6840-426e-4920-941f-214323632d22"
      unitRef="usd">6307000</us-gaap:DividendsCommonStock>
    <us-gaap:NetIncomeLoss
      contextRef="icc4d4debbecb42c6a5c7bf76f83cfd04_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfOS01LTEtMS0xNDU4NA_96cf3396-c557-4290-b169-c917e3109e8f"
      unitRef="usd">2579000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="if04a59c0e21b4165abb829478afa536e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTAtMS0xLTEtMjAwNDk_f0051515-031a-4887-bd6d-03cd6ad8349e"
      unitRef="usd">21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id0616732cc964c29af2566aecd430715_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTAtMy0xLTEtMjAwNTc_9b3d4238-07d1-4da4-a319-9693a636e7ff"
      unitRef="usd">14877000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib30acdba9294412b8455cee53c346bbc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTAtNS0xLTEtMjAwNjU_ce0bf050-3c36-49be-9644-1e1c1b2479f7"
      unitRef="usd">123246000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i49e30612ead546a68ffa3cc45d3f0c77_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTEtMy0xLTEtMjAxMjg_ac9e4528-52ac-4038-99fb-a5fe514760fb"
      unitRef="usd">1770000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsCommonStock
      contextRef="i46d17e7cf38c48cca155dcb2ddb012cc_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTItNS0xLTEtMjAxNTM_d35acecb-dc93-4ace-918e-cdf6992bad48"
      unitRef="usd">6319000</us-gaap:DividendsCommonStock>
    <us-gaap:NetIncomeLoss
      contextRef="i46d17e7cf38c48cca155dcb2ddb012cc_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTMtNS0xLTEtMjAxNjE_385e68ab-fbac-4a90-b3f3-142b9d19cebe"
      unitRef="usd">-19000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="iae5e3adc0e244df78831aead28031b7c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTAtMS0xLTEtMTQ1ODQ_83cc1610-2327-49ea-9f80-522cda264e7b"
      unitRef="usd">21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iedd0a502d0114c6b9a8e7b297688cbcf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTAtMy0xLTEtMTQ1ODQ_1c05cde9-09b2-44c3-987c-0e61f8674e26"
      unitRef="usd">16647000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i28a4779f6fab4613b28885ae9cac19e6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOmNlYjQ3ZDg4NTM5ZDQ2YjE5ZGMyMGM1YjU3ZTVlOTI3L3RhYmxlcmFuZ2U6Y2ViNDdkODg1MzlkNDZiMTlkYzIwYzViNTdlNWU5MjdfMTAtNS0xLTEtMTQ1ODQ_ac1e8d8b-37fa-491f-b0e9-beab3dc2f6fb"
      unitRef="usd">116908000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib7ae2226e077465abd6ae8cf00b6f532_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMS0xLTEtMS0xNDU4NA_ae19f47f-39be-4bc0-91a3-58453b9fd314"
      unitRef="usd">20000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i562c11f99bb548b69e78e029f0d65860_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMS0zLTEtMS0xNDU4NA_c7e756d8-b01b-4302-88e6-9b11dd14cd75"
      unitRef="usd">7111000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if1dae6dbb35c4a6da152924d34b0365d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMS01LTEtMS0xNDU4NA_c0b61d5d-edf7-43b9-8c92-c10b9545f848"
      unitRef="usd">134141000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icc4da35a89ae49178deb59c2d6bb3d07_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMi0zLTEtMS0xNDU4NA_fd000d53-878f-49d0-8c63-e710bb85eb56"
      unitRef="usd">718000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsCommonStock
      contextRef="i0ffa3d3f184241dabcf76d81522ac2d2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMy01LTEtMS0xNDU4NA_1754fee5-5512-4425-8929-175f97e2fe2d"
      unitRef="usd">6080000</us-gaap:DividendsCommonStock>
    <us-gaap:NetIncomeLoss
      contextRef="i0ffa3d3f184241dabcf76d81522ac2d2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfNC01LTEtMS0xNDU4NA_c45da009-0126-4ee7-a25e-7172a8c4eda9"
      unitRef="usd">4428000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="icfb6fe66922848658885a8bc6e9481e9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfNS0xLTEtMS0xNDU4NA_10e985b4-f0ee-4262-a8eb-14816577c2c8"
      unitRef="usd">20000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i35f0d7d912c3464e849f72990a167356_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfNS0zLTEtMS0xNDU4NA_124dd89e-d7fd-410d-8e88-733e360eb615"
      unitRef="usd">7829000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5acf5cd16dff4f088c9398f33c3cddca_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfNS01LTEtMS0xNDU4NA_80348e85-ace4-4647-8988-694fff078e99"
      unitRef="usd">132489000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i8c67a17e20334c189d487ee28cf75bf1_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfNi0xLTEtMS0xNDU4NA_46ace039-67a8-473c-afd8-67dd3b891852"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia9a920eeb13942fe81148b446dcc66cf_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfNy0zLTEtMS0xNDU4NA_59e0263e-b6a0-4168-a8bd-78c53a413712"
      unitRef="usd">882000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsCommonStock
      contextRef="i128c8af1cec14be1ae200b38a29fd0a9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfOC01LTEtMS0xNDU4NA_f71c287d-17be-4971-a2c1-dfc8a432983a"
      unitRef="usd">6092000</us-gaap:DividendsCommonStock>
    <us-gaap:NetIncomeLoss
      contextRef="i128c8af1cec14be1ae200b38a29fd0a9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfOS01LTEtMS0xNDU4NA_2a27b1b4-adc2-4cc2-a3df-9d0dfd879fa1"
      unitRef="usd">6349000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="ic12b54a9ab4242d5a1dca7c82eba46df_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTAtMS0xLTEtMjAyNTQ_bc022ea2-cadd-4702-b847-9582dad97806"
      unitRef="usd">21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5d10742b5f544f5594cb0909107de875_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTAtMy0xLTEtMjAyNjI_85a5231f-5c25-4264-9ce0-4b59469f1855"
      unitRef="usd">8711000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i75d4eab0c05241e793a7d11cdc5e2f2a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTAtNS0xLTEtMjA1MDU_489ddb8c-d5fc-4f85-b919-9bc774f4e03e"
      unitRef="usd">132746000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i88fc8739d1ab480e97d26ea983b689de_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTEtMy0xLTEtMjAzMzE_b952026b-fb4c-4953-8225-4d9b51b57b59"
      unitRef="usd">1440000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsCommonStock
      contextRef="i26b4c5393a8c4e5092769bb380417953_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTItNS0xLTEtMjAzNjM_d4ae1b73-4f63-40fb-85a5-563517674152"
      unitRef="usd">6282000</us-gaap:DividendsCommonStock>
    <us-gaap:NetIncomeLoss
      contextRef="i26b4c5393a8c4e5092769bb380417953_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTMtNS0xLTEtMjAzNzE_7519e234-3339-4ef5-81f9-2ffaa721c556"
      unitRef="usd">4257000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="ib6f47c348e3745359b8952cad7998881_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTAtMS0xLTEtMTQ1ODQ_12aa6835-ae66-42f4-936d-d7bcf6fe4abd"
      unitRef="usd">21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3794039ab2794369b1521e3a036acaab_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTAtMy0xLTEtMTQ1ODQ_db7f9853-e701-4401-838b-08e61c8f0459"
      unitRef="usd">10151000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6978944526c3459c9248ffc7c6ca9745_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RhYmxlOjg4MTE3YzAwOGNiOTQ4OTNhNzIxYzZjZWRlOGFiYzliL3RhYmxlcmFuZ2U6ODgxMTdjMDA4Y2I5NDg5M2E3MjFjNmNlZGU4YWJjOWJfMTAtNS0xLTEtMTQ1ODQ_dfb8e04f-aa6a-49a1-92b9-65c2a9c3ff90"
      unitRef="usd">130721000</us-gaap:StockholdersEquity>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RleHRyZWdpb246ODJlZjkxYTk4NzA1NGFjMGFmYTU5MDRiMGVkNjMzY2RfMjU0_25247c8e-50d2-4019-bb0e-03dc0fb5459d"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RleHRyZWdpb246ODJlZjkxYTk4NzA1NGFjMGFmYTU5MDRiMGVkNjMzY2RfMjU0_45922e20-bfc4-4d34-a037-f2e9a2609004"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i137fc368100c4411981905d28135f59f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80My9mcmFnOjgyZWY5MWE5ODcwNTRhYzBhZmE1OTA0YjBlZDYzM2NkL3RleHRyZWdpb246ODJlZjkxYTk4NzA1NGFjMGFmYTU5MDRiMGVkNjMzY2RfMzY4_ae8f34e2-9ddd-497e-90de-a7055e96ceae"
      unitRef="usd">28700000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfNjYy_7f5212cc-734d-4dbe-853c-e0b3a9ccd637">Income TaxesFor the quarters ended December&#160;31, 2022 and 2021, the Company recorded an income tax provision of approximately $0.2 million and $1.3 million, respectively, and for the nine months ended December&#160;31, 2022 and 2021 the Company recorded an income tax provision of approximately $2.3 million and $4.6 million, respectively. The decrease in the tax provision for the three and nine  months ended December&#160;31, 2022 is related to a decrease in operating income during the periods. The effective tax rate for the quarter ended December&#160;31, 2022 was approximately 109.6%, compared to approximately 22.9% for the quarter ended December&#160;31, 2021, and the effective tax rate for the nine months ended December&#160;31, 2022 was approximately 29.9% compared to approximately 23.4% for the nine months ended December&#160;31, 2021. The increase to the effective tax rate for the three and nine  months ended December&#160;31, 2022 can be attributed to more non-deductible expenses and an increase in state tax due to the extension of the Company's business operations.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfMTIy_f6f24b9c-e2fe-4bdb-b616-2ff0b853c8ea"
      unitRef="usd">200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfMTI5_8c984194-d023-4e17-b21d-4d21adfbb75a"
      unitRef="usd">1300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfMjM0_035d622a-215f-4d8f-a204-0420a8513b27"
      unitRef="usd">2300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfMjQx_4339dc42-7810-4d7a-8c4e-419239ab35cf"
      unitRef="usd">4600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfMzI1_36527148-22d2-4a61-a5cc-6d457b67e873"
      unitRef="number">1.096</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ifa0563c4f677450fbbf0cbd3d1a1d25e_D20211001-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfMzU1_7dd61248-6c25-4bbb-aa91-99454636e6a0"
      unitRef="number">0.229</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfNDQz_b8c07f2f-7a6c-4ead-8be4-c39eea2e5187"
      unitRef="number">0.299</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib179aa2887c046c3b10f0f79ae43a6a9_D20210401-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV80Ni9mcmFnOmY0YzIzMjE2Y2ZmZDRjYmQ4MTgzNGFiNTllMjJjNzIxL3RleHRyZWdpb246ZjRjMjMyMTZjZmZkNGNiZDgxODM0YWI1OWUyMmM3MjFfNDcy_31c33f3f-9d27-41fe-8e37-da9a2c83170b"
      unitRef="number">0.234</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81Mi9mcmFnOjI1YWEyZmNiM2NmNjQxOWI5MDBlNDIzMWQ2YmFmZTg5L3RleHRyZWdpb246MjVhYTJmY2IzY2Y2NDE5YjkwMGU0MjMxZDZiYWZlODlfNzEx_e82f7bda-c015-4235-8d8d-c206531e0840">Minority Interest Investment in VetsterOn April&#160;19, 2022, the Company engaged in a three-year partnership agreement with Vetster Inc. (&#x201c;Vetster&#x201d;), a veterinary telehealth Canadian company. The Company also purchased a 5% minority interest in Vetster in the amount of $5.0 million and received warrants for additional equity in Vetster, which are tied to future performance milestones. Under the terms of the agreement, the Company became the exclusive e-commerce provider for Vetster, and Vetster became the exclusive provider of telehealth and telemedicine services to the Company. The minority interest investment is being valued on the cost basis and the investment will be evaluated periodically for any impairment.</us-gaap:MinorityInterestDisclosureTextBlock>
    <pets:TermOfAgreement
      contextRef="iab14d6c222714d4fa9eeef808f9de70c_D20220419-20220419"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81Mi9mcmFnOjI1YWEyZmNiM2NmNjQxOWI5MDBlNDIzMWQ2YmFmZTg5L3RleHRyZWdpb246MjVhYTJmY2IzY2Y2NDE5YjkwMGU0MjMxZDZiYWZlODlfNzEy_ebf5f006-5251-401c-81a5-6e8139522e38">P3Y</pets:TermOfAgreement>
    <pets:NoncontrollingInterestOwnershipPercentagePurchased
      contextRef="i443214d583e24ab29051706bdba05419_I20220419"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81Mi9mcmFnOjI1YWEyZmNiM2NmNjQxOWI5MDBlNDIzMWQ2YmFmZTg5L3RleHRyZWdpb246MjVhYTJmY2IzY2Y2NDE5YjkwMGU0MjMxZDZiYWZlODlfMjE4_c9f2241f-0ff5-4b84-b5cf-57e29feb32b1"
      unitRef="number">0.05</pets:NoncontrollingInterestOwnershipPercentagePurchased>
    <us-gaap:Investments
      contextRef="i443214d583e24ab29051706bdba05419_I20220419"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81Mi9mcmFnOjI1YWEyZmNiM2NmNjQxOWI5MDBlNDIzMWQ2YmFmZTg5L3RleHRyZWdpb246MjVhYTJmY2IzY2Y2NDE5YjkwMGU0MjMxZDZiYWZlODlfMjY3_1a5e15fc-0f31-44b4-a65c-d7366c1f4ff5"
      unitRef="usd">5000000</us-gaap:Investments>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81NS9mcmFnOjc5Nzk3NTc1ZWFmNzQ0ZjJhZDA2NDY1YjVmMmNjMGY4L3RleHRyZWdpb246Nzk3OTc1NzVlYWY3NDRmMmFkMDY0NjViNWYyY2MwZjhfNDE2_205463c9-8566-4b35-b599-84408bb8750a">Subsequent EventsOn January&#160;13, 2023, the Company entered into an Agreement and Plan of Merger to acquire PetCareRx, Inc. ("PetCareRx"), a leading supplier of pet medications, food, and supplies, for an aggregate consideration of approximately $36.0&#160;million in cash, subject to adjustment. The closing of the transaction is subject to customary closing conditions and certain state pharmacy license and permit filings related to the change of control of PetCareRx. The transaction has been approved by the Board of Directors of both the Company and PetCareRx, and the stockholders of PetCareRx, and is expected to close in the fourth quarter of fiscal year 2023. Upon completion of the acquisition, PetCareRx will become a wholly-owned subsidiary of the Company.&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;6, 2023, the Board of Directors declared a quarterly dividend of $0.30 per share. The Board established a February&#160;20, 2023 record date and a February&#160;27, 2023 payment date. Based on the outstanding share balance as of February&#160;7, 2023 the Company estimates the dividend payable to be approximately $6.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to December&#160;31, 2022, the Board of Directors approved and issued 1,200 restricted &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;shares to employees pursuant to the 2016 Employee Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to December&#160;31, 2022, the Board of Directors approved and issued 6,000 restricted shares to MZHCI, LLC pursuant to an Investor Relations Consulting Agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="iba0d1147b871412bb5ee913ee43a4458_D20230113-20230113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81NS9mcmFnOjc5Nzk3NTc1ZWFmNzQ0ZjJhZDA2NDY1YjVmMmNjMGY4L3RleHRyZWdpb246Nzk3OTc1NzVlYWY3NDRmMmFkMDY0NjViNWYyY2MwZjhfMTA5OTUxMTYzMTM4OQ_205aa45d-a906-4c38-bf86-c259d73da9b7"
      unitRef="usd">36000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i193309c747ed4183bc1fc06e289d1aba_D20230206-20230206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81NS9mcmFnOjc5Nzk3NTc1ZWFmNzQ0ZjJhZDA2NDY1YjVmMmNjMGY4L3RleHRyZWdpb246Nzk3OTc1NzVlYWY3NDRmMmFkMDY0NjViNWYyY2MwZjhfOTU_bb153880-dbf7-45e9-bb0e-1bed303fd506"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="if721328002364681bee1ba0655718256_I20230207"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81NS9mcmFnOjc5Nzk3NTc1ZWFmNzQ0ZjJhZDA2NDY1YjVmMmNjMGY4L3RleHRyZWdpb246Nzk3OTc1NzVlYWY3NDRmMmFkMDY0NjViNWYyY2MwZjhfMjgy_72af1345-b697-473b-af13-62971201e841"
      unitRef="usd">6300000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib5ac5ca2e988435eaad69a43bc5b154f_D20230101-20230207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81NS9mcmFnOjc5Nzk3NTc1ZWFmNzQ0ZjJhZDA2NDY1YjVmMmNjMGY4L3RleHRyZWdpb246Nzk3OTc1NzVlYWY3NDRmMmFkMDY0NjViNWYyY2MwZjhfMzQ3_20be111c-cf29-449f-a57f-0483ac0f83eb"
      unitRef="shares">1200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia7ef6fce92814d58987c014afa0ebf0d_D20230101-20230207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhMTBjYWFiNmY1MDQ3ZTFhMDJmMDM2NmJkYjkwZDdhL3NlYzo3YTEwY2FhYjZmNTA0N2UxYTAyZjAzNjZiZGI5MGQ3YV81NS9mcmFnOjc5Nzk3NTc1ZWFmNzQ0ZjJhZDA2NDY1YjVmMmNjMGY4L3RleHRyZWdpb246Nzk3OTc1NzVlYWY3NDRmMmFkMDY0NjViNWYyY2MwZjhfNTQ5NzU1ODE4NDI5_0d11e129-e307-42d8-8917-569e86904692"
      unitRef="shares">6000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>42
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MK!3%/1 88#^(EV2VC>8RM*(?-%$S*U<3KHE5KHGAOF:?3#)Y]E8\7HI:CWA
MZ&$TNQU9UZ%XX*F$E4EB1YFD<::46<D4RY<\E3"A9-:]EP.*GZP[-F,\ZE3.
MRARQH\S1?0S+[6*7SBQ)^1[<RHDKUG$VX8)8Y8+842[(+-G U8,G6$IE'8L.
MZ(P\3X $"/B%F)6U"0_$*@_$CO) LXB'(;G)4O@ZM;=87*=V[8W'G<I761]V
ME/691$(M39=\"PJY%8\2'MN3B@O6@S;A?%CE?!AN7/:)7 E()(:'R]3C->&
M6.6 &&Y>]F/L%]/[+-_;)A\R#7XV-K.GE?@;>9M=/11JO5S-G*6LAXPZ@RZ[
M@/7LVL98N2!VU%;1&,92!7;O/O;%,_E5V--X<,>(.EV'NHZ5H0FGPRJGPW"C
MLI\H[X+4V-I/ EP:MK]Y0*[==MRV:[7M>.2)H&YE?5S<L92;FR])[^"A=80]
M(/;UN<?N7*$)\^-6YL?%K<IKQMU^=3TE+O?1SMB$\7$KX^/B-F4$@'X!&7+K
M&'- H'94Q>/^+UCGQ7&AF?#R4]24>&9CLC@Y+)^6)[6C_'RR4[U>'/.^YV:^
M3$DH%A#JG%_ @*>*D]/B1LLD/WR<2ZUEE%^N!/>%,B_ ]PLI]?[&_$!Y?CW\
M#U!+ P04    " !&BT=6,+Y^&Z\%   Y%P  &    'AL+W=O<FMS:&5E=',O
M<VAE970R+GAM;*U8;6_;. S^*T*NN!<@:R3Y+>[2 %N*X?9AAV+=[CZKMI((
MLRW/DI/V?OU1CF<[MNQTN'YI;8>D'E(B'U*KHRR^J3WG&CVE2:9N9WNM\YO%
M0D5[GC)U+7.>P2];6:1,PVNQ6ZB\X"RNE-)D03'V%RD3V6R]JK[=%^N5+'4B
M,GY?(%6F*2N>W_-$'F]G9/;CPV>QVVOS8;%>Y6S''[C^FM\7\+9HK,0BY9D2
M,D,%W][.WI&;#0V,0B7QM^!'U7E&QI5'*;^9EX_Q[0P;1#SAD38F&/P[\ U/
M$F,)<'ROC<Z:-8UB]_F']0^5\^#,(U-\(Y-_1*SWM[/E#,5\R\I$?Y;'/WGM
MD&?L13)1U5]TK&7Q#$6ETC*ME0%!*K+3?_94!Z*C0-P1!5HKT)<J.+6"4SEZ
M0E:Y=<<T6Z\*>42%D09KYJ&*3:4-WHC,;..#+N!7 7IZO9%9#)O"8P1/2B8B
M9AI>WK.$91%'#\:P0F_0UX<[]/O5'^@*B0Q]V<M2L2Q6JX4&#,;2(JK7>W]:
MCXZL=\>C:^20.:*84HOZ9EK]$RO&U!?@>>,^;=RGE3UGS/VR*'BF$5,*_+RQ
M^7,RX-H-F"R[43F+^.T,TDCQXL!GZU]_(3Y^:_/NE8R=^>HTOCI3UM<;IO8(
M=@U%YH%_+\6!)>"\=1=/IOS*E"D%AS7!U*7+U>+0]<<B1@A>XD;L#*G;('4G
MD;Z+(ED",*@3$0>4CPF?HX0KA5@"=:<ZF5#!4"S+1[TM$R@&M8+<HBL75UY>
M.>$<#*B<5Y4B>;:Y><+A=?&'KMMSTB9$'+N+7N.B-^GBQ^P H9>%X":[MB(3
MD,,QVDEISRIO@(%2%],>TJ&40UW/LT/U&ZC^)-3[@N=,Q(@_Y:92J"JZ4N]Y
M 06JFSXVW/X D><[00_V4,A=^KX==="@#EZ$6F213#G2[(E; 0;#S?5Q_Y@/
MA?PEL>-;-OB6D_B^2,V2%P1P.<3GN)B$/806,0^'X<C6APW(<+(\_B6SZ'*%
M#%^S0KZ2L3-W"6[9$%\X-= @%?JY.N.F1.;0LN@YRKBV<AT>IJ4'9;*W.38Q
MU_5=^^:0#G>3"T5$LVPGH#QV<G+\*-76SI)QZ>,^V*%45^@<:LNS9)+:ZN.>
M]<^3%28=5C$@E4%0AV+4@W(W@K1E23)-DR>D$_ <2\7P""5]?!:YP'<ZF7L.
ML"5'XKZH9TD$>Q2)T$ AUK0DDR3[LWGY6M;.G6[IDDSS9=,2Y.S9] -6ARTD
MZ3JDSS8VL<##8T>\I4DRS9, L2CY)$]VMLSJP) (_<#KMR,6*<\/@Q'X+5^2
M:<(\)Z1+2(>,Z! <#'+ (@89,(:UY4XR39YW?,L!9VQH_2+4(36ZOM<'.A0*
MG9$.A+3L22;9J@[I)7RA)91>9_$:H47,)<Y(&TI;QJ/3C+>1:2JT8;G3@8UD
MID6VXUDT@G?:GKT0(.LL]/\-G?O<\B8EDQ7T8<\*OI=)S OU6T7S^MD^^TWR
M[T\/?Z]D[=SKSJ@[3<'0$==9H[2,OLW1U37&! IJ@6 0+&'$\N888Z1,=. P
ME'H/\\F_/'Z+'',L#M 85;U&+2"4,N6NJG*E5M"*Q'!PT%%H&#/AU$-88U;=
MU>35RMR,;=6 AJ#'.EFQ!GU([/UN=U+D/#PM[],+XS$D F =BXV+QX)#R1P'
M014'BN=A$$X'Z/)02H>=PZ"[F)8Y#T';6= +<W<<"[-A4+3,[/1&9"ABN8 B
M9H5IF8M]W^W3K4T,Y$;HEK8= 9WN"#YSS> 3\"TK,HBKO5@-N1X6#P<#GDW.
MP6XX0@&T;0KH=%-PH@!E*3A6N$-JAQ+O+?MT99-S*5F.P6V; /J2)J##6-7I
M?3'\8'@=9&N-;7*VUGC1N=<TE\J?6+$3F4()WX(BO@X@ ,7IGO;THF5>774^
M2JUE6CWN.0/81@!^WTJI?[R8V]/FMGS]'U!+ P04    " !&BT=6:1&.QEH#
M  #;"P  &    'AL+W=O<FMS:&5E=',O<VAE970S+GAM;*V6WV_;-A#'_Q5"
M*X8$R")*_A5GMH#$0=$]%##J=GL8]D!+9XL(1:HD97?[ZW>4%%5R9#ON]F*3
MXMU7GSOQR)OME7XV*8 EWS(AS=Q+K<WO?=_$*63,W*H<)*YLE,Z8Q:G>^B;7
MP)+2*1-^2.G8SQB77C0KGRUU-%.%%5S"4A-39!G3?S^"4/NY%W@O#S[Q;6K=
M S^:Y6P+*[!?\J7&F=^H)#P#:;B21,-F[CT$]XL@= ZEQ>\<]J8U)BZ4M5+/
M;O);,O>H(P(!L742#/]VL  AG!)R?*U%O>:=SK$]?E%_7P:/P:R9@842?_#$
MIG/OSB,);%@A[">U_P!U0".G%RMARE^RKVVI1^+"6)75SDB0<5G]LV]U(EH.
MP?"(0U@[A&]U&-0.@S+0BJP,ZXE9%LVTVA/MK%'-#<K<E-X8#9?N,ZZLQE6.
M?C9:*)G@1X&$X,@HP1-F<?+(!),QD)43-N1JR31(FX+E,1/7Y!?R9?5$KMY=
M$Y/BBB%<DL^I*@R3B;DA[SKSF6\1U+W.CVNHQPHJ/ +U!/$M&00W)*1AV..^
M..W^D>EC[CZFI\E1V.0H+/4&1_16%G."6]<2M2'ON<3,<";(4AE>;L4_'];&
M:MR0?_6%6FD/^[5=E=Z;G,4P][ ,#>@=>-'//P5C^FM?X/^36"<-@R8-@U/J
MT8/ FB]W!9X>)%'%VFX*@848JT+:WL]<"8Y+07>@[*(AG?F[=D2O30;3QJ3#
M.6PXAR<YEW@0@-:XB[%ZXN<;DC--=DP40*YP7R9*"*8-R4%7N_>ZC[QZQ:2%
M16\I#0[@SUEU^$<-_^@R_KK&6&%3I?D_N.#BJ)[VPE?ZHQ;6B-+#Q)\QZJ"/
M&_3Q#Z%S8XKSV.-71(,#YE,6'>!) SSY(6"\\(S%PXO+[3GJR5GJ4Q8=ZKN&
M^NXR:L&_%N[D=J=17BZ"J].W;_>[UX5Z$,0IBTX0TR:(Z<D@%BK+$/<_U.CT
M335ZSJH#']#O]R:] /_B$JW51YVC\761GC7KTK=N_>!R^K=5::W<1@H#.ID<
MDO>8T>GDR-D>?+^+@Y-W7#_Y!>5:RY_%[S'KP?=;G9=K>['UV')IB( -^M';
M"0KHJI.L)E;E93.V5A9;NW*88O<-VAG@^D8I^S)Q_5W3ST?_ E!+ P04
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M=(%[:DB^KV\H'[B4/*\?=XPFK*P ZO\;SN6Y47707J,O_@%02P,$%     @
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M8_4F2LF?H?]JT0N.,6N?[COHZT)F"RQK?#))&?\W_>I$,6YI$BM!K=^3HB$
MSJ..F*F:3IM+=#TF Y"W&S68 C"@ZZ$@6$\=KRJKYWRL6AJ.7%/YV ;)$_,,
M@;#EN_9D*YRBC?I\>?X8[BXO V&@:SN_N!V!&571BDQN-N49,5A?@#&&!Y:A
MAXWT7&%Y]%0+#&G8YN-6]L;J.?14O>6)D$UN?'PAYUUVDCEB= AR!FPYN'OJ
M&U8^=E4NN'88-+/D#\T F2<\GE>4U7)XT>@U/U6ZP2SY49P3J<_#*H*F?LR
MD(3TD"=@_G+HZI1$>.S&YS%:W] GWSC!.UR;+O7[/N0F6]_?8.%2?F60/+J4
M/\6'I\,/&1?Y^WVS//\* C%9PB%\YBRP=3I^],-(A?S+0KY)OI&O^;E/F!GE
MD@= "KP [WDZZ&_8P/#SSOD_4$L#!!0    ( $:+1U;4!AQ3HP<  ($3   8
M    >&PO=V]R:W-H965T<R]S:&5E=#<N>&ULO5A=C]NV$OTK S<M-H!B2[)L
MR^GN LGV7MP\M TV:>Y#T0=:HBUV95$EJ75\?WW/D)(_-IMM;M$66*PEDC-S
MYLQP.-3E3IL[6TGIZ..V;NS5J'*N?3F9V**26V''NI4-9M;:;(7#J]E,;&ND
M*+W0MIZD<3R?;(5J1M>7?NRMN;[4G:M5(]\:LMUV*\S^M:SU[FJ4C(:!6[6I
M' ],KB];L9'OI/NI?6OP-CEH*=56-E;IAHQ<7XU>)2]?9[S>+_B@Y,Z>/!-[
MLM+ZCE_>E%>CF ')6A:.-0C\W,L;6=>L"#!^ZW6.#B99\/1YT/YO[SM\60DK
M;W3]7U6ZZFJ4CZB4:]'5[E;O_B-[?V:LK]"U]?]I%]9FBQ$5G75ZVPL#P58U
MX5=\['DX$<CCSPBDO4#J<0=#'N5WPHGK2Z-W9'@UM/&#=]5+ YQJ."COG,&L
M@IR[OI7WLNDDW<I";QK%3%U.'!3S]*3HE;P.2M+/*%G2][IQE:5_-:4LS^4G
M '1 E0ZH7J=/*OQ.%F.:)A&E<9H^H6]Z\'+J]4W_P,NUT5NZ 5:#; #3KJ(;
MS[$T]/.KE?7COSQ&0-"?/:Z?=\Y+VXI"7HVP-:PT]W)T_<U7R3S^]@GTV0%]
M]I3V+XW1_ZWD?25!QK85S9XVLI%&.&FQT\+"U9ZP>:!F0RV*PU:6JA!^)[5&
MEUWA+(FF]'.V:]M:09:K0+TGIZ'%"57W&2R-'=.--!AJS@7T>BV-+ E:W1'-
M-U_E:;+XUM).KJQRDH215!K=DJU4VV(]+)RH/G6DT"@8)89).>!?>[VM44VA
M6E&3"H:$,:+92%071RM9B,[*4P"LQ1EL+3]H6UFHM8+9C=8EUJ,62J@GA7GH
ML?#!!%"\?  VIH'SHL\XZY^8!-T E#2^J#:%)+VJU<:S&]&N4D7%NDM9HV*9
M/5CJO?"\CX\Y6S Q' 4F5!L7I.!628UV#&B%>83%2:/@O>$:=<#9HPK\>4=$
MT0=8 1-TB?)7F((VX;Q("46,QHH:FTD;8JX$Q[(0*PSQ.! H6^BNZ1-$-"2M
M4]M>M'>"$Z0SC1W<94>XNOI4J!3\ P8@;H4#=EY7Z1WH-, !8/AC!X=@,T*Z
MDWOZM2LW'-0C]XHSVJ?\_[!J5\EF".XA=O9AY 9W6ZV0'YPR.(=X,&#U.8%$
M]-ES'AO21=&%E(3A4T0A-/ %19SAVH.:UF\Q-C608:2O(LS@IS"\"Z>Y6D&7
MH%[B&.)6[-EN!"F'T/"J)Y(U\K$Z(\'KM3BM99@PRMZ%D!JY$Z;DW4MZA[K!
M7HSIQ\ZM$/;RZ!2OK?#/%Y&U1&J$?,59[!,D.([DV=/QF.:4X>W5%'6'TX3]
M#FG54_;G-_H&NZGAU7# MBR^4K5R>Y_)?4DR9,^@<"XC5?E5<_;QU@#L,;T;
MG"RT=9XH72C!>\4?*WH@8VU\8T!B[7C#]JGG=8E#UCP2''&2C5],6K\$&OSF
MM+3NZK6J:^]^#_01?GEFV-8/RBG\%YN-D1M_-H1 ]-2N=8V6CN&X'<HQ%FRP
M::5]21?)<U"L3<ET>I%[[%=T:"=#(>$NTN=0QSN<3X5^Z3B42?!22)X[Q75B
MU%<<.-?QL7U$AW/K7ABE.U3;&F%!Y0[G%H"]KXR49\T*H=60VQ6,<+LQ%(V+
M-^PB5 "C?>Z[$/J:?Q+\/*,/T._+]M?'Q]LS?Y_1;!I-DSDMX_'<R\QF43I;
MTC(9Q_[](HF6V?0YO9B.9QCXX9P=FD6S64;+<8:Y693-<CRSX').R3C'PWOM
MD.5'VF AC_)%3$D<]R;F<;1(%B<#L)EG"V^3!]Z<$P\-293$2\KGWH)_G\8S
MRC,/D>67<TC''M7-(S&B1;28)Y1,Q\S7,LJ2E)*9EX;M^0QY\2)9^/>_ /\/
MJ*3_3#"3Q3R:YAE'<^&%DCR+YO&"\N4 +8_2E,.9/1K.)(_B^0(QG++I-,KC
MG)*0"A=9M,B8F#3^3&"3988,2$Z(2.,%N)V=49-&RWD&-7-OXY/8)O-%M)RE
M'-PLN+"8@MXIY=,^VA<S#IYG=_JY^*;S*%LN.<"<U5-HB!'AN0_WQ2)*8Z8@
M3;R)O\:1L]ZNXEH>3B/<O%1H8[ER"5]>#A43@Z]0J6OJKQ 15]2^XG'/PNW7
MKM*^[G(?X4/%O4=H,'".",LM@#)N_\*JC[3U619*T%#9N'X]*&HDMJ'QX?++
M>IPO.'XE)VM00_+39 THAS/X[S*1\#V:#XW019UQ=D)HX'E,/S7EP =N!;ZD
M/D5[]"3N'1BF9S..ZA95>SBVGF5(EGX@\@>S]!?U>A\]</%IS_X6M$F^? @W
MR9'L?X#W"P(QI@](KD[4N"[AWZ.WGS[>AM-1E7RPH14I<>\H?/<U),NP.SH;
MU*'=E0 4NJ5"V HMC4,+&+K0QI_6OOMC4E>BN>/3M!1[OJ,=]??6T:VJ+5KG
MT$P5?5\?3/@#>"5J+ID\5@LF@G4_TDA4@N\DQZO(</O@SDGR#J1:B;X?.^@4
MOL?\9*/PZN^%0:<\C(P?NV9/3CZ+(. ;__&'[V#P(7PA.8P>OB^]"I]5CLO#
MQRE8VZC&4BW7$,4I,!N%3GMX<;KU'UE6VB&[_&,E!?*)%V!^K;4;7MC X:O;
M]>]02P,$%     @ 1HM'5@@5K!74!   ]PP  !@   !X;"]W;W)K<VAE971S
M+W-H965T."YX;6S-5]MNVS@0_96!NB@20&M+LIV[#>328OO0(&C:[<-B'VB)
MMHA0I):D[.3O=X949"5VO&V?%C!,B9PY<SLSIB_6VCS8DG,'CY54=AJ5SM5G
MPZ'-2UXQ.] U5WBRT*9B#E_-<FAKPUGAE2HYS)+D:%@QH:+9A=^[,[,+W3@I
M%+\S8)NJ8N;IBDN]GD9I]+SQ12Q+1QO#V47-EOR>NV_UG<&W88=2B(HK*[0"
MPQ?3Z#(]NQJ3O!?X4_"U[3T#13+7^H%>/A73*"&'N.2Y(P2&RXI?<RD)"-WX
MI\6,.I.DV']^1O_H8\=8YLSR:RV_B\*5T^@D@H(O6"/=%[W^@[?Q3 @OU]+Z
M;U@'V5$20=Y8IZM6&3VHA HK>VSST%,X>4LA:Q4R[W<PY+V\88[-+HQ>@R%I
M1*,''ZK71N>$HJ+<.X.G O7<[!;K_DGENN)PQPW<E\SPBZ%#9#H?YBW*54#)
MWD YA<]:N=+"!U7PXJ7^$#WJW,J>W;K*]@+>\'P HS2&+,FR/7BC+LR1QQN]
M@?>!&274TFZ"A+\NY]899,7?N^(-<./=<-0I9[9F.9]&V J6FQ6/9N_?I4?)
M^1YGQYVSXWWH/UR3GT?!#>R#7)N"J9PCU5P)KN10&[T2U&<6] (N4:)1#O,%
M]XZI@IG"PK4NQ$+DS/?2P?MW)UF6G%_>7_NG]/P0ONI:Y) =)=TI[,AZ)XZM
MA.(*G13!R1IEK)<1%G"G;APO8/X$A5B)@ISI";,5$Y+-)0>G2;A"I[QRJ67!
MC24]"FSMNQ)QV(H;'#*@FFJ.AC#*OA:&W3A+L9*=HC&T^,1P(W0Q@!LAO3NO
M_.UCT+YL"L0BQ8(4<-X 7RQP )'!6CN.6642AQDR3^0$B V>/P :]EI!V!?!
M6^\T<JTP #\)"0DG%S>&U+WW,>1,YHUDA-C89^<=3FG;F*?62,5=2;%\0RA+
MDCO="):<H-R^MH.5L4TH"N%?8Y&8>D(<WP3*^5VMY--6^ A$<QAUA=KD!U^W
M"K1=CP%\186%EO@#0J$A/1@"HJ.YD"(0LDT85A=1G$8"4"P%5QIG9MAH10+O
M_.GNFH9B!@)Z<(NV38\-%MIP4?? AZ,;BX!8!OZ8\]IY^0T4JZB;[.$9QF$X
M?S$J 0<=]XRD87>++?SRF,8??:6]I]N-OP=26WL(!UW<:*1W_!L<I*>'N(SC
M;'*,ZR0>C2:XII,X&8U#2UHXZ.4) ;[_2L\T-M0VI+>7/?0Y'B7D?YPE)WY!
M5W!)CR;$H!X>L<OW=%/C)I&4D-'L%E%IBJ39.:1I"L<9I*?)7JC]W;-!2]I/
MFY?GF)Z)LCNJ47;JEU%8,*KM KV>%6=PY?.$!4H&24(E2@986K\<^>5XT@V=
M?5)C^-B2TWER$;$5T:@*-.+;+/-,(CEB$[Z.1_%1,FYW)G&6GG8%[BK^N@(Q
M[=3<7ZGD4XQMC$1']M, +&!A=.5]>M%%B/9&R_53$P/S$U28,%!]U=:ZD064
M2$C\0F+BKQC.Q=^WAJSZ$0N#5RG;GZD8CM.?)R@E$XGT*VS\[U3^?S*YZ[(S
M[%U&<2HM_96;?M%Q"(9[:;?;W>HOPV5V(Q[^$GQF9BF0.9(O4)5Z(@(3KMGA
MQ>G:7VWGVN%%V3^6^,^$&Q+ \X7&7]#VA0QT_W5F_P)02P,$%     @ 1HM'
M5KZ<MUU-!@  ^Q$  !@   !X;"]W;W)K<VAE971S+W-H965T.2YX;6R]6%EO
MVT80_BL#I<@!R!)U^8@/0#Z"ND!J(W;:AZ(/*W(D;DSN*KM+R^JO[\PN25&'
MC31I^V+SF)WY9N:;@SI9:/-@4T0'3WFF[&DK=6[^OMNU<8JYL!T]1T5OIMKD
MPM&MF77MW*!(_*$\Z_:C:+^;"ZE:9R?^V:TY.]&%RZ3"6P.VR'-AEN>8Z<5I
MJ]>J'GR2L]3Q@^[9R5S,\ [=Y_FMH;MNK261.2HKM0*#T]/6N/?^?,CR7N W
MB0O;N ;V9*+U ]]<)Z>MB %AAK%C#8+^/>(%9ADK(AA?2YVMVB0?;%Y7VC]X
MW\F7B;!XH;/?9>+2T]9A"Q*<BB)SG_3B9RS]&;&^6&?6_X5%D!T.6A 7UNF\
M/$P(<JG"?_%4QJ%QX#!ZYD"_/-#WN(,AC_)2.'%V8O0"#$N3-K[PKOK3!$XJ
M3LJ=,_16TCEW-HYC72@GU0PHPW#G=/RP=TYN)G"A<TJ]%1R]DZXC8WRD&Y>*
MSX/B_C.*C^"C5BZU<*423-;/=PEDC;1?(3WOOZCP$N,.#'IMZ$?]_@OZ!K7G
M Z]O\(R^NU08+%V]%4LBFH.Q,4+-T%__,9Y89X@U?^YR/N@>[M;-E?3>SD6,
MIRTJ%8OF$5MGKU_U]J/C%Y /:^3#E[3_2,[^%<5PGZ)_(-22"C/6)K$0-P7P
MB:\1A+4ZEL*1@H5T*0E32&7,]Y:5@^2Z9 5"Q1ADQG<7<*_G,H:#WB&\??WJ
ML-^/CL&G"];3Y=_UCM_!V_'=9^)%;W\O.GK76<.7B@2.1D?MT?"0,>:$SK(J
M"]+:@I05Q$\#CHZP KC*YYE>(L+5UT*ZY;KCGU;X?7#@-A.JQKA^GE]5 -L@
M5 +]8=0^&(V^ <8(;@IG98)P*2G CI+Q77!&J_--." <4#EA/B&354D1QBRK
M0.DI+%(9I[! BGH)T1:3+Z0,G 91IY)QD'KBRQ2E*TAZCD;JA%PA*YF86U)G
MJ#5-LB60+'LXE<:Z-EBBCDI";%PJ34)7BGJTL<+( (*E$^(/7\^H-ETE34J$
M-/ HL@)7:*6%"3)]1:Z-DW\1:/U8AE4KA&L%XV)&794])K]=@RBEDT=1.XJB
M-::&D+#=42^\)1?]/&32;DM2?!J*.>B]@V,+%U<W[5V$][)7-[4<>@9Y@HN9
M0=^-VL_2E/,:&/\R**Z>B:\>/PM3B8\^4!.KLX("'.HQ+4R2D70-S*6$8&^)
MPE1YG1J=^U<^'SX[';@.J2IMY;Q-\/V&]CE!PM*&#_Z2#!'IM")N/!+DBB";
M;%CNY$('QIXD.ZBL.-OEF69<-KQD<N=(BM:(T=])C-[@!6(,_C$MWEA0M+-<
M?'B!%!]NWOPO=/"I<HY6.&^&XM8\'!OI*/4"\&M!+8)RYE<=.CI!MT D\,D7
M"AT]N#J_OK\<^X@8?$158,!2&N6A@L2]DCH^]Q-&EZ&'XJG5;"R515_$(I 1
MW@[>09.0E0/;;%DQ-+0-&21C,K:+'%M1:C=;WC<&:7WZE-P9C:)&9]V<@D17
M] I7391,D\D8#=LK*8!T^J6T0U(8+FE^2W$SA >0EZ_M ND K;1-0?N<9!A<
M6\V2I_Y,^0;[4Z]S2)MIEODE6_D'P^I!FYV=HU^]LV6;G=RY*! %_)90QGF'
M<P''YD1;.:)HEX$\K)S?[\NH$ZW[,E@]^.]]&>\8RS5H5D9%NQ"6(AQU]C=B
M/EP%G9$5JN'6&LQ84Y?;P$CM<H_[+R;;*YI8"-KO-IVOYRU['9>J?"W75NO)
MJ_#)5>/WEX+*>:O'UK//>_Q#*UCS_-K.,\%8Y @XG08OH)A7G6,^-YHVB;HG
ML,;)<B= 7\6ISJ@,;2CU;9,@"I=J0T&PT./!X(?#JO[7IT"U#89@/PJ9T:J$
MOE=R]^#N$@S5NPZ?W]ZD+7V,4B73-R)WYF9KIZ_M!VHP:^=+<V%,5W;*87[?
MT,\AK_KLKBUOP^SNH*TED&YRZ1QB:,FV)([20"/9\MJHH!<:/ O0<]KE,#QW
M-&SXC>4!Z,4U5\5"4MDQ.^54KJ/8MMJ!7W65"_XVF/  V[&#;R=U]Z[1V?5!
MUVU\D.=H9OYG!TXU?5V%;_/Z:?W+QCA\T*_$P\\B'X69264I.%,Z&G4.1BTP
MX:>&<./TW'_>3[1S.O>7*0IRA 7H_51K5]VP@?KWGK._ 5!+ P04    " !&
MBT=6$T!EP$L$  ";"0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6R-
M5FUOVS80_BL'=2A:P+%LV>VRQ#:0EP4ML&!!TW8?AGV@Q+/%AB(5DK+C_?K=
M4;*C($ZZ+S9)W3WWW"LYVUAWYTO$  ^5-GZ>E"'4)VGJBQ(KX8>V1D-?EM95
M(M#6K5)?.Q0R*E4ZS4:CCVDEE$D6LWAVXQ8SVP2M#-XX\$U5";<]1VTW\V2<
M[ Z^J%49^"!=S&JQPEL,W^H;1[MTCR)5A<8K:\#A<IZ<C4_.IRP?!;XKW/C>
M&MB3W-H[WGR6\V3$A%!C$1A!T-\:+U!K!B(:]QUFLC?)BOWU#OTJ^DZ^Y,+C
MA=5_*1G*>7*<@,2E:'3X8C>?L//G ^,55OOX"YM6=C)-H&A\L%6G3 PJ9=I_
M\=#%H:=P/'I!(>L4LLB[-1197HH@%C-G-^!8FM!X$5V-VD1.&4[*;7#T59%>
M6%P)Y>"[T W.TD!X?)H6G>YYJYN]H/L;7%L32@^_&XGRJ7Y*//9DLAV9\^Q5
MP$LLAC 9#R ;9=DK>).]<Y.(-_FI<W"I?*&M;QQZ^/LL]\%1/?QSR.<6<GH8
MDGODQ->BP'E"3>#1K3%9O'TS_C@Z?87P=$]X^AKZ3[+Q?W7A:XEP8:M:F"T4
MPCE%3A?"ER",;!=XWZBUT&B"!Q%@R;KKJ*L,A*A..34>):^\U4J*0)MSH84I
M$&ZYX/P0KGJ*GKN!2$D0!&H 'U2 VJD"!]2^,5HF*+.*^**RC0FT).L;VV@)
M.9)4@=2C$H(%:ES-*,)[&DW602U4_$"9,WZ)#@1H)7*E5=@R:Y*U3J+3VU9$
MM&V?8]@@&NH9=T= M7!!%8I"P_3//$VCHAP\"0"1[Z2/N-\E5"BX<&@4=81]
MN6,L,:"KHM.MK(V,FZIFX[X5/V"Z\[GQ,> <) Y,W]V>=\3S]@*^VEH5<)R-
MX-W;-\=9-CJ%7LJO'SEZB-_'I^\!?1"Y5C0>V*E0.L2CH"AV/7]+V@M7E-L!
M;$I5E,S&.A74O^ACJI2I&P)MV+VN.EA3Q/!6&$HKK;8K+C)ENF"Q-X\V3N /
M7*.&,1S!GSDW#;': \<8T2SF00WWC>4ZBV7CX5UCA/Q!4Q#E>Z ;")3D&BJ$
M;@/E.5*[.'4$VCG?!9URW)K.R/1G4^A&(EARP3VQ+ARE4E'Y!:H>-F,>=WV^
MT?D6N=8T!';H$T+_9NPSU]J ,KIOZMHZ=BW?$N,02(@,&;NKCD@[)IN[]U!^
M0&AO*5#4NCS%N,,H%E3\@4$>5$49BP2YJNP2GM/A]J=B?2;9'*2.AY-)U1B
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M+\8:#,1FX H*T4L#F4CI<OH/GJ4?Y&:'$PVOCP?Y;]>@%\O9%^C^X/S6<=H
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M5"#Y8NJ<D].+P,3;@#]ROE(;8S!*YD+<F<F7=.KXAA O>*(- L/;/;_D16&
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MU(OL,H,*UZ+3X9/M_\!]/!?,)ZWV\0M]VCLK,I"=#[;9@TE!HTSZB\=]'HX
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MA<FQ ,XQ;<-AP0:ZW[_Y/U!+ P04    " !&BT=6VAYL-=<%  #L#P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6RM5VMOVS84_2N$!W0;X,:.\^K:
MQ$"2-E@P%,N2M?LP[ ,M75EL)5(EJ3CY]SOW4I;=UO8:=!\22WR<^^"YYXJG
M"^<_AI(HJH>ZLN%L4,;8O!R-0E92K<.>:\ABIG"^UA&O?CX*C2>=RZ:Z&DW&
MX^-1K8T=3$]E[,9/3UT;*V/IQJO0UK7VCQ=4N<798'^P'+@U\S+RP&AZVN@Y
MW5%\U]QXO(UZE-S49(-Q5GDJS@;G^R\O3GB]+'AO:!'6GA5',G/N([]<YV>#
M,3M$%661$31^[NF2JHJ!X,:G#G/0F^2-Z\]+]"N)';',=*!+5_UE\EB>#5X,
M5$Z%;JMXZQ:_4A?/$>-EK@KR7RW2VJ/#@<K:$%W=;88'M;'I5S]T>5C;\&*\
M9<.DVS 1OY,A\?*UCGIZZMU">5X--'Z04&4WG#.6#^4N>LP:[(O3NW08RA7J
MSLRM*4RF;53G6>9:&XV=JQM7F<Q04#\MGWX^'4689H!1UIFY2&8F6\S\HMXZ
M&\N@WMB<\L_WC^!R[_=DZ??%9"?@:\KVU,'^4$W&D\D.O(,^#P>"=[ %;U/
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M7L1#CZBVVVHG1JY=A[.0!OLE-\RQ005E-^#[I91F.[$']"WO[%]02P,$%
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M2%Z?7ZPO2':L#NA]S0C)DNKC 8=TB5 :T.\?LXP\7Y0!VE.DZ_\ 4$L#!!0
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M!O+YBE)QO%$!JO]<3/X%4$L#!!0    ( $:+1U8<6_48+@0  (@1   9
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M- #>;SA7IX)NH/GXLOH/4$L#!!0    ( $:+1U99QRI'B@,  $P3   9
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MJL[<;UE99LOFYKV*%BJO=ZB^?YMEY>L7]01/6?Z]^3$O_@]02P,$%     @
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M,EK29/R#/FUFY;(JZ!R?5X1<B1+2XCKW&KG#[EU(F[DTSR!A/N^]H9GVT/T
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ME,'@% VHNCO6@9&E:S K:;!=N6&./Q10=@'.KZ4TN\!NT/ZBXM]02P,$%
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M7 )?FEXH4,)65-;'LUUMV^V5Z3('ZQ-W-'4[UF/5GNMN^D>^[NVWF"\)%:B
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MG&?C9CL;TWJ8, <3YF+"/$R8CPD+D& UZPTJZPU:%[V+Q8+#@DI0N4T]#H?
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M)YH#JZ E%RL?[D%@JH32D;'59JUT(5+_\G#7]Z 0&YV22Z5=;I_!?T^:X7O
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M>TJ2),O""&!A!TF"(? TX@CF #Q@2)*X]^#>^RA>OZ?BS?_.1K\!4$L#!!0
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M%2AD%2AD':&0=?2?9'TW9OG7/YK:-6MDK0_^K/N;-_L$4$L! A0#%     @
M1HM'5@=!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " !&BT=6Y9KP&^T    K @  $0
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M965T-"YX;6Q02P$"% ,4    " !&BT=613-(-0$&  "Y&0  &
M    @($%'@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @
M1HM'5C9+K]LX!P  ZA$  !@              ("!/"0  'AL+W=O<FMS:&5E
M=',O<VAE970V+GAM;%!+ 0(4 Q0    ( $:+1U;4!AQ3HP<  ($3   8
M          " @:HK  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M    " !&BT=6"!6L%=0$  #W#   &               @(&#,P  >&PO=V]R
M:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ 1HM'5KZ<MUU-!@  ^Q$
M !@              ("!C3@  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+
M 0(4 Q0    ( $:+1U830&7 2P0  )L)   9              " @1 _  !X
M;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ 1HM'5O\890[M
M!@  ,!$  !D              ("!DD,  'AL+W=O<FMS:&5E=',O<VAE970Q
M,2YX;6Q02P$"% ,4    " !&BT=6YM\L)P,$  #P"P  &0
M@(&V2@  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( $:+
M1U923Y%&.0,  ,L(   9              " @?!.  !X;"]W;W)K<VAE971S
M+W-H965T,3,N>&UL4$L! A0#%     @ 1HM'5FTZW=-> P  G@<  !D
M         ("!8%(  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
M    " !&BT=671%W3FL$   *"@  &0              @('U50  >&PO=V]R
M:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( $:+1U;:'FPUUP4  .P/
M   9              " @9=:  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL
M4$L! A0#%     @ 1HM'5@)MN]RN P  L @  !D              ("!I6
M 'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " !&BT=6I-G'
M:&X#  #8!P  &0              @(&*9   >&PO=V]R:W-H965T<R]S:&5E
M=#$X+GAM;%!+ 0(4 Q0    ( $:+1U9_=';WK@,  /X*   9
M  " @2]H  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @
M1HM'5EER&],>!@  42H  !D              ("!%&P  'AL+W=O<FMS:&5E
M=',O<VAE970R,"YX;6Q02P$"% ,4    " !&BT=6#/]01A8$  #%&   &0
M            @(%I<@  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4
M Q0    ( $:+1U8<6_48+@0  (@1   9              " @;9V  !X;"]W
M;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ 1HM'5EG'*D>* P
M3!,  !D              ("!&WL  'AL+W=O<FMS:&5E=',O<VAE970R,RYX
M;6Q02P$"% ,4    " !&BT=6.:AZ/(8*  ! E0  &0              @('<
M?@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( $:+1U;3
M&WC=)0(   (%   9              " @9F)  !X;"]W;W)K<VAE971S+W-H
M965T,C4N>&UL4$L! A0#%     @ 1HM'5G19G <Q @  Q@0  !D
M     ("!]8L  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $:+1U:E"=(&1 4  *\K   9              "
M@96=  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ 1HM'
M5CFMD>DV P  2!,   T              ( !$*,  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " !&BT=6EXJ[',     3 @  "P              @ %QI@
M7W)E;',O+G)E;'-02P$"% ,4    " !&BT=6V$OCBB<#   X%0  #P
M        @ %:IP  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 1HM'5H]Z
MM&%= 0  )!,  !H              ( !KJH  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ 1HM'5N];R@F& 0  U1,  !,
M     ( !0ZP  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     "< )P"("@
&^JT

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>101</ContextCount>
  <ElementCount>144</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>28</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome</Role>
      <ShortName>Condensed Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Net Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Accounting for Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/AccountingforStockBasedCompensation</Role>
      <ShortName>Accounting for Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Changes in Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ChangesinShareholdersEquity</Role>
      <ShortName>Changes in Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Minority Interest Investment in Vetster</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster</Role>
      <ShortName>Minority Interest Investment in Vetster</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/RevenueRecognition</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/NetIncomePerShare</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Changes in Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ChangesinShareholdersEquityTables</Role>
      <ShortName>Changes in Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/ChangesinShareholdersEquity</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Revenue Recognition - Summary of Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue Recognition - Summary of Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Revenue Recognition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails</Role>
      <ShortName>Revenue Recognition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Net Income Per Share - Schedule of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails</Role>
      <ShortName>Net Income Per Share - Schedule of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Net Income Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails</Role>
      <ShortName>Net Income Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Accounting for Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails</Role>
      <ShortName>Accounting for Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/AccountingforStockBasedCompensation</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/FairValueDetails</Role>
      <ShortName>Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/FairValue</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/CommitmentsandContingencies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Changes in Shareholders' Equity - Schedule of Changes in Shareholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails</Role>
      <ShortName>Changes in Shareholders' Equity - Schedule of Changes in Shareholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Changes in Shareholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ChangesinShareholdersEquityNarrativeDetails</Role>
      <ShortName>Changes in Shareholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/IncomeTaxes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Minority Interest Investment in Vetster (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails</Role>
      <ShortName>Minority Interest Investment in Vetster (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="pets-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/SubsequentEvents</ParentRole>
      <Position>31</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: pets:RestrictionPeriod, us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 -  pets-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="pets-20221231.htm">pets-20221231.htm</File>
    <File>pets-20221231.xsd</File>
    <File>pets-20221231_cal.xml</File>
    <File>pets-20221231_def.xml</File>
    <File>pets-20221231_lab.xml</File>
    <File>pets-20221231_pre.xml</File>
    <File>pets-20221231xexx311.htm</File>
    <File>pets-20221231xexx312.htm</File>
    <File>pets-20221231xexx321.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="340">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>48
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pets-20221231.htm": {
   "axisCustom": 0,
   "axisStandard": 13,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 340,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 101,
   "dts": {
    "calculationLink": {
     "local": [
      "pets-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pets-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "pets-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pets-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pets-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pets-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 242,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 1,
    "http://www.1800petmeds.com/20221231": 1,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 7
   },
   "keyCustom": 10,
   "keyStandard": 134,
   "memberCustom": 15,
   "memberStandard": 12,
   "nsprefix": "pets",
   "nsuri": "http://www.1800petmeds.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.1800petmeds.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Fair Value",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.1800petmeds.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.1800petmeds.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Changes in Shareholders' Equity",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.1800petmeds.com/role/ChangesinShareholdersEquity",
     "shortName": "Changes in Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.1800petmeds.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Minority Interest Investment in Vetster",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster",
     "shortName": "Minority Interest Investment in Vetster",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.1800petmeds.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pets:BasisOfPresentationAndConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "16",
     "role": "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pets:BasisOfPresentationAndConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Revenue Recognition (Tables)",
     "menuCat": "Tables",
     "order": "17",
     "role": "http://www.1800petmeds.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Net Income Per Share (Tables)",
     "menuCat": "Tables",
     "order": "18",
     "role": "http://www.1800petmeds.com/role/NetIncomePerShareTables",
     "shortName": "Net Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Changes in Shareholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "19",
     "role": "http://www.1800petmeds.com/role/ChangesinShareholdersEquityTables",
     "shortName": "Changes in Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i137fc368100c4411981905d28135f59f_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i137fc368100c4411981905d28135f59f_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Revenue Recognition - Summary of Disaggregation of Revenue (Details)",
     "menuCat": "Details",
     "order": "20",
     "role": "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails",
     "shortName": "Revenue Recognition - Summary of Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231",
      "decimals": "3",
      "lang": "en-US",
      "name": "pets:RevenueFromContractWithCustomerPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Revenue Recognition - Narrative (Details)",
     "menuCat": "Details",
     "order": "21",
     "role": "http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails",
     "shortName": "Revenue Recognition - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i8877e07cd58945f6bbc7b58579686efe_D20211001-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Net Income Per Share - Schedule of Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "22",
     "role": "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails",
     "shortName": "Net Income Per Share - Schedule of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "iad23aff6e73f4936ae99c55a2a704298_D20221001-20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Net Income Per Share - Narrative (Details)",
     "menuCat": "Details",
     "order": "23",
     "role": "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails",
     "shortName": "Net Income Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "iad23aff6e73f4936ae99c55a2a704298_D20221001-20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i7d5cbb72af874387884242be4246de02_D20221001-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Accounting for Stock-Based Compensation (Details)",
     "menuCat": "Details",
     "order": "24",
     "role": "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails",
     "shortName": "Accounting for Stock-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i7d5cbb72af874387884242be4246de02_D20221001-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i137fc368100c4411981905d28135f59f_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Fair Value (Details)",
     "menuCat": "Details",
     "order": "25",
     "role": "http://www.1800petmeds.com/role/FairValueDetails",
     "shortName": "Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i137fc368100c4411981905d28135f59f_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i137fc368100c4411981905d28135f59f_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "iaf36910fa826464cac0a33af2dcec06b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Changes in Shareholders' Equity - Schedule of Changes in Shareholders' Equity (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails",
     "shortName": "Changes in Shareholders' Equity - Schedule of Changes in Shareholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i8c67a17e20334c189d487ee28cf75bf1_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Changes in Shareholders' Equity - Narrative (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.1800petmeds.com/role/ChangesinShareholdersEquityNarrativeDetails",
     "shortName": "Changes in Shareholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.1800petmeds.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i137fc368100c4411981905d28135f59f_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i137fc368100c4411981905d28135f59f_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "iab14d6c222714d4fa9eeef808f9de70c_D20220419-20220419",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pets:TermOfAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Minority Interest Investment in Vetster (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails",
     "shortName": "Minority Interest Investment in Vetster (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "iab14d6c222714d4fa9eeef808f9de70c_D20220419-20220419",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pets:TermOfAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.1800petmeds.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "iba0d1147b871412bb5ee913ee43a4458_D20230113-20230113",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Statements of Income",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome",
     "shortName": "Condensed Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "ica2e7bdebbdf4cb88b69811b7ed5d4f4_D20221001-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000006 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "6",
     "role": "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - Revenue Recognition",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.1800petmeds.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Net Income Per Share",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.1800petmeds.com/role/NetIncomePerShare",
     "shortName": "Net Income Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Accounting for Stock-Based Compensation",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.1800petmeds.com/role/AccountingforStockBasedCompensation",
     "shortName": "Accounting for Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20221231.htm",
      "contextRef": "i3fb89e4e031f4fb099ab84b56c148692_D20220401-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 28,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "pets_A2022EmployeePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Employee Plan",
        "label": "2022 Employee Plan [Member]",
        "terseLabel": "2022 Employee Plan"
       }
      }
     },
     "localname": "A2022EmployeePlanMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_AccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued expenses and other current liabilities",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_AccruedSeveranceCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Severance Costs",
        "label": "Accrued Severance Costs",
        "terseLabel": "Accrued severance costs"
       }
      }
     },
     "localname": "AccruedSeveranceCosts",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_BasisOfPresentationAndConsolidationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation and , used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Also consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements.",
        "label": "Basis Of Presentation and Consolidation [Policy Text Block]",
        "terseLabel": "Basis Of Presentation and Consolidation"
       }
      }
     },
     "localname": "BasisOfPresentationAndConsolidationPolicyTextBlock",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pets_ContactCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disaggregate of revenue in contact center sales.",
        "label": "Contact Center [Member]",
        "terseLabel": "Contact center sales"
       }
      }
     },
     "localname": "ContactCenterMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_EmployeeAndDirectorPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to information regarding employee and director plans.",
        "label": "Employee and Director Plans [Member]",
        "terseLabel": "2016 Employee Plan and 2015 Director Plan"
       }
      }
     },
     "localname": "EmployeeAndDirectorPlansMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_IntangibleAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible And Other Assets",
        "label": "Intangible And Other Assets",
        "terseLabel": "Intangible and other assets"
       }
      }
     },
     "localname": "IntangibleAndOtherAssets",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_InternetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disaggregate of revenue in internet sales.",
        "label": "Internet [Member]",
        "terseLabel": "Internet sales"
       }
      }
     },
     "localname": "InternetMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_MZHCILLCInvestorRelationsConsultingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MZHCI LLC Investor Relations Consulting Agreement",
        "label": "MZHCI LLC Investor Relations Consulting Agreement [Member]",
        "terseLabel": "MZHCI LLC Investor Relations Consulting Agreement"
       }
      }
     },
     "localname": "MZHCILLCInvestorRelationsConsultingAgreementMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_NetIncomePerCommonShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income Per Common Share, Basic And Diluted",
        "label": "Net Income Per Common Share, Basic And Diluted [Abstract]",
        "terseLabel": "Net income (loss) per common share:"
       }
      }
     },
     "localname": "NetIncomePerCommonShareBasicAndDilutedAbstract",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pets_NewOrderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disaggregate of revenue in new order sales.",
        "label": "New Order Customer [Member]",
        "terseLabel": "New order sales"
       }
      }
     },
     "localname": "NewOrderMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails",
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_NoncontrollingInterestOwnershipPercentagePurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents minority interest purchased.",
        "label": "Noncontrolling Interest Ownership Percentage Purchased",
        "terseLabel": "Minority interest purchased, percent"
       }
      }
     },
     "localname": "NoncontrollingInterestOwnershipPercentagePurchased",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to information regarding 2015 Outside Director Equity Compensation Restricted Stock Plan (\"2015 Director Plan\").",
        "label": "2015 Outside Director Equity Compensation Restricted Stock Plan (\"2015 Director Plan\") [Member]",
        "terseLabel": "2015 Director Plan"
       }
      }
     },
     "localname": "OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_PartnershipAgreementWithVetsterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents partnership agreement with Vestster.",
        "label": "Partnership Agreement with Vetster [Member]",
        "terseLabel": "Partnership Agreement with Vetster"
       }
      }
     },
     "localname": "PartnershipAgreementWithVetsterMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_PerformanceRestrictedStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents performance restricted stock.",
        "label": "Performance Restricted Stock [Member]",
        "terseLabel": "Performance Restricted Stock"
       }
      }
     },
     "localname": "PerformanceRestrictedStockMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_PetCareRxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PetCareRx",
        "label": "PetCareRx [Member]",
        "terseLabel": "PetCareRx"
       }
      }
     },
     "localname": "PetCareRxMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_QuarterlyDividendMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents quarterly dividend.",
        "label": "Quarterly Dividend [Member]",
        "terseLabel": "Quarterly Dividend"
       }
      }
     },
     "localname": "QuarterlyDividendMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_ReorderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disaggregate of revenue in reorder sales.",
        "label": "Reorder Customer [Member]",
        "terseLabel": "Reorder sales"
       }
      }
     },
     "localname": "ReorderMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails",
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_RestrictionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of restriction of forfeiture.",
        "label": "Restriction Period",
        "terseLabel": "Restriction period"
       }
      }
     },
     "localname": "RestrictionPeriod",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_RevenueFromContractWithCustomerPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenue from the specified category to the total revenue during the period.",
        "label": "Revenue From Contract With Customer Percentage",
        "terseLabel": "Revenues, percentage"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPercentage",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pets_RevenueFromContractWithCustomerVariance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of changes in revenue in current period comparing to the same period in the previous year.",
        "label": "Revenue From Contract With Customer Variance",
        "terseLabel": "Revenues, variance"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerVariance",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_RevenueFromContractWithCustomerVariancePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of changes in revenue in current period comparing to the same period in the previous year.",
        "label": "Revenue From Contract With Customer Variance Percentage",
        "terseLabel": "Revenues, variance, percentage"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerVariancePercentage",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pets_SharesIssuableUponVestingOfRestrictedStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Issuable Upon Vesting Of Restricted Stock",
        "label": "Shares Issuable Upon Vesting Of Restricted Stock [Member]",
        "terseLabel": "Shares Issuable Upon Vesting of Restricted Stock"
       }
      }
     },
     "localname": "SharesIssuableUponVestingOfRestrictedStockMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_TermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents term of agreement.",
        "label": "Term Of Agreement",
        "terseLabel": "Term of agreement"
       }
      }
     },
     "localname": "TermOfAgreement",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "represents the 2016 Employee Equity Compensation Restricted Stock Plan.",
        "label": "The 2016 Employee Equity Compensation Restricted Stock Plan [Member]",
        "terseLabel": "2016 Employee Plan"
       }
      }
     },
     "localname": "The2016EmployeeEquityCompensationRestrictedStockPlanMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the 2016 Employee Equity Compensation Restricted Stock Plan.",
        "label": "2016 Employee Equity Compensation Restricted Stock Plan [Member]",
        "terseLabel": "2016 Employee Equity Compensation Restricted Stock Plan"
       }
      }
     },
     "localname": "TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember",
     "nsuri": "http://www.1800petmeds.com/20221231",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefFinancialOfficerMember": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Financial Officer [Member]",
        "terseLabel": "Chief Financial Officer"
       }
      }
     },
     "localname": "ChiefFinancialOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r175",
      "r347",
      "r391",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails",
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r190",
      "r230",
      "r317",
      "r324",
      "r336",
      "r337",
      "r344",
      "r354",
      "r357",
      "r389",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r190",
      "r230",
      "r317",
      "r324",
      "r336",
      "r337",
      "r344",
      "r354",
      "r357",
      "r389",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r175",
      "r347",
      "r391",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails",
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r190",
      "r229",
      "r230",
      "r258",
      "r259",
      "r260",
      "r316",
      "r317",
      "r324",
      "r336",
      "r337",
      "r344",
      "r354",
      "r357",
      "r385",
      "r389",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r190",
      "r229",
      "r230",
      "r258",
      "r259",
      "r260",
      "r316",
      "r317",
      "r324",
      "r336",
      "r337",
      "r344",
      "r354",
      "r357",
      "r385",
      "r389",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r98",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r152",
      "r181",
      "r182",
      "r281",
      "r297",
      "r298",
      "r299",
      "r300",
      "r310",
      "r311",
      "r312",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r98",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r152",
      "r181",
      "r182",
      "r281",
      "r297",
      "r298",
      "r299",
      "r300",
      "r310",
      "r311",
      "r312",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r98",
      "r121",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r135",
      "r152",
      "r281",
      "r297",
      "r298",
      "r299",
      "r310",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r382",
      "r383",
      "r420",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r380",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r10",
      "r356"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r176",
      "r177"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less allowance for doubtful accounts of $40 and $39, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent": {
     "auth_ref": [
      "r65",
      "r82",
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes.",
        "label": "Accrual for Taxes Other than Income Taxes",
        "terseLabel": "State sales tax assessment accruals"
       }
      }
     },
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r5",
      "r356"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r267",
      "r268",
      "r269",
      "r371",
      "r372",
      "r373",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r63",
      "r64",
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r107",
      "r178",
      "r183"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r79",
      "r87",
      "r103",
      "r118",
      "r164",
      "r167",
      "r171",
      "r179",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r292",
      "r294",
      "r302",
      "r356",
      "r387",
      "r388",
      "r425"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r100",
      "r108",
      "r118",
      "r179",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r292",
      "r294",
      "r302",
      "r356",
      "r387",
      "r388",
      "r425"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r118",
      "r179",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r292",
      "r294",
      "r302",
      "r387",
      "r388",
      "r425"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total noncurrent assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Noncurrent assets:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r291",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r67",
      "r68",
      "r291",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r69",
      "r70",
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Aggregate consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r35",
      "r102",
      "r338"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.1800petmeds.com/role/FairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r29",
      "r35",
      "r40"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, at end of period",
        "periodStartLabel": "Cash and cash equivalents, at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r29",
      "r77"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r13",
      "r83",
      "r92"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r50",
      "r185",
      "r186",
      "r335",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares available for issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r371",
      "r372",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r4",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r4",
      "r356"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $.001 par value, 40,000 shares authorized; 21,077 and 20,979 shares issued and outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r351",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r351",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r200",
      "r201",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r21",
      "r318"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r33",
      "r66",
      "r279",
      "r284",
      "r285",
      "r370"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r272",
      "r273"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r33",
      "r48"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails",
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r226",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails",
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Summary of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r235",
      "r263",
      "r264",
      "r266",
      "r270",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Accounting for Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about distribution of earnings to shareholders including, but not limited to, cash, property or capital stock.",
        "label": "Dividends [Axis]",
        "terseLabel": "Dividends [Axis]"
       }
      }
     },
     "localname": "DividendsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r61",
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributions of earnings to shareholders including but not limited to cash, property or capital stock.",
        "label": "Dividends [Domain]",
        "terseLabel": "Dividends [Domain]"
       }
      }
     },
     "localname": "DividendsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r80",
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income (loss) per common share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r114",
      "r126",
      "r127",
      "r129",
      "r130",
      "r131",
      "r137",
      "r139",
      "r146",
      "r147",
      "r148",
      "r152",
      "r299",
      "r300",
      "r319",
      "r322",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r114",
      "r126",
      "r127",
      "r129",
      "r130",
      "r131",
      "r139",
      "r146",
      "r147",
      "r148",
      "r152",
      "r299",
      "r300",
      "r319",
      "r322",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate, percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Recognition period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r54",
      "r97",
      "r111",
      "r112",
      "r113",
      "r121",
      "r122",
      "r123",
      "r125",
      "r132",
      "r135",
      "r154",
      "r180",
      "r216",
      "r267",
      "r268",
      "r269",
      "r280",
      "r281",
      "r298",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r312",
      "r325",
      "r326",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r75",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r19",
      "r118",
      "r164",
      "r166",
      "r170",
      "r172",
      "r179",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r302",
      "r342",
      "r387"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r17",
      "r78",
      "r84",
      "r96",
      "r164",
      "r166",
      "r170",
      "r172",
      "r320",
      "r342"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r119",
      "r276",
      "r277",
      "r278",
      "r282",
      "r286",
      "r288",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r120",
      "r134",
      "r135",
      "r163",
      "r274",
      "r283",
      "r287",
      "r323"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r30",
      "r36"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r367"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the book value of finished goods inventory and work in process inventory.",
        "label": "Increase (Decrease) in Finished Goods and Work in Process Inventories",
        "negatedLabel": "Inventories - finished goods"
       }
      }
     },
     "localname": "IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "(Increase) decrease in operating assets and increase (decrease) in operating liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r143",
      "r144",
      "r148"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock",
        "terseLabel": "Common shares issuable upon conversion of preferred shares (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r148",
      "r234"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Common shares issuable upon vesting of restricted stock (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r365"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Inventories - finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r23",
      "r162"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income, net"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Minority interest purchased, amount"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r11",
      "r118",
      "r179",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r293",
      "r294",
      "r295",
      "r302",
      "r341",
      "r387",
      "r425",
      "r426"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r9",
      "r81",
      "r90",
      "r356",
      "r369",
      "r381",
      "r421"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r37",
      "r38",
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "terseLabel": "Dividends payable in accrued expenses"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r101",
      "r118",
      "r179",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r293",
      "r294",
      "r295",
      "r302",
      "r356",
      "r387",
      "r425",
      "r426"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Minority Interest Investment in Vetster"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r16",
      "r20",
      "r72",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r29",
      "r31",
      "r34"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r18",
      "r34",
      "r85",
      "r95",
      "r99",
      "r109",
      "r110",
      "r113",
      "r118",
      "r124",
      "r126",
      "r127",
      "r129",
      "r130",
      "r134",
      "r135",
      "r145",
      "r164",
      "r166",
      "r170",
      "r172",
      "r179",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r300",
      "r302",
      "r342",
      "r387"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails",
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Net income (loss) (numerator):"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r164",
      "r166",
      "r170",
      "r172",
      "r342"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r0",
      "r41",
      "r46",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "negatedTerseLabel": "Purchase of minority interest investment in Vetster"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "auth_ref": [
      "r3",
      "r55",
      "r56",
      "r368",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
        "label": "Preferred Stock, Liquidation Preference Per Share",
        "terseLabel": "Preferred stock, liquidation preference (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r3",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r3",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r3",
      "r356"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r339",
      "r343",
      "r384"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r49",
      "r91",
      "r321",
      "r356"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r115",
      "r184"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expense"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails",
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r6",
      "r61",
      "r89",
      "r329",
      "r334",
      "r356"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r97",
      "r121",
      "r122",
      "r123",
      "r125",
      "r132",
      "r135",
      "r180",
      "r267",
      "r268",
      "r269",
      "r280",
      "r281",
      "r298",
      "r325",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r160",
      "r161",
      "r165",
      "r168",
      "r169",
      "r173",
      "r174",
      "r175",
      "r225",
      "r226",
      "r318"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/RevenueRecognitionNarrativeDetails",
      "http://www.1800petmeds.com/role/RevenueRecognitionSummaryofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r231",
      "r233",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r51",
      "r52",
      "r53",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r104",
      "r105",
      "r106",
      "r155",
      "r200",
      "r201",
      "r202",
      "r204",
      "r208",
      "r213",
      "r215",
      "r344",
      "r364",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Changes in Shareholders' Equity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Grant release restriction period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Issued restricted shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r247",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Nonvested restricted shares issued and outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r15",
      "r54",
      "r97",
      "r111",
      "r112",
      "r113",
      "r121",
      "r122",
      "r123",
      "r125",
      "r132",
      "r135",
      "r154",
      "r180",
      "r216",
      "r267",
      "r268",
      "r269",
      "r280",
      "r281",
      "r298",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r312",
      "r325",
      "r326",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r54",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Restricted common shares issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccountingforStockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r3",
      "r4",
      "r54",
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Shares Issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r3",
      "r4",
      "r54",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "terseLabel": "Shares repurchased and retired (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r4",
      "r7",
      "r8",
      "r47",
      "r356",
      "r369",
      "r381",
      "r421"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquityScheduleofChangesinShareholdersEquityDetails",
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r62",
      "r117",
      "r201",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r216",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Changes in Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ChangesinShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r309",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r309",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r309",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r309",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r313",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r43",
      "r44",
      "r45",
      "r156",
      "r157",
      "r158",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r138",
      "r148"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Shares used in diluted computation (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Shares (denominator):"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r137",
      "r148"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding used in basic computation (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/NetIncomePerShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted average number of common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r358": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r359": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r361": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r362": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r363": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>49
<FILENAME>0001040130-23-000013-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001040130-23-000013-xbrl.zip
M4$L#!!0    ( $:+1U;+;-[6CQ ! #>##  1    <&5T<RTR,#(R,3(S,2YH
M=&WLO6E7&\FR+OS]_@J]G//>T[T6:><\T+VYBS;8F[Z6L$&V#WSQRA&$-7 D
M80.__D:6)!L$=F-3:*)Z;]N@H2HK(YZ()R(C(__\/Q>==NUS[ ]:O>Z_UL@S
MO%;[/YM__G\(_?=?^Z]KVSU_WHG=8>U%/]IA#+4OK>%)[4.(@T^UU.]U:A]Z
M_4^MSQ:AXCLO>F>7_=;QR;!&,653;_8WI/3.1*&1Q3PAK@.'GYQ'5F(2%'<4
M)[5^O&$8890:B2SW\#&)&3)*!$0H58H'XE-(ZV%#68*]M4XF@;F*Q&*:,)/2
M!6=P4,5M3X;P=/"$W<&_UDZ&P[.-Y\^_?/GR[ M[UNL?/R?&F.<7^3-KHP]M
MM 8]3HFZ\>$+UV\7'Z<8L^?C3WS]PL7W/DO@L]UVJQOS1$X^?@$O?/K^4/*[
MDX^>#]"QM6=?/YSLP!4?';\!MZ#TZW7AOJT?C;H[&-JNC]^&/42#Z&]\ WY_
M=MS[?&W4SX=]VQVD7K]CAZ >^:$$PAHQ,KG.K<>Y>=O\MK.#K[<=](>WGP=>
MO/DL@]9=,P07),__N_[ZP)_$CD733W06AS=E3#3&\&(GAL$SW^L4MR#TV]#S
M2,.W.UT?N'P^>O/:;-W]D#^:*HH1IJ"SDXN$.'6SR7S#&]^>?Z-MN\?_6HM=
M].Y@#?0WVK#Y9R<.;2U_%<7_.6]]_M?:BUYW"*A$S<LSF  _^NU?:\-X,7Q>
MJ//SS?_UO_[7G\/6L!TW\\R@R=/_^7STXI_/1Y=VO7"Y^6=H?:X-AI?M^*^U
MT!J<M>WE1K?7C3" UL5&_F#LCWYLA1"[Q8_P?@-,0[_E1_>_&.[']*^U%DM.
MF\@C9B3QY+ QUFGNA/2$:VGHQ^T\%,PQ0=\DTK6=?.O8VMCIPO@N7\#C]&U[
MMQOBQ?^-EVNU5H!+!_;^TFWW/K^F^Y\/6?T\G.Y\/GIE3O=.PTF]^=?IX8>7
MK4;GD-2WW[*CYLN3^O;?G?IVG38Z?W\Z//WTY6@[G+QFC?;A58\=-G>^'-*7
M)X>G1YU&<PLWZ+N+P^;6Y='IUE7C]*AU]&I7U%^]98?O-7Y-CRX//WC9^'!X
M4?^P>P'7[AQUZE>-5[NT<7K2/GIU2(^VWW<:V\=7C>U&^ZCYZ7-X];+E7KV3
M>]OP_H<=7/_PCM>OWF%X__3HPRX_:L*X/KQO[;W:O3KJ'(K&Z=;X.^_A7J)[
MU.SQO5?OVX?-MW _N&[S+89OM _A?O6K0Y*O<7C:Z!R=?J+UE_KR=7-G6#_
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MB8$H3#<\7MN>#>+&Y(<_0FMPUK:7&ZUN,<CB2W^,+S:V*AD54U:[F,;1V]\
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MM+\I9KURCZ6YQ]:M?!3#-*9(%0K)0?SJN$!:, &DU^'$P?DY3\$]BG7*'MP
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MK-B;#R9(5B:H,D%+9H(>N/90F:#',4'3V[&"I9B$@)0Q&'$B&-*$)H2]!LD
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M<>T=TBD)Y+VP">:5X 4&6J&FK9W;;SM;/!5+K+D+(!1%<Q]"<Z<\%2Q8Q:5
M +8&<2HE<C!PB%J#(R,ZUWA?VR335;@>17&?E8?B=QM 1=RPBHW$%\_$@WDF
M_LIQQ $\]8]>?[MWYH;IK+/E/73L<% 0YPZ(L_]JBBO(1(77EB'I,,MV2U[&
M93G*"U9M,KG6?5C;I&;NT$9Q0"ROQB[< 5$T=G$:.\D1L.>>BI"0]MPBCG4
MCI S99@V!N@9]PS8/8S6$FGLL_(S_ +DN!_M(/Z:=:3^5+6[5S-@!H,X'%2V
M6[LBFA-^&9_ZZ_5S.VWKVITYTF7N83N1A=]CD422J247CS$.YORIV/Z<%\,]
M,R[YP$ZHZU/36#FW1_JVVQT/R)N+\2A3U%V2.0^VI@K<.1R"$L$BX0C,4<P2
M9"4/>8A@) 471+FU34:GYZC;&[*%4#YI0GF# ^IVZEL"70O4[8G"'T(Y&[W
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M1"H<H6#'_?H1[A9K*?/^76!C*IP2M8U.:# F0MX/%29[!'@/GXP3E%$IC&:
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M)/>*6DLSZ>'S%QXLI*>0GI4E/7=)#%B JV>NQ(!":>X"B-.%E3$6.'"'L#.
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MY+F)N78=M2A(KY5((D7#UC8I9^L23^/[U!<U=MQ-8G2*W!(1<>0TE]O26,=
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M>?EK]<O6VW? I(E$V/RZ45T=ISSSW-FEJ:505EKLN!'4P7PBL0:BY+F)3/_
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M7.=.<>JES)><4\<%0A F/,Y])CA+/"%9F^49-NZ4%I6U3RSN8D+8Y?<+8/4
MC'50:])V:0BV4IA*.Y(1Z+J()XD;<!I$N$&\=$I1Y8"I:K:%U2]*>3,EF<\#
M/_( E@G8UVX")I$ )>HR#J@G1/0PE-Q1Q_7R^QB(&89!0C%4A:5K;!H+AG<U
MX54DGN/C520Q V+6<K#:;<6D5B65!=J-%QGXG6B/9&DV+^S+PMU=4^]1+Y"A
M$W PE#GU21P[TF4LHCR)O9@ZZ0(OW%CO["&*)Z39#RGL2UD6.ZS^OE^"ZQ1S
MX@('^;83I[AC[\5V3*AC@]Z+ YEP^#^"!:^NU'M8WB7!O.0591.6C:=KCE0]
M9'VQ\!G4%_.?JK[8>Y:5?Z-),2TTMCG5P\:ME)S\.'+?C;_N']"/QWL_3L[^
M(B?'?V0GEU_/#H\/R-'^*3GZY^3RX_$**3E[!WW^\?WP[-0_W(=Q[O_=.^S_
M<7;4/_QQ>/;%^;C_A4 K_J%*I3[ *&$0!Q&+ #)B#W"6LB2T&7.Y[;@!I;'D
ME'MTL0:7YT0)7@/O^]2A41HDJ62IYZ2>3]T41&RQ>A@NNZ76_0X%PF[L;$N]
MRMD$:<Y*58"$LZJGS!'U08(?"0:P"EV"U3M3?V02]\19Z")LU\0;W\^\B)9O
MJLQ>#-1B$#>K]?E2]-N'( ]2EWE3'J8JH*D+J^B"BWH[1H(?JG9G*IGGJO9B
MA3%4L+4Q4*IV@$I8F50=ML@SEF0Y.L1X/ 5KMP"*@C>M'FG4;'L I+'ZAPPO
M5,B&>-I('5:M1KS7F5L C#+KIYO0=%\R%&>55Z\&7/7:$:_R,6#$H[X.)^G'
M5W3=S'E4J07'15(G?V>F.S.[[DR1M<AU-K3(VE02K</I@E4;46@-[!MP([.J
MA\>*F@/4=08\-$/W'OS-2MZ;;!<"50HL"XM!"^46#H8CH-RHFL;Q\4V-)WU9
M]PH!\SI%8<L&#=.HJH:3/E[=(V+U1%#R'WDN<XM8MO4QP4")\L:;E5#,7<HT
MQR,H_QT5"!!*WBOKY6C0GKCZ53OOB(EXDXGF\ I9O&7P9L68#D)I::FNCNYM
MV-JXL#8'>G]'NP5SRX.'V(1*OL$S8OC;]*_9!9V)3 QSQA?KQF[N]#V8_I=!
ML<0<6H9P^M5H."S*6GM(0.X:'H*50+=8 Z,B/.+<,PCH'L]7\YJ B@5N60'"
M GI7'^:U4!Y <]6X##^R/O2A>&"D#W\M+RCJ;MRX7'QRM'+QY6H$NB;U:SY1
M%QV4K-D+:7CS#-%0'5[+ZC6SPKPPY5X0$<?AE!(21UBS6[@1\?S4C]/;9H6]
M!=-E;R#P/^^F!LQ>_19LG#%,5&F?+<G7>723_!WFQT8^]4/"J$V=(,4ZW9AJ
M3E([X(X ?S3%:F>8X>5>E[!SM2F9-.8AZK]B(,>MA*?@W\Y" L]!"^BH2;/7
MWNB9!W1GE?F^[>YL\%3NK Y<*0L.)4[1X%0...CJJ8.[(?ZM<SB) AU>'.$U
M<9<"A.'W_L?]ORX_[A_X)\=?\\/]H_SH[/?LR'U_=G+Y1[XH3">7>^[A_A?O
MR#UP#C^<T*/]0WIXEO>.^E\N#MTO[N&' ^_DGZ.SP[[:!+D\NOCFN"SFW$MM
M<!^E#2OKV[%DKAW20 KI@H0Y[J)_ZS+'\QS/A]]]FKA)S/U \MB1<>+*E(I%
M_W:&#KK\W"PE[N#RWMS_@C\N*0]BQ_6H!*<]B1@-HS1, ^8*#Q CO-Y%OD*Z
MKM;<CR-PRP5UW'_I80@LCZV6ZY4*R>%3:.F<@N%ZR&IUB!')\*D8U9BH\V=9
M<"EQCM4S,5ZF!@#XQA*--9V;E;-LT!JUD^AEFN5MK?!S!N[2"-[!G*BJV>JR
MACT&NIB/K:3 '+S6T!VRJE9[Q:@+<&M9[7>AXURB_JA ;PBI^](FM6Y5EV,8
M%#6>=)?@8ZMX /L.-B:813GNMW#M=[-3&&Y5SQ?G:0JVJEW>^6K;RCB#^4E4
M4]#F>79:E# ;L-*%3*5*+:LPK""4Z5KIM$.EW:IKYJ%G,#N&MIY$->(PS2H=
MY=K_!ZSG*C9R73^:#3$CMEI,B65)H5RGAD/+25J;"L9D SY2]V=TWZM*8< S
MZD7X[[S5UV=C'!T8?D5^KMU<Y/:9,@,BJ\#";,K1Y&I PZD,J/LT+E3D!J-!
MP)"8BPO:/NM735I<*6'<&"]!Q^]4(U/C*675Q!,J2F@/2R7P8E1J.Q=7)AE5
MP+257G/X>J9K-?8FSPZK_\K3YFXE/1E<V_9M> WYA..Y\&R0HHDLVZ()R 0Y
M.K0C/;.A+.MQ9[;""=!%\V2SVIJ31CFLIJJ$-JI5&B"TA2NZN$087BI2W& :
M#9H#Z6U&WCT8:%5/.@]Q-$C9.4 :.@?-T'"3?7+#";,&:J7@8P8]Z'M-8,UQ
MPQOFI'8><!&:Q<0FTTGM4RQYK/(8N^ !7W,S /4=&^-6+S8K8O6?HJH6%>K3
M!:M>_+I\5!(A<R',B6(PI4 US4!-]0G-:@H#R@N$UW&:P';?!\6%JF\-9,.B
MW*4*UQ2)XHTV9[6)RS:\",):%0-5[AIKQB"#BWGD+.5Y)B^J)HF"U2/%,:J"
M3@4:#FQ\CD5.])#T]VQZX4>3-('QXFE&+(BD<N"4S=(.6R?NHK[4?:E)F?*
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MKWT'^AI]=;\$)^[?V=&^^/YQ_Y0<7N;?C_:_9H?'^?>3RX.+DTOX[5CD1_^
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MS/<"V:3VW(C&)N/Z?F=5C_?J23G2L[V+H_WOWU+'\0G\G^UXA-DTBD([$8&
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MOM'@1=O,-6J_,3UL=%N4DI_3^O:CJ/UP=2I 44LK>J6E</G?1MR.1GUHGC^
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MJ>N"16<[:8J.9$3MQ.>I[8?2C5.9>&Y"7KSQ5]AU_1:SLQ:SIT#=ALN8RNI
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MN;KZ+K+9 .\O7CSWS@/GEST1G_ZM(D/-)D<;RWD.&\8'T[C4?'Q=@FK(AA,
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M&L$"4&YPJER;COH3D6\19CJ*X!=%J>S2!E8,J3>*U"" ((R\B9UJ^U][ ]/
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M'1QJ-0*I P:#%<B*LIE8H6E58&92GEM86+OHCV>7&R43^NZ!X,.W::YK;N?
M"GG53  ?FW10 ?/BB\!LO0SDHU]4-0HNFU#CRR!#R55;QI4F"&B#$;*1>AC7
M <8RX0P\!51FO"6' H4IN[3RJDF2:88 N5"JO@()E\! '7P'N"FKK!'P:UG#
M<@$*E/*4E6J6"G?8*8QL)+1,@_Q-RHOCKWIIH,,9L9[PCWYDB9?U&JNN 96D
M$AW.!BA]PQ(AK%[]'E(=6O]1X\I#XWJ96V(E9<% G[3$PO52*Z*L/5A,^'L
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M 9!P3!3#V;5:9'/%GTKZ*RE1 Z#EA*0'&07RZ>NID48E".G49%)\5@'Q2N#
MAL4J"UX"H9]'O*R:2M1[(,G_W]Z3-J>-;/M75*Y)O60**XC%&.?>J7)LG%#C
M)6/PG7F?;@D01A,A\;389G[].TMWJR4D#,2),<Y4C6.#U.H^^R[G 62>YU1H
M-^).>% 1@2%M2=SH0"W-N_TH:#=J;Q">*INE&'L: %A .B*#9H5;L0E8,9*9
M,0Z#*?Q5LF1D3TF@N<&(H3YW;-;H\M9Z.W=KY/Q?@B+&]@"P0@R @1R$J3
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M!$:E&\4A&>#2)8UV(1F^RC&7A3%J.4>N?FC6BBV$:IH1?P(+H:6%#=8/8ZC
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M(@/FQ+B\I+J0D[L9/F1:7;S=>7"YBKMP'<%_'.MR8A5W=$)2<DHJAG=8"R/
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M;<\9+\(FF#V32*U;IO6K(AIQZJ<Z4+',?+3\:#S^;@=>-C;J7W:A+'(>)N[
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M S^-U1]KK'YW+^\QGT7\' 2C.?PSB:?>;_\/4$L#!!0    ( $:+1U;:%L9
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M$?PT'^42WHI(-?\[Q]SE++"$=7W"V02X)""RR=( C#GXG9I.F4Z:-/X(\/!
M]205R36P& GZ=5VI0' WMR35U61T:D(1$$#LFWTV?,*AK.%*1:BD;8C^O[??
MQ4%9^Y6*&P5_#_,]\,N:KU0()5M8K[4'ZCTB7J?696JE5T/ZV=?'VXTSNVDU
MED\!4\AY7RX:YK\F<N;K0@<9K4_U9=DEE$B ]T OS.?EX$Z4$Y$-BDM145AO
MT9TKU9*'J?\V>I5Z0)6R^B!80#R]+K["@9XU^V-0U)=RN17,RD=+D=!7WH09
M(0DFRH*B!!7%L#\)R_BXA[DR;PR2J Z_*7N+R%8JV]M0B3XNM/+/JE,[<Z!@
M_JTJ;D/8E=(5B%8J#XM1.8=&S$<Q^$\"Y^[N8C&^"=C+SDEU-:B5QJ-M:-3X
MR#10(2K[41AB_LK\/AE1XJM41.6EZ[*(2D)'/>4J5ZV82M!8$-!*X;%>KQ#A
M!DQ$'#2?,;!F*@.-YM@H!:\0?8_P##12ZTR7C6+0$E2M4+;2<K),2P*",B@5
M\O\]R#C[]X#WQVI"+^'^O*[5^Z?+WE<8R?2#% HR,!5R_WSP^XSW)7.?KK"9
M0<*)2O>XY'@H@F:EZ&R9HDR"4K#(X#H&&&61*\3:#2;\&PZB,H-EKF-CH-E8
M9D#K(J-<(2>KV J)-(L;3/6:2D<@T)*S^284*Q'-92(R:$C!H06\*G$SQLIJ
M0:C)UV,6>,#%YQ\1D:]EN-F 8N6FE>,F1D.$HBS>+RA&K! [\7PZP--2(R6K
M9?5^>]G[R1QNU"ODZB^$,JZBZY9*4(:H]="S^E<G"$*_@12RU$YH$30K-8?+
MU*2H*(5%<UP]6A+D"K'6CX8"?D3*@,_/.I>7J@Z75*U\'.7KP!0"Q1B5\GR1
MXOK=JO;"U7MSA^H=?4P_56E/-%^+#_ P*,7A6@@K6T6*>O0Q1JL2*;D*O30G
MZQ"LE!2J]*O(R895;VEV[%A6GG+EOF4=747*\HEI-MTHU^'1B,/(=)'YB>@U
M2$R"W9)?T39L%+=R^PFKLN/"#+?8HGZ2JGQ,6JTV_?>8<]6IYS?A.0=F)32W
M+[&:T!EP)5G+S5SZ9[A>% #S/V-.U8I-I&_*L[@%N)75W([&RAE3C=.D*3TL
MT\:R4^I/KCGL,$#M6%8F<[LC:YBL]@ M<%I1GKT2H%8:<SLI!4]"*LGF['RC
M/&<Y52LSN3V5^0E))9V_X92C/!T%P*P$Y;9/-IZ<5).S];7;?#&Q06@+8M^H
M12O[N>T86TVYN*BQ5J _HR5+RPYKG3*H5M9S.SYVUJN] ,J<N)6G;H6RE:'<
M7D_VU*Z2%!0X<2M/30E0&V7MW-Y-P=.\2K*Y?#A7GKIU"%:><ELRN5.^OSLC
MG^J+=P+C[POW!O6MP>1>L.%+7UCZ0Z\$L2N[H./Y"X1#?62.AT)R];13DUS_
MS$I?=C0_V\Z+4A($>D<Z%37WG\\GP GS!N;.DA?QY)=T0I$BB8STM]\XBR:=
M6BQ.)(0U%%]QFEV(/O=8B F]5>\TT/PV9,Z&_T28JRX%K]?DF7A O;P=/@[$
MS)"U\OM@C*IR5=O>YZDN:$%<4N]!CH%W(ZZO>]P1/"0!D>9X=HUY)1#L!L=7
M@V7Z:AA?0NG47 X>D07=$#\)&55#D+\6<,+@A0W&+-(54)],)0#]'$X"]@H0
M+UZR]?ZC2K^<N.;7_LQ]ZJD.;H[C-P+?AV"YAY<'[MD&[K+4/O3\RW__W;V]
MN^O&TR?CCQ G2Z%O6$2!KDXO1QR,UF;KMD':!P\,@(</_JQK:X=S3N[-.Q\_
M294*=#T=+RJU7!,.KO*Z'AEB,U$VK7T@)<F=?7@&KA-=EPEIS;3+TON:57L@
MNZH0?)QNYBDGM@_$J/6V*F>)ZD4ZGUT* 1NX6:^P/3T>#-^/G4=@]E2^)+0/
MS/348HH"%V,RF26I[T2.DU+($FO%E/?!SN24]X:S4*^$M2VZI]U(33HA\&^8
M$QTE/>"NKAA&L#8TMT!Z1P=,XF;>S@.[VEW.VC\U@YJJ7TEO#NIEJ?V(WG@A
MJV![IN$-+.4D__H5QSVCK@X9%JC:=Y1NOCR\)+EC/E1Z$7?'^DQPK7W;0)68
M,MYM]#U$4JAJ-5TZ%:I56HWF47:MM3ENW[*%?8CYP1A4]X[?LG3< 7$?/'*I
M_SY-VGN[N6O%]\&6["]%]/DFBX]1KK @KBDQ@DC1<)D8MKXV+H?R3JE01XU*
M1CO/P;NO/O9NU:&I$ ]^+[,3>TDS?^5!SU/JD_LZ@*F\"M2H6VOZ-E#OZ .9
MME+ "R8JQ:T0D>[,UPFCWU2J43'SX"_EG,U#NCS./HQU%90^XZ%>XI6RUJ[W
MIUIG-N7C/PAX\>%_4$L#!!0    ( $:+1U:V*YOE9A   *N,   5    <&5T
M<RTR,#(R,3(S,5]C86PN>&ULY5U9<QLYDG[O7Z'5OBXLW(>CW1/R->$(3]MA
M=V_/&P-'PJIHBJ6I*LK6O]\$*=JZ19$HF?:&'119+%;E\2'Q)9! _?J/+\?3
MO5/H^J:=/=MG3^C^'LQBFYK9IV?[?_[QFMC]?_SVRR^__A<A_W[^X>W>RS;.
MCV$V[+WHP ^0]CXWP]'>7PGZO_=RUQ[O_=5V?S>GGI#?%C]ZT9Z<=<VGHV&/
M4RZN?ML]U3H&!\H23V4FTB:)[T(D7E.6C R<9O,_GYXZP03G3A,O(YZFJ2#.
MJ$08Y\;(Q&).>7'1:3/[^VEY";Z'/51NUB\^/ML_&H:3IP<'GS]_?O(E=-,G
M;??I@%,J#E9G[Y^?_N7:^9_%XFSFG#M8?/OUU+ZYZ42\+#OX][_>?HQ'<.Q)
M,^L'/XOE!GWSM%\<?-M&/RQL?J]<>[>>43Z1U6FD'$*#$,&>?.G3_F^_[.TM
MS=&U4_@ >:_\_?/#FTNW9);2$QB.(?5/8GM\4,XY>-'.$LQZ2/BF;Z=-*IY^
M[J=%B8]' $./JBPN/9R=P+/]OCD^F<+JV%$'^=D^7K1'D3AG?"G0?Z]QU8-O
M0D<_C?/IPD9O\?/YM8MX]>6'+P/@+Y8V6PDP;>.EDZ;%8VVW^N74!Y@NCD[F
M/?GD_<GD;>-#,VV&!OK#6?HXM/'OHW::L'&]^L^\&<XFW%(.43$B/&)71A6(
M$_C.> T2J =OPF4K%DU[5'7A]^S[L'#^^0T/BGD/8#KTJR,+@R^,O:Y,2Y-7
MT7GB=$@@DL!&BJU14@W$"D =-9/>. 9"B?'4NZS)!?@<=G&O[5!EC&_[>Y^A
M1*/S4+>4Q7?Q&JXN-[3S,P[Z^?'QXIJD&>!X]?L2]T9$PM#6,?G2I:C*MCZ_
M01\J71",2T*MLT0RGHASX E8%93F(D-RE5U_'Y9O1@#_&1"PI0.J >%%>WS<
M#(4.%"4QV Y(&Y ^%&0*PQ3^X\1PYU$_YTBPRA AHE'">R>=J8R(.\19!QKB
M9X!&+9=4P\AAWV-_^WL[B_.N0[$FR/>0M4$F2GE)9%)(Y3@B54F1LDPR4E$;
M&%=EV%:G]UU[ MUP]AX9Q8!F+GX[*3;_'8:)8-+Z$#2)0J+W@J?(:'TD+@5A
MN(\\Z5Q9O[ODV:5N<2LL7$5Z-2=L#?5"=2=O9LCQ/S5A"BC+N^$(NJ6VDZ0"
MBSX!2=ZC*"HK$I+ ]F=#--E1A>WP/NI\YQUVJ=NKXN%Z]JP6Q2YRKHAH\A)S
M+821)E)$28(6BFA4-1EJ%67^L6CNPS5Y"1G0->D-9OG'\(?_<N':I>5P&I*#
MD$C"1D*DMZ@G@$ BH94W/,4H:I/X>T3:I0BV*0ZN!J^:7A@#Y"_.FZ\&S;F3
M0()$MB %3<32+(GFD$+VB0&MW9E=EV*7 EPM &QIZ\KT;"6"Q/"I7=$C 8K
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M^F/5O-RB3ZVR%QC*#1!8IPU>[?G9GWW9@60Y]UQ@$)$8+XLO(3J6D1H3X7W
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M3-'+5;HXGQE7<V>Q5RXRFYD1DN7J)S%70SE8PO3.*KZ',]N(NH^3N;=AS=.
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M](B(4,$R.,2GQ'KQGZ6&]V\)5)9[4TEHFY[(GO^X?"FWE/STW?\#4$L#!!0
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MCSP_:[D<%Z7KU/8*1^/#]B9S(^Y4H^TDW/V TYQ.E6?>0<:5W48?PS2(?$*
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M9P-'IXN?50-79YMZHY.]BQ7?U:!X(]A2_<,7,HC\)*("*"-2,59,8I P3H%
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M"8]#JYP=/7W-T 9H1"T32["VL';SMP]AL_GL"+>1Y_<Q9*^-(+.>\ 9@."*
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MK]1.2UG6ZP?QC?SX0C:B<J+?JFUSG=)>=;N(&?81APS@%(< *=,6)$1$@+.
M<#],(VP7N&;>]=P6H)WDBD6TZ-Z&_/"4K.)&AZUI9T2[Y<=B$,P6D'&@'?NF
M>8=J);6GQ/:TW&5>E17+EEDI\XTF[EZ0K9G;'B]'W&O1\:3L:0_(,?\-:&%
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M:&\(:'84=PF,7K([^_)TM'=)_@,"O/CP "J\92S?"OY5+48Y4?)JYZAB(?S
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M^)?1)PC[2GCWNEU5:KM]7Q?YJJ>VE:-6LF[TN:X>#(RM5IN-,O9@25(JJ92
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M! <1^W$%E\?#G)"VS<MM)6^E[95BO\=MSDW7@@$R0A@WVH!CV\!"(09(2@E
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MV^U/R8NQ1D0M1W-.ZNC0AJR#@ZDW';LSN+!MM-M 3QKLS<'D35+#3PS^I!7
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M)DMXD'0U;<)GK% SK*HSN>V-P/>OQNCX8MQE]JRV[Y]85:GGMI>8R#*-J>!
MRQ0#S,P/+G@!-):*,&YL-4[\##*7:9=GFC6HF\NK'6YC8%CD20O=LW>;YT*X
MFFFQZ9W<8(O";(#UYD-4-#O.:=*9+3H?(DYM.Z]W^[>"^&0^.W?Z'^P_ZTTW
M?KLAI,HXR@4&HD"%,>,$!!QR C*)4J@$*@1W.GL8G&5QBJA%%] G\C*3PZHE
M&C]3:Q)G:KRZ/5P5?42OA\MCS];IX:IX_3X/UQ\.N"[\\*1@FA6_?'EY7G]3
MJJFCV;^+_/N^FG#M0]I,TJXD3*E%:<L,2(HR@(G9_3RCQCB1&=&ISC&E3J6;
M1^)8FI*P8B2=''4.M<<UUA'+,:Q'9B1Y8DUCA$@..6[K&!]407Z3I E'U0L1
M4EIFQ(IX7#*>9V5FNG"\>2M"LPM?K%C%:<93.W@K><3P\]U0'L_!P6WE",,%
M1AR; Y(']K?:/I*"942J J2*2H#+7 ."- 20E*Q4F#&LO!*/^X,O[4NE.PQL
MZU/L+$;/H%^?.L=@7B A4P?I6BX>!DGP#[N=D396.*T_]+QALC-"G82_SCUS
M:7_V^?[-O/KYA^XOYH<MOO3S#_\'4$L#!!0    ( $:+1U8+EJ>(N3\  %FL
M @ 5    <&5T<RTR,#(R,3(S,5]P<F4N>&UL[;U9<UM)DB;ZWK\B;][7&Y6Q
M+V5=/<:4E#6R44EL254U,R^P6#Q(=(& &HM2ZE]_/0X(K@"))0Y/J*S-,B6*
M!,_Q</_"M_!P_]?_\>UJ\M-7F"_&L^F??F9_H#__!-,X2^/IQ9]^_NOGWXC]
M^7_\V[_\R[_^/X3\[U\_OOOI]2RNKF"Z_.G5'/P2TD^_CY>7/_T]P>(?/^7Y
M[.JGO\_F_QA_]83\6_=+KV9?OL_'%Y?+GSCEXN%/YW_4.@8'RA)/92;2)HE?
MA4B\IBP9&3C-YO^[^*,33'#N-/$RXL<T%<09E0CCW!B96,PI=P^=C*?_^&/Y
M(_@%_(2+FRZZ?_[IY\OE\LL??_GE]]]__\.W,)_\83:_^(53*G[9?/KGZX]_
M>_3YWT7W:>:<^Z7[Z<U'%^-M'\3'LE_^]U_>?8J7<.7)>+I8^FDL+UB,_[CH
MOOEN%OVRX_FS=/VT\Q/E7V3S,5*^A0PA@OWAVR+]_&__\M-/:W;,9Q/X"/FG
M\O=?/[Z]]TIF*?T"RRM(BS_$V=4OY3._O)HA(I#:[K>7W[_ GWY>C*^^3&#S
MO<LYY#_]C+^WP+=RSOCZG?_O^A=_N7WUESDL$"W=4M_A-ZY_O[SE*#+@VQ*F
M"=:KV[QD,HOW/C0IO)W=_.;$!YATWQTE&(^ZIYZ%Q7+NXW*4DZ=),D02$XQ(
M:@*QFB&ZO,]@(4KGU/U5%ZH72'8GB@7$/US,OOZ"#_ZE<*)\T;&D8\>CUZU9
M<QS=FYWW&3\[BMH8;1DC/DE)I%&96!D,"2XR*WE(D/-)9-]]VWVJ[XKT;!Y_
MFLT3S%%U;%[GY_&1>._#]OH3OWSQ<WP0B9?C2=K\=M$A-62UG%7@W%HL2.[/
M/^&J,\SGD-ZMI;)S<=W*EJA0H?MD#8G_^\K/\8F3[Q_ARVR^'%E@SC!NB=(9
MEY"2(XXE2T3P/!E#4^"^BO ?O'@O'/#V<7 */QN!Q#G,Q[/T9II>HQ$>91,U
MLPCB[)DC,AI#O-,>T4VEB]IQ+D]38EM?NQ<<1/MP.)Z7C8#A\]Q/%^/"^&M
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MG/"LQ-:!P5&TWMD<_-J3YEZJB/ZS"0*=)(S B0-< 01%H^.6"WT:'.Z^;3\
M-)SB/)IU XN\G(Y.SB]GTTT&AG(6&6"@+3)J,!EI.;]1DBB6J'+,R"S926)_
M^,;]1-]P*O,D%@XL_D\05W.$+N/A\W@Y@9&/$D!33V)&LB4'9 )SZ/=@5.VE
MDYX[<9+X'[YQ/_$WG,,\B84#B__SW)?ZDT_?K\)L@M&/HCR;XL'H1&1 C>4S
M!6*S2"9)]'5%/$GV]UZWG^ ;3EL>S[Q&-OV;;_'23R^@R[?:C-9)B43 ZA+F
M&$>\ D6B80 I0G#ZM 3EMK?NAX&&4Y(GL[*)<.#5:E[8M3Z!*Y!&&:P6(\N=
MM-PD0L&48UF0Q$7#B9.))I&\C++&8<;VM^\'C>93D!58VP1$WD[Q:<B.\5=X
M[9?^>EDC(\ $;=#5X5P@U'51>%R5&A^(3E-MO*D D>UOWP\BS2<B*["V"8B4
M8]SY*[^$B]G\^\A(YB-D02A3$7V?DE[/)I+@K1?>@13AM+JY+2_=KVRJ^1SD
M\8QL @>?KOQD\NMJ,9["8C&27$-4V1#G:$!-YY$+.@/ABEG4@$KX$RMDMKQT
M/QPTGVT\GI%-X.#-%<POT.3]>3[[?7GY:G;UQ4^_CW+.VFI)2:8>X:R51N>(
M9R*HSM)PD95)%?"P]>7[X:+Y-./IC&T"'Y\N83+94.^-=?B60,"@C9,RH4-$
MO2;1 U T> P-7@TU<>>=^Z&AX9SCB6QL @1(^%4IXYC%?WRZ1+XM/JR6Y0Y'
MB:SQ8SDPR0()QF8B<T@D,,L1W,$$](\RSZ<E))ZG83^0-)R=K,SF-D"#G)O[
MR=MI@F__"[Z/) /-=4#4RU)6KC*Z2,(YC*; 9<U54N&TI.76U^X'C88SEZ<S
M<^CSJG6H]-MX$?WD_X"?;TK+?1 V<>2#8TZCKX2ZT M5CO"M5I09_,9I3N>N
M-^^'B8:3FE58VDBU_NTB?L/O+$8^26<Q8D*7*";4<XQC,&TM"9$J(XWP*;N3
M4+'CQ?N!HN$L9PV&-H6)]464]2*23#XR&@GG%*U?L@DC+)8)MSX&FDVV)R:^
M=[YZ/UPTG.*LP]2!D7&&*TC=*B;^8J2#BT$;1417/RP4)0$40\X4#9>49NRT
MX^][K]L/ 0UG,(]G7C6I_^LOCYCW#K]QTJ5L](6F"TCXQ6(V&:=R_?Y7/RDW
MRS':@N7B_B+VO;'][%/K7><^; $GWO5>+<B%]U]&75E< <.'_-MXBB\;HU*8
MK6]WW2!-Q&R-1/<R!RG*_2Y&O+2T6 ]*,?2PE#^5%\Y^$3I 7+]TO<M@LEQL
MOG.[W0ZAZU@-LGG'V6*!;+U9)4;;N \$QE"<XQ\^. RN:"DIEM*ZB#%Y?"IR
M/6:5]RD8YB9Y;TC8Z)P*[![0W-RG_MK5OM7!6DI%G2=!>5Q$+&>"2002!:-,
M@-51/>6>'H^9!X0,"YU3)+L5)*>PN0&LO/*+R[-I*G^]^<_5^*N?X&(69\M7
M?C[_/IY>_,U/5C "J;B.Z'K+TJL%@W9*O-&<<$93DAJL8+6QLQ=A+6#I) #,
M^I9& Q [B['<H%M\A BXI#"!][#<'$.7,@6:<R0YB\Z3I\06]Y#9:*GB1C%X
M*CPZ2BL]0<\PG3'Z U0UWC> H[?3KTCU;/X=;?YX<0GIS[-96HPX=1(M/274
M)XP*J$(5[GTYN+2,1R%<K.X+;:=DF#8:_6&G K\;0,WY'+[X<7KS[4L)65"Y
M?EA>8F1ZEULC[AFS@.&I ?02)0A+7.">Z)"3]BP$L$]%Y<= : ^RANG!T1^>
M:DNB'7!]]M]@,;+)LLRS)RF+TI!*)Q)<SB7T$#H)Z91^ZICH!!1U[Q^F64?O
M<#F<MPW@XCZH XC2:@3M+ 6,/YG0Q/JLB-*:)F=TH/2IJTXG1U[#-/#HT:DY
MFKO'0V.V]).*T'@_F\:''*$\F:@ST9Y&5'U>D!"L((HK4RYX))MKJX]=M+3@
M!5<,T4]D=@/ZY'P^^P+SY??SB<=%3%,)#K^4!!AZ\R,?,@3@B2#@==?>C#@=
M<%4RV)2,,1YL=;NSFYX68O)3)?[(%%5B_X!0*B<&Z-(O_?1BC&'@??=K1&/,
MO)R\*Q%+RQ*&FRP%3IS"I07!O5</;N\_/H%X\@TMJ)1*J*C'R08TRT/.C+)E
M@>MD$+]H2650D7@7)<DR1)&U$4;7/D!Y2$,+@71E#7(2FYOQ6D8\%D\M8;"?
M<B$]%*]->V(<<P&]+JN>O+)U/#A:@$1%C^0@1C8@_G=C'\:3\7(,"U1W79WG
MY6R"3%\44[C\?L,:PQ2'+(LQ9*C].*XPE-LD5O%H0$LJ<FU?9%_:AK5 O1]9
M]B*B!@S4G74]C"%-#D%BA$?0YN+NTYH3W#F<T"#0%P-!PY/=DD\$6U/'FOU(
M?S?$3A%% Z#:'(N<^^_E3&232@"NO99,(ME!E.L-E#A/,\(@!&V# &&?NCQT
MRF'4?4J: =-)<MYQ%G4"TX>.GW )\Q5L4MB+C>M_O90[?!M)S4W0CA+.RR5]
M"KY,)[ DB&2UD,RBI[!70+7W*X>U;Y4QTR.W&U _CYDU,C&SQ*DEAI4;^]&C
M0QA00U,!2F!T8)BKG2-^3,6P7G9/:N=$9C?@?;^^?FUI37P%G_VW.TLJ&2B5
M<L+?8L12AX&ITP:7HP0QQJ+NC,%"J(V=9TAJ1A?UYPS5%$I;*FGDC:..!DJB
M-FB1M15(NDV$26.IIDI%_]1EV1-U43-*Z$4<Z8.8W8 N*C<]Q\NKKBQM6@K
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MB=DX%873ZF&Z>H>L[S]WF#/^GH1] LL:.'/=YCY]\A-8E*3&%":=^N,& \5
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M\BZ%<GO$J:T*61M-:,IERE7.)&2126(VF:"<@5![EL3^U#73J;2N-]V/=!K
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M,&)*41X$)TY0-*:,>^) HD55F9=N-LSDVD'\G=</6WM9%SRG<K?A_.&G55C
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M!FS*9\ TS"3,D9GM5!J\2I6V3"7L4NF8!?7*/]A8:6P$]GO&->X4!KB:@EU
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M08Y4;:@4X%]2Y\7.A-\SB5-PNS!+0G>X\>:O![IO*1&Z$0H^7"N)"*3':GI
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M*%E.].:P\PGA:O6;9>]>B9 8U_]*[8I\XJO#]EI_ #&?8H[_ 5!+ 0(4 Q0
M   ( $:+1U;+;-[6CQ ! #>##  1              "  0    !P971S+3(P
M,C(Q,C,Q+FAT;5!+ 0(4 Q0    ( $:+1U;:%L9 $PD  )=5   1
M      "  ;X0 0!P971S+3(P,C(Q,C,Q+GAS9%!+ 0(4 Q0    ( $:+1U:V
M*YOE9A   *N,   5              "  0 : 0!P971S+3(P,C(Q,C,Q7V-A
M;"YX;6Q02P$"% ,4    " !&BT=6)3>!&Q0;   <% $ %0
M@ &9*@$ <&5T<RTR,#(R,3(S,5]D968N>&UL4$L! A0#%     @ 1HM'5AV*
MQ0DP;   Y%<$ !4              ( !X$4! '!E=',M,C R,C$R,S%?;&%B
M+GAM;%!+ 0(4 Q0    ( $:+1U8+EJ>(N3\  %FL @ 5              "
M 4.R 0!P971S+3(P,C(Q,C,Q7W!R92YX;6Q02P$"% ,4    " !&BT=6A#!3
MT5D(   7*@  &               @ $O\@$ <&5T<RTR,#(R,3(S,7AE>'@S
M,3$N:'1M4$L! A0#%     @ 1HM'5F4$5^=&"   #RH  !@
M ( !OOH! '!E=',M,C R,C$R,S%X97AX,S$R+FAT;5!+ 0(4 Q0    ( $:+
M1U9"7H'*V 0  .49   8              "  3H# @!P971S+3(P,C(Q,C,Q
A>&5X>#,R,2YH=&U02P4&      D "0!< @  2 @"

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
